¾¦ÉÊ°ìÍ÷
|
Ë¡Îá | ¥Ö¥é¥ó¥É | ¥«¥¿¥í¥°ÈÖ¹æ | ¾¦ÉÊ̾ | ¥µ¥¤¥º | ²Á³Ê | Êݸ²¹ÅÙ | £Ã£Á£Ó | | | |
|
¡¡ |
BML |
BML-2800-0100 |
Bioactive lipid library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Bioactive Lipid Library contains 195 bioactive lipids in a 96 well format. Ideal for screening or identifiying recombinant orphan G protein-coupled receptors, target validation, secondary screening, validating new assays and for routine pharmacological applications. Kit/Set Contains: 195 compounds including: Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsaturated fatty acids, Leukotrienes, lipoxins, LPA & phosphatidic acids, Octadecanoids, PAFs, Prostaglandins & thromboxanes, Retinoids, vitamin D metabolites, Sphingolipids.
|
|
¡¡ |
BML |
BML-2800-0500 |
Bioactive lipid library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Bioactive Lipid Library contains 195 bioactive lipids in a 96 well format. Ideal for screening or identifiying recombinant orphan G protein-coupled receptors, target validation, secondary screening, validating new assays and for routine pharmacological applications. Kit/Set Contains: 195 compounds including: Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsaturated fatty acids, Leukotrienes, lipoxins, LPA & phosphatidic acids, Octadecanoids, PAFs, Prostaglandins & thromboxanes, Retinoids, vitamin D metabolites, Sphingolipids.
|
|
¡¡ |
BML |
BML-2801-0100 |
Endocannabinoid library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Endocannabinoid Library contains 60 compounds with defined, putative, potential or speculative activity at cannabinoid (CB) and vanilloid (VR) receptors. The library is an array of 10 different fatty acids and 6 different polar head groups. Ligands are supplied dissolved in biocompatible solvents at 1 mM and aliquoted into deep-well plates at 100ul per well. The library is a rich source of ligands for receptor de-orphaning. Includes the following classes of ligands: Amides, Ethanolamides, Lipo-amino acids, Acyl-GABAs, Acyl-dopamines.
|
|
¡¡ |
BML |
BML-2801-0500 |
Endocannabinoid library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Endocannabinoid Library contains 60 compounds with defined, putative, potential or speculative activity at cannabinoid (CB) and vanilloid (VR) receptors. The library is an array of 10 different fatty acids and 6 different polar head groups. Ligands are supplied dissolved in biocompatible solvents at 1 mM and aliquoted into deep-well plates at 100ul per well. The library is a rich source of ligands for receptor de-orphaning. Includes the following classes of ligands: Amides, Ethanolamides, Lipo-amino acids, Acyl-GABAs, Acyl-dopamines.
|
|
·àʪ |
BML |
BML-2802-0100 |
Nuclear receptor ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Nuclear Receptor Ligand Library contains 76 compounds with defined, putative and potential activity at nuclear receptors. Receptor agonists and antagonists are included. The library consists of a chemically diverse group of compounds which are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well, 96-well plates at 500ul or 100ul per well. The library is an ideal tool for chemical genomics, receptor de-orphaning and other routine pharmacological applications.
|
|
·àʪ |
BML |
BML-2802-0500 |
Nuclear receptor ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Nuclear Receptor Ligand Library contains 76 compounds with defined, putative and potential activity at nuclear receptors. Receptor agonists and antagonists are included. The library consists of a chemically diverse group of compounds which are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well, 96-well plates at 500ul or 100ul per well. The library is an ideal tool for chemical genomics, receptor de-orphaning and other routine pharmacological applications.
|
|
¡¡ |
BML |
BML-2803-0100 |
Fatty acid library(100 ul/well)(20 assays) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Fatty Acid Library contains 68 fatty acids of varying saturation and chain length. Many free fatty acids and their metabolites serve as precursors to important signaling systems (e.g. prostaglandins), act directly as receptor ligands or enzyme inhibitors, and have pro- or anti-atherosclerotic and anti-hypertensive properties through mechanisms that are still being characterized. Therefore, a diverse set of fatty acids can be a rich source of compounds for receptor de-orphaning, inhibitor screening, and high content screening.
|
|
¡¡ |
BML |
BML-2803-0500 |
Fatty acid library(500 ul/well)(20 assays) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Fatty Acid Library contains 68 fatty acids of varying saturation and chain length. Many free fatty acids and their metabolites serve as precursors to important signaling systems (e.g. prostaglandins), act directly as receptor ligands or enzyme inhibitors, and have pro- or anti-atherosclerotic and anti-hypertensive properties through mechanisms that are still being characterized. Therefore, a diverse set of fatty acids can be a rich source of compounds for receptor de-orphaning, inhibitor screening, and high content screening.
|
|
·àʪ |
BML |
BML-2805-0100 |
Ion channel ligand library(100 ul/well)(20 assays) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Ion Channel Ligand Library contains 71 ion channel blockers and openers for use in characterizing and identifying ion channels in individual cells or tissue.
|
|
·àʪ |
BML |
BML-2805-0500 |
Ion channel ligand library(500 ul/well)(20 assays) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Ion Channel Ligand Library contains 71 ion channel blockers and openers for use in characterizing and identifying ion channels in individual cells or tissue.
|
|
·àʪ |
BML |
BML-2810-0100 |
Neurotransmitter library(10 plate set)(650 compounds, 100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well neurotransmitter library contains 651 CNS receptor ligands in a 96-well format. Ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, validating new assays, and for routine pharmacological applications. Includes 13 classes of receptor ligands in 10 deep-well plates.
|
|
·àʪ |
BML |
BML-2810-0500 |
Neurotransmitter library(10 plate set)(650 compounds, 500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well neurotransmitter library contains 651 CNS receptor ligands in a 96-well format. Ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, validating new assays, and for routine pharmacological applications. Includes 13 classes of receptor ligands in 10 deep-well plates.
|
|
·àʪ |
BML |
BML-2811-0100 |
Adrenergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The adrenergic ligand library contains 84 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The adrenergic ligand library is 1 plate of the larger neurotransmitter library (Prod. No. BML-2810) which contains over 650 CNS receptor ligands.
|
|
·àʪ |
BML |
BML-2811-0500 |
Adrenergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The adrenergic ligand library contains 84 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The adrenergic ligand library is 1 plate of the larger neurotransmitter library (Prod. No. BML-2810) which contains over 650 CNS receptor ligands.
|
|
·àʪ |
BML |
BML-2812-0100 |
Dopaminergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Dopaminergic Ligands Plate contains 81 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Dopaminergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands
|
|
·àʪ |
BML |
BML-2812-0500 |
Dopaminergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Dopaminergic Ligands Plate contains 81 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Dopaminergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands
|
|
·àʪ |
BML |
BML-2813-0100 |
Serotonergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Serotonergic Ligands Plate contains 83 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Serotonergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2813-0500 |
Serotonergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Serotonergic Ligands Plate contains 83 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Serotonergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2814-0100 |
Opioid ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Opioid and Sigma Ligands Plate contains 79 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Opioid and Sigma Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2814-0500 |
Opioid ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Opioid and Sigma Ligands Plate contains 79 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Opioid and Sigma Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2815-0100 |
Cholinergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Cholinergic Ligands Plate contains 74 compounds ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Cholinergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2815-0500 |
Cholinergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Cholinergic Ligands Plate contains 74 compounds ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Cholinergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2816-0100 |
Histaminergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Histaminergic and Melatonin Ligands Plate contains 42 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Histaminergic and Melatonin Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2816-0500 |
Histaminergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Histaminergic and Melatonin Ligands Plate contains 42 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Histaminergic and Melatonin Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2817-0100 |
Ionotropic glutamatergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Ionotropic Glutamatergic Ligands Plate contains 64 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Ionotropic Glutamatergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2817-0500 |
Ionotropic glutamatergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Ionotropic Glutamatergic Ligands Plate contains 64 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Ionotropic Glutamatergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2818-0100 |
Metabotropic glutamatergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Metabotropic Glutamatergic Ligands Plate contains 56 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Metabotropic Glutamatergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2818-0500 |
Metabotropic glutamatergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Metabotropic Glutamatergic Ligands Plate contains 56 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Metabotropic Glutamatergic Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2819-0100 |
GABAergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The GABAergic Ligands library contains 58 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The GABAergics Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 CNS receptor ligands.
|
|
¡¡ |
BML |
BML-2819-0500 |
GABAergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The GABAergic Ligands library contains 58 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The GABAergics Ligands plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 CNS receptor ligands.
|
|
¡¡ |
BML |
BML-2820-0100 |
Purinergic ligand library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Purinergic and Adenosine Ligands Plate contains 52 CNS receptor ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Purinergic and Adenosine Ligands Plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
¡¡ |
BML |
BML-2820-0500 |
Purinergic ligand library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Purinergic and Adenosine Ligands Plate contains 52 CNS receptor ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening or identifying recombinant orphan G protein coupled receptors, target validation, secondary screening, assay development, and other pharmacological applications. The Purinergic and Adenosine Ligands Plate is 1 plate of the larger Neurotransmitter Library (Prod. No. BML-2810) which contains over 650 ligands.
|
|
·àʪ |
BML |
BML-2825-0500 |
Orphan ligand library(84 compounds)(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Orphan ligand library contains 84 compounds with defined, putative, potential or speculative biological activity but whose protein binding partners have not been identified. Ligands are supplied dissolved in biocompatible solvents at 10mM and aliquoted into a deep-well plate at 500ul per well. The library is a rich source of ligands for receptor de-orphaning. Includes the following classes of ligands: Trace Amines, Neurotransmitter Metabolites, Endogenous ¦Â-carbolines, Urinary Metabolites, Nicotine Congeners, D-Amino Acids.
|
|
·àʪ |
BML |
BML-2832-0100 |
Kinase inhibitor library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Kinase Inhibitor Library contains 80 known kinase inhibitors of well-defined activity. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100 or 500 microliters per well. The library is an ideal tool for chemical genomics, assay development and other pharmacological applications. Includes inhibitors of these important kinases: Insulin/IGF Receptors, PI 3-Kinase, CaM Kinase II, JAK, PKA, CDK, JNK, PKC, CKI II, MAPK, RAF, EGFR, MEK, SAPK, GSK, MLCK, Src-family, IKK, PDGFR, VEGFR and many more.
Kit/Set Contains: 80 compounds including inhibitors of these important kinases: BTK, CaM Kinase, CDK, CKI & II, EGFR, GSK, IKK, Insulin receptor, JAK, JNK, MAPK, MEK, MLCK, PI 3-Kinase, PDGFR, PKA, PKC, RAF, SAPK, Src-family, VEGFR, and more.
|
|
·àʪ |
BML |
BML-2832-0500 |
Kinase inhibitor library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Kinase Inhibitor Library contains 80 known kinase inhibitors of well-defined activity. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100 or 500 microliters per well. The library is an ideal tool for chemical genomics, assay development and other pharmacological applications. Includes inhibitors of these important kinases: Insulin/IGF Receptors, PI 3-Kinase, CaM Kinase II, JAK, PKA, CDK, JNK, PKC, CKI II, MAPK, RAF, EGFR, MEK, SAPK, GSK, MLCK, Src-family, IKK, PDGFR, VEGFR and many more.
Kit/Set Contains: 80 compounds including inhibitors of these important kinases: BTK, CaM Kinase, CDK, CKI & II, EGFR, GSK, IKK, Insulin receptor, JAK, JNK, MAPK, MEK, MLCK, PI 3-Kinase, PDGFR, PKA, PKC, RAF, SAPK, Src-family, VEGFR, and more.
|
|
·àʪ |
BML |
BML-2833-0100 |
Protease inhibitor library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-WellProtease Inhibitor Library includes 53 known protease inhibitors on a single 96-well plate. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100 or 500 microliters per well. The library includes inhibitors to a broad range of important proteases and is a convenient and cost-effective way to purchase a panel of protease inhibitors for chemical genomics, assay development, and other applications. It includes inhibitors of: Calpains, TPPII, Neutrophil Elastase, Cathepsins, DPPIV, Caspases, Granzyme B, ¦Ã-Secretase, Furin, MMPs, ACE, Kallikrein, Proteasome, Aminopeptidase B, and many more.
|
|
¡¡ |
BML |
BML-2833-0500 |
Protease inhibitor library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-WellProtease Inhibitor Library includes 53 known protease inhibitors on a single 96-well plate. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100 or 500 microliters per well. The library includes inhibitors to a broad range of important proteases and is a convenient and cost-effective way to purchase a panel of protease inhibitors for chemical genomics, assay development, and other applications. It includes inhibitors of: Calpains, TPPII, Neutrophil Elastase, Cathepsins, DPPIV, Caspases, Granzyme B, ¦Ã-Secretase, Furin, MMPs, ACE, Kallikrein, Proteasome, Aminopeptidase B, and many more.
|
|
¡¡ |
BML |
BML-2834-0100 |
Phosphatase inhibitor library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Phosphatase Inhibitor Library contains 33 known phosphatase inhibitors of well-defined activity. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100ul or 500ul per well. The library is ideal for chemical genomics, assay development, and as a reference set for secondary screening. Includes inhibitors of these important phosphatases: Calcineurin(PP2B), JSP-1, PRL-1, CD45, PP1, PRL-3, CDC25, PP2A, PTEN, and many more.
|
|
·àʪ |
BML |
BML-2834-0500 |
Phosphatase inhibitor library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Phosphatase Inhibitor Library contains 33 known phosphatase inhibitors of well-defined activity. Inhibitors are supplied dissolved in DMSO at 10 mM and aliquoted into deep-well plates at either 100ul or 500ul per well. The library is ideal for chemical genomics, assay development, and as a reference set for secondary screening. Includes inhibitors of these important phosphatases: Calcineurin(PP2B), JSP-1, PRL-1, CD45, PP1, PRL-3, CDC25, PP2A, PTEN, and many more.
|
|
·àʪ |
BML |
BML-2835-0100 |
REDOX library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well REDOX library contains 84 compounds with defined prooxidant or antioxidant activity. Compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates at 100 or 500ul per well.A variety of structurally and mechanistically different compound classes are included such as hydroperoxides, polyphenolics, metal chelators, thiols, thiol traps, radical scavengers, lazaroids and glutathione modulators as well as small molecule enzyme mimetics for SOD and glutathione peroxidase.
|
|
·àʪ |
BML |
BML-2835-0500 |
REDOX library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well REDOX library contains 84 compounds with defined prooxidant or antioxidant activity. Compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates at 100 or 500ul per well.A variety of structurally and mechanistically different compound classes are included such as hydroperoxides, polyphenolics, metal chelators, thiols, thiol traps, radical scavengers, lazaroids and glutathione modulators as well as small molecule enzyme mimetics for SOD and glutathione peroxidase.
|
|
·àʪ |
BML |
BML-2836-0100 |
Epigenetics library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Application: Useful tool for chemical genomics, assay development, or other pharmacological applications in the study of epigenetic modifications of lysine and DNA methylation.. Kit Contents: 43 compounds supplied in DMSO at a concentration of 10mM.
|
|
·àʪ |
BML |
BML-2836-0500 |
Epigenetics Library(500ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2837-0100 |
Autophagy Library(100ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2837-0500 |
Autophagy Library(500ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2838-0100 |
Wnt Pathway Library |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2838-0500 |
Wnt Pathway Library |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2840-0100 |
ICCB Known Bioactives Library(100 ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2841-0100 |
FDA Approved Drug Library(100 ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2841-0500 |
FDA Approved Drug Library(500 ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2842-0100 |
FDA Approved Drug Library (10mM)(100 ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2842-0500 |
FDA Approved Drug Library (10mM)(500 ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
ÆÇʪ |
BML |
BML-2850-0100 |
Cardiotoxicity library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Cardiotoxicity Library is a focused collection of 131 compounds with defined and diverse cardiotoxicity, including ion channel blockage, mitochondrial toxicity, arrhythmia, fibrosis, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 131 compounds with defined and diverse cardiotoxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
ÆÇʪ |
BML |
BML-2850-0500 |
Cardiotoxicity library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Cardiotoxicity Library is a focused collection of 131 compounds with defined and diverse cardiotoxicity, including ion channel blockage, mitochondrial toxicity, arrhythmia, fibrosis, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 131 compounds with defined and diverse cardiotoxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
·àʪ |
BML |
BML-2851-0100 |
Hepatotoxicity library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Hepatotoxicity Library is a focused collection of 240 compounds with defined and diverse hepatotoxicity, including steatosis, mitochondrial toxicity, Mallory body formation, cholestatic effects, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 240 compounds with defined and diverse hepatotoxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
·àʪ |
BML |
BML-2851-0500 |
Hepatotoxicity library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Hepatotoxicity Library is a focused collection of 240 compounds with defined and diverse hepatotoxicity, including steatosis, mitochondrial toxicity, Mallory body formation, cholestatic effects, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 240 compounds with defined and diverse hepatotoxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
¡¡ |
BML |
BML-2852-0100 |
Hematopoietic toxicity library(100 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Hematopoietic Toxicity Library is a focused collection of 116 compounds with defined and diverse hematopoietic toxicity, including myelosuppression, neutropenia, leukopenia, anemia, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 116 compounds with defined and diverse hematopoietic toxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
¡¡ |
BML |
BML-2852-0500 |
Hematopoietic toxicity library(500 ul/well) |
Pack |
¾È²ñ |
-80¡î |
none |
|
Description: The Screen-Well Hematopoietic Toxicity Library is a focused collection of 116 compounds with defined and diverse hematopoietic toxicity, including myelosuppression, neutropenia, leukopenia, anemia, and many more. A variety of structurally and mechanistically different compound classes are included, as well as nontoxic controls. The compounds are dissolved in DMSO at 10mM and aliquoted into deep-well plates. The library is an essential tool for predictive toxicology screening and assay development. Kit/Set Contains: 116 compounds with defined and diverse hematopoietic toxicity. A variety of structurally and mechanistically different compound classes, as well as nontoxic controls, are included.
|
|
·àʪ |
BML |
BML-2865-0100 |
Natural Products Library(100ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
·àʪ |
BML |
BML-2865-0500 |
Natural Products Library(500ul/well) |
Pack |
¾È²ñ |
|
none |
|
|
|
¡¡ |
BML |
BML-A150-0005 |
Alamethacin ¡ÚU-22324¡Û |
5mg |
¡ï14,000 |
|
27061-78-5, 59588-86-2 |
|
|
|
¡¡ |
BML |
BML-A150-0025 |
Alamethacin ¡ÚU-22324¡Û |
25mg |
¡ï58,000 |
|
27061-78-5, 59588-86-2 |
|
|
|
¡¡ |
BML |
BML-A165-0001 |
Ascomycin ¡ÚFK520¡Û(Isolated from Streptomyces sp) |
1mg |
¡ï21,000 |
|
11011-38-4 |
|
|
|
¡¡ |
BML |
BML-A190-0020 |
Clindamycin, HCl ¡ÚU-21251F¡Û |
20mg |
¡ï5,000 |
|
21462-39-5 |
|
|
|
¡¡ |
BML |
BML-A190-0100 |
Clindamycin, HCl ¡ÚU-21251F¡Û |
100mg |
¡ï22,000 |
|
21462-39-5 |
|
|
|
¡¡ |
BML |
BML-A192-0020 |
Clindamycin Phosphate ¡ÚU-28508E¡Û |
20mg |
¡ï5,000 |
|
24729-96-2 |
|
|
|
¡¡ |
BML |
BML-A192-0100 |
Clindamycin Phosphate ¡ÚU-28508E¡Û |
100mg |
¡ï21,000 |
|
24729-96-2 |
|
|
|
¡¡ |
BML |
BML-A195-0100 |
Cyclosporin A ¡ÚCsA¡Û(Isolated from Fusarium solani) |
100mg |
¡ï7,000 |
|
59865-13-3 |
|
|
|
¡¡ |
BML |
BML-A195-0500 |
Cyclosporin A ¡ÚCsA¡Û(Isolated from Fusarium solani) |
500mg |
¡ï28,000 |
|
59865-13-3 |
|
|
|
¡¡ |
BML |
BML-A201-0020 |
Daptomycin ¡ÚCubicin¡Û¡ÚLY146032¡Û |
20mg |
¡ï12,000 |
|
103060-53-3 |
|
|
|
¡¡ |
BML |
BML-A201-0100 |
Daptomycin ¡ÚCubicin¡Û¡ÚLY146032¡Û |
100mg |
¡ï46,000 |
|
103060-53-3 |
|
|
|
¡¡ |
BML |
BML-A230-0010 |
Decoyinine ¡ÚU-7984¡Û¡ÚAngustmycin A¡Û¡Ú9-(6-Deoxy-D-B-erythro-hex-5-en-2-ulofuranosyl)-adenine¡Û¡Ú9-[Tetrahydro-3,4-dihydroxy-2-(hydroxymethyl0-5-methylene-2-furyl]¡Û |
10mg |
¡ï14,000 |
|
2004-04-8 |
|
|
|
¡¡ |
BML |
BML-A230-0050 |
Decoyinine ¡ÚU-7984¡Û¡ÚAngustmycin A¡Û¡Ú9-(6-Deoxy-D-B-erythro-hex-5-en-2-ulofuranosyl)-adenine¡Û¡Ú9-[Tetrahydro-3,4-dihydroxy-2-(hydroxymethyl0-5-methylene-2-furyl]¡Û |
50mg |
¡ï56,000 |
|
2004-04-8 |
|
|
|
¡¡ |
BML |
BML-A239-0001 |
Kasugamycin(Isolated from Streptomyces kasugaensis) |
1g |
¡ï8,000 |
|
6980-18-3 |
|
|
|
¡¡ |
BML |
BML-A240-0001 |
Lincomycin ¡ÚU-10149A¡Û(Isolated from Streptomyces lincolnensis) |
1g |
¡ï8,000 |
|
154-21-2 |
|
|
|
¡¡ |
BML |
BML-A240-0005 |
Lincomycin ¡ÚU-10149A¡Û(Isolated from Streptomyces lincolnensis) |
5g |
¡ï33,000 |
|
154-21-2 |
|
|
|
¡¡ |
BML |
BML-A245-0010 |
Lomofungin ¡ÚU-24792¡Û |
10mg |
¡ï10,000 |
|
26786-84-5 |
|
|
|
¡¡ |
BML |
BML-A245-0050 |
Lomofungin ¡ÚU-24792¡Û |
50mg |
¡ï39,000 |
|
26786-84-5 |
|
|
|
¡¡ |
BML |
BML-A249-0100 |
Mycophenolic Acid(Isolated from Penicillium brevi-compactum)¡Ú6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic Acid¡Û |
100mg |
¡ï8,000 |
|
24280-93-1 |
|
|
|
¡¡ |
BML |
BML-A249-0500 |
Mycophenolic Acid(Isolated from Penicillium brevi-compactum)¡Ú6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic Acid¡Û |
500mg |
¡ï32,000 |
|
24280-93-1 |
|
|
|
¡¡ |
BML |
BML-A256-0001 |
Novobiocin Sodium salt ¡ÚU-6591¡Û¡ÚAlbamycin¡Û¡ÚStreptonivicin¡Û¡ÚN-[7-[[3-O-Aminocarbonyl-6-deoxy-5-C-methyl-4-O-B-L-lyxo-hexapyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3 |
1g |
¡ï7,000 |
|
1476-53-5 |
|
|
|
¡¡ |
BML |
BML-A256-0005 |
Mycophenolic Acid(Isolated from Penicillium brevi-compactum)¡Ú6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic Acid¡Û |
5g |
¡ï29,000 |
|
1476-53-5 |
|
|
|
¡¡ |
BML |
BML-A260-0050 |
Puromycin Aminonucleoside ¡Ú3'-Amino-3'-deoxy-N,N-dimethyladenosine¡Û |
50mg |
¡ï25,000 |
|
58-60-6 |
|
|
|
¡¡ |
BML |
BML-A275-0005 |
Rapamycin ¡ÚSirolimus¡Û¡ÚAY-22,989¡Û¡ÚRAPA¡Û¡ÚRapamune¡Û |
5mg |
¡ï21,000 |
|
53123-88-9 |
|
|
|
¡¡ |
BML |
BML-A275-0025 |
Rapamycin ¡ÚSirolimus¡Û¡ÚAY-22,989¡Û¡ÚRAPA¡Û¡ÚRapamune¡Û |
25mg |
¡ï53,000 |
|
53123-88-9 |
|
|
|
¡¡ |
BML |
BML-A280-0010 |
Spectinomycin, 2HCl ¡ÚU-18409AE¡Û¡ÚSpectinomycin, 2HCl, 5H2O ¡Û |
10g |
¡ï14,000 |
|
22189-32-8 (21736-83-4) |
|
|
|
¡¡ |
BML |
BML-A281-0010 |
Spectinomycin, Sulfate ¡ÚU-18409E¡Û |
10g |
¡ï8,000 |
|
64058-48-6 |
|
|
|
¡¡ |
BML |
BML-A283-0100 |
2,4-Pyridinedicarboxylic Acid, H2O |
100mg |
¡ï3,000 |
|
499-80-9 |
|
|
|
¡¡ |
BML |
BML-AA1105-0025 |
Atrial Natriuretic Peptide ¡ÚANP¡Û(human, aa 1-28), rabbit pAb. |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-AA1105-0100 |
Atrial Natriuretic Peptide ¡ÚANP¡Û(human, aa 1-28), rabbit pAb. |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-AA6240-0100 |
Adrenocorticotropic Hormone ¡ÚACTH¡Û(peptide, aa 1-24)(NT)[57], mouse mAb, purified |
100ul |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 57 | human¡¢ rat¡¢ monkey | IHC |
|
|
¡¡ |
BML |
BML-AA6240-0500 |
Adrenocorticotropic Hormone ¡ÚACTH¡Û(peptide, aa 1-24)(NT)[57], mouse mAb, purified |
500ul |
¡ï51,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 57 | human¡¢ rat¡¢ monkey | IHC |
|
|
¡¡ |
BML |
BML-AA6244-0100 |
Atrial Natriuretic Peptide ¡ÚANP¡Û(human, aa 1-28)(recombinant)[23/1], mouse mAb, purified |
100ul |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 23/1. | human | IHC |
|
|
¡¡ |
BML |
BML-AA6244-0500 |
Atrial Natriuretic Peptide ¡ÚANP¡Û(human, aa 1-28)(recombinant)[23/1], mouse mAb, purified |
500ul |
¡ï51,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 23/1. | human | IHC |
|
|
¡¡ |
BML |
BML-AD100-0020 |
PD 116,948 ¡Ú8-Cyclopentyl-1,3-dipropylxanthine¡Û |
20mg |
¡ï8,000 |
|
102146-07-6 |
|
|
|
¡¡ |
BML |
BML-AD100-0100 |
PD 116,948 ¡Ú8-Cyclopentyl-1,3-dipropylxanthine¡Û |
100mg |
¡ï32,000 |
|
102146-07-6 |
|
|
|
¡¡ |
BML |
BML-AD101-0050 |
S-(4-Nitrobenzyl)-6-thioinosine ¡ÚNBTI¡Û¡ÚNBMPR¡Û |
50mg |
¡ï17,000 |
|
38048-32-7 |
|
|
|
¡¡ |
BML |
BML-AG6070-0100 |
a-Actinin(chicken gizzard)[CB11], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CB11 | mammalian¡¢ chicken | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-AK004-0001 |
Caspase Colorimetric Quantipak |
Kit |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK005-0001 |
Caspase Fluorescent(AMC)Quantipak |
Kit |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK006-0001 |
Caspase Fluorescent(AFC)Quantipak |
Kit |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK010-0001 |
MultiCasPak-4 Active Caspases |
Kit |
¡ï84,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK011-0001 |
ApoCourse-1: Time Course of Etoposide-induced Apoptosis |
Kit |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK012-0001 |
ApoCourse-2: Time Course of TRAIL-induced Apoptosis |
Kit |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK013-0001 |
Matrix Metalloproteinase ¡ÚMMP¡Û Multipack-1 |
Kit |
¡ï80,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK014-0001 |
Matrix Metalloproteinase ¡ÚMMP¡Û Multipack-2 |
Kit |
¡ï80,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK015-0001 |
MMP Inhibitor Profiling Kit ¡ÚMatrix Metalloproteinase Inhibitor Profiling Kit¡Û, Colorimetric |
Kit |
¡ï104,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK016-0001 |
MMP Inhibitor Profiling Kit ¡ÚMatrix Metalloproteinase Inhibitor Profiling Kit¡Û, Fluorimetric |
Kit |
¡ï111,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK020-0001 |
Dual Specificity Phosphatase Multipack |
1set |
¡ï109,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK021-0001 |
Tyrosine Phosphatase Multipack |
1set |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK111-0250 |
BIOMOL Green Reagent |
250ml |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK111-1000 |
BIOMOL Green Reagent |
1L |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK115-0001 |
Sulforhodamine MultiCaspase Activity Kit(100 tests) |
Kit |
¡ï61,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK116-0001 |
Mit-E-¦× Mitochondrial Permeability Detection Kit(100 tests) |
Kit |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK117-0001 |
Carboxyfluorescein Multi-Caspase Activity Kit |
Kit |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK118-0001 |
CV-Caspase 3 & 7 Detection Kit ¡ÚCresyl Violet-Caspase 3 & 7 Detection Kit¡Û |
Kit |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK120-0001 |
ApoStrand ELISA Apoptosis Detection Kit |
96wells |
¡ï65,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK125-0001 |
CV-Cathepsin B Dectection Kit ¡ÚCresyl Violet-Cathepsin B Dectection Kit¡Û |
Kit |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK126-0001 |
CV-Cathepsin K Detection Kit ¡ÚCresyl Violet-Cathepsin K Detection Kit¡Û |
Kit |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK127-0001 |
CV-Cathepsin L Detection Kit ¡ÚCresyl Violet-Cathepsin L Detection Kit¡Û |
Kit |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK170-0001 |
ALDetect Lipid Peroxidation Assay Kit(100 assays) |
Kit |
¡ï69,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK171-0001 |
ALDetect(MDA-specific)Lipid Peroxidation Assay Kit(25 assays) |
Kit |
¡ï76,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK301-0001 |
Matrix Metalloproteinase-1 ¡ÚMMP-1 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-1 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-1 enzyme, 1 vial substrate (OmniMMP RED), 1 vial 6'-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK302-0001 |
Matrix Metalloproteinase-2 ¡ÚMMP-2 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-2 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-2 enzyme, 1 vial substrate (OmniMMP RED), 1 vial 6'-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK303-0001 |
Matrix Metalloproteinase-3 ¡ÚMMP-3 Kit¡Û Fluorometric Drug Discovery Kit, GREEN |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-3 inhibitors using a quenched fluorogenic substrate. Kit Contents: 1 vial MMP-3 enzyme, 1 vial substrate (MMP-3 fluorogenic substrate), 1 vial 5-FAM calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK304-0001 |
Matrix Metalloproteinase-7 ¡ÚMMP-7 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-7 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-7 enzyme, 1 vial substrate (OmniMMP RED), 1 vial 6'-TAMRA calibration standard. 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK305-0001 |
Matrix Metalloproteinase-8 ¡ÚMMP-8 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-8 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-8 enzyme, 1 vial Substrate (OmniMMP RED). 1 vial 6¡Ç-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK306-0001 |
Matrix Metalloproteinase-9 ¡ÚMMP-9 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï65,000 |
-80¡î |
none |
|
Kit/Set Contains: 1 vial MMP-9 enzyme, 1 vial Substrate (OmniMMP RED), 1 vial 6¡Ç-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK307-0001 |
Matrix Metalloproteinase-19 ¡ÚMMP-19 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï63,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-19 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-19 enzyme, 1 vial Substrate (OmniMMP RED), 1 vial 6¡Ç-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK308-0001 |
Matrix Metalloproteinase(MMP)Inhibitor Profiling Kit ¡ÚMMP inhibitor profiling kit¡Û, Fluorometric RED |
Kit |
¡ï116,000 |
-80¡î |
none |
|
Application: Designed to examine the specificity of inhibitors against a panel of ten matrix metalloproteinase enzymes, using a quenched fluorogenic peptide. Kit Contents: 10 vials (10 MMP enzymes), 1 vial Substrate (OmniMMP RED), 1 vial 6'-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 2 bottles (20 ml each) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK310-0001 |
ADAM17 Fluorometric Drug Discovery Kit |
Kit |
¡ï56,000 |
-80¡î |
none |
|
Application: Designed to screen ADAM17 (TACE) inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial ADAM17 enzyme, 1 vial Substrate (Mca-PLAQAV-Dpa-RSSSR-NH2), 1 vial DMSO, 1 vial CALIBRATION STANDARD, 1 vial control inhibitor (GM6001), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK311-0001 |
Matrix Metalloproteinase-3 ¡ÚMMP-3 Kit¡Û Fluorometric Drug Discovery Kit, RED |
Kit |
¡ï63,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-3 inhibitors using a quenched fluorogenic peptide. Kit Contents: 1 vial MMP-3 enzyme, 1 vial substrate (OmniMMP RED), 1 vial 6'-TAMRA calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK312-0001 |
Matrix Metalloproteinase-12 ¡ÚMMP-12 Kit¡Û Fluorometric Drug Discovery Kit, GREEN |
Kit |
¡ï63,000 |
-80¡î |
none |
|
Application: Designed to screen MMP-12 inhibitors using a quenched fluorogenic substrate.. Kit Contents: 1 vial MMP-12 enzyme, 1 vial substrate (MMP-3 fluorogenic substrate), 1 vial 5-FAM calibration standard, 1 vial control inhibitor (NNGH), 1 bottle (20 ml) assay buffer, 1 black 96-well microplate, Instructions
|
|
¡¡ |
BML |
BML-AK400-0001 |
Matrix Metalloproteinase-3 ¡ÚMMP-3¡Û¡ÚStromelysin-1¡Û¡ÚTransin¡Û Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK401-0001 |
Matrix Metalloproteinase-3 ¡ÚMMP-3¡Û¡ÚStromelysin-1¡Û¡ÚTransin¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK402-0001 |
Matrix Metalloproteinase-12 ¡ÚMMP-12¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK403-0001 |
Matrix Metalloproteinase-12 ¡ÚMMP-12¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK404-0001 |
Matrix Metalloproteinase-1 ¡ÚMMP-1¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK405-0001 |
Matrix Metalloproteinase-1 ¡ÚMMP-1¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK406-0001 |
Matrix Metalloproteinase-7 ¡ÚMMP-7¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK407-0001 |
Matrix Metalloproteinase-7 ¡ÚMMP-7¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK408-0001 |
Matrix Metalloproteinase-2 ¡ÚMMP-2¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK409-0001 |
Matrix Metalloproteinase-2 ¡ÚMMP-2¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK410-0001 |
Matrix Metalloproteinase-9 ¡ÚMMP-9¡Û¡ÚGelatinase B¡Û¡Ú92 kDa Type IV Collagenase¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK411-0001 |
Matrix Metalloproteinase-9 ¡ÚMMP-9¡Û¡ÚGelatinase B¡Û¡Ú92 kDa Type IV Collagenase¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK412-0001 |
Matrix Metalloproteinase-13 ¡ÚMMP-13¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK413-0001 |
Matrix Metalloproteinase-13 ¡ÚMMP-13¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK414-0001 |
Matrix Metalloproteinase-8 ¡ÚMMP-8¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK415-0001 |
Matrix Metalloproteinase-8 ¡ÚMMP-8¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK416-0001 |
Matrix Metalloproteinase-14 ¡ÚMMP-14¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK417-0001 |
Matrix Metalloproteinase-14 ¡ÚMMP-14¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK418-0001 |
Matrix Metalloproteinase-10 ¡ÚMMP-10¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK419-0001 |
Matrix Metalloproteinase-10 ¡ÚMMP-10¡Û Fluorescent Assay Kit for Drug Discovery(1 x 96-well plate) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK422-0001 |
Matrix Metalloproteinase-20 ¡ÚMMP-20¡Û Colorimetric Drug Discovery Kit(1 x 96-well plate) |
Kit |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK430-0001 |
Cathepsin K Drug Discovery Kit(96 assays) |
Kit |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK431-0001 |
Cathepsin S Drug Discovery Kit(96 assays) |
Kit |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK497-0001 |
Neutrophil Elastase Colorimetric Drug Discovery Kit(96 assays) |
Kit |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK498-0001 |
DPPIV/CD26 Assay Kit ¡ÚCD26 Assay Kit¡Û¡ÚDipeptidyl Peptidase IV Assay Kit¡Û for biological samples(96 assays) |
Kit |
¡ï51,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK499-0001 |
DPPIV Drug Discovery Kit ¡ÚCD26 Drug Discovery kit¡Û¡ÚDipeptidyl Peptidase IV Drug Discovery Kit¡Û¡ÚDPP4 Drug Discovery Kit¡Û(96 assays) |
Kit |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK500-0001 |
Fluor-de-Lys HDAC Fluorometric Activity Assay Kit ¡ÚHDAC Fluorometric Activity Assay Kit¡Û¡ÚHistone Deacetylase Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK501-0001 |
Color-de-Lys HDAC Colorimetric Activity Assay Kit ¡ÚHDAC Colorimetric Activity Assay Kit¡Û¡ÚHistone Deacetylase Colorimetric Assay Kit¡Û(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK503-0001 |
Fluor-de-Lys HDAC Fluorometric Cellular Activity Assay Kit ¡ÚHDAC Fluorometric Cellular Activity Assay¡Û¡ÚCellular Histone Deacetylase Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK511-0001 |
Fluor-de-Lys HDAC1 Fluorometric Drug Discovery Assay Kit ¡ÚHDAC1 Fluorometric Drug Discovery Assay Kit¡Û¡ÚHistone Deacetylase 1 Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK512-0001 |
Fluor-de-Lys-Green HDAC2 Fluorometric Drug Discovery Assay Kit ¡ÚGreen HDAC2 Fluorometric Drug Discovery Assay Kit¡Û¡ÚHDAC2 Fluorometric Drug Discovery Assay Kit, Green-¡Û(96-192 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK513-0001 |
Fluor-de-Lys SIRT5 Fluorometric Drug Discovery Assay Kit ¡ÚSirtuin 5 fluorescent assay kit¡Û(100 assays) |
Kit |
¡ï74,000 |
-80¡î |
none |
|
Description: The SIRT5 Fluorometric Drug Discovery Kit is a complete assay system designed to measure the lysyl desuccinylase activity of the recombinant human SIRT5 included in the kit. A black 96-well microplate is packaged with the kit, but it should be noted that reagents of the Fluor de Lys system have also been successfully employed in other formats, including cuvettes and 384-well plates. The SIRT5 Fluorometric Activity Assay is based on the unique Fluor de Lys-Succinyl Substrate/Developer combination. Kit/Set Contains: SIRT5 (Sirtuin 5) (human, rec.), Succinyl, Desuccinylase Substrate, Developer Concentrate (20x), NAD+ (Sirtuin Substrate), Nicotinamide (Sirtuin Inhibitor), Suramin sodium (Sirtuin Inhibitor), Desuccinylated Standard, Sirtuin Assay Buffer, 1/2 Volume Black NBS Microplate
|
|
¡¡ |
BML |
BML-AK514-0001 |
Fluor-de-Lys Green SIRT5 Fluorometric Green Drug Discovery Assay Kit ¡ÚGreen Sirtuin 5 fluorescent assay kit¡Û¡ÚSirtuin 5, Green-, fluorescent assay kit¡Û(100 assays) |
Kit |
¡ï74,000 |
-80¡î |
none |
|
Description: The Fluor de LysGreen SIRT5 Fluorometric Drug Discovery Kitis a complete assay system designed to measure the lysyl desuccinylase activity of the recombinant human SIRT5 included in the kit. A black 96-well microplate is packaged with the kit, but it should be noted that reagents of the Fluor de Lyssystem have also been successfully employed in other formats, including cuvettes and 384-well plates. Kit/Set Contains: SIRT5 (Sirtuin 5) (human, recombinant), Succinyl Green, Desuccinylase Substrate, Developer Concentrate (20x), NAD+ (Sirtuin Substrate), Nicotinamide (Sirtuin Inhibitor), Suramin sodium (Sirtuin Inhibitor), Green Desuccinylated Standard, Sirtuin Assay Buffer, 1/2 VOLUME BLACK NBS MICROPLATE
|
|
¡¡ |
BML |
BML-AK516-0001 |
Fluor-de-Lys HDAC6 Fluorometric Drug Discovery Kit ¡ÚHDAC6 Fluorometric Drug Discovery Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK518-0001 |
Fluor-de-Lys HDAC8 Fluorometric Drug Discovery Kit ¡ÚHDAC8 Fluorometric Drug Discovery Kit¡Û¡ÚHistone Deacetylase 8 Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK530-0001 |
Fluor-de-Lys-Green HDAC Fluorometric Activity Assay Kit ¡ÚGreen HDAC Fuorometric Activity Assay Kit¡Û¡ÚHDAC Fluorometric Activity Assay Kit, Green-¡Û¡ÚHistone Deacetylase Green Fluorescent Assay Kit¡Û |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK531-0001 |
Fluor-de-Lys HDAC3/NCOR1 Fluorometric Drug Discovery Kit ¡ÚNCOR1 Fluorometric Drug Discovery Kit¡Û¡ÚHistone deacetylase 3/Nuclear Receptor Corepressor 1 Fluorometric Drug Discovery Kit¡Û(96-192 assays |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK532-0001 |
Chemilum de LysTM HDAC/SIRT Chemiluminescent Drug Discovery Kit ¡ÚHistone deacetylase fluorescent assay kit¡Û¡ÚSIRT Chemiluminescent drug discovery kit¡Û |
Kit |
¡ï74,000 |
-80¡î |
none |
|
Description: The HDAC/SIRT Chemiluminescent Drug Discovery Kit is a complete assay system designed to measure histone deacetylase (HDAC) and sirtuin activity in cell or nuclear extracts, immunoprecipitates or purified enzymes. It comes in a convenient 96-well format, with all reagents necessary for fluorescent HDAC activity measurements and calibration of the assay. In addition, a HeLa nuclear extract, rich in HDAC activity, is included with the kit. The extract is useful as either a positive control or as the source of HDAC activity for inhibitor/drug screening. Kit/Set Contains: Nuclear Extract from HeLa Cells, Substrate, Developer Concentrate, Trichostatin A (HDAC Inhibitor) , NAD (Sirtuin Substrate), Nicotinamide (Sirtuin Inhibitor), HDAC Assay Buffer, DeveloperBuffer, Enhancer part A, Enhancer part B, 1/2 volume white microplate
|
|
¡¡ |
BML |
BML-AK544-0001 |
LSD1 Fluorimetric Drug Discovery Kit ¡ÚLysine-specific Histone Demethylase 1 Fluorimetric Drug Discovery Kit¡Û¡ÚKDM1 Fluorimetric Drug Discovery Kit¡Û¡ÚAOF2 Fluorimetric Drug Discovery Kit¡Û(96 assays |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK555-0001 |
Fluor-de-Lys SIRT1 Fluorometric Drug Discovery Assay Kit ¡ÚSIRT1 Fluorometric Drug Discovery Assay Kit¡Û¡ÚSirtuin 1 Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK556-0001 |
Fluor-de-Lys SIRT2 Fluorometric Drug Discovery Assay Kit ¡ÚSIRT2 Fluorometric Drug Discovery Assay Kit¡Û¡ÚSirtuin 2 Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK557-0001 |
Fluor-de-Lys SIRT3 Fluorometric Drug Discovery Assay Kit ¡ÚSIRT3 Fluorometric Drug Discovery Assay Kit¡Û¡ÚSirtuin 3 Fluorescent Assay Kit¡Û(96 assays) |
Kit |
¡ï77,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK601-0001 |
Inducible Nitric Oxide Synthase(iNOS)Antisense MultiOligo Pack ¡ÚiNOS Antisense MultiOligo Pack¡Û |
Set |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK700-0001 |
Caspase-3 Assay Kit for Drug Discovery(96 assays) |
Kit |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK701-0001 |
Caspase-1 Assay Kit for Drug Discovery(96 assays) |
Kit |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK702-0001 |
Caspase-2 Assay Kit for Drug Discovery(96 assays) |
Kit |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK703-0001 |
Caspase-3 Cell Assay Kit(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK711-0001 |
Granzyme B Assay Kit for Drug Discovery(96 assays) |
Kit |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK715-0001 |
Caspase-8 Assay Kit for Drug Discovery(96 assays) |
Kit |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK740-0001 |
Proteasome 20S Assay Kit(96 assays) |
Kit |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK800-0001 |
Cyclic Nucleotide Phosphodiesterase Assay Kit(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK804-0001 |
Calcineurin Phosphatase Assay Kit(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK812-0001 |
CD45 Tyrosine Phosphatase Assay Kit(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK815-0001 |
LAR Tyrosine Phosphatase Assay Kit for Drug Discovery ¡ÚLeukocyte Antigen Related Tyrosine Phosphatase Assay Kit¡Û(96 assays) |
Kit |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK816-0001 |
Calcineurin Cellular Activity Assay Kit(96 assays) |
Kit |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AK822-0001 |
PTP1B Drug Discovery Kit ¡ÚProtein Tyrosine Phosphatase-1B Drug Discovery Kit¡Û(96 assays) |
Kit |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AM100-0001 |
Cyclo(Arg-Gly-Asp-D-Phe-Val)¡ÚIntegrin avB3 Antagonist¡Û |
1mg |
¡ï11,000 |
|
137813-35-5 |
|
|
|
¡¡ |
BML |
BML-AM101-0001 |
Cyclo(Arg-Ala-Asp-D-Phe-Val)¡ÚRADfv¡Û |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AP101-0020 |
4-Amino-1,8-naphthalimide ¡Ú4-ANI¡Û |
20mg |
¡ï9,000 |
|
1742-95-6 |
|
|
|
¡¡ |
BML |
BML-AP101-0100 |
4-Amino-1,8-naphthalimide ¡Ú4-ANI¡Û |
100mg |
¡ï39,000 |
|
1742-95-6 |
|
|
|
¡¡ |
BML |
BML-AP102-0020 |
1,5-Isoquinolinediol |
20mg |
¡ï7,000 |
|
5154-02-9 |
|
|
|
¡¡ |
BML |
BML-AP102-0100 |
1,5-Isoquinolinediol |
100mg |
¡ï30,000 |
|
5154-02-9 |
|
|
|
¡¡ |
BML |
BML-AP200-0005 |
Sulindac Sulfide ¡ÚZ-5-Fluoro-2-methyl-1-[p-(methylthio)benzylidene]indene-3-acetic Acid¡Û |
5mg |
¡ï8,000 |
|
32004-67-4 |
|
|
|
¡¡ |
BML |
BML-AP200-0025 |
Sulindac Sulfide ¡ÚZ-5-Fluoro-2-methyl-1-[p-(methylthio)benzylidene]indene-3-acetic Acid¡Û |
25mg |
¡ï24,000 |
|
32004-67-4 |
|
|
|
¡¡ |
BML |
BML-AP201-0005 |
Sulindac Sulfone ¡ÚZ-5-Fluoro-2-methyl-1-[p-(methylsulfonyl)benzylidene]indene-3-acetic Acid¡Û |
5mg |
¡ï8,000 |
|
59864-04-9 |
|
|
|
¡¡ |
BML |
BML-AP201-0025 |
Sulindac Sulfone ¡ÚZ-5-Fluoro-2-methyl-1-[p-(methylsulfonyl)benzylidene]indene-3-acetic Acid¡Û |
25mg |
¡ï24,000 |
|
59864-04-9 |
|
|
|
¡¡ |
BML |
BML-AP302-0010 |
Bleomycin Sulfate ¡ÚBlenoxane¡Û |
10mg |
¡ï33,000 |
|
9041-93-4 |
|
|
|
¡¡ |
BML |
BML-AP302-0050 |
Bleomycin Sulfate ¡ÚBlenoxane¡Û |
50mg |
¡ï136,000 |
|
9041-93-4 |
|
|
|
¡¡ |
BML |
BML-AP303-0010 |
Bufalin ¡Ú5B,20(22)-Bufadienolide-3B,14-diol¡Û¡Ú(3B,5B)-3,14-Dihydroxybufa-20,22-dienolide¡Û |
10mg |
¡ï12,000 |
|
465-21-4 |
|
|
|
¡¡ |
BML |
BML-AP305-0005 |
Gambogic Acid |
5mg |
¡ï10,000 |
|
2752-65-0 |
|
|
|
¡¡ |
BML |
BML-AP305-0025 |
Gambogic Acid |
25mg |
¡ï40,000 |
|
2752-65-0 |
|
|
|
¡¡ |
BML |
BML-AP306-0005 |
2,3-DCPE, HCl ¡Ú2-[[3-(2,3-Dichlorophenoxy)propyl]amino]ethanol, HCl¡Û |
5mg |
¡ï8,000 |
|
418788-90-6 |
|
|
|
¡¡ |
BML |
BML-AP306-0025 |
2,3-DCPE, HCl ¡Ú2-[[3-(2,3-Dichlorophenoxy)propyl]amino]ethanol, HCl¡Û |
25mg |
¡ï34,000 |
|
418788-90-6 |
|
|
|
¡¡ |
BML |
BML-AP308-0001 |
a-Tocopheryl Succinate |
1g |
¡ï3,000 |
|
4345-03-3 |
|
|
|
¡¡ |
BML |
BML-AP309-0020 |
Necrostatin-1 ¡ÚMethylthiohydantoin-DL-tryptophan¡Û |
20mg |
¡ï10,000 |
|
4311-88-0 |
|
|
|
¡¡ |
BML |
BML-AP309-0100 |
Necrostatin-1 ¡ÚMethylthiohydantoin-DL-tryptophan¡Û |
100mg |
¡ï41,000 |
|
4311-88-0 |
|
|
|
¡¡ |
BML |
BML-AP400-0001 |
7-Aminoactinomycin D ¡Ú7-AAD¡Û |
1mg |
¡ï12,000 |
|
7240-37-1 |
|
|
|
¡¡ |
BML |
BML-AP402-0010 |
DAPI ¡Ú4¡Ç,6-Diamidino-2-phenylindole, 2HCl¡Û |
10mg |
¡ï14,000 |
|
28718-90-3 |
|
|
|
¡¡ |
BML |
BML-AP500-0005 |
C1 ¡Ú1,3-Dibutyl-2-thiooxoimidazolidine-4,5-dione¡Û |
5mg |
¡ï7,000 |
|
143413-73-4 |
|
|
|
¡¡ |
BML |
BML-AP500-0025 |
C1 ¡Ú1,3-Dibutyl-2-thiooxoimidazolidine-4,5-dione¡Û |
25mg |
¡ï27,000 |
|
143413-73-4 |
|
|
|
¡¡ |
BML |
BML-AP501-0005 |
STF-62247 ¡ÚN-(3-Methylphenyl)-4-(4-pyridinyl)-1,3-thiazol-2-amine¡Û |
5mg |
¡ï11,000 |
|
315702-99-9 |
|
|
|
¡¡ |
BML |
BML-AP501-0025 |
STF-62247 ¡ÚN-(3-Methylphenyl)-4-(4-pyridinyl)-1,3-thiazol-2-amine¡Û |
25mg |
¡ï41,000 |
|
315702-99-9 |
|
|
|
¡¡ |
BML |
BML-AP502-0025 |
3-Methyladenine ¡Ú6-Amino-3-methylpurine¡Û |
25mg |
¡ï10,000 |
|
5142-23-4 |
|
|
|
¡¡ |
BML |
BML-AP503-0005 |
Pifithrin ¦Ì ¡Ú2-Phenylethynesulfonamide¡Û |
5mg |
¡ï6,000 |
|
64984-31-2 |
|
|
|
¡¡ |
BML |
BML-AP503-0025 |
Pifithrin ¦Ì ¡Ú2-Phenylethynesulfonamide¡Û |
25mg |
¡ï23,000 |
|
64984-31-2 |
|
|
|
¡¡ |
BML |
BML-AP504-0005 |
Timosaponin AIII |
5mg |
¡ï10,000 |
|
41059-79-4 |
|
|
|
¡¡ |
BML |
BML-AP505-0010 |
Plumbagin ¡Ú5-Hydroxy-2-methyl-naphthalene-1,4-dione¡Û |
10mg |
¡ï3,000 |
|
481-42-5 |
|
|
|
¡¡ |
BML |
BML-AP600-0005 |
16F16 ¡ÚMethyl-2-(2-chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylate¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AP600-0025 |
16F16 ¡ÚMethyl-2-(2-chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylate¡Û |
25mg |
¡ï51,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AR100-0100 |
Bopindolol Malonate |
100mg |
¡ï8,000 |
|
62658-64-4 |
|
|
|
¡¡ |
BML |
BML-AR100-0500 |
Bopindolol Malonate |
500mg |
¡ï32,000 |
|
62658-64-4 |
|
|
|
¡¡ |
BML |
BML-AR101-0010 |
(¡Þ)-Cyanopindolol Hemifumarate |
10mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AR101-0050 |
(¡Þ)-Cyanopindolol Hemifumarate |
50mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AR102-0100 |
Guanfacine, HCl ¡ÚN-Amidino-2-(2,6-dichlorophenyl)acetamide, HCl¡Û |
100mg |
¡ï8,000 |
|
29520-14-7 |
|
|
|
¡¡ |
BML |
BML-AR102-0500 |
Guanfacine, HCl ¡ÚN-Amidino-2-(2,6-dichlorophenyl)acetamide, HCl¡Û |
500mg |
¡ï32,000 |
|
29520-14-7 |
|
|
|
¡¡ |
BML |
BML-AR103-0100 |
Tizanidine, HCl ¡Ú5-Chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazol, HCl¡Û |
100mg |
¡ï8,000 |
|
51322-75-9 |
|
|
|
¡¡ |
BML |
BML-AR103-0500 |
Tizanidine, HCl ¡Ú5-Chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazol, HCl¡Û |
500mg |
¡ï32,000 |
|
51322-75-9 |
|
|
|
¡¡ |
BML |
BML-AR104-0010 |
ICI-118,551 ¡Ú((¡Þ)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy-3-[(1-methylethyl)amino-2-butanol), HCl¡Û |
10mg |
¡ï29,000 |
|
72795-26-7 |
|
|
|
¡¡ |
BML |
BML-AR106-0100 |
Rauwolscine, HCl ¡Úa-Yohimbine, HCl¡Û |
100mg |
¡ï12,000 |
|
6211-32-1 |
|
|
|
¡¡ |
BML |
BML-AR107-0100 |
S(-)-Propranolol, HCl ¡ÚS(-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol, HCl¡Û |
100mg |
¡ï14,000 |
|
4199-10-4 |
|
|
|
¡¡ |
BML |
BML-AR108-0005 |
BRL-37344 ¡Ú(R*R*)-(¡Þ)-4-[2-[(2-(3-Chlorophenyl)-2-hydroxyethyl)amino]propyl]phenoxyacetic Acid, HCl¡Û |
5mg |
¡ï13,000 |
|
114333-71-0 |
|
|
|
¡¡ |
BML |
BML-AR109-0100 |
Urapidil, HCl ¡Ú6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, HCl¡Û |
100mg |
¡ï8,000 |
|
64887-14-5 |
|
|
|
¡¡ |
BML |
BML-AR111-0001 |
Maprotiline, HCI ¡Ú1-(3-Methylaminopropyl)dibenzo[b,e]bicyclo[2.2.2]octadiene, HCl¡Û |
1g |
¡ï3,000 |
|
10347-81-6 |
|
|
|
¡¡ |
BML |
BML-AR112-0100 |
Carvedilol ¡Ú1-(9H-Carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol¡Û |
100mg |
¡ï7,000 |
|
72956-09-3 |
|
|
|
¡¡ |
BML |
BML-AR119-0100 |
Desipramine, HCl ¡Ú10-11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine, HCl¡Û |
100mg |
¡ï5,000 |
|
58-28-6 |
|
|
|
¡¡ |
BML |
BML-AR119-1000 |
Desipramine, HCl ¡Ú10-11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine, HCl¡Û |
1g |
¡ï11,000 |
|
58-28-6 |
|
|
|
¡¡ |
BML |
BML-AW8655-0005 |
Aclacinomycin A ¡ÚAclarubicin¡Û |
5mg |
¡ï10,000 |
|
57576-44-0 |
|
|
|
¡¡ |
BML |
BML-AW9155-0100 |
Ada-(Ahx)3-(Leu)3-vinyl Sulfone ¡ÚAdaAhx3L3VS¡Û |
100ug |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9160-0100 |
Ada-Tyr-(Ahx)3-(Leu)3-vinyl Sulfone |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9165-0100 |
Ada-Lys(biotinyl)-(Ahx)3-(Leu)3-vinyl Sulfone |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9485-0100 |
Ac-Ala-Pro-Nle-Asp-H |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9555-0005 |
Ac-Nle-Pro-Nle-Asp-AMC ¡ÚAc-nLPnLD-AMC¡Û |
5mg* |
¡ï84,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9560-0005 |
Ac-Gly-Pro-Leu-Asp-AMC ¡ÚAc-GPLD-AMC¡Û |
5mg* |
¡ï84,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AW9785-0005 |
Ac-Arg-Leu-Arg-AMC ¡ÚAc-RLR-AMC¡Û |
5mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-AZ1030-0050 |
Aromatic L-Amino Acid Decarboxylase ¡ÚAADC¡Û¡ÚDOPA decarboxylase¡Û(bovine), rabbit pAb |
50ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-AZ1072-0100 |
Atrial Natriuretic Peptide ¡ÚANP¡Û(peptide), rabbit pAb |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-B100-0020 |
Flumazenil ¡ÚRo 15-1788¡Û¡ÚEthyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate¡Û |
20mg |
¡ï8,000 |
|
78755-81-4 |
|
|
|
¡¡ |
BML |
BML-B100-0100 |
Flumazenil ¡ÚRo 15-1788¡Û¡ÚEthyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate¡Û |
100mg |
¡ï33,000 |
|
78755-81-4 |
|
|
|
¡¡ |
BML |
BML-B102-0500 |
Ethyl B-Carboline-3-carboxylate ¡ÚB-CCE¡Û |
500mg |
¡ï17,000 |
|
74214-62-3 |
|
|
|
¡¡ |
BML |
BML-B103-0005 |
3-Hydroxymethyl-B-carboline |
5mg |
¡ï6,000 |
|
65474-79-5 |
|
|
|
¡¡ |
BML |
BML-BA1115-0025 |
Bombesin(synthetic amphibian Bombesin ¡ÚPyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2¡Û), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ chicken | IHC |
|
|
¡¡ |
BML |
BML-BA1115-0100 |
Bombesin(synthetic amphibian Bombesin ¡ÚPyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2¡Û), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ chicken | IHC |
|
|
¡¡ |
BML |
BML-BA1117-0025 |
Brain Natriuretic Peptide ¡ÚBNP¡Û(human, peptide), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-BA1117-0100 |
Brain Natriuretic Peptide ¡ÚBNP¡Û(human, peptide), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-BP9115-0500 |
Bombesin Peptide, Blocking peptide for Bombesin pAb(Prod. No. BML-BA1115) |
500ug |
¡ï5,000 |
|
31362-50-2 |
|
|
|
¡¡ |
BML |
BML-BP9117-0100 |
Brain Natriuretic Peptide ¡ÚBNP¡Û, Blocking peptide for Brain natriuretic peptide pAb(Prod. No. BML-BA1117) |
100ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-BW8515-0005 |
Boc-Leu-Arg-Arg-AMC ¡ÚBoc-LRR-AMC¡Û(Fluorogenic Substrate) |
5mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-BW9315-0100 |
Bactenecin-5 Precursor Peptide ¡ÚBac5-GRR¡Û |
0.1mg* |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-BW9375-0005 |
Bz-Val-Gly-Arg-AMC ¡ÚBz-VGR-AMC¡Û(Fluorogenic Substrate) |
5mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-C104-0050 |
4-DAMP ¡Ú4-Diphenylacetoxy-N-methylpiperidine Methiodide¡Û |
50mg |
¡ï20,000 |
|
1952-15-4 |
|
|
|
¡¡ |
BML |
BML-C106-0200 |
Hydroxytacrine, Maleate ¡Ú9-Amino-1,2,3,4-tetrahydroacridin-1-ol Maleate¡Û |
200mg |
¡ï8,000 |
|
118909-22-1 |
|
|
|
¡¡ |
BML |
BML-C106-1000 |
Hydroxytacrine, Maleate ¡Ú9-Amino-1,2,3,4-tetrahydroacridin-1-ol Maleate¡Û |
1g |
¡ï33,000 |
|
118909-22-1 |
|
|
|
¡¡ |
BML |
BML-C109-0100 |
Oxotremorine, Sesquifumarate ¡ÚOxotremorine Sesquifumarate¡Û |
100mg |
¡ï5,000 |
|
17360-35-9 |
|
|
|
¡¡ |
BML |
BML-C110-0001 |
Tacrine, HCl |
1g |
¡ï3,000 |
|
1684-40-8 |
|
|
|
¡¡ |
BML |
BML-C110-0005 |
Tacrine, HCl |
5g |
¡ï14,000 |
|
1684-40-8 |
|
|
|
¡¡ |
BML |
BML-C111-0200 |
(¡Þ)-Vesamicol, HCl ¡ÚAH-5183¡Û |
200mg |
¡ï13,000 |
|
120447-62-3 |
|
|
|
¡¡ |
BML |
BML-C114-0001 |
(¡Þ)-Epibatidine |
1mg |
¡ï8,000 |
|
140111-52-0 |
|
|
|
¡¡ |
BML |
BML-C114-0005 |
(¡Þ)-Epibatidine |
5mg |
¡ï32,000 |
|
140111-52-0 |
|
|
|
¡¡ |
BML |
BML-C118-0001 |
(¡Þ)-Anatoxin ¡Ú(¡Þ)2-Acetyl-9-azabicyclo[4.2.1]non-2-ene, Fumarate¡Û |
1mg |
¡ï27,000 |
|
64285-06-9 |
|
|
|
¡¡ |
BML |
BML-C119-0050 |
McN-A-343 ¡Ú4-(N-[3-Chlorophenyl]carbamoyloxy)-2-butynyltrimethylammonium Chloride¡Û |
50mg |
¡ï12,000 |
|
55-45-8 |
|
|
|
¡¡ |
BML |
BML-C120-0010 |
Bombesin(synthetic amphibian Bombesin ¡ÚPyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2¡Û), rabbit pAb |
10mg |
¡ï11,000 |
|
123464-89-1 |
|
|
|
¡¡ |
BML |
BML-C120-0050 |
PNU-282987 ¡ÚN-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide¡Û |
50mg |
¡ï46,000 |
|
123464-89-1 |
|
|
|
¡¡ |
BML |
BML-C121-0010 |
BQCA ¡Ú1-(4-Methoxybenzyl)-4-oxo-1,4-dihydro-3-quinoline carboxylic Acid¡Û |
10mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-C121-0050 |
BQCA ¡Ú1-(4-Methoxybenzyl)-4-oxo-1,4-dihydro-3-quinoline carboxylic Acid¡Û |
50mg |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA100-0010 |
Antibiotic A-23187 ¡ÚCalcimycin¡Û |
10mg |
¡ï13,000 |
|
52665-69-7 |
|
|
|
¡¡ |
BML |
BML-CA101-0001 |
Antibiotic A-23187, 4-Bromo ¡Ú4-BromoAntibiotic A-23187¡Û |
1mg |
¡ï12,000 |
|
76455-82-8 |
|
|
|
¡¡ |
BML |
BML-CA1120-0050 |
Caldesmon(human)[TD107], mouse mAb,(ascites fluid)(specificity: human) |
50ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | TD107 | human | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-CA1123-0025 |
Cholecystokinin-39 ¡ÚCCK-39¡Û(mammalian, peptide, aa 9-20), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1123-0100 |
Cholecystokinin-39 ¡ÚCCK-39¡Û(mammalian, peptide, aa 9-20), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1124-0025 |
Cholecystokinin-39 ¡ÚCCK-39¡Û(mammalian, peptide), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1124-0100 |
Cholecystokinin-39 ¡ÚCCK-39¡Û(mammalian, peptide), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1125-0025 |
Cholecystokinin-8 ¡ÚCCK-8¡Û(mammalian, peptide, 8aa(Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-OH)), rabbit pAb. |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1125-0100 |
Cholecystokinin-8 ¡ÚCCK-8¡Û(mammalian, peptide, 8aa(Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-OH)), rabbit pAb. |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-CA1128-0050 |
Chromogranin A ¡ÚCgA¡Û(human, peptide(Leu-Pro-Val-Asn-Ser-Pro-Met-Asn-Lys-Gly-Asp-Thr-Glu-Val-Met-Lys-Cys))(NT), sheep pAb, purified |
50ul |
¡ï26,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CA1128-0100 |
Chromogranin A ¡ÚCgA¡Û(human, peptide(Leu-Pro-Val-Asn-Ser-Pro-Met-Asn-Lys-Gly-Asp-Thr-Glu-Val-Met-Lys-Cys))(NT), sheep pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CA1134-0025 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide), rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-CA1134-0100 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide), rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-CA1135-0025 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide:37aa)(CT)[CD8], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CD8 | human¡¢ guinea pig | IHC |
|
|
¡¡ |
BML |
BML-CA1135-0100 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide:37aa)(CT)[CD8], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CD8 | human¡¢ guinea pig | IHC |
|
|
¡¡ |
BML |
BML-CA1137-0025 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide), sheep pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat¡¢ rabbit¡¢ many mammalian | IHC |
|
|
¡¡ |
BML |
BML-CA1137-0100 |
Calcitonin Gene Related Peptide ¡ÚCGRP¡Û(rat, peptide), sheep pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat¡¢ rabbit¡¢ many mammalian | IHC |
|
|
¡¡ |
BML |
BML-CA1138-0100 |
Cytokeratin 18(porcine kidney epithelial cells(LLC-PK))[4B11], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 4B11 | human¡¢ mouse¡¢ rat¡¢ pig | WB(45 kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-CA1139-0100 |
Cytokeratin 7, 17 & 19 (porcine kidney epithelial cells(LLC-PK))[4F5], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 4F5 | human¡¢ mouse¡¢ rat¡¢ pig | WB(54¡¢ 46¡¢ 40 kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-CA1141-0100 |
Cytokeratin 8, 18 & 19(porcine kidney epithelial cells(LLC-PK))[2A4], mouse mAb, Affinity-purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 2A4 | human¡¢ mouse¡¢ rat¡¢ pig | WB(52¡¢ 45¡¢ 40 kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-CA202-0100 |
Amlodipine |
100mg |
¡ï8,000 |
|
88150-42-9 |
|
|
|
¡¡ |
BML |
BML-CA202-1000 |
Amlodipine |
1g |
¡ï24,000 |
|
88150-42-9 |
|
|
|
¡¡ |
BML |
BML-CA204-0005 |
2',4'-Dichlorobenzamil, HCl |
5mg |
¡ï10,000 |
|
1166-01-4 |
|
|
|
¡¡ |
BML |
BML-CA204-0025 |
2',4'-Dichlorobenzamil, HCl |
25mg |
¡ï39,000 |
|
1166-01-4 |
|
|
|
¡¡ |
BML |
BML-CA207-0005 |
L-cis-Diltiazem, HCl |
5mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA213-0010 |
Isradipine |
10mg |
¡ï10,000 |
|
75695-93-1 |
|
|
|
¡¡ |
BML |
BML-CA213-0050 |
Isradipine |
50mg |
¡ï40,000 |
|
75695-93-1 |
|
|
|
¡¡ |
BML |
BML-CA216-0010 |
Niguldipine, HCl |
10mg |
¡ï10,000 |
|
113317-61-6 |
|
|
|
¡¡ |
BML |
BML-CA216-0050 |
Niguldipine, HCl |
50mg |
¡ï40,000 |
|
113317-61-6 |
|
|
|
¡¡ |
BML |
BML-CA2218-0025 |
Chromogranin A ¡ÚCgA¡Û(human phaeochromocytoma)[LK2H10], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | LK2H10 | mammalian | IHC¡¢ WB(68kDa)¡¢ Electron Microscopy |
|
|
¡¡ |
BML |
BML-CA230-0005 |
SK&F 96365 ¡ÚSKF-96365, HCl¡Û¡Ú1-[B-[3-(4-Methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole, HCl¡Û |
5mg |
¡ï12,000 |
|
130495-35-1 |
|
|
|
¡¡ |
BML |
BML-CA230-0025 |
SK&F 96365 ¡ÚSKF-96365, HCl¡Û¡Ú1-[B-[3-(4-Methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole, HCl¡Û |
25mg |
¡ï50,000 |
|
130495-35-1 |
|
|
|
¡¡ |
BML |
BML-CA231-0010 |
BCTC ¡ÚN-(4-tert-Butylphenyl)-4-(3-Chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA231-0050 |
BCTC ¡ÚN-(4-tert-Butylphenyl)-4-(3-Chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide¡Û |
50mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA232-0010 |
AMG-9810 ¡Ú(E)-3-(4-tert-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide¡Û |
10mg |
¡ï10,000 |
|
545395-94-6 |
|
|
|
¡¡ |
BML |
BML-CA232-0050 |
AMG-9810 ¡Ú(E)-3-(4-tert-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide¡Û |
50mg |
¡ï43,000 |
|
545395-94-6 |
|
|
|
¡¡ |
BML |
BML-CA234-0020 |
Gabapentin ¡Ú1-(Aminomethyl)cyclohexaneacetic Acid¡Û¡ÚNeurontin¡Û |
20mg |
¡ï9,000 |
|
60142-96-3 |
|
|
|
¡¡ |
BML |
BML-CA234-0100 |
Gabapentin ¡Ú1-(Aminomethyl)cyclohexaneacetic Acid¡Û¡ÚNeurontin¡Û |
100mg |
¡ï37,000 |
|
60142-96-3 |
|
|
|
¡¡ |
BML |
BML-CA236-0010 |
Felodipine ¡ÚEthyl Methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine Dicarboxylate¡Û |
10mg |
¡ï8,000 |
|
72509-76-3 |
|
|
|
¡¡ |
BML |
BML-CA236-0050 |
Felodipine ¡ÚEthyl Methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine Dicarboxylate¡Û |
50mg |
¡ï28,000 |
|
72509-76-3 |
|
|
|
¡¡ |
BML |
BML-CA237-0010 |
Cilnidipine ¡ÚFRC-8653¡Û¡Ú1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl(2E)-3-Phenyl-2-propenyl Ester¡Û |
10mg |
¡ï9,000 |
|
132203-70-4 |
|
|
|
¡¡ |
BML |
BML-CA237-0050 |
Cilnidipine ¡ÚFRC-8653¡Û¡Ú1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl(2E)-3-Phenyl-2-propenyl Ester¡Û |
50mg |
¡ï37,000 |
|
132203-70-4 |
|
|
|
¡¡ |
BML |
BML-CA239-0005 |
AP-18 ¡Ú4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA239-0025 |
AP-18 ¡Ú4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime¡Û |
25mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA241-0010 |
HC31 ¡ÚTheophylline-7-(N-4-isopropylphenyl)acetamide¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA241-0050 |
HC31 ¡ÚTheophylline-7-(N-4-isopropylphenyl)acetamide¡Û |
50mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA242-0005 |
Polygodial |
5mg |
¡ï11,000 |
|
6754-20-7 |
|
|
|
¡¡ |
BML |
BML-CA242-0025 |
Polygodial |
25mg |
¡ï43,000 |
|
6754-20-7 |
|
|
|
¡¡ |
BML |
BML-CA260-0050 |
Tetrandrine ¡Ú6,6¡Ç,7,12-Tetramethoxy-2,2¡Ç-dimethylberbaman¡Û |
50mg |
¡ï5,000 |
|
518-34-3 |
|
|
|
¡¡ |
BML |
BML-CA260-0250 |
Tetrandrine ¡Ú6,6¡Ç,7,12-Tetramethoxy-2,2¡Ç-dimethylberbaman¡Û |
250mg |
¡ï18,000 |
|
518-34-3 |
|
|
|
¡¡ |
BML |
BML-CA300-0010 |
Calmidazolium Chloride ¡ÚR24571¡Û |
10mg |
¡ï14,000 |
|
57265-65-3 |
|
|
|
¡¡ |
BML |
BML-CA300-0050 |
Calmidazolium Chloride ¡ÚR24571¡Û |
50mg |
¡ï59,000 |
|
57265-65-3 |
|
|
|
¡¡ |
BML |
BML-CA302-0010 |
E6 Berbamine |
10mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA302-0050 |
E6 Berbamine |
50mg |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA315-0020 |
W-5 ¡ÚN-(6-Aminohexyl)-1-naphthalenesulfonamide, HCl¡Û |
20mg |
¡ï17,000 |
|
61714-25-8 |
|
|
|
¡¡ |
BML |
BML-CA320-0050 |
W-7 ¡ÚN-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide, HCl¡Û |
50mg |
¡ï11,000 |
|
61714-27-0 |
|
|
|
¡¡ |
BML |
BML-CA325-0050 |
Fluphenazine-N-2-chloroethane, 2HCl |
50mg |
¡ï11,000 |
|
83016-35-7 |
|
|
|
¡¡ |
BML |
BML-CA409-0050 |
Xestospongin C(Isolated from an Okinawan marine sponge Xestospongia sp) |
50ug |
¡ï47,000 |
|
88903-69-9 |
|
|
|
¡¡ |
BML |
BML-CA410-0005 |
BAY K-8644 ¡Ú1,4-Dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)pyridine-3-carboxylic Acid, Methyl Ester¡Û |
5mg |
¡ï24,000 |
|
93468-89-4 |
|
|
|
¡¡ |
BML |
BML-CA411-0025 |
BAPTA-AM ¡Ú1,2-bis-(o-Aminophenoxy)ethane-N,N,-N¡Ç,N¡Ç-tetraacetic Acid Tetraacetoxy Methyl Ester¡Û |
25mg |
¡ï21,000 |
|
139890-68-9 |
|
|
|
¡¡ |
BML |
BML-CA412-0100 |
BAPTA, free Acid ¡Ú1,2-bis-(o-Aminophenoxy)ethane-N,N,-N¡Ç,N¡Ç-tetraacetic Acid¡Û |
100mg |
¡ï8,000 |
|
85233-19-8 |
|
|
|
¡¡ |
BML |
BML-CA412-0500 |
BAPTA, free Acid ¡Ú1,2-bis-(o-Aminophenoxy)ethane-N,N,-N¡Ç,N¡Ç-tetraacetic Acid¡Û |
500mg |
¡ï31,000 |
|
85233-19-8 |
|
|
|
¡¡ |
BML |
BML-CA415-0010 |
Cyclopiazonic Acid ¡ÚCPA¡Û |
10mg |
¡ï14,000 |
|
18172-33-3 |
|
|
|
¡¡ |
BML |
BML-CA415-0050 |
Cyclopiazonic Acid ¡ÚCPA¡Û |
50mg |
¡ï58,000 |
|
18172-33-3 |
|
|
|
¡¡ |
BML |
BML-CA416-0100 |
cADP-ribose ¡ÚcADPR¡Û |
100ug |
¡ï9,000 |
|
119340-53-3 |
|
|
|
¡¡ |
BML |
BML-CA416-0500 |
cADP-ribose ¡ÚcADPR¡Û |
500ug |
¡ï37,000 |
|
119340-53-3 |
|
|
|
¡¡ |
BML |
BML-CA417-0100 |
8-Bromo-cADP-ribose ¡Ú8-Br-cADPR¡Û |
100ug |
¡ï8,000 |
|
151898-26-9 |
|
|
|
¡¡ |
BML |
BML-CA417-0500 |
8-Bromo-cADP-ribose ¡Ú8-Br-cADPR¡Û |
500ug |
¡ï24,000 |
|
151898-26-9 |
|
|
|
¡¡ |
BML |
BML-CA421-0005 |
Nigericin, Na salt ¡ÚAntibiotic K 178¡Û |
5mg |
¡ï8,000 |
|
28643-80-3; 28380-24-7 |
|
|
|
¡¡ |
BML |
BML-CA422-0005 |
Gingerol ¡Ú[6]-Gingerol¡Û¡Ú(S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone¡Û |
5mg |
¡ï13,000 |
|
23513-14-6 |
|
|
|
¡¡ |
BML |
BML-CA422-0020 |
Gingerol ¡Ú[6]-Gingerol¡Û¡Ú(S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone¡Û |
20mg |
¡ï47,000 |
|
23513-14-6 |
|
|
|
¡¡ |
BML |
BML-CA501-0005 |
SNX-482 |
5ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA502 |
Calciseptine |
70ug |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CA9360-0025 |
aB-Crystallin(human, aa 1-10), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CA9360-0100 |
aB-Crystallin(human, aa 1-10), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CB10218-0050 |
Cytokeratin 3(rabbit corneal epithelial keratin)[AE5], mouse mAb, purified |
50ug |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | AE5 | human¡¢ rabbit¡¢ dog¡¢ bovine | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-CC100-0100 |
2-Aminopurine ¡Ú2-AP¡Û |
100mg |
¡ï9,000 |
|
452-06-2 |
|
|
|
¡¡ |
BML |
BML-CC100-0500 |
2-Aminopurine ¡Ú2-AP¡Û |
500mg |
¡ï38,000 |
|
452-06-2 |
|
|
|
¡¡ |
BML |
BML-CC101-0001 |
(+)-Aphidicolin |
1mg |
¡ï9,000 |
|
38966-21-1 |
|
|
|
¡¡ |
BML |
BML-CC102-0500 |
L-Mimosine ¡ÚB-[N-(3-hydroxy-4-pyridone)]-a-aminopropionic Acid¡Û |
500mg |
¡ï31,000 |
|
500-44-7 |
|
|
|
¡¡ |
BML |
BML-CC104-0010 |
Tunicamycin(Isolated from Streptomyces lysosuperficus) |
10mg |
¡ï19,000 |
|
11089-65-9 |
|
|
|
¡¡ |
BML |
BML-CC205-0002 |
(R)-Roscovitine ¡ÚRoscovitine,(R)-¡Û¡Ú6-Benzylamino-2-(R)-((1-ethyl)-2-hydroxyethylamino)-9-isopropylpurine, 2(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine¡Û |
2mg |
¡ï8,000 |
-20¡î |
186692-46-6 |
|
Purity: ¡ä95%, Formula: C19H26N6O, MW: 354.4 Solubility: soluble in DMSO.
|
|
¡¡ |
BML |
BML-CC205-0005 |
(R)-Roscovitine ¡ÚRoscovitine,(R)-¡Û¡Ú6-Benzylamino-2-(R)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine¡Û¡Ú2(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine¡Û |
5mg |
¡ï20,000 |
|
186692-46-6 |
|
|
|
¡¡ |
BML |
BML-CC207-0001 |
Indirubin-3'-monoxime |
1mg |
¡ï9,000 |
|
160807-49-8 |
|
|
|
¡¡ |
BML |
BML-CC207-0005 |
Indirubin-3'-monoxime |
5mg |
¡ï40,000 |
|
160807-49-8 |
|
|
|
¡¡ |
BML |
BML-CC210-0200 |
Butyrolactone I |
200ug |
¡ï13,000 |
|
87414-49-1 |
|
|
|
¡¡ |
BML |
BML-CC210-1000 |
Butyrolactone I |
1mg |
¡ï55,000 |
|
87414-49-1 |
|
|
|
¡¡ |
BML |
BML-CG1920-0100 |
Calpain I, II small subunit p30 ¡Úm-Calpain and ¦Ì-Calpain¡Û(human placenta)[28F3], mouse mAb, purified |
100ug |
¡ï32,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 28F3 | human¡¢ bovine | WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-CG1925-0500 |
Calpain I, II small subunit p30 ¡Úm-Calpain and ¦Ì-Calpain¡Û(human placenta)[28F3], mouse mAb, -agarose immobilized |
0.5mL |
¡ï38,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 28F3 | human¡¢ bovine | IP |
|
|
¡¡ |
BML |
BML-CG1928-0100 |
Calpain I ¡Ú¦Ì-calpain¡Û(human placenta)[15C10], mouse mAb, purified |
100ug |
¡ï32,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 15C10 | human¡¢ mouse¡¢ rat¡¢ bovine | WB(80kDa)¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-CL3710-0025 |
Cysteine String Proteins ¡Úcsp1and csp2¡Û(bovine)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CL3710-0100 |
Cysteine String Proteins ¡Úcsp1and csp2¡Û(bovine)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CM100-0010 |
NPPB ¡Ú5-Nitro-2-(3¡Ç-phenylpropylamino)benzoic Acid¡Û |
10mg |
¡ï6,000 |
|
107254-86-4 |
|
|
|
¡¡ |
BML |
BML-CM100-0050 |
NPPB ¡Ú5-Nitro-2-(3¡Ç-phenylpropylamino)benzoic Acid¡Û |
50mg |
¡ï26,000 |
|
107254-86-4 |
|
|
|
·àʪ |
BML |
BML-CM102-0020 |
Fipronil ¡Ú5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile¡Û |
20mg |
¡ï6,000 |
|
120068-37-3 |
|
|
|
·àʪ |
BML |
BML-CM102-0100 |
Fipronil ¡Ú5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile¡Û |
100mg |
¡ï27,000 |
|
120068-37-3 |
|
|
|
¡¡ |
BML |
BML-CM110-0100 |
Bafilomycin A1 |
100ug |
¡ï20,000 |
|
88899-55-2 |
|
|
|
¡¡ |
BML |
BML-CM111-0005 |
Oligomycin A |
5mg |
¡ï19,000 |
|
579-13-5 |
|
|
|
¡¡ |
BML |
BML-CM111-0025 |
Oligomycin A |
25mg |
¡ï79,000 |
|
579-13-5 |
|
|
|
¡¡ |
BML |
BML-CM112-0500 |
Clopamide ¡Ú4-Chloro-N-(2,6-dimethylpiperidinyl)-3-sulfamoylbenzamide¡Û |
500mg |
¡ï4,000 |
|
636-54-4 |
|
|
|
¡¡ |
BML |
BML-CM113-0100 |
Bongkrekic Acid |
100ug |
¡ï16,000 |
|
11076-19-0 |
|
|
|
¡¡ |
BML |
BML-CM113-1000 |
Bongkrekic Acid |
1mg |
¡ï144,000 |
|
11076-19-0 |
|
|
|
¡¡ |
BML |
BML-CM115-0010 |
Decylubiquinine ¡Ú2,3-Dimethoxy-5-methyl-6-decyl-1,4-benzoquinone¡Û |
10mg |
¡ï6,000 |
|
55486-00-5 |
|
|
|
¡¡ |
BML |
BML-CM115-0050 |
Decylubiquinine ¡Ú2,3-Dimethoxy-5-methyl-6-decyl-1,4-benzoquinone¡Û |
50mg |
¡ï27,000 |
|
55486-00-5 |
|
|
|
¡¡ |
BML |
BML-CM116-0005 |
Citrinin |
5mg |
¡ï11,000 |
|
518-75-2 |
|
|
|
¡¡ |
BML |
BML-CM116-0025 |
Citrinin |
25mg |
¡ï44,000 |
|
518-75-2 |
|
|
|
¡¡ |
BML |
BML-CM118-0005 |
PK-11195 ¡Ú1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide¡Û |
5mg |
¡ï7,000 |
|
85532-75-8 |
|
|
|
¡¡ |
BML |
BML-CM118-0025 |
PK-11195 ¡Ú1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide¡Û |
25mg |
¡ï30,000 |
|
85532-75-8 |
|
|
|
¡¡ |
BML |
BML-CM119-0005 |
CGP-37157 ¡Ú7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one¡Û |
5mg |
¡ï12,000 |
|
75450-34-9 |
|
|
|
¡¡ |
BML |
BML-CM119-0025 |
CGP-37157 ¡Ú7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one¡Û |
25mg |
¡ï51,000 |
|
75450-34-9 |
|
|
|
·àʪ |
BML |
BML-CM120-0010 |
FCCP ¡ÚCarbonylcyanide-4-(trifluoromethoxy)phenylhydrazone¡Û |
10mg |
¡ï10,000 |
|
370-86-5 |
|
|
|
·àʪ |
BML |
BML-CM120-0050 |
FCCP ¡ÚCarbonylcyanide-4-(trifluoromethoxy)phenylhydrazone¡Û |
50mg |
¡ï39,000 |
|
370-86-5 |
|
|
|
¡¡ |
BML |
BML-CM123-0001 |
2-Methoxyantimycin A3 |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CM123-0005 |
2-Methoxyantimycin A3 |
5mg |
¡ï33,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-CM124-0500 |
CCCP ¡ÚCarbonylcyanide 3-Chlorophenylhydrazone¡Û |
500mg |
¡ï14,000 |
|
555-60-2 |
|
|
|
¡¡ |
BML |
BML-CM125-0010 |
Embelin ¡Ú2,5-Dihydroxy-3-undecyl-1,4-benzoquinone¡Û |
10mg |
¡ï9,000 |
|
550-24-3 |
|
|
|
¡¡ |
BML |
BML-CM125-0050 |
Embelin ¡Ú2,5-Dihydroxy-3-undecyl-1,4-benzoquinone¡Û |
50mg |
¡ï36,000 |
|
550-24-3 |
|
|
|
¡¡ |
BML |
BML-CM126-0010 |
Icilin ¡ÚAG 3-5¡Û¡Ú3,6-Dihydro-1-(2-hydroxyphenyl)-4-(3-nitrophenyl)-2(1H)-pyrimidinone¡Û |
10mg |
¡ï10,000 |
|
36945-98-9 |
|
|
|
¡¡ |
BML |
BML-CM126-0050 |
Icilin ¡ÚAG 3-5¡Û¡Ú3,6-Dihydro-1-(2-hydroxyphenyl)-4-(3-nitrophenyl)-2(1H)-pyrimidinone¡Û |
50mg |
¡ï41,000 |
|
36945-98-9 |
|
|
|
¡¡ |
BML |
BML-CM127-0010 |
Mdivi-1 ¡Ú3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CM127-0050 |
Mdivi-1 ¡Ú3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone¡Û |
50mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CM128-0050 |
4,4-Pentamethylenepiperidine, HCl ¡Ú3-Azaspiro[5.5]undecane, HCl¡Û |
50mg |
¡ï9,000 |
|
180-44-9 |
|
|
|
¡¡ |
BML |
BML-CN100-0010 |
Forskolin ¡ÚColforsin¡Û(Isolated from Coleus forskohlii) |
10mg |
¡ï14,000 |
|
66575-29-9 |
|
|
|
¡¡ |
BML |
BML-CN100-0100 |
Forskolin ¡ÚColforsin¡Û(Isolated from Coleus forskohlii) |
100mg |
¡ï85,000 |
|
66575-29-9 |
|
|
|
¡¡ |
BML |
BML-CN105-0005 |
L-858051 ¡Ú7-Deacetyl-7B-(¦Ã-N-methylpiperazino)-butyrylforskolin, 2HCl¡Û |
5mg |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CN110-0005 |
2',5'-Dideoxyadenosine |
5mg |
¡ï12,000 |
|
6698-26-6 |
|
|
|
¡¡ |
BML |
BML-CN110-0025 |
2',5'-Dideoxyadenosine |
25mg |
¡ï51,000 |
|
6698-26-6 |
|
|
|
¡¡ |
BML |
BML-CN115-0010 |
8-Bromo-cAMP ¡Ú8-Bromoadenosine-3',5'-cyclic Monophosphate, Na salt¡Û |
10mg |
¡ï6,000 |
|
76939-46-3 |
|
|
|
¡¡ |
BML |
BML-CN115-0050 |
8-Bromo-cAMP ¡Ú8-Bromoadenosine-3',5'-cyclic Monophosphate, Na salt¡Û |
50mg |
¡ï20,000 |
|
76939-46-3 |
|
|
|
¡¡ |
BML |
BML-CN120-0001 |
Sp-5,6-Dichloro-cBIMPS ¡ÚSp-5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate¡Û |
1mg |
¡ï28,000 |
|
120912-54-1 |
|
|
|
¡¡ |
BML |
BML-CN125-0030 |
Dibutyryl-cAMP |
30mg |
¡ï9,300 |
|
16980-89-5 |
|
|
|
¡¡ |
BML |
BML-CN125-0100 |
Dibutyryl-cAMP |
100mg |
¡ï14,000 |
|
16980-89-5 |
|
|
|
¡¡ |
BML |
BML-CN130-0020 |
8-CPT-cAMP ¡Ú8-(4-Chlorophenylthio)adenosine-3',5'-cyclic Monophosphate, Na salt¡Û |
20mg |
¡ï8,000 |
|
93882-12-3 |
|
|
|
¡¡ |
BML |
BML-CN130-0100 |
8-CPT-cAMP ¡Ú8-(4-Chlorophenylthio)adenosine-3',5'-cyclic Monophosphate, Na salt¡Û |
100mg |
¡ï32,000 |
|
93882-12-3 |
|
|
|
¡¡ |
BML |
BML-CN135-0001 |
Rp-cAMPS ¡ÚRp-Adenosine-3',5'-cyclic Monophosphorothioate¡Û |
1mg |
¡ï15,000 |
|
73208-40-9 |
|
|
|
¡¡ |
BML |
BML-CN136-0001 |
Sp-cAMPS ¡ÚSp-Adenosine-3',5'-cyclic Monophosphorothioate¡Û |
1mg |
¡ï7,000 |
|
71774-13-5 |
|
|
|
¡¡ |
BML |
BML-CN140-0005 |
SQ 22536 ¡Ú9-(Tetrahydro-2¡Ç-furyl)adenine¡Û |
5mg |
¡ï11,000 |
|
17318-31-9 |
|
|
|
¡¡ |
BML |
BML-CN140-0025 |
SQ 22536 ¡Ú9-(Tetrahydro-2¡Ç-furyl)adenine¡Û |
25mg |
¡ï45,000 |
|
17318-31-9 |
|
|
|
¡¡ |
BML |
BML-CN145-0005 |
MDL-12,330A ¡Úcis-N-(2-Phenylcyclopentyl)azacyclotridec-1-en-2-amine, HCl¡Û |
5mg |
¡ï7,000 |
|
40297-09-4 |
|
|
|
¡¡ |
BML |
BML-CN145-0025 |
MDL-12,330A ¡Úcis-N-(2-Phenylcyclopentyl)azacyclotridec-1-en-2-amine, HCl¡Û |
25mg |
¡ï31,000 |
|
40297-09-4 |
|
|
|
¡¡ |
BML |
BML-CN150-0050 |
Adenylate Cyclase Toxin ¡ÚAC Toxin¡Û |
50ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CN205-0010 |
8-Bromo-cGMP ¡Ú8-Bromoguanosine-3',5'-cyclic Monophosphate, Na salt¡Û |
10mg |
¡ï8,000 |
|
51116-01-9 |
|
|
|
¡¡ |
BML |
BML-CN205-0050 |
8-Bromo-cGMP ¡Ú8-Bromoguanosine-3',5'-cyclic Monophosphate, Na salt¡Û |
50mg |
¡ï32,000 |
|
51116-01-9 |
|
|
|
¡¡ |
BML |
BML-CN206-0001 |
Rp-8-pCPT-cGMPS, Na salt ¡ÚRp-8-(4-Chlorophenylthio)guanosine-3¡Ç,5¡Ç-cyclic Monophosphorothioate, Na salt¡Û |
1mg |
¡ï30,000 |
|
153660-04-9 |
|
|
|
¡¡ |
BML |
BML-CN207-0001 |
Sp-8-pCPT-cGMPS, Na salt ¡ÚSp-8-(4-Chlorophenylthio)guanosine-3¡Ç,5¡Ç-cyclic Monophosphorothioate, Na salt¡Û |
1mg |
¡ï27,000 |
|
160385-87-5 |
|
|
|
¡¡ |
BML |
BML-CN210-0020 |
SNAP ¡ÚS-Nitroso-N-acetyl-DL-penicillamine¡Û |
20mg |
¡ï8,000 |
|
79032-48-7 |
|
|
|
¡¡ |
BML |
BML-CN210-0100 |
SNAP ¡ÚS-Nitroso-N-acetyl-DL-penicillamine¡Û |
100mg |
¡ï32,000 |
|
79032-48-7 |
|
|
|
¡¡ |
BML |
BML-CN215-0010 |
Dibutyryl-cGMP ¡ÚN2,2'-O-Dibutyrylguanosine-3',5'-cyclic Monophosphate, Na salt¡Û |
10mg |
¡ï12,000 |
|
51116-00-8 |
|
|
|
¡¡ |
BML |
BML-CN215-0050 |
Dibutyryl-cGMP ¡ÚN2,2'-O-Dibutyrylguanosine-3',5'-cyclic Monophosphate, Na salt¡Û |
50mg |
¡ï46,000 |
|
51116-00-8 |
|
|
|
¡¡ |
BML |
BML-CN216-0500 |
Rp-8-Br-cGMPS ¡ÚRp-8-Bromoguanosine-3',5'-cyclic Monophosphorothioate, Na salt¡Û |
500ug |
¡ï19,000 |
|
150418-07-8 |
|
|
|
¡¡ |
BML |
BML-CN217-0500 |
Sp-8-Br-cGMPS ¡ÚSp-8-Bromoguanosine-3',5'-cyclic Monophosphorothioate, Na salt¡Û |
500ug |
¡ï7,000 |
|
153660-03-8 |
|
|
|
¡¡ |
BML |
BML-CN240-0010 |
Diphenyleneiodonium Chloride ¡ÚDibenziodolium Chloride¡Û¡ÚDPI Chloride¡Û |
10mg |
¡ï6,000 |
|
4673-26-1 |
|
|
|
¡¡ |
BML |
BML-CN245-0020 |
3-Morpholinosydnonimine ¡ÚSIN-1¡Û |
20mg |
¡ï8,000 |
|
33876-97-0 |
|
|
|
¡¡ |
BML |
BML-CN245-0100 |
3-Morpholinosydnonimine ¡ÚSIN-1¡Û |
100mg |
¡ï32,000 |
|
33876-97-0 |
|
|
|
¡¡ |
BML |
BML-CN248-0010 |
N(5)-(1-Iminoethyl)-L-ornithine?HCl ¡ÚL-NIO¡Û |
10mg |
¡ï20,000 |
|
36889-13-1 |
|
|
|
¡¡ |
BML |
BML-CN248-0050 |
N(5)-(1-Iminoethyl)-L-ornithine?HCl ¡ÚL-NIO¡Û |
50mg |
¡ï68,000 |
|
36889-13-1 |
|
|
|
¡¡ |
BML |
BML-CN254-0010 |
N,O-Diacetyl-N-hydroxy-4-chlorobenzenesulphonamide |
10mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CN254-0050 |
N,O-Diacetyl-N-hydroxy-4-chlorobenzenesulphonamide |
50mg |
¡ï31,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-CN255-0010 |
Furoxan ¡Ú4-Phenyl-3-furoxancarbonitrile¡Û |
10mg |
¡ï8,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-CN255-0050 |
Furoxan ¡Ú4-Phenyl-3-furoxancarbonitrile¡Û |
50mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0111-0100 |
Cytochrome P450 1A1(rat)C-terminal Peptide, Blocking peptide for Cytochrome P450 1A1(rat)pAbs(Prod. No.(Prod. No. BML-CR3110 & BML-CR3115) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0121-0100 |
Cytochrome P450 1A1(human)C-terminal Peptide, Blocking peptide for Cytochrome P450 1A1(human)pAbs(Prod. No. BML-CR3120 & BML-CR3125 ) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0123-0100 |
Cytochrome P450 1A2(human)Peptide ¡ÚCYP1A2(human, aa 284-295)¡Û, Blocking peptide for Cytochrome P450 1A2(human)pAb(Prod. No. BML-CR3130) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0124-0100 |
Cytochrome P450 1A2(rat)C-terminal Peptide, Blocking peptide for Cytochrome P450 1A2(rat)pAb(Prod. No. BML-CR3135) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0201-0100 |
Cytochrome P450 2D1(rat)C-terminal Peptide, Blocking peptide for Cytochrome P450 2D1(rat)pAb(Prod. No. BML-CR3210) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0265-0100 |
Cytochrome P450 2D6(human)C-terminal Peptide, Blocking peptide for Cytochrome P450 2D6(human)pAb(Prod. No. BML-CR3245) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0270-0100 |
Cytochrome P450 2E1(rat/human/rabbit/mouse)C-terminal Peptide, Blocking peptide for Cytochrome P450 2E1 pAbs(Prod. No. BML-CR3271 & BML-CR3275) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0281-0100 |
Cytochrome P450 2C8, 2C9, 2C19 and 2C12 C-terminal Peptide, Blocking peptide for Cytochrome P450(human)and CYP2C12(rat)pAbs(Prod. No. BML-CR3280 & BML-CR3285) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0331-0100 |
Cytochrome P450 3A1(rat)C-terminal Peptide, Blocking peptide for Cytochrome P450 3A1(rat)pAbs(Prod. No. BML-CR3310 & BML-CR3315) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0334-0100 |
Cytochrome P450 3A4/3A7(human)C-terminal Peptide, Blocking peptide for Cytochrome P450 3A4(human)pAbs(Prod. No. BML-CR3340 & BML-CR3345) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP0335-0100 |
Cytochrome P450 3A5(human)C-terminal Peptide, Blocking Peptide for Cytochrome P450 3A5(human)pAb(Prod. No. BML-CR3350) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP1428-0100 |
Chromogranin A Peptide, Blocking Peptide for Chromogranin A pAb(Prod. No. BML-CA1128) |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP6420-0001 |
Catestatin(human)¡ÚG643S¡Û¡ÚP370L¡Û¡ÚChromogranin A(352-372)¡Û |
1mg* |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP6425-0001 |
Catestatin(P370L)(human)¡Ú[P370L]Catestatin¡Û¡Ú[P370L]Chromogranin A(352-372)¡Û¡ÚP370L¡Û |
1mg* |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP6430-0001 |
Catestatin(G364S)(human)¡Ú[G364S]Catestatin¡Û¡Ú[G364S]Chromogranin A(352-372)¡Û¡ÚG364S¡Û |
1mg* |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CP6435-0001 |
Catestatin(G364S, P370L)(human)¡Ú[G364S P370L]Catestatin¡Û¡Ú[G364S, P370L]Chromogranin A(352-372)¡Û¡ÚG364S¡Û |
1mg* |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CR102-0005 |
CP-55,940 ¡Ú(-)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxyphenyl)cyclohexanol¡Û |
5mg |
¡ï19,000 |
|
83002-04-4 |
|
|
|
¡¡ |
BML |
BML-CR102-0025 |
CP-55,940 ¡Ú(-)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxyphenyl)cyclohexanol¡Û |
25mg |
¡ï78,000 |
|
83002-04-4 |
|
|
|
¡¡ |
BML |
BML-CR104-0010 |
BML-190 ¡ÚIndomethacin Morpholinylamide¡Û |
10mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CR104-0050 |
BML-190 ¡ÚIndomethacin Morpholinylamide¡Û |
50mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-CR105-0010 |
WIN-55,212-2 ¡Ú(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone, Mesylate¡Û |
10mg |
¡ï8,000 |
|
131543-23-2 |
|
|
|
¡¡ |
BML |
BML-CR105-0050 |
WIN-55,212-2 ¡Ú(R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone, Mesylate¡Û |
50mg |
¡ï34,000 |
|
131543-23-2 |
|
|
|
¡¡ |
BML |
BML-CR106-0010 |
AM-404 ¡ÚN-(4-Hydroxyphenyl)-5Z,8Z,11Z-eicosatetraenamide¡Û¡ÚN-(4-Hydroxyphenyl)arachidonoylamide¡Û |
10mg |
¡ï7,000 |
|
198022-70-7 |
|
|
|
¡¡ |
BML |
BML-CR106-0050 |
AM-404 ¡ÚN-(4-Hydroxyphenyl)-5Z,8Z,11Z-eicosatetraenamide¡Û¡ÚN-(4-Hydroxyphenyl)arachidonoylamide¡Û |
50mg |
¡ï30,000 |
|
198022-70-7 |
|
|
|
¡¡ |
BML |
BML-CR107-0010 |
AM-630 ¡Ú6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone¡Û |
10mg |
¡ï20,000 |
|
164178-33-0 |
|
|
|
¡¡ |
BML |
BML-CR108-0010 |
AM-251 ¡ÚN-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,3-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide¡Û |
10mg |
¡ï27,000 |
|
18323-66-8 |
|
|
|
¡¡ |
BML |
BML-CR109-0005 |
JWH-015 ¡Ú(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone¡Û |
5mg |
¡ï9,000 |
|
155471-08-2 |
|
|
|
¡¡ |
BML |
BML-CR109-0025 |
JWH-015 ¡Ú(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone¡Û |
25mg |
¡ï39,000 |
|
155471-08-2 |
|
|
|
¡¡ |
BML |
BML-CR110-0005 |
Pravadoline ¡Ú(4-Methoxyphenyl)(2-methyl-1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)methanone¡Û |
5mg |
¡ï8,000 |
|
92623-83-1 |
|
|
|
¡¡ |
BML |
BML-CR110-0025 |
Pravadoline ¡Ú(4-Methoxyphenyl)(2-methyl-1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)methanone¡Û |
25mg |
¡ï32,000 |
|
92623-83-1 |
|
|
|
¡¡ |
BML |
BML-CR111-0010 |
VDM-11 ¡ÚN-Arachidonoyl-4-hydroxy-2-methylaniline¡Û¡ÚN-(4-Hydroxy-2-methylphenyl)arachidonoylamide¡Û |
10mg |
¡ï7,000 |
|
313998-81-1 |
|
|
|
¡¡ |
BML |
BML-CR111-0050 |
VDM-11 ¡ÚN-Arachidonoyl-4-hydroxy-2-methylaniline¡Û¡ÚN-(4-Hydroxy-2-methylphenyl)arachidonoylamide¡Û |
50mg |
¡ï31,000 |
|
313998-81-1 |
|
|
|
¡¡ |
BML |
BML-CR112-0010 |
GW-405833 ¡Ú1-(2,3-Dichlorobenzoyl)-5-methoxy-2-methyl-(2-(morpholin-4-yl)ethyl)-1H-indole¡Û¡ÚL-768242¡Û |
10mg |
¡ï13,000 |
|
180002-83-9 |
|
|
|
¡¡ |
BML |
BML-CR112-0050 |
GW-405833 ¡Ú1-(2,3-Dichlorobenzoyl)-5-methoxy-2-methyl-(2-(morpholin-4-yl)ethyl)-1H-indole¡Û¡ÚL-768242¡Û |
50mg |
¡ï55,000 |
|
180002-83-9 |
|
|
|
¡¡ |
BML |
BML-CR113-0010 |
LY 2183240 ¡Ú5-Biphenyl-4-ylmethyl-tetrazole-1-carboxylic Acid Dimethylamide¡Û |
10mg |
¡ï8,000 |
|
874902-19-9 |
|
|
|
¡¡ |
BML |
BML-CR113-0050 |
LY 2183240 ¡Ú5-Biphenyl-4-ylmethyl-tetrazole-1-carboxylic Acid Dimethylamide¡Û |
50mg |
¡ï36,000 |
|
874902-19-9 |
|
|
|
¡¡ |
BML |
BML-CR114-0010 |
Leelamine, HCl ¡Ú(+)-Dehydroabietylamine, HCl¡Û |
10mg |
¡ï9,000 |
|
1446-61-3 |
|
|
|
¡¡ |
BML |
BML-CR114-0050 |
Leelamine, HCl ¡Ú(+)-Dehydroabietylamine, HCl¡Û |
50mg |
¡ï39,000 |
|
1446-61-3 |
|
|
|
¡¡ |
BML |
BML-CR3110-0025 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3110-0100 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3115-0025 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3115-0100 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3120-0025 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(human, peptide)(CT), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3120-0100 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(human, peptide)(CT), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3125-0025 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3125-0100 |
Cytochrome P450 1A1 ¡ÚCYP1A1¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3130-0025 |
Cytochrome P450 1A2 ¡ÚCYP1A2¡Û(human, aa 284-298)(internal domain), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3130-0100 |
Cytochrome P450 1A2 ¡ÚCYP1A2¡Û(human, aa 284-298)(internal domain), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3135-0025 |
Cytochrome P450 1A2 ¡ÚCYP1A2¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3135-0100 |
Cytochrome P450 1A2 ¡ÚCYP1A2¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3210-0025 |
Cytochrome P450 2D1 ¡ÚCYP2D1¡Û(rat liver, peptide)(CT), rabbit pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3210-0100 |
Cytochrome P450 2D1 ¡ÚCYP2D1¡Û(rat liver, peptide)(CT), rabbit pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3240-0025 |
Cytochrome P450 2D4 ¡ÚCYP2D4¡Û(rat liver, peptide)(CT), rabbit pAb, purified(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3240-0100 |
Cytochrome P450 2D4 ¡ÚCYP2D4¡Û(rat liver, peptide)(CT), rabbit pAb, purified(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3245-0025 |
Cytochrome P450 2D6 ¡ÚCYP2D6¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3245-0100 |
Cytochrome P450 2D6 ¡ÚCYP2D6¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3260-0025 |
Cytochrome P450 2A6 ¡ÚCYP2A6¡Û(human liver, peptide)(CT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3260-0100 |
Cytochrome P450 2A6 ¡ÚCYP2A6¡Û(human liver, peptide)(CT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3265-0025 |
Cytochrome P450 2A6 ¡ÚCYP2A6¡Û(human liver, peptide)(CT), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3265-0100 |
Cytochrome P450 2A6 ¡ÚCYP2A6¡Û(human liver, peptide)(CT), sheep pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3271-0025 |
Cytochrome P450 2E1 ¡ÚCYP2E1¡Û(hepatic human/rat/rabbit/mouse, peptide)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3271-0100 |
Cytochrome P450 2E1 ¡ÚCYP2E1¡Û(hepatic human/rat/rabbit/mouse, peptide)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3275-0025 |
Cytochrome P450 2E1 ¡ÚCYP2E1¡Û(hepatic human/rat/rabbit/mouse, peptide)(CT), sheep pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3275-0100 |
Cytochrome P450 2E1 ¡ÚCYP2E1¡Û(hepatic human/rat/rabbit/mouse, peptide)(CT), sheep pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3280-0025 |
Cytochrome P450 2C8, 2C9, 2C19(human liver)and 2C12(rat)(peptide)(CT)¡ÚCYP2C8, 2C9, 2C19 and CYP2C12¡Û, rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3280-0100 |
Cytochrome P450 2C8, 2C9, 2C19(human liver)and 2C12(rat)(peptide)(CT)¡ÚCYP2C8, 2C9, 2C19 and CYP2C12¡Û, rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3285-0025 |
Cytochrome P450 2C8, 2C9, 2C19(human liver)and 2C12(rat)(peptide)(CT)¡ÚCYP2C8, 2C9, 2C19 and CYP2C12¡Û, sheep pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3285-0100 |
Cytochrome P450 2C8, 2C9, 2C19(human liver)and 2C12(rat)(peptide)(CT)¡ÚCYP2C8, 2C9, 2C19 and CYP2C12¡Û, sheep pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3290-0025 |
Cytochrome P450 2B6 ¡ÚCYP2B6¡Û(human liver, aa 265-276), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3290-0100 |
Cytochrome P450 2B6 ¡ÚCYP2B6¡Û(human liver, aa 265-276), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3295-0025 |
Cytochrome P450 2B6 ¡ÚCYP2B6¡Û(human liver, aa 265-276 ), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3295-0100 |
Cytochrome P450 2B6 ¡ÚCYP2B6¡Û(human liver, aa 265-276 ), sheep pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3310-0025 |
Cytochrome P450 3A1 ¡ÚCYP3A1¡Û(rat, peptide)(CT), rabbit pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3310-0100 |
Cytochrome P450 3A1 ¡ÚCYP3A1¡Û(rat, peptide)(CT), rabbit pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3315-0025 |
Cytochrome P450 3A1 ¡ÚCYP3A1¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3315-0100 |
Cytochrome P450 3A1 ¡ÚCYP3A1¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3320-0025 |
Cytochrome P450 3A2 ¡ÚCYP3A2¡Û(rat, peptide)(CT), rabbit pAb(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3320-0100 |
Cytochrome P450 3A2 ¡ÚCYP3A2¡Û(rat, peptide)(CT), rabbit pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat (not human) | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3325-0100 |
Cytochrome P450 3A2 ¡ÚCYP3A2¡Û(rat, peptide)(CT), sheep pAb(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat (not human) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3340-0025 |
Cytochrome P450 3A4 ¡ÚCYP3A4¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3340-0100 |
Cytochrome P450 3A4 ¡ÚCYP3A4¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3345-0025 |
Cytochrome P450 3A4 ¡ÚCYP3A4¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3345-0100 |
Cytochrome P450 3A4 ¡ÚCYP3A4¡Û(human, peptide)(CT), sheep pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3350-0025 |
Cytochrome P450 3A5 ¡ÚCYP3A5¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3350-0100 |
Cytochrome P450 3A5 ¡ÚCYP3A5¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not rat) | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3410-0025 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3410-0100 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC(PS¡¢FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3415-0025 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), sheep pAb, purified(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3415-0100 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), sheep pAb, purified(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3420-0025 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC(FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CR3420-0100 |
Cytochrome P450 4A1, 4A2, 4A3 ¡ÚCYP4A1, CYP4A2 and CYP4A3¡Û(rat, peptide)(CT), rabbit pAb, purified(specificity: rat) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC(FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-CT100-0001 |
Fumagillin ¡ÚFumidil B¡Û¡ÚFumadil B¡Û¡ÚTNP-470¡Û |
1mg |
¡ï11,000 |
|
23110-15-8 |
|
|
|
¡¡ |
BML |
BML-CT100-0005 |
Fumagillin ¡ÚFumidil B¡Û¡ÚFumadil B¡Û¡ÚTNP-470¡Û |
5mg |
¡ï48,000 |
|
23110-15-8 |
|
|
|
¡¡ |
BML |
BML-CT104-0010 |
Withaferin A ¡Ú5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2,24-dienolide¡Û(Isolated from Withania somnifera) |
10mg |
¡ï46,000 |
|
5119-48-2 |
|
|
|
¡¡ |
BML |
BML-CT105-0050 |
Ursolic Acid |
50mg |
¡ï6,000 |
|
77-52-1 |
|
|
|
¡¡ |
BML |
BML-CT105-0250 |
Ursolic Acid |
250mg |
¡ï22,000 |
|
77-52-1 |
|
|
|
¡¡ |
BML |
BML-CT107-0001 |
Thiolutin ¡Ú6-(Acetamido)-4-methyl-1,2-dithiolo[4,3-b]pyrrol-5(4H)-one¡Û(Isolated from Streptomyces luteosporeus) |
1mg |
¡ï12,000 |
|
87-11-6 |
|
|
|
¡¡ |
BML |
BML-CT107-0005 |
Thiolutin ¡Ú6-(Acetamido)-4-methyl-1,2-dithiolo[4,3-b]pyrrol-5(4H)-one¡Û(Isolated from Streptomyces luteosporeus) |
5mg |
¡ï51,000 |
|
87-11-6 |
|
|
|
¡¡ |
BML |
BML-CT115-0010 |
Shikonin |
10mg |
¡ï7,000 |
|
517-89-5 |
|
|
|
¡¡ |
BML |
BML-CT115-0050 |
Shikonin |
50mg |
¡ï27,000 |
|
517-89-5 |
|
|
|
¡¡ |
BML |
BML-CT120-0001 |
Cytochalasin E |
1mg |
¡ï6,000 |
|
36011-19-5 |
|
|
|
¡¡ |
BML |
BML-CT120-0005 |
Cytochalasin E |
5mg |
¡ï27,000 |
|
36011-19-5 |
|
|
|
¡¡ |
BML |
BML-CX101-0010 |
ZK-756326 ¡Ú2-[2-[4-[(3-Phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol, 2HCl¡Û |
10mg |
¡ï12,000 |
|
874911-96-3 |
|
|
|
¡¡ |
BML |
BML-CX101-0050 |
ZK-756326 ¡Ú2-[2-[4-[(3-Phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol, 2HCl¡Û |
50mg |
¡ï52,000 |
|
874911-96-3 |
|
|
|
¡¡ |
BML |
BML-D100-0025 |
6,7-ADTN ¡Ú(¡Þ)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, HBr¡Û |
25mg |
¡ï8,000 |
|
73304-33-3 |
|
|
|
¡¡ |
BML |
BML-D101-0010 |
AJ-76 ¡Ú(1S,2R)-cis-5-Methoxy-1-methyl-2-(n-propylamino)tetralin, HCl¡Û |
10mg |
¡ï23,000 |
|
85379-09-5 |
|
|
|
¡¡ |
BML |
BML-D102-0100 |
Bromocriptine, Mesylate ¡Ú(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-ergotaman-3',6',18-trione Methanesulfonate¡Û |
100mg |
¡ï9,000 |
|
22260-51-1 |
|
|
|
¡¡ |
BML |
BML-D102-0500 |
Bromocriptine, Mesylate ¡Ú(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-ergotaman-3',6',18-trione Methanesulfonate¡Û |
500mg |
¡ï38,000 |
|
22260-51-1 |
|
|
|
¡¡ |
BML |
BML-D103-0010 |
BTCP ¡Ú1-[1-(2-Benzo[b]thienyl)cyclohexyl)]piperidine, Maleate¡Û |
10mg |
¡ï25,000 |
|
112726-66-6 |
|
|
|
¡¡ |
BML |
BML-D104-0005 |
GBR-12909 ¡Ú1-(2-bis-(4-Fluorophenyl)methoxy)ethyl)-4-(3-phenyl-2-propyl)¡Û |
5mg |
¡ï8,000 |
|
67469-78-7 |
|
|
|
¡¡ |
BML |
BML-D104-0025 |
GBR-12909 ¡Ú1-(2-bis-(4-Fluorophenyl)methoxy)ethyl)-4-(3-phenyl-2-propyl)¡Û |
25mg |
¡ï32,000 |
|
67469-78-7 |
|
|
|
¡¡ |
BML |
BML-D105-0010 |
7-Hydroxy-DPAT, HBr ¡Ú(¡Þ)-7-Hydroxy-2-dipropylaminotetralin, HBr¡Û |
10mg |
¡ï9,000 |
|
94938-11-7 |
|
|
|
¡¡ |
BML |
BML-D105-0050 |
7-Hydroxy-DPAT, HBr ¡Ú(¡Þ)-7-Hydroxy-2-dipropylaminotetralin, HBr¡Û |
50mg |
¡ï37,000 |
|
94938-11-7 |
|
|
|
¡¡ |
BML |
BML-D106-0005 |
trans-7-Hydroxy-PIPAT, Maleate ¡Útrans-7-Hydroxy-2-[N-propyl-N(3'-iodo-2'-propenyl)amino]tetralin, Maleate¡Û |
5mg |
¡ï25,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-D107-0050 |
Clozapine ¡Ú8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e]-[1,4]diazepine¡Û |
50mg |
¡ï7,000 |
|
5786-21-0 |
|
|
|
¡¡ |
BML |
BML-D107-0500 |
Clozapine ¡Ú8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e]-[1,4]diazepine¡Û |
500mg |
¡ï45,000 |
|
5786-21-0 |
|
|
|
¡¡ |
BML |
BML-D108-0020 |
Clothiapine |
20mg |
¡ï3,000 |
|
2058-52-8 |
|
|
|
¡¡ |
BML |
BML-D108-0100 |
Clothiapine |
100mg |
¡ï17,000 |
|
2058-52-8 |
|
|
|
¡¡ |
BML |
BML-D109-0005 |
(-)-Quinpirole, HCl ¡ÚL-171,555¡Û¡Útrans-(-)-4aR-4,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline¡Û |
5mg |
¡ï14,000 |
|
85760-74-3 |
|
|
|
¡¡ |
BML |
BML-D109-0025 |
(-)-Quinpirole, HCl ¡ÚL-171,555¡Û¡Útrans-(-)-4aR-4,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline¡Û |
25mg |
¡ï59,000 |
|
85760-74-3 |
|
|
|
¡¡ |
BML |
BML-D110-0005 |
SCH 23390 ¡ÚR-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, HCl¡Û |
5mg |
¡ï11,000 |
|
87134-87-0 |
|
|
|
¡¡ |
BML |
BML-D110-0025 |
SCH 23390 ¡ÚR-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, HCl¡Û |
25mg |
¡ï49,000 |
|
87134-87-0 |
|
|
|
¡¡ |
BML |
BML-D111-0010 |
Remoxipride ¡Ú(S)-(-)-3-Bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxybenzamide, HCl¡Û |
10mg |
¡ï12,000 |
|
73220-03-8 |
|
|
|
¡¡ |
BML |
BML-D122-0050 |
12(S),20-Dihydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic Acid ¡Ú12(S),20-DiHETE¡Û |
50ug |
¡ï30,000 |
|
89614-44-8 |
|
|
|
¡¡ |
BML |
BML-D515-0050 |
5(S),15(S)-DiHETE ¡Ú5(S),15(S)-Dihydroxyeicosa-6E,8Z,11Z,13E-tetraenoic Acid¡Û |
50ug |
¡ï19,000 |
|
82200-87-1 |
|
|
|
¡¡ |
BML |
BML-D815-0050 |
8(S),15(S)-DiHETE ¡Ú8(S),15(S)-Dihydroxyeicosa-5Z,9E,11Z,13E-tetraenoic Acid¡Û |
50ug |
¡ï19,000 |
|
80234-65-7 |
|
|
|
¡¡ |
BML |
BML-DA1140-0025 |
Dopamine, rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-DA1140-0100 |
Dopamine, rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-DA4170-0100 |
Dishevelled-1 ¡ÚDVL-1¡Û(human, aa 557-571), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat | WB |
|
|
¡¡ |
BML |
BML-DA4270-0025 |
Dishevelled-2 ¡ÚDVL-2¡Û(human/mouse, aa 600-614), rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-DA4270-0100 |
Dishevelled-2 ¡ÚDVL-2¡Û(human/mouse, aa 600-614), rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-DA4370-0025 |
Dishevelled-3 ¡ÚDVL-3¡Û(human/mouse, aa 582-596), rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-DA4370-0100 |
Dishevelled-3 ¡ÚDVL-3¡Û(human/mouse, aa 582-596), rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-DA4470-0025 |
Dishevelled-2 ¡ÚDVL-2¡Û(human, aa 633-645), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-DA4470-0100 |
Dishevelled-2 ¡ÚDVL-2¡Û(human, aa 633-645), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-DG100-0010 |
(¡Þ)-1,2-Didecanoylglycerol(10:0) |
10mg |
¡ï8,000 |
|
82950-64-9 |
|
|
|
¡¡ |
BML |
BML-DG100-0050 |
(¡Þ)-1,2-Didecanoylglycerol(10:0) |
50mg |
¡ï27,000 |
|
82950-64-9 |
|
|
|
¡¡ |
BML |
BML-DG112-0020 |
1,2-Dioctanoyl-sn-glycerol(8:0)¡ÚDOG¡Û |
20mg |
¡ï8,000 |
|
60514-48-9 |
|
|
|
¡¡ |
BML |
BML-DG112-0100 |
1,2-Dioctanoyl-sn-glycerol(8:0)¡ÚDOG¡Û |
100mg |
¡ï27,000 |
|
60514-48-9 |
|
|
|
¡¡ |
BML |
BML-DG115-0020 |
(¡Þ)-1,2-Dioleoylglycerol(18:1) |
20mg |
¡ï8,000 |
|
3738-74-7 |
|
|
|
¡¡ |
BML |
BML-DG115-0100 |
(¡Þ)-1,2-Dioleoylglycerol(18:1) |
100mg |
¡ï27,000 |
|
3738-74-7 |
|
|
|
¡¡ |
BML |
BML-DG125-0010 |
1-Oleoyl-2-acetyl-sn-glycerol ¡ÚOAG¡Û |
10mg |
¡ï13,000 |
|
86390-77-4 |
|
|
|
¡¡ |
BML |
BML-DG125-0050 |
1-Oleoyl-2-acetyl-sn-glycerol ¡ÚOAG¡Û |
50mg |
¡ï55,000 |
|
86390-77-4 |
|
|
|
¡¡ |
BML |
BML-DG130-0010 |
1-Stearoyl-2-arachidonoyl-sn-glycerol |
10mg |
¡ï9,000 |
|
65914-84-3 |
|
|
|
¡¡ |
BML |
BML-DG135-0010 |
1-Stearoyl-2-linoleoyl-sn-glycerol |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DG135-0050 |
1-Stearoyl-2-linoleoyl-sn-glycerol |
50mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DG140-0005 |
1-O-Hexadecyl-2-O-arachidonoyl-sn-glycerol |
5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DG140-0025 |
1-O-Hexadecyl-2-O-arachidonoyl-sn-glycerol |
25mg |
¡ï65,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DG6080-0100 |
Desmin(human)[37EH], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 37EH | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB(55kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-DM100-0001 |
25-Hydroxyvitamin D3 |
1mg |
¡ï12,000 |
|
19356-17-3 |
|
|
|
¡¡ |
BML |
BML-DM100-0005 |
25-Hydroxyvitamin D3 |
5mg |
¡ï46,000 |
|
19356-17-3 |
|
|
|
¡¡ |
BML |
BML-DM101-0001 |
25-Hydroxyvitamin D2 ¡ÚErcalcidiol¡Û¡Ú25-Hydroxyergocalciferol¡Û¡Ú25-Hydroxycalciferol¡Û |
1mg |
¡ï25,000 |
-20¡î |
21343-40-8 |
|
TOXIC. Protect from light and oxygen
|
|
¡¡ |
BML |
BML-DM200-0050 |
1a,25-Dihydroxyvitamin D3 ¡ÚCalcitriol¡Û¡Ú1a,25-Dihydroxycholecalciferol¡Û |
50ug |
¡ï25,000 |
|
32222-06-3 |
|
|
|
¡¡ |
BML |
BML-DM200-1000 |
1a,25-Dihydroxyvitamin D3 ¡ÚCalcitriol¡Û¡Ú1a,25-Dihydroxycholecalciferol¡Û |
1mg |
¡ï234,000 |
|
32222-06-3 |
|
|
|
¡¡ |
BML |
BML-DM300-0050 |
24(R),25-Dihydroxyvitamin D3 |
50ug |
¡ï35,000 |
|
55721-11-4 |
|
|
|
¡¡ |
BML |
BML-DP9417-0100 |
Dishevelled-1 Peptide, Blocking peptide for Dishevelled-1(human)pAb(Prod. No. BML-DA4170) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DP9427-0100 |
Dishevelled-2 Peptide, Blocking peptide for Dishevelled-2 pAb(Prod. No. BML-DA4270) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DP9437-0100 |
Dishevelled-3 Peptide, Blocking peptide for Dishevelled-3 pAb(Prod. No. BML-DA4370) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DP9447-0100 |
Dishevelled-2 Peptide, Blocking peptide for Dishevelled-2(human)pAb(Prod. No. BML-DA4470) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DS056-0050 |
5(S),6(R)-Dihydroxyeicosa-7E,9E,11Z,14Z-tetraenoic Acid(DiHETE)¡Ú5(S),6(R)-DiHETE¡Û |
50ug |
¡ï25,000 |
|
82948-88-7 |
|
|
|
¡¡ |
BML |
BML-DS056-1000 |
5(S),6(R)-Dihydroxyeicosa-7E,9E,11Z,14Z-tetraenoic Acid(DiHETE)¡Ú5(S),6(R)-DiHETE¡Û |
1mg |
¡ï313,000 |
|
82948-88-7 |
|
|
|
¡¡ |
BML |
BML-DTR512-0050 |
5(S),12(R)-Dihydroxyeicosa-6E,8E,10E,14Z-tetraenoic Acid ¡Ú5(S),12(R)-DiHETE¡Û¡Ú6-trans-LTB4¡Û |
50ug |
¡ï25,000 |
|
71652-82-9 |
|
|
|
¡¡ |
BML |
BML-DTR512-1000 |
5(S),12(R)-Dihydroxyeicosa-6E,8E,10E,14Z-tetraenoic Acid ¡Ú5(S),12(R)-DiHETE¡Û¡Ú6-trans-LTB4¡Û |
1mg |
¡ï313,000 |
|
71652-82-9 |
|
|
|
¡¡ |
BML |
BML-DTR815-0050 |
8(R),15(S)-Dihydroxyeicosa-5Z,9E,11E,13E-tetraenoic Acid ¡Ú8(R),15(S)-DiHETE¡Û |
50ug |
¡ï25,000 |
|
80234-67-9 |
|
|
|
¡¡ |
BML |
BML-DTS512-0050 |
5(S),12(S)-Dihydroxyeicosa-6E,8E,10E,14Z-tetraenoic Acid ¡Ú5(S),12(S)-DiHETE¡Û¡Ú6-trans-12-epi-LTB4¡Û |
50ug |
¡ï25,000 |
|
73151-67-4 |
|
|
|
¡¡ |
BML |
BML-DTS815-0050 |
8(S),15(S)-Dihydroxyeicosa-5Z,9E,11E,13E-tetraenoic Acid ¡Ú8(S),15(S)-DiHETE(Z, E, E, E)¡Û |
50ug |
¡ï25,000 |
|
80234-66-8 |
|
|
|
¡¡ |
BML |
BML-DW8720-0005 |
pJY2 Plasmid |
5ug |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-DZ1020-0050 |
Dopamine-B-hydroxylase ¡ÚDBH¡Û(bovine), rabbit pAb(antiserum) |
50ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ cat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-DZ1041-0025 |
Dopamine, rat pAb(antiserum) |
25ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-EA101-0050 |
AP4 ¡ÚDL-2-Amino-4-phosphonobutanoic Acid¡Û |
50mg |
¡ï4,000 |
|
20263-07-4 |
|
|
|
¡¡ |
BML |
BML-EA101-0250 |
AP4 ¡ÚDL-2-Amino-4-phosphonobutanoic Acid¡Û |
250mg |
¡ï19,000 |
|
20263-07-4 |
|
|
|
¡¡ |
BML |
BML-EA104-0005 |
D-AP5 ¡ÚD(-)-2-Amino-5-phosphonovaleric Acid¡Û |
5mg |
¡ï11,000 |
|
79055-68-8 |
|
|
|
¡¡ |
BML |
BML-EA105-0005 |
L-AP5 ¡ÚL(+)-2-Amino-5-phosphonovaleric Acid¡Û |
5mg |
¡ï19,000 |
|
79055-67-7 |
|
|
|
¡¡ |
BML |
BML-EA109-0050 |
Bicuculline Methobromide |
50mg |
¡ï17,000 |
|
73604-30-5 |
|
|
|
¡¡ |
BML |
BML-EA110-0005 |
AMPA ¡Ú(¡Þ)-a-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid¡Û |
5mg |
¡ï13,000 |
|
74341-63-2 |
|
|
|
¡¡ |
BML |
BML-EA113-0010 |
5,7-Dichlorokynurenic Acid |
10mg |
¡ï12,000 |
|
131123-76-7 |
|
|
|
¡¡ |
BML |
BML-EA113-0050 |
5,7-Dichlorokynurenic Acid |
50mg |
¡ï53,000 |
|
131123-76-7 |
|
|
|
¡¡ |
BML |
BML-EA1149-0025 |
Leu Enkephalin ¡ÚLeucine Enkephalin¡Û¡Ú[Leu5]-enkephalin¡Û(synthetic leucine enkephalin), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-EA1149-0100 |
Leu Enkephalin ¡ÚLeucine Enkephalin¡Û¡Ú[Leu5]-enkephalin¡Û(synthetic leucine enkephalin), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-EA1150-0025 |
Met Enkephalin ¡ÚMethionine enkephalin¡Û¡Ú[Met5]-enkephalin¡Û(synthetic methionine enkephalin), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-EA115-0005 |
Dihydrokainic Acid |
5mg |
¡ï16,000 |
|
52497-36-6 |
|
|
|
¡¡ |
BML |
BML-EA1150-0100 |
Met Enkephalin ¡ÚMethionine enkephalin¡Û¡Ú[Met5]-enkephalin¡Û(synthetic methionine enkephalin), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-EA115-0025 |
Dihydrokainic Acid |
25mg |
¡ï64,000 |
|
52497-36-6 |
|
|
|
¡¡ |
BML |
BML-EA116-0010 |
6,7-Dinitroquinoxaline-2,3-dione ¡ÚDNQX¡Û |
10mg |
¡ï7,000 |
|
2379-57-9 |
|
|
|
¡¡ |
BML |
BML-EA117-0001 |
Domoic Acid ¡Ú[2S-[2a,3B,4B(1Z,3E,5R)]]-2-Carboxy-4-(5-carboxy-1-methyl-1,3-hexadienyl)-3-pyrrolidineacetic Acid¡Û(Isolated from Nitzschia pungens f. multiseries) |
1mg |
¡ï17,000 |
|
14277-97-5 |
|
|
|
¡¡ |
BML |
BML-EA120-0001 |
Ibotenic Acid ¡Úa-Amino-3-hydroxy-5-isoxazoleacetic Acid¡Û |
1mg |
¡ï12,000 |
|
2552-55-8 |
|
|
|
¡¡ |
BML |
BML-EA120-0005 |
Ibotenic Acid ¡Úa-Amino-3-hydroxy-5-isoxazoleacetic Acid¡Û |
5mg |
¡ï48,000 |
|
2552-55-8 |
|
|
|
¡¡ |
BML |
BML-EA121-0010 |
Isoguvacine |
10mg |
¡ï3,000 |
|
64603-90-3 |
|
|
|
¡¡ |
BML |
BML-EA121-0050 |
Isoguvacine |
50mg |
¡ï14,000 |
|
64603-90-3 |
|
|
|
¡¡ |
BML |
BML-EA123-0005 |
Kainic Acid |
5mg |
¡ï8,000 |
|
487-79-6 |
|
|
|
¡¡ |
BML |
BML-EA123-0025 |
Kainic Acid |
25mg |
¡ï33,000 |
|
487-79-6 |
|
|
|
¡¡ |
BML |
BML-EA124-0005 |
Homoquinolinic Acid |
5mg |
¡ï13,000 |
|
490-75-5 |
|
|
|
¡¡ |
BML |
BML-EA124-0025 |
Homoquinolinic Acid |
25mg |
¡ï53,000 |
|
490-75-5 |
|
|
|
¡¡ |
BML |
BML-EA127-0005 |
Phaclofen ¡Ú3-Amino-2-(4-chlorophenyl)propylphosphonic Acid¡Û |
5mg |
¡ï10,000 |
|
114012-12-3 |
|
|
|
¡¡ |
BML |
BML-EA127-0025 |
Phaclofen ¡Ú3-Amino-2-(4-chlorophenyl)propylphosphonic Acid¡Û |
25mg |
¡ï42,000 |
|
114012-12-3 |
|
|
|
¡¡ |
BML |
BML-EA128-0001 |
Baclofen |
1g |
¡ï11,000 |
|
1134-47-0 |
|
|
|
¡¡ |
BML |
BML-EA128-0005 |
Baclofen |
5g |
¡ï53,000 |
|
1134-47-0 |
|
|
|
¡¡ |
BML |
BML-EA133-0005 |
SK&F 97541 ¡Ú3-Aminopropyl(methyl)phosphinic Acid¡Û |
5mg |
¡ï13,000 |
|
127729-35-5 |
|
|
|
¡¡ |
BML |
BML-EA133-0025 |
SK&F 97541 ¡Ú3-Aminopropyl(methyl)phosphinic Acid¡Û |
25mg |
¡ï50,000 |
|
127729-35-5 |
|
|
|
¡¡ |
BML |
BML-EA134-0005 |
Z-3-(Amidinothio)propenoic Acid ¡ÚZAPA, H2SO4¡Û |
5mg |
¡ï9,000 |
|
92138-10-8 |
|
|
|
¡¡ |
BML |
BML-EA134-0025 |
Z-3-(Amidinothio)propenoic Acid ¡ÚZAPA, H2SO4¡Û |
25mg |
¡ï36,000 |
|
92138-10-8 |
|
|
|
¡¡ |
BML |
BML-EA135-0005 |
Gabaculine ¡Ú(¡Þ)3-Amino-2,3-dihydrobenzoic Acid, HCl¡Û |
5mg |
¡ï21,000 |
|
59556-17-1 |
|
|
|
¡¡ |
BML |
BML-EA136-0020 |
Arcaine Sulfate ¡ÚN,N'-1,4-Butanediyl-bis(guanidine), Sulfate¡Û |
20mg |
¡ï9,000 |
|
14923-17-2 |
|
|
|
¡¡ |
BML |
BML-EA137-0010 |
Synthalin ¡ÚN,N'-1,10-Decanediyl-bis(guanidine), Sulfate¡Û |
10mg |
¡ï15,000 |
|
111-23-9 |
|
|
|
¡¡ |
BML |
BML-EA138-0005 |
N-Acetylglycyl-D-glutamic Acid |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA138-0025 |
N-Acetylglycyl-D-glutamic Acid |
25mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA139-0005 |
L-trans-Pyrrolidine-2,4-dicarboxylic Acid |
5mg |
¡ï11,000 |
|
64769-66-0 |
|
|
|
¡¡ |
BML |
BML-EA139-0025 |
L-trans-Pyrrolidine-2,4-dicarboxylic Acid |
25mg |
¡ï55,000 |
|
64769-66-0 |
|
|
|
¡¡ |
BML |
BML-EA143-0010 |
L-701,252 ¡Ú7-Chloro-3-(cyclopropylcarbonyl)-4-hydroxy-2(1H)-quinoline¡Û |
10mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA144-0005 |
U-54494A ¡Úcis(¡Þ)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide, HCl¡Û |
5mg |
¡ï12,000 |
|
92953-41-8 |
|
|
|
¡¡ |
BML |
BML-EA144-0025 |
U-54494A ¡Úcis(¡Þ)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide, HCl¡Û |
25mg |
¡ï52,000 |
|
92953-41-8 |
|
|
|
¡¡ |
BML |
BML-EA145-0010 |
CFM-2 ¡Ú1-(4'-Aminophenyl)-3,5-dihydro-7,8-Dimethoxy-4H-2,3-benzodiazepin-4-one¡Û |
10mg |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA146-0005 |
CPCCOEt ¡Ú7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate Ethyl Ester¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA147-0005 |
CPPG ¡Ú(¡Þ)-a-Cyclopropyl-4-phosphonophenylglycine¡Û |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA147-0025 |
CPPG ¡Ú(¡Þ)-a-Cyclopropyl-4-phosphonophenylglycine¡Û |
25mg |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EA148-0010 |
AMN082 ¡ÚN,N¡Ç-Dibenzhydrylethane-1,2-diamine, 2HCl¡Û |
10mg |
¡ï11,000 |
|
83027-13-8 |
|
|
|
¡¡ |
BML |
BML-EA148-0050 |
AMN082 ¡ÚN,N¡Ç-Dibenzhydrylethane-1,2-diamine, 2HCl¡Û |
50mg |
¡ï48,000 |
|
83027-13-8 |
|
|
|
¡¡ |
BML |
BML-EA149-0050 |
(-)-Bicuculline Methiodide |
50mg |
¡ï16,000 |
|
40709-69-1 |
|
|
|
¡¡ |
BML |
BML-EA150-0005 |
FrPbAII ¡ÚL-2-Amino-5-ureidopentanamide¡Û |
5mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EC23-0500 |
ec23 ¡Ú4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylethynyl)benzoic Acid¡Û |
5mg |
¡ï8,000 |
|
104561-41-3 |
|
|
|
¡¡ |
BML |
BML-EC23-2500 |
ec23 ¡Ú4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylethynyl)benzoic Acid¡Û |
25mg |
¡ï37,000 |
|
104561-41-3 |
|
|
|
¡¡ |
BML |
BML-EE11-0050 |
(¡Þ)11,12-Epoxyeicosa-5Z,8Z,14Z-trienoic Acid ¡Ú(¡Þ)11,12-EET¡Û¡Ú11(12)-EpETrE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE11-1000 |
(¡Þ)11,12-Epoxyeicosa-5Z,8Z,14Z-trienoic Acid ¡Ú(¡Þ)11,12-EET¡Û¡Ú11(12)-EpETrE¡Û |
1mg |
¡ï105,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE14-0050 |
(¡Þ)14,15-Epoxyeicosa-5Z,8Z,11Z-trienoic Acid ¡Ú(¡Þ)14,15-EET¡Û¡Ú14(15)-EpETrE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE14-1000 |
(¡Þ)14,15-Epoxyeicosa-5Z,8Z,11Z-trienoic Acid ¡Ú(¡Þ)14,15-EET¡Û¡Ú14(15)-EpETrE¡Û |
1mg |
¡ï105,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE56-0050 |
(¡Þ)5,6-Epoxyeicosa-8Z,11Z,14Z-trienoic Acid ¡Ú(¡Þ)5,6-EET¡Û¡Ú5(6)-EpETre¡Û |
50ug |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE56-1000 |
(¡Þ)5,6-Epoxyeicosa-8Z,11Z,14Z-trienoic Acid ¡Ú(¡Þ)5,6-EET¡Û¡Ú5(6)-EpETre¡Û |
1mg |
¡ï108,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE614-0050 |
(¡Þ)14,15-Epoxyeicosa-5Z,8Z,11Z-trienoic Acid-d8 ¡Ú(¡Þ)14,15-EET-d8¡Û |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE656-0050 |
(¡Þ)-5,6-EET-d8 Methyl Ester ¡Ú(¡Þ)5,6-Epoxyeicosa-8Z,11Z,14Z-trienoic Acid-d8 Methyl Ester¡Û |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE89-0050 |
(¡Þ)8,9-Epoxyeicosa-5Z,11Z,14Z-trienoic Acid ¡Ú(¡Þ)8,9-EET¡Û¡Ú8(9)-EpETrE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EE89-1000 |
(¡Þ)8,9-Epoxyeicosa-5Z,11Z,14Z-trienoic Acid ¡Ú(¡Þ)8,9-EET¡Û¡Ú8(9)-EpETrE¡Û |
1mg |
¡ï100,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EG6000-0100 |
PECAM-1 ¡ÚPlatelet Endothelial Cell Adhesion Molecule-1¡Û¡ÚCD31¡Û(human, umbilical vein endothelial cells)[CE6], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CE6 | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-EI100-0001 |
Esculetin ¡Ú6,7-Dihydroxycoumarin¡Û |
1g |
¡ï4,000 |
|
305-01-1 |
|
|
|
¡¡ |
BML |
BML-EI101-0001 |
Nordihydroguairetic Acid ¡ÚNDGA¡Û¡Ú4,4'-(2,3-Dimethyl-1,4-butanediyl)bis[1,2-benzenediol]¡Û(synthetic) |
1g |
¡ï9,000 |
|
500-38-9 |
|
|
|
¡¡ |
BML |
BML-EI102-0050 |
Leukotriene B4-Dimethylamide |
50ug |
¡ï41,000 |
|
83024-92-4 |
|
|
|
¡¡ |
BML |
BML-EI103-0001 |
17-Octadecynoic Acid ¡Ú17-ODYA¡Û |
1mg |
¡ï5,000 |
|
34450-18-5 |
|
|
|
¡¡ |
BML |
BML-EI103-0010 |
17-Octadecynoic Acid ¡Ú17-ODYA¡Û |
10mg |
¡ï31,000 |
|
34450-18-5 |
|
|
|
¡¡ |
BML |
BML-EI104-0050 |
Leukotriene A3 Methyl Ester ¡ÚLTA3-ME¡Û |
50ug |
¡ï21,000 |
|
83851-38-1 |
|
|
|
¡¡ |
BML |
BML-EI105-0250 |
SKF-525A, HCl ¡ÚProadifen¡Û |
250mg |
¡ï10,000 |
|
62-68-0 |
|
|
|
¡¡ |
BML |
BML-EI105-1000 |
SKF-525A, HCl ¡ÚProadifen¡Û |
1g |
¡ï30,000 |
|
62-68-0 |
|
|
|
¡¡ |
BML |
BML-EI106-0010 |
Baicalein ¡Ú5,6,7-Trihydroxyflavone¡Û |
10mg |
¡ï8,000 |
|
491-67-8 |
|
|
|
¡¡ |
BML |
BML-EI106-0050 |
Baicalein ¡Ú5,6,7-Trihydroxyflavone¡Û |
50mg |
¡ï32,000 |
|
491-67-8 |
|
|
|
¡¡ |
BML |
BML-EI107-0050 |
Ketoconazole |
50mg |
¡ï6,000 |
|
65277-42-1 |
|
|
|
¡¡ |
BML |
BML-EI107-0500 |
Ketoconazole |
500mg |
¡ï32,000 |
|
65277-42-1 |
|
|
|
¡¡ |
BML |
BML-EI108-0020 |
4-Phenylchalcone Oxide ¡Ú4-PCO¡Û |
20mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI108-0100 |
4-Phenylchalcone Oxide ¡Ú4-PCO¡Û |
100mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI110-0025 |
TMB-8, HCl ¡Ú8-(Diethylamino)octyl-3,4,5-trimethoxybenzoate, HCl¡Û |
25mg |
¡ï9,000 |
|
53464-72-5 |
|
|
|
¡¡ |
BML |
BML-EI112-0010 |
7,7-Dimethyleicosadienoic Acid ¡ÚDEDA¡Û |
10mg |
¡ï10,000 |
|
89560-01-0 |
|
|
|
¡¡ |
BML |
BML-EI112-0050 |
7,7-Dimethyleicosadienoic Acid ¡ÚDEDA¡Û |
50mg |
¡ï40,000 |
|
89560-01-0 |
|
|
|
¡¡ |
BML |
BML-EI113-0010 |
Acivicin ¡ÚU-42126¡Û¡ÚAT-125¡Û |
10mg |
¡ï16,000 |
-20¡î |
42228-92-2 |
|
Purity: ¡ä99%, Formula: C5H7ClN2O3, MW: 178.6 Solubility: soluble in water (max. 18mg/ml).
|
|
¡¡ |
BML |
BML-EI114-0010 |
Oxatomide |
10mg |
¡ï13,000 |
|
60607-34-3 |
|
|
|
¡¡ |
BML |
BML-EI114-0050 |
Oxatomide |
50mg |
¡ï50,000 |
|
60607-34-3 |
|
|
|
¡¡ |
BML |
BML-EI116-0001 |
8,11-Eicosadiynoic Acid ¡ÚEDYA¡Û |
1mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI117-0100 |
Ro 20-1724 ¡Ú4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone¡Û |
100mg |
¡ï13,000 |
|
29925-17-5 |
|
|
|
¡¡ |
BML |
BML-EI117-1000 |
Ro 20-1724 ¡Ú4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone¡Û |
1g |
¡ï43,000 |
|
29925-17-5 |
|
|
|
¡¡ |
BML |
BML-EI118-0010 |
Oleyloxyethyl Phosphorylcholine |
10mg |
¡ï8,000 |
|
96720-06-8 |
|
|
|
¡¡ |
BML |
BML-EI118-0050 |
Oleyloxyethyl Phosphorylcholine |
50mg |
¡ï34,000 |
|
96720-06-8 |
|
|
|
¡¡ |
BML |
BML-EI119-0010 |
Carboxyheptyl Imidazole |
10mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI119-0050 |
Carboxyheptyl Imidazole |
50mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI120-0010 |
Carbethoxyhexyl Imidazole |
10mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI120-0050 |
Carbethoxyhexyl Imidazole |
50mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI121-0001 |
Disodium Cromoglycate ¡ÚDSCG¡Û¡ÚCromolyn Sodium¡Û |
1g |
¡ï4,000 |
|
15826-37-6 |
|
|
|
¡¡ |
BML |
BML-EI121-0005 |
Disodium Cromoglycate ¡ÚDSCG¡Û¡ÚCromolyn Sodium¡Û |
5g |
¡ï10,000 |
|
15826-37-6 |
|
|
|
¡¡ |
BML |
BML-EI123-0100 |
CDP-Choline ¡ÚCytidine 5'-diphosphocholine, Na salt¡Û |
100mg |
¡ï6,000 |
|
33818-15-4 |
|
|
|
¡¡ |
BML |
BML-EI123-1000 |
CDP-Choline ¡ÚCytidine 5'-diphosphocholine, Na salt¡Û |
1g |
¡ï21,000 |
|
33818-15-4 |
|
|
|
¡¡ |
BML |
BML-EI125-0200 |
Capsaicin ¡Ú8-Methyl-N-vanillyl-6-nonenamide¡Û(Isolated from Capsicum fruit) |
200mg |
¡ï13,000 |
|
404-86-4 |
|
|
|
¡¡ |
BML |
BML-EI125-1000 |
Capsaicin ¡Ú8-Methyl-N-vanillyl-6-nonenamide¡Û(Isolated from Capsicum fruit) |
1g |
¡ï51,000 |
|
404-86-4 |
|
|
|
¡¡ |
BML |
BML-EI126-0001 |
Dexamethasone ¡Ú9a-Fluoro-16a-methylprednisolone¡Û |
1g |
¡ï8,000 |
|
50-02-2 |
|
|
|
¡¡ |
BML |
BML-EI126-0005 |
Dexamethasone ¡Ú9a-Fluoro-16a-methylprednisolone¡Û |
5g |
¡ï32,000 |
|
50-02-2 |
|
|
|
¡¡ |
BML |
BML-EI127-0001 |
Dipyridamole ¡Ú2,6-bis(Diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine¡Û |
1g |
¡ï3,000 |
|
58-32-2 |
|
|
|
¡¡ |
BML |
BML-EI127-0005 |
Dipyridamole ¡Ú2,6-bis(Diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine¡Û |
5g |
¡ï9,000 |
|
58-32-2 |
|
|
|
¡¡ |
BML |
BML-EI128-0001 |
Ethacrynic Acid ¡Ú2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxyacetic Acid¡Û |
1g |
¡ï4,000 |
|
58-54-8 |
|
|
|
¡¡ |
BML |
BML-EI130-0020 |
Gossypol ¡Ú2,2¡Ç-bis[8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene]¡Û(Isolated from Gossypium genus, Malvaceae) |
20mg |
¡ï4,000 |
|
303-45-7 |
|
|
|
¡¡ |
BML |
BML-EI130-0100 |
Gossypol ¡Ú2,2¡Ç-bis[8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene]¡Û(Isolated from Gossypium genus, Malvaceae) |
100mg |
¡ï13,000 |
|
303-45-7 |
|
|
|
¡¡ |
BML |
BML-EI132-0001 |
Methoxsalen ¡Ú8-Methoxypsoralen¡Û |
1g |
¡ï7,000 |
|
298-81-7 |
|
|
|
¡¡ |
BML |
BML-EI134-0005 |
Phenidone ¡Ú1-Phenyl-3-pyrazolidinone¡Û |
5g |
¡ï3,000 |
|
92-43-3 |
|
|
|
¡¡ |
BML |
BML-EI143-0010 |
SC-10 ¡Ú5-Chloro-N-heptylnaphthalene-1-sulfonamide¡Û¡ÚN-Heptyl-5-chloro-1-naphthalene-sulfonamide¡Û |
10mg |
¡ï7,000 |
|
102649-79-6 |
|
|
|
¡¡ |
BML |
BML-EI143-0050 |
SC-10 ¡ÚN-Heptyl-5-chloronaphthalene-1-sulfonamide¡Û |
50mg |
¡ï31,000 |
|
102649-79-6 |
|
|
|
¡¡ |
BML |
BML-EI145-0010 |
A-3 ¡ÚN-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide, HCl¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI146-0005 |
Erbstatin Analog ¡ÚMethyl 2,5-Dihydroxycinnamate¡Û |
5mg |
¡ï10,000 |
|
63177-57-1 |
|
|
|
¡¡ |
BML |
BML-EI146-0025 |
Erbstatin Analog ¡ÚMethyl 2,5-Dihydroxycinnamate¡Û |
25mg |
¡ï39,000 |
|
63177-57-1 |
|
|
|
¡¡ |
BML |
BML-EI148-0010 |
H-7 ¡Ú1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl¡Û |
10mg |
¡ï10,000 |
|
108930-17-2 |
|
|
|
¡¡ |
BML |
BML-EI148-0050 |
H-7 ¡Ú1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl¡Û |
50mg |
¡ï40,000 |
|
108930-17-2 |
|
|
|
¡¡ |
BML |
BML-EI150-0005 |
1-O-Hexadecyl-2-O-acetyl-sn-glycerol |
5mg |
¡ï12,000 |
|
77133-35-8 |
|
|
|
¡¡ |
BML |
BML-EI152-0100 |
K-252a |
100ug |
¡ï15,000 |
|
97161-97-2 |
|
|
|
¡¡ |
BML |
BML-EI152-1000 |
K-252a |
1mg |
¡ï61,000 |
|
97161-97-2 |
|
|
|
¡¡ |
BML |
BML-EI153-0010 |
ML-9 ¡Ú1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine, HCl¡Û |
10mg |
¡ï10,000 |
|
105637-50-1 |
|
|
|
¡¡ |
BML |
BML-EI153-0050 |
ML-9 ¡Ú1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine, HCl¡Û |
50mg |
¡ï40,000 |
|
105637-50-1 |
|
|
|
¡¡ |
BML |
BML-EI154-0200 |
Phloretin |
200mg |
¡ï7,000 |
|
60-82-2 |
|
|
|
¡¡ |
BML |
BML-EI154-1000 |
Phloretin |
1g |
¡ï31,000 |
|
60-82-2 |
|
|
|
¡¡ |
BML |
BML-EI155-0025 |
Sphingosine, D-erythro ¡ÚD-erythro-Sphingosine¡Û¡Ú D(+)-erythro-1,3-Dihydroxy-2-amino-4- trans-octadecene¡Û |
25mg |
¡ï13,000 |
|
123-78-4 |
|
|
|
¡¡ |
BML |
BML-EI155-0100 |
Sphingosine, D-erythro ¡ÚD-erythro-Sphingosine¡Û¡Ú D(+)-erythro-1,3-Dihydroxy-2-amino-4- trans-octadecene¡Û |
100mg |
¡ï38,000 |
|
123-78-4 |
|
|
|
¡¡ |
BML |
BML-EI156-0100 |
Staurosporine |
100ug |
¡ï10,000 |
|
62996-74-1 |
|
|
|
¡¡ |
BML |
BML-EI156-1000 |
Staurosporine |
1mg |
¡ï61,000 |
|
62996-74-1 |
|
|
|
¡¡ |
BML |
BML-EI158-0010 |
H-8, 2HCl ¡ÚN-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide, 2HCl¡Û |
10mg |
¡ï10,000 |
|
113276-94-1 |
|
|
|
¡¡ |
BML |
BML-EI158-0050 |
H-8, 2HCl ¡ÚN-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide, 2HCl¡Û |
50mg |
¡ï44,000 |
|
113276-94-1 |
|
|
|
¡¡ |
BML |
BML-EI161-0100 |
Muscone ¡Ú3-Methylcyclopentadecanone¡Û |
100mg |
¡ï7,000 |
|
541-91-3 |
|
|
|
¡¡ |
BML |
BML-EI161-0500 |
Muscone ¡Ú3-Methylcyclopentadecanone¡Û |
500mg |
¡ï32,000 |
|
541-91-3 |
|
|
|
¡¡ |
BML |
BML-EI162-0001 |
Benzylimidazole |
1g |
¡ï3,000 |
|
4238-71-5 |
|
|
|
¡¡ |
BML |
BML-EI162-0005 |
Benzylimidazole |
5g |
¡ï9,000 |
|
4238-71-5 |
|
|
|
¡¡ |
BML |
BML-EI163-0001 |
Meclofenamate Sodium ¡ÚSodium 2-[(2,6-Dichloro-3-methylphenyl)amino]benzoate¡Û |
1g |
¡ï3,000 |
|
6385-02-0 |
|
|
|
¡¡ |
BML |
BML-EI163-0005 |
Meclofenamate Sodium ¡ÚSodium 2-[(2,6-Dichloro-3-methylphenyl)amino]benzoate¡Û |
5g |
¡ï9,000 |
|
6385-02-0 |
|
|
|
¡¡ |
BML |
BML-EI164-0005 |
Ibuprofen ¡Úa-Methyl-4-(2-methylpropyl)benzeneacetic Acid¡Û¡Ú(¡Þ)-2-(4-Isobutylphenyl)propionic Acid¡Û |
5g |
¡ï10,000 |
|
15687-27-1 |
|
|
|
¡¡ |
BML |
BML-EI165-1000 |
Benserazide, HCl ¡ÚRo 4-4602¡Û |
1g |
¡ï6,000 |
|
322-35-0 |
|
|
|
¡¡ |
BML |
BML-EI166-0050 |
Debrisoquin Sulfate ¡ÚRo 5-3307¡Û |
50mg |
¡ï7,000 |
|
581-88-4 |
|
|
|
¡¡ |
BML |
BML-EI166-0500 |
Debrisoquin Sulfate ¡ÚRo 5-3307¡Û |
500mg |
¡ï46,000 |
|
581-88-4 |
|
|
|
¡¡ |
BML |
BML-EI168-0005 |
Bumetanide ¡ÚRo 10-6338¡Û |
5g |
¡ï23,000 |
|
28395-03-1 |
|
|
|
¡¡ |
BML |
BML-EI169-0010 |
(¡Þ)-4-Hydroxydebrisoquin |
10mg |
¡ï9,000 |
|
59333-79-8 |
|
|
|
¡¡ |
BML |
BML-EI169-0050 |
(¡Þ)-4-Hydroxydebrisoquin |
50mg |
¡ï37,000 |
|
59333-79-8 |
|
|
|
¡¡ |
BML |
BML-EI176-0050 |
Aristolochic Acid, Na salt |
50mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI176-0250 |
Aristolochic Acid, Na salt |
250mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI177-0001 |
Manoalide |
1mg |
¡ï21,000 |
|
75088-80-1 |
|
|
|
¡¡ |
BML |
BML-EI178-0050 |
N-(p-Amylcinnamoyl)anthranilic Acid ¡ÚACA¡Û |
50mg |
¡ï10,000 |
|
110683-10-8 |
|
|
|
¡¡ |
BML |
BML-EI178-0250 |
N-(p-Amylcinnamoyl)anthranilic Acid ¡ÚACA¡Û |
250mg |
¡ï38,000 |
|
110683-10-8 |
|
|
|
¡¡ |
BML |
BML-EI184-0010 |
HA-1004, HCl ¡ÚN-(2¡Ç-Guanidinoethyl)-5-isoquinolinesulfonamide, 2HCl¡Û |
10mg |
¡ï11,000 |
|
91742-10-8 |
|
|
|
¡¡ |
BML |
BML-EI184-0050 |
HA-1004, HCl ¡ÚN-(2¡Ç-Guanidinoethyl)-5-isoquinolinesulfonamide, 2HCl¡Û |
50mg |
¡ï43,000 |
|
91742-10-8 |
|
|
|
¡¡ |
BML |
BML-EI185-0001 |
Lavendustin A ¡Ú5-Amino-[(N-2,5-dihydroxybenzyl)-N'-2-hydroxybenzyl]salicylic acid¡Û¡ÚRG14355¡Û |
1mg |
¡ï13,000 |
|
125697-92-9 |
|
|
|
¡¡ |
BML |
BML-EI185-0005 |
Lavendustin A ¡Ú5-Amino-[(N-2,5-dihydroxybenzyl)-N'-2-hydroxybenzyl]salicylic acid¡Û¡ÚRG14355¡Û |
5mg |
¡ï58,000 |
|
125697-92-9 |
|
|
|
·àʪ |
BML |
BML-EI187-0005 |
Tyrphostin 25 ¡ÚRG-50875¡Û¡Ú3,4,5-Trihydroxybenzylidenemalononitrile¡Û |
5mg |
¡ï8,000 |
|
118409-58-8 |
|
|
|
·àʪ |
BML |
BML-EI187-0025 |
Tyrphostin 25 ¡ÚRG-50875¡Û¡Ú3,4,5-Trihydroxybenzylidenemalononitrile¡Û |
25mg |
¡ï36,000 |
|
118409-58-8 |
|
|
|
·àʪ |
BML |
BML-EI188-0005 |
Tyrphostin 47 ¡ÚRG-50864¡Û¡ÚAG-213¡Û¡Ú3,4-Dihydroxy-(a-cyano)thiocinnamamide¡Û |
5mg |
¡ï9,000 |
|
122520-86-9 |
|
|
|
·àʪ |
BML |
BML-EI188-0025 |
Tyrphostin 47 ¡ÚRG-50864¡Û¡ÚAG-213¡Û¡Ú3,4-Dihydroxy-(a-cyano)thiocinnamamide¡Û |
25mg |
¡ï39,000 |
|
122520-86-9 |
|
|
|
·àʪ |
BML |
BML-EI189-0005 |
Tyrphostin 51 |
5mg |
¡ï9,000 |
|
122520-90-5 |
|
|
|
·àʪ |
BML |
BML-EI189-0025 |
Tyrphostin 51 |
25mg |
¡ï39,000 |
|
122520-90-5 |
|
|
|
·àʪ |
BML |
BML-EI190-0020 |
Tyrphostin 1 ¡Úa-Cyano-(4-methoxy)cinnamonitrile¡Û |
20mg |
¡ï7,000 |
|
2826-26-8 |
|
|
|
·àʪ |
BML |
BML-EI190-0100 |
Tyrphostin 1 ¡Úa-Cyano-(4-methoxy)cinnamonitrile¡Û |
100mg |
¡ï31,000 |
|
2826-26-8 |
|
|
|
·àʪ |
BML |
BML-EI191-0010 |
Tyrphostin 23 ¡ÚRG-50810¡Û¡Úa-Cyano-(3,4-dihydroxy)cinnamonitrile¡Û |
10mg |
¡ï9,000 |
|
118409-57-7 |
|
|
|
·àʪ |
BML |
BML-EI191-0050 |
Tyrphostin 23 ¡ÚRG-50810¡Û¡Úa-Cyano-(3,4-dihydroxy)cinnamonitrile¡Û |
50mg |
¡ï36,000 |
|
118409-57-7 |
|
|
|
·àʪ |
BML |
BML-EI192-0025 |
Calyculin A |
25ug |
¡ï17,000 |
|
101932-71-2 |
|
|
|
·àʪ |
BML |
BML-EI192-0100 |
Calyculin A |
100ug |
¡ï48,000 |
|
101932-71-2 |
|
|
|
¡¡ |
BML |
BML-EI195-0010 |
H-9, HCl ¡ÚN-(2-Aminoethyl)-5-isoquinolinesulfonamide, HCl¡Û |
10mg |
¡ï10,000 |
|
116970-50-4 |
|
|
|
¡¡ |
BML |
BML-EI195-0050 |
H-9, HCl ¡ÚN-(2-Aminoethyl)-5-isoquinolinesulfonamide, HCl¡Û |
50mg |
¡ï41,000 |
|
116970-50-4 |
|
|
|
¡¡ |
BML |
BML-EI196-0005 |
H-89, 2HCl ¡ÚN-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide, 2HCl¡Û |
5mg |
¡ï11,000 |
|
127243-85-0 |
|
|
|
¡¡ |
BML |
BML-EI196-0025 |
H-89, 2HCl ¡ÚN-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide, 2HCl¡Û |
25mg |
¡ï48,000 |
|
127243-85-0 |
|
|
|
¡¡ |
BML |
BML-EI197-0010 |
ML-7, HCl ¡Ú1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-l,4-diazepine, HCl¡Û |
10mg |
¡ï10,000 |
|
109376-83-2 |
|
|
|
¡¡ |
BML |
BML-EI197-0050 |
ML-7, HCl ¡Ú1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-l,4-diazepine, HCl¡Û |
50mg |
¡ï42,000 |
|
109376-83-2 |
|
|
|
¡¡ |
BML |
BML-EI198-0100 |
Calphostin C ¡ÚUCN-1028C¡Û |
100ug |
¡ï13,000 |
|
121263-19-2 |
|
|
|
¡¡ |
BML |
BML-EI198-1000 |
Calphostin C ¡ÚUCN-1028C¡Û |
1mg |
¡ï92,000 |
|
121263-19-2 |
|
|
|
¡¡ |
BML |
BML-EI199-0100 |
KT5720 |
100ug |
¡ï17,000 |
|
108068-98-0 |
|
|
|
¡¡ |
BML |
BML-EI200-0100 |
KT5823 |
100ug |
¡ï17,000 |
|
126643-37-6 |
|
|
|
¡¡ |
BML |
BML-EI206-0100 |
Auranofin ¡ÚSKF 39162¡Û¡Ú1-Thio-b-D-glucopyranosatotriethylphosphine Gold-2,3,4,6-tetraacetate¡Û |
100mg |
¡ï9,000 |
|
34031-32-8 |
|
|
|
¡¡ |
BML |
BML-EI208-1000 |
NPC-14686 ¡ÚFmoc-L-Homophenylalanine¡Û |
1g |
¡ï25,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI209-0010 |
REV-5901 ¡Úa-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol¡Û |
10mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI209-0050 |
REV-5901 ¡Úa-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol¡Û |
50mg |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI210-0010 |
L-655,238 ¡Úa-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol REV-5901para-isomer¡Û |
10mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI210-0050 |
L-655,238 ¡Úa-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol REV-5901para-isomer¡Û |
50mg |
¡ï43,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-EI211-0010 |
CDC ¡ÚCinnamyl-3,4-dihydroxy-a-cyanocinnamate¡Û |
10mg |
¡ï9,000 |
|
132465-11-3 |
|
|
|
·àʪ |
BML |
BML-EI211-0050 |
CDC ¡ÚCinnamyl-3,4-dihydroxy-a-cyanocinnamate¡Û |
50mg |
¡ï39,000 |
|
132465-11-3 |
|
|
|
·àʪ |
BML |
BML-EI215-0050 |
Tyrphostin 9 ¡ÚRG-50872¡Û¡ÚMalonaben¡Û¡ÚSF 6847¡Û¡Ú3,5-Di-tert-butylhydroxybenzylidenemalononitrile¡Û |
50mg |
¡ï8,000 |
|
10537-47-0 |
|
|
|
·àʪ |
BML |
BML-EI215-0250 |
Tyrphostin 9 ¡ÚRG-50872¡Û¡ÚMalonaben¡Û¡ÚSF 6847¡Û¡Ú3,5-Di-tert-butylhydroxybenzylidenemalononitrile¡Û |
250mg |
¡ï35,000 |
|
10537-47-0 |
|
|
|
¡¡ |
BML |
BML-EI216-0020 |
AA-861 ¡Ú2-(12-Hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone¡Û |
20mg |
¡ï11,000 |
|
80809-81-0 |
|
|
|
¡¡ |
BML |
BML-EI216-0100 |
AA-861 ¡Ú2-(12-Hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone¡Û |
100mg |
¡ï43,000 |
|
80809-81-0 |
|
|
|
¡¡ |
BML |
BML-EI217-0001 |
Tranylcypromine ¡Útrans-2-Phenylcyclopropylamine, Hemisulfate¡Û |
1g |
¡ï13,000 |
|
13492-01-8 |
|
|
|
¡¡ |
BML |
BML-EI217-0005 |
Tranylcypromine ¡Útrans-2-Phenylcyclopropylamine, Hemisulfate¡Û |
5g |
¡ï53,000 |
|
13492-01-8 |
|
|
|
¡¡ |
BML |
BML-EI218-0100 |
Triacsin C ¡Ú2,4,7-Undecatrienal Nitrosohydrazone¡Û¡ÚWS1228A¡Û¡Ú2E, 4E, 7E-Undecatriene-1-triazene¡Û |
100ug |
¡ï14,000 |
|
76896-80-5 |
|
|
|
¡¡ |
BML |
BML-EI218-1000 |
Triacsin C ¡Ú2,4,7-Undecatrienal Nitrosohydrazone¡Û¡ÚWS1228A¡Û¡Ú2E, 4E, 7E-Undecatriene-1-triazene¡Û |
1mg |
¡ï58,000 |
|
76896-80-5 |
|
|
|
¡¡ |
BML |
BML-EI225-0005 |
Chelerythrine Chloride |
5mg |
¡ï10,000 |
|
3895-92-9 |
|
|
|
¡¡ |
BML |
BML-EI225-0025 |
Chelerythrine Chloride |
25mg |
¡ï43,000 |
|
3895-92-9 |
|
|
|
¡¡ |
BML |
BML-EI227-0100 |
Herbimycin A |
100ug |
¡ï19,000 |
|
70563-58-5 |
|
|
|
¡¡ |
BML |
BML-EI227-1000 |
Herbimycin A |
1mg |
¡ï106,000 |
|
70563-58-5 |
|
|
|
·àʪ |
BML |
BML-EI228-0010 |
AG-494 ¡ÚN-Phenyl-3,4-dihydroxybenzylidenecyanoacetamide¡Û |
10mg |
¡ï8,000 |
|
133550-35-3 |
|
|
|
·àʪ |
BML |
BML-EI228-0050 |
AG-494 ¡ÚN-Phenyl-3,4-dihydroxybenzylidenecyanoacetamide¡Û |
50mg |
¡ï33,000 |
|
133550-35-3 |
|
|
|
·àʪ |
BML |
BML-EI229-0002 |
AG-370 ¡ÚTyrphostin AG 370¡Û¡ÚTyrphostin B7¡Û¡Ú2-Amino-4-(1H-indol-5-yl)-1,1,3-tricyanobuta-1,3-diene¡Û |
2mg |
¡ï13,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-EI229-0010 |
AG-370 ¡ÚTyrphostin AG 370¡Û¡ÚTyrphostin B7¡Û¡Ú2-Amino-4-(1H-indol-5-yl)-1,1,3-tricyanobuta-1,3-diene¡Û |
10mg |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI230-0001 |
KN-62 ¡Ú4-[(2S)-2-[(5-Isoquinolinylsulfonyl)methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl isoquinolinesulfonic Acid Ester¡Û |
1mg |
¡ï17,000 |
|
127191-97-3 |
|
|
|
¡¡ |
BML |
BML-EI231-0010 |
5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole ¡ÚDRB¡Û¡Ú5,6-Dichlorobenzimidazole Riboside¡Û |
10mg |
¡ï4,000 |
|
53-85-0 |
|
|
|
¡¡ |
BML |
BML-EI231-0050 |
5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole ¡ÚDRB¡Û¡Ú5,6-Dichlorobenzimidazole Riboside¡Û |
50mg |
¡ï18,000 |
|
53-85-0 |
|
|
|
¡¡ |
BML |
BML-EI232-0002 |
2-Hydroxy-5-(2,5-dihydroxybenzylamino)benzoic Acid ¡ÚHDBA¡Û |
2mg |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI232-0010 |
2-Hydroxy-5-(2,5-dihydroxybenzylamino)benzoic Acid ¡ÚHDBA¡Û |
10mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI233-0010 |
HA-1077 ¡Ú1-(5-Isoquinolinesulfonyl)homopiperazine, 2HCl¡Û¡ÚFasudil¡Û |
10mg |
¡ï15,000 |
|
103745-39-7 |
|
|
|
¡¡ |
BML |
BML-EI233-0050 |
HA-1077 ¡Ú1-(5-Isoquinolinesulfonyl)homopiperazine, 2HCl¡Û¡ÚFasudil¡Û |
50mg |
¡ï61,000 |
|
103745-39-7 |
|
|
|
¡¡ |
BML |
BML-EI234-0100 |
K-252b |
100ug |
¡ï15,000 |
|
99570-78-2 |
|
|
|
¡¡ |
BML |
BML-EI234-1000 |
K-252b |
1mg |
¡ï63,000 |
|
99570-78-2 |
|
|
|
¡¡ |
BML |
BML-EI241-0200 |
Ro 16-6491 ¡ÚN-(2-Aminoethyl)-4-chlorobenzamide, HCl¡Û |
200mg |
¡ï7,000 |
|
94319-79-6 |
|
|
|
¡¡ |
BML |
BML-EI242-0020 |
U-5021 ¡Ú3',4'-Dihydroxy-2-methylpropiophenone¡Û |
20mg |
¡ï6,000 |
|
5466-89-7 |
|
|
|
¡¡ |
BML |
BML-EI242-0100 |
U-5021 ¡Ú3',4'-Dihydroxy-2-methylpropiophenone¡Û |
100mg |
¡ï27,000 |
|
5466-89-7 |
|
|
|
¡¡ |
BML |
BML-EI244-0100 |
Benzylphosphonic Acid |
100mg |
¡ï3,000 |
|
6881-57-8 |
|
|
|
¡¡ |
BML |
BML-EI244-0500 |
Benzylphosphonic Acid |
500mg |
¡ï6,000 |
|
6881-57-8 |
|
|
|
¡¡ |
BML |
BML-EI245-0010 |
Benzylphosphonic Acid-(AM)2 ¡ÚBenzylphosphonic Acid bis(Acetoxymethyl)Ester¡Û |
10mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI245-0050 |
Benzylphosphonic Acid-(AM)2 ¡ÚBenzylphosphonic Acid bis(Acetoxymethyl)Ester¡Û |
50mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI246-0001 |
GF109203X ¡ÚBisindolylmaleimide I¡Û¡Ú2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide¡Û |
1mg |
¡ï13,000 |
|
133052-90-1 |
|
|
|
¡¡ |
BML |
BML-EI247-0005 |
Hydroxy-2-naphthalenylmethylphosphonic Acid ¡ÚHNMPA¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI247-0025 |
Hydroxy-2-naphthalenylmethylphosphonic Acid ¡ÚHNMPA¡Û |
25mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI248-0005 |
HNMPA-(AM)3 ¡ÚHydroxy-2-naphthalenylmethylphosphonic Acid-tris(Acetoxymethyl)Ester¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI248-0025 |
HNMPA-(AM)3 ¡ÚHydroxy-2-naphthalenylmethylphosphonic Acid-tris(Acetoxymethyl)Ester¡Û |
25mg |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI249-0010 |
Troleandomycin |
10mg |
¡ï11,000 |
|
2751-09-9 |
|
|
|
¡¡ |
BML |
BML-EI249-0050 |
Troleandomycin |
50mg |
¡ï46,000 |
|
2751-09-9 |
|
|
|
·àʪ |
BML |
BML-EI252-0005 |
RG-13022 ¡Ú3,4-Dimethoxy-a-(3-pyridyl)-(Z)-cinnamonitrile¡Û |
5mg |
¡ï12,000 |
|
136831-48-6 |
|
|
|
·àʪ |
BML |
BML-EI252-0025 |
RG-13022 ¡Ú3,4-Dimethoxy-a-(3-pyridyl)-(Z)-cinnamonitrile¡Û |
25mg |
¡ï48,000 |
|
136831-48-6 |
|
|
|
·àʪ |
BML |
BML-EI253-0005 |
RG-14620 ¡Ú3,5-Dichloro-a-(3-pyridyl)-(Z)-cinnamonitrile¡Û |
5mg |
¡ï8,000 |
|
136831-49-7 |
|
|
|
¡¡ |
BML |
BML-EI254-0001 |
Lavendustin B ¡ÚN,N-bis(2'-Hydroxybenzyl)-3-aminosalicylic Acid¡Û |
1mg |
¡ï8,000 |
|
125697-91-8 |
|
|
|
¡¡ |
BML |
BML-EI254-0005 |
Lavendustin B ¡ÚN,N-bis(2'-Hydroxybenzyl)-3-aminosalicylic Acid¡Û |
5mg |
¡ï32,000 |
|
125697-91-8 |
|
|
|
¡¡ |
BML |
BML-EI256-0200 |
Metyrapone |
200mg |
¡ï4,000 |
|
54-36-4 |
|
|
|
·àʪ |
BML |
BML-EI257-0010 |
Tyrphostin 46 ¡Ú3,4-Dihydroxy-a-cyanocinnamide¡Û |
10mg |
¡ï7,000 |
|
122520-85-8 |
|
|
|
·àʪ |
BML |
BML-EI257-0050 |
Tyrphostin 46 ¡Ú3,4-Dihydroxy-a-cyanocinnamide¡Û |
50mg |
¡ï28,000 |
|
122520-85-8 |
|
|
|
·àʪ |
BML |
BML-EI258-0005 |
AG-879 ¡Ú3,5-Di-tert-butyl-4-hydroxybenzylidenecyanothioacetamide¡Û |
5mg |
¡ï10,000 |
|
148741-30-4 |
|
|
|
·àʪ |
BML |
BML-EI258-0025 |
AG-879 ¡Ú3,5-Di-tert-butyl-4-hydroxybenzylidenecyanothioacetamide¡Û |
25mg |
¡ï42,000 |
|
148741-30-4 |
|
|
|
¡¡ |
BML |
BML-EI259-0100 |
1-Aminobenzotriazole |
100mg |
¡ï15,000 |
|
1614-12-6 |
|
|
|
¡¡ |
BML |
BML-EI260-0010 |
6-Methoxy-2-naphthylacetic Acid |
10mg |
¡ï10,000 |
|
23981-47-7 |
|
|
|
¡¡ |
BML |
BML-EI260-0050 |
6-Methoxy-2-naphthylacetic Acid |
50mg |
¡ï42,000 |
|
23981-47-7 |
|
|
|
¡¡ |
BML |
BML-EI261-0005 |
NS-398 ¡ÚN-(2-Cyclohexyloxy-4-nitrophenyl)-Methanesulfonamide¡Û |
5mg |
¡ï10,000 |
|
123653-11-2 |
|
|
|
¡¡ |
BML |
BML-EI261-0025 |
NS-398 ¡ÚN-(2-Cyclohexyloxy-4-nitrophenyl)-Methanesulfonamide¡Û |
25mg |
¡ï42,000 |
|
123653-11-2 |
|
|
|
¡¡ |
BML |
BML-EI262-0010 |
7-Ethoxyresorufin ¡Ú7-ER¡Û |
10mg |
¡ï24,000 |
|
5725-91-7 |
|
|
|
·àʪ |
BML |
BML-EI263-0005 |
AG-126 ¡Ú3-Hydroxy-4-nitrobenzylidenemalononitrile¡Û |
5mg |
¡ï10,000 |
|
118409-62-4 |
|
|
|
·àʪ |
BML |
BML-EI263-0025 |
AG-126 ¡Ú3-Hydroxy-4-nitrobenzylidenemalononitrile¡Û |
25mg |
¡ï42,000 |
|
118409-62-4 |
|
|
|
¡¡ |
BML |
BML-EI265-0020 |
S(-)-Carbidopa ¡ÚS-a-Hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic Acid¡Û |
20mg |
¡ï9,000 |
|
28860-95-9 |
|
|
|
¡¡ |
BML |
BML-EI265-0100 |
S(-)-Carbidopa ¡ÚS-a-Hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic Acid¡Û |
100mg |
¡ï32,000 |
|
28860-95-9 |
|
|
|
¡¡ |
BML |
BML-EI266-0005 |
MK-886 ¡ÚL-663,536¡Û¡Ú3-[1-(p-Chlorobenzyl)-5-(isopropyl)-3-t-butylthioindol-2-yl]-2,2-dimethylpropanoic Acid, Na¡Û |
5mg |
¡ï10,000 |
|
118414-82-7 |
|
|
|
¡¡ |
BML |
BML-EI266-0025 |
MK-886 ¡ÚL-663,536¡Û¡Ú3-[1-(p-Chlorobenzyl)-5-(isopropyl)-3-t-butylthioindol-2-yl]-2,2-dimethylpropanoic Acid, Na¡Û |
25mg |
¡ï40,000 |
|
118414-82-7 |
|
|
|
·àʪ |
BML |
BML-EI267-0002 |
AG-825 ¡ÚTyrphostin AG 825¡Û¡ÚTyrphostin C15¡Û¡Ú5-[(Benzothiazol-2-yl)thiomethyl]-4-hydroxy-3-methoxybenzyl-idenecyanoacetamide¡Û |
2mg |
¡ï10,000 |
|
149092-50-2 |
|
|
|
·àʪ |
BML |
BML-EI267-0010 |
AG-825 ¡ÚTyrphostin AG 825¡Û¡ÚTyrphostin C15¡Û¡Ú5-[(Benzothiazol-2-yl)thiomethyl]-4-hydroxy-3-methoxybenzyl-idenecyanoacetamide¡Û |
10mg |
¡ï40,000 |
|
149092-50-2 |
|
|
|
¡¡ |
BML |
BML-EI268-0001 |
KN-93 ¡Ú2-[N-(2-Hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine¡Û |
1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI269-0500 |
G? 6976 ¡Ú12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole¡Û |
500ug |
¡ï27,000 |
|
136194-77-9 |
|
|
|
·àʪ |
BML |
BML-EI272-0010 |
AG-490 ¡ÚN-Benzyl-3,4-dihydroxybenzylidenecyanoacetamide¡Û |
10mg |
¡ï10,000 |
|
133550-30-8 |
|
|
|
·àʪ |
BML |
BML-EI272-0050 |
AG-490 ¡ÚN-Benzyl-3,4-dihydroxybenzylidenecyanoacetamide¡Û |
50mg |
¡ï40,000 |
|
133550-30-8¡¡ |
|
|
|
¡¡ |
BML |
BML-EI273-0001 |
HBDDE ¡Ú2,2',3,3',4,4'-Hexahydroxy-1,1'-biphenyl-6,6'-dimethanol Dimethyl Ether¡Û |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI273-0005 |
HBDDE ¡Ú2,2',3,3',4,4'-Hexahydroxy-1,1'-biphenyl-6,6'-dimethanol Dimethyl Ether¡Û |
5mg |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI274-0001 |
Damnacanthal ¡Ú3-Hydroxy-1-methoxyanthraquinone-2-aldehyde¡Û |
1mg |
¡ï30,000 |
|
477-84-9 |
|
|
|
¡¡ |
BML |
BML-EI275-0001 |
PP1 ¡Ú1-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine¡Û |
1mg |
¡ï10,000 |
|
172889-26-8 |
|
|
|
¡¡ |
BML |
BML-EI275-0005 |
PP1 ¡Ú1-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine¡Û |
5mg |
¡ï42,000 |
|
172889-26-8 |
|
|
|
¡¡ |
BML |
BML-EI276-0001 |
(S)-Ibuprofen ¡Ú(S)-(+)-2-(4-Isobutylphenyl)propionic Acid¡Û |
1g |
¡ï10,000 |
|
51146-56-6 |
|
|
|
·àʪ |
BML |
BML-EI278-0010 |
BAY 11-7082 ¡Ú(E)-3-(4-Methylphenylsulfonyl)-2-propenenenitrile¡Û |
10mg |
¡ï10,000 |
|
195462-67-7 |
|
|
|
·àʪ |
BML |
BML-EI278-0050 |
BAY 11-7082 ¡Ú(E)-3-(4-Methylphenylsulfonyl)-2-propenenenitrile¡Û |
50mg |
¡ï42,000 |
|
195462-67-7 |
|
|
|
·àʪ |
BML |
BML-EI279-0010 |
BAY 11-7085 ¡Ú(E)-3-[(4-tert-Butylphenylsulfonyl]-2-propenenitrile¡Û |
10mg |
¡ï10,000 |
|
196309-76-9 |
|
|
|
·àʪ |
BML |
BML-EI279-0050 |
BAY 11-7085 ¡Ú(E)-3-[(4-tert-Butylphenylsulfonyl]-2-propenenitrile¡Û |
50mg |
¡ï42,000 |
|
196309-76-9 |
|
|
|
¡¡ |
BML |
BML-EI280-0001 |
Geldanamycin |
1mg |
¡ï11,000 |
|
30562-34-6 |
|
|
|
¡¡ |
BML |
BML-EI280-0005 |
Geldanamycin |
5mg |
¡ï48,000 |
|
30562-34-6 |
|
|
|
·àʪ |
BML |
BML-EI282-0001 |
U-0126 ¡ÚBis[amino[(2-aminophenyl)thio]methylene]butanedinitrile¡Û |
1mg |
¡ï8,000 |
|
109522-58-2 |
|
|
|
·àʪ |
BML |
BML-EI282-0005 |
U-0126 ¡ÚBis[amino[(2-aminophenyl)thio]methylene]butanedinitrile¡Û |
5mg |
¡ï30,000 |
|
109522-58-2 |
|
|
|
¡¡ |
BML |
BML-EI283-0001 |
Ro 31-8220 ¡ÚBisindolylmaleimide IX, Methanesulfonate¡Û |
1mg |
¡ï10,000 |
|
138489-18-6 |
|
|
|
¡¡ |
BML |
BML-EI284-0001 |
Ro 32-0432 ¡ÚBisindolylmaleimide XI, HCl¡Û |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI285-0001 |
Radicicol ¡ÚMonorden¡Û¡Ú1aS-(1aR*,2Z,4E,14*,15aR*)]-8-Chloro-1a,14,15,15a-tetrahydro-9,11-dihydroxy-14-methyl-6H-oxireno[e][2]benzoxacyclotetradecin-6,12(7H)-dione¡Û(Isolated from Humicola fuscoatra.) |
1mg |
¡ï16,000 |
|
12772-57-5 |
|
|
|
¡¡ |
BML |
BML-EI286-0001 |
SB-203580 ¡Ú4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole¡Û |
1mg |
¡ï10,000 |
|
152121-47-6 |
|
|
|
¡¡ |
BML |
BML-EI286-0005 |
SB-203580 ¡Ú4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole¡Û |
5mg |
¡ï42,000 |
|
152121-47-6 |
|
|
|
¡¡ |
BML |
BML-EI288-0001 |
(S)-Ketoprofen ¡Ú(S)-(+)-3-Benzoyl-a-methylbenzeneacetic Acid¡Û |
1g |
¡ï20,000 |
|
22161-88-5 |
|
|
|
¡¡ |
BML |
BML-EI290-0200 |
(R)-Ibuprofen ¡Ú(R)-(-)-2-(4-Isobutylphenyl)propionic Acid¡Û |
200mg |
¡ï14,000 |
|
51146-57-7 |
|
|
|
¡¡ |
BML |
BML-EI292-0020 |
Meloxicam ¡Ú4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-2-carboxamide-1,1-dioxide¡Û |
20mg |
¡ï7,000 |
|
71125-38-7 |
|
|
|
¡¡ |
BML |
BML-EI292-0100 |
Meloxicam ¡Ú4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-2-carboxamide-1,1-dioxide¡Û |
100mg |
¡ï16,000 |
|
71125-38-7 |
|
|
|
¡¡ |
BML |
BML-EI293-0001 |
5-Iodotubercidin ¡Ú4-Amino-5-iodo-7-(b-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine¡Û |
1mg |
¡ï11,000 |
|
24386-93-4 |
|
|
|
¡¡ |
BML |
BML-EI293-0005 |
5-Iodotubercidin ¡Ú4-Amino-5-iodo-7-(b-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine¡Û |
5mg |
¡ï48,000 |
|
24386-93-4 |
|
|
|
¡¡ |
BML |
BML-EI294-0001 |
SB-202190 ¡ÚFHPI¡Û¡Ú4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole¡Û |
1mg |
¡ï12,000 |
|
152121-30-7 |
|
|
|
·àʪ |
BML |
BML-EI295-0005 |
LFM-A13 ¡Úa-Cyano-B-hydroxy-B-methyl-N-(2,5-dibromophenyl)propenamide¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-EI295-0025 |
LFM-A13 ¡Úa-Cyano-B-hydroxy-B-methyl-N-(2,5-dibromophenyl)propenamide¡Û |
25mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI296-0500 |
G?-6983 |
0.5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI297-0001 |
PP2 ¡Ú4-Amino-5-(4-chlorophenyl)-7-(tert-butyl)pyrazolo[3,4-d]pyrimidine¡Û |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI297-0005 |
PP2 ¡Ú4-Amino-5-(4-chlorophenyl)-7-(tert-butyl)pyrazolo[3,4-d]pyrimidine¡Û |
5mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI298-0005 |
ZM 336372 ¡ÚN-[5-(3-Dimethylaminobenzamido)-2-methylphenyl]-4-hydroxybenzamide¡Û |
5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI298-0025 |
ZM 336372 ¡ÚN-[5-(3-Dimethylaminobenzamido)-2-methylphenyl]-4-hydroxybenzamide¡Û |
25mg |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI300-0001 |
GM-6001 ¡ÚGalardin¡Û¡ÚIlomastat¡Û¡ÚN-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan Methylamide¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI300-0005 |
GM-6001 ¡ÚGalardin¡Û¡ÚIlomastat¡Û¡ÚN-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan Methylamide¡Û |
5mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI302-0005 |
CL-82198 ¡ÚN-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide, HCl¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI302-0025 |
CL-82198 ¡ÚN-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide, HCl¡Û |
25mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI303-0005 |
AG-1296 ¡ÚTyrphostin AG 1296¡Û¡Ú6,7-Dimethoxy-3-phenylquinoxaline¡Û |
5mg |
¡ï14,000 |
|
146535-11-7 |
|
|
|
¡¡ |
BML |
BML-EI303-0025 |
AG-1296 ¡ÚTyrphostin AG 1296¡Û¡Ú6,7-Dimethoxy-3-phenylquinoxaline¡Û |
25mg |
¡ï60,000 |
|
146535-11-7 |
|
|
|
¡¡ |
BML |
BML-EI304-0005 |
BW B70C ¡ÚN-[3-[3-(Fluorophenoxy)phenyl]-1-methyl-2-propenyl]-N-hydroxyurea¡Û |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI304-0025 |
BW B70C ¡ÚN-[3-[3-(Fluorophenoxy)phenyl]-1-methyl-2-propenyl]-N-hydroxyurea¡Û |
25mg |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI305-0010 |
SP600125 ¡ÚAnthra[1,9-cd]pyrazol-6(2H)-one¡Û¡Ú1,9-Pyrazoloanthrone¡Û |
10mg |
¡ï8,000 |
|
129-56-6 |
|
|
|
¡¡ |
BML |
BML-EI305-0050 |
SP600125 ¡ÚAnthra[1,9-cd]pyrazol-6(2H)-one¡Û¡Ú1,9-Pyrazoloanthrone¡Û |
50mg |
¡ï34,000 |
|
129-56-6 |
|
|
|
¡¡ |
BML |
BML-EI306-0005 |
SU4312 ¡Ú3-(4-Dimethylaminobenzylidene)-1,3-dihydroindol-2-one¡Û |
5mg |
¡ï10,000 |
|
5812-07-7 |
|
|
|
¡¡ |
BML |
BML-EI306-0025 |
SU4312 ¡Ú3-(4-Dimethylaminobenzylidene)-1,3-dihydroindol-2-one¡Û |
25mg |
¡ï40,000 |
|
5812-07-7 |
|
|
|
¡¡ |
BML |
BML-EI307-0005 |
GW-5074 ¡Ú3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one¡Û |
5mg |
¡ï13,000 |
|
220904-83-6 |
|
|
|
¡¡ |
BML |
BML-EI307-0025 |
GW-5074 ¡Ú3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one¡Û |
25mg |
¡ï53,000 |
|
220904-83-6 |
|
|
|
¡¡ |
BML |
BML-EI308-0001 |
17-AAG ¡Ú17-(Allylamino)-17-demethoxygeldanamycin¡Û(semisynthetic derivative from geldanamycin) |
1mg |
¡ï25,000 |
|
75747-14-7 |
|
|
|
¡¡ |
BML |
BML-EI309-0005 |
NSC-95397 ¡Ú2,3-bis[(2-Hydroxyethyl)thiol]-1,4-naphthoquinone¡Û |
5mg |
¡ï16,000 |
|
93718-83-30 |
|
|
|
¡¡ |
BML |
BML-EI309-0025 |
NSC-95397 ¡Ú2,3-bis[(2-Hydroxyethyl)thiol]-1,4-naphthoquinone¡Û |
25mg |
¡ï67,000 |
|
93718-83-30 |
|
|
|
¡¡ |
BML |
BML-EI310-0005 |
Kenpaullone ¡Ú8-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one¡Û |
5mg |
¡ï26,000 |
|
142273-20-9 |
|
|
|
¡¡ |
BML |
BML-EI311-0001 |
SB-415286 ¡Ú3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI311-0005 |
SB-415286 ¡Ú3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione¡Û |
5mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI312-0001 |
SB-216763 ¡Ú3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3yl)-1H-pyrrole-2,5-dione¡Û |
1mg |
¡ï8,000 |
|
280744-09-4 |
|
|
|
¡¡ |
BML |
BML-EI312-0005 |
SB-216763 ¡Ú3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3yl)-1H-pyrrole-2,5-dione¡Û |
5mg |
¡ï24,000 |
|
280744-09-4 |
|
|
|
¡¡ |
BML |
BML-EI313-0500 |
Ikarugamycin |
500ug |
¡ï25,000 |
|
36531-78-9 |
|
|
|
¡¡ |
BML |
BML-EI315-0005 |
Blebbistatin(+/-)¡Ú(¡Þ)-1-Phenyl-1,2,3,4-tetrahydro-4-hydroxypyrrolo[2,3-b]-7-methylquinolin-4-one¡Û |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI315-0025 |
Blebbistatin(+/-)¡Ú(¡Þ)-1-Phenyl-1,2,3,4-tetrahydro-4-hydroxypyrrolo[2,3-b]-7-methylquinolin-4-one¡Û |
25mg |
¡ï61,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI316-0001 |
Wedelolactone ¡Ú7-Methoxy-5,11,12-trihydroxycoumestan¡Û |
1mg |
¡ï13,000 |
|
524-12-9 |
|
|
|
¡¡ |
BML |
BML-EI317-0020 |
TMP-153 ¡ÚN-(4-(2-Chlorophenyl)-6,7-dimethyl-3-quinolyl)-N'-(2,4-difluorophenyl)urea¡Û |
20mg |
¡ï8,000 |
|
128831-46-9 |
|
|
|
¡¡ |
BML |
BML-EI317-0100 |
TMP-153 ¡ÚN-(4-(2-Chlorophenyl)-6,7-dimethyl-3-quinolyl)-N'-(2,4-difluorophenyl)urea¡Û |
100mg |
¡ï33,000 |
|
128831-46-9 |
|
|
|
¡¡ |
BML |
BML-EI318-0100 |
Terbinafine, HCl ¡ÚN-[(2E)-6,6-Dimethyl-2-hepten-4-ynyl]-N-methyl-1-naphthalenemethanamine, HCl¡Û |
100mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI319-0100 |
Depudecin ¡Ú(2R,3S,4S,5E,7S,8S,9R)-2,9-Dihydroxy-3,4;7,8-diepoxyundeca-5,10-diene¡Û |
100ug |
¡ï10,000 |
|
139508-73-9 |
|
|
|
¡¡ |
BML |
BML-EI320-0001 |
Phenylbutyrate Sodium ¡ÚSodium 4-Phenylbutyrate¡Û¡Ú4-Phenylbutyric Acid, Na salt¡Û¡ÚSBP¡Û¡Ú4PBA¡Û¡ÚPBNa¡Û |
1g |
¡ï8,000 |
|
1716-12-7 |
|
|
|
¡¡ |
BML |
BML-EI321-0010 |
TOFA ¡Ú5-(Tetradecyloxy)-2-furoic Acid¡Û¡ÚRMI-14514¡Û |
10mg |
¡ï8,000 |
|
54857-86-2 |
|
|
|
¡¡ |
BML |
BML-EI321-0050 |
TOFA ¡Ú5-(Tetradecyloxy)-2-furoic Acid¡Û¡ÚRMI-14514¡Û |
50mg |
¡ï36,000 |
|
54857-86-2 |
|
|
|
¡¡ |
BML |
BML-EI322-0010 |
Exo1 ¡Ú2-[(4-Fluorobenzoyl)amino]benzoic Acid Methyl Ester¡Û |
10mg |
¡ï8,000 |
|
461681-88-9 |
|
|
|
¡¡ |
BML |
BML-EI322-0050 |
Exo1 ¡Ú2-[(4-Fluorobenzoyl)amino]benzoic Acid Methyl Ester¡Û |
50mg |
¡ï36,000 |
|
461681-88-9 |
|
|
|
¡¡ |
BML |
BML-EI323-0001 |
MU-Phe-hPhe-FMK ¡ÚN-Morpholineureaphenylalanylhomophenylalanylfluoromethyl Ketone¡Û |
1mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI325-0001 |
SB-3CT ¡Ú3-(4-Phenoxyphenylsulfonyl)propylthiirane¡Û |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI325-0005 |
SB-3CT ¡Ú3-(4-Phenoxyphenylsulfonyl)propylthiirane¡Û |
5mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI327-0005 |
URB-597 ¡ÚCyclohexylcarbamic Acid 3'-Carbamoylbiphenyl-3-yl Ester¡Û |
5mg |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI327-0025 |
URB-597 ¡ÚCyclohexylcarbamic Acid 3'-Carbamoylbiphenyl-3-yl Ester¡Û |
25mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI328-0001 |
Terreic Acid ¡Ú(1R,6S)-3-Hydroxy-4-methyl-7-oxabicyclo[4.1.0]hept-3-ene-2,5-dione¡Û |
1mg |
¡ï7,000 |
|
121-40-4 |
|
|
|
¡¡ |
BML |
BML-EI328-0005 |
Terreic Acid ¡Ú(1R,6S)-3-Hydroxy-4-methyl-7-oxabicyclo[4.1.0]hept-3-ene-2,5-dione¡Û |
5mg |
¡ï30,000 |
|
121-40-4 |
|
|
|
¡¡ |
BML |
BML-EI330-0050 |
AICAR ¡Ú5-Aminoimidazole-4-carboxamide 1-B-D-Ribofuranoside¡Û |
50mg |
¡ï10,000 |
|
2627-69-2 |
|
|
|
¡¡ |
BML |
BML-EI330-0250 |
AICAR ¡Ú5-Aminoimidazole-4-carboxamide 1-B-D-Ribofuranoside¡Û |
250mg |
¡ï40,000 |
|
2627-69-2 |
|
|
|
¡¡ |
BML |
BML-EI331-0010 |
LM-4108 ¡ÚN-(2-Phenylethyl)Indomethacin Amide¡Û |
10mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI331-0050 |
LM-4108 ¡ÚN-(2-Phenylethyl)Indomethacin Amide¡Û |
50mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI332-0001 |
Triciribine ¡ÚTricyclic Nucleoside(TCN)¡Û¡ÚNSC-154020¡Û¡ÚAPI-2¡Û |
1mg |
¡ï19,000 |
|
35943-35-2 |
|
|
|
¡¡ |
BML |
BML-EI332-0005 |
Triciribine ¡ÚTricyclic Nucleoside(TCN)¡Û¡ÚNSC-154020¡Û¡ÚAPI-2¡Û |
5mg |
¡ï80,000 |
|
35943-35-2 |
|
|
|
¡¡ |
BML |
BML-EI334-0001 |
Fusicoccin |
1mg |
¡ï22,000 |
|
20108-30-9 |
|
|
|
·àʪ |
BML |
BML-EI335-0010 |
AG-1288 ¡Úa-Cyano-(3,4-dihydroxy-5-nitro)cinnamonitrile¡Û |
10mg |
¡ï10,000 |
|
116313-73-6 |
|
|
|
·àʪ |
BML |
BML-EI335-0050 |
AG-1288 ¡Úa-Cyano-(3,4-dihydroxy-5-nitro)cinnamonitrile¡Û |
50mg |
¡ï39,000 |
|
116313-73-6 |
|
|
|
¡¡ |
BML |
BML-EI336-0010 |
BML-257 ¡Ú2,3-Diphenylquinoxaline-6-carboxylic Acid¡Û |
10mg |
¡ï9,000 |
|
32387-96-5 |
|
|
|
¡¡ |
BML |
BML-EI336-0050 |
BML-257 ¡Ú2,3-Diphenylquinoxaline-6-carboxylic Acid¡Û |
50mg |
¡ï37,000 |
|
32387-96-5 |
|
|
|
¡¡ |
BML |
BML-EI337-0001 |
17-DMAG ¡ÚNSC 707545¡Û¡Ú17-[2-(Dimethylamino)ethyl]amino-17-desmethoxygeldanamycin¡Û |
1mg |
¡ï25,000 |
|
150270-08-9 |
|
|
|
¡¡ |
BML |
BML-EI338-0001 |
17-GMB-APA-GA ¡Ú17-[3-(4-Maleimidobutyrcarboxamido)propylamino]demethoxygeldanamycin¡Û |
1mg |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI339-0010 |
APHS ¡Ú2-Acetoxyphenylhept-2-ynylsulfide¡Û |
10mg |
¡ï10,000 |
|
209125-28-0 |
|
|
|
¡¡ |
BML |
BML-EI339-0050 |
APHS ¡Ú2-Acetoxyphenylhept-2-ynylsulfide¡Û |
50mg |
¡ï40,000 |
|
209125-28-0 |
|
|
|
¡¡ |
BML |
BML-EI340-0010 |
BIBB-515 ¡Ú1-(4-Chlorobenzoyl)-4-(4-(2-oxazolin-2-yl)benzylidene)piperidine¡Û |
10mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI340-0050 |
BIBB-515 ¡Ú1-(4-Chlorobenzoyl)-4-(4-(2-oxazolin-2-yl)benzylidene)piperidine¡Û |
50mg |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI341-0001 |
Geldanamycin-Biotin ¡ÚGDA-Et-dPEG2-dPEG4-Biotin¡Û |
1mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI342-0010 |
Ro 48-8071 ¡Ú4¡Ç-[6-(Allylmethylamino)hexyloxy]-4-bromo-2¡Ç-fluorobenzophenone Fumarate¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI342-0050 |
Ro 48-8071 ¡Ú4¡Ç-[6-(Allylmethylamino)hexyloxy]-4-bromo-2¡Ç-fluorobenzophenone Fumarate¡Û |
50mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI343-0010 |
SC-514 ¡Ú5-(Thien-3-yl)-3-aminothiophene-2-carboxamide¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI343-0050 |
SC-514 ¡Ú5-(Thien-3-yl)-3-aminothiophene-2-carboxamide¡Û |
50mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI344-0005 |
BML-259 ¡ÚN-(5-Isopropylthiazol-2-yl)phenylacetamide¡Û |
5mg |
¡ï9,000 |
|
267654-00-2 |
|
|
|
¡¡ |
BML |
BML-EI344-0025 |
BML-259 ¡ÚN-(5-Isopropylthiazol-2-yl)phenylacetamide¡Û |
25mg |
¡ï35,000 |
|
267654-00-2 |
|
|
|
¡¡ |
BML |
BML-EI345-0020 |
Apigenin ¡Ú4¡Ç,5,7-Trihydroxyflavone¡Û |
20mg |
¡ï10,000 |
|
520-36-5 |
|
|
|
¡¡ |
BML |
BML-EI345-0100 |
Apigenin ¡Ú4¡Ç,5,7-Trihydroxyflavone¡Û |
100mg |
¡ï40,000 |
|
520-36-5 |
|
|
|
¡¡ |
BML |
BML-EI347-0010 |
Dimethyloxaloylglycine ¡ÚDMOG¡Û¡ÚN-(Methoxyoxoacetyl)glycine Methyl Ester¡Û |
10mg |
¡ï9,000 |
|
89464-63-1 |
|
|
|
¡¡ |
BML |
BML-EI347-0050 |
Dimethyloxaloylglycine ¡ÚDMOG¡Û¡ÚN-(Methoxyoxoacetyl)glycine Methyl Ester¡Û |
50mg |
¡ï37,000 |
|
89464-63-1 |
|
|
|
¡¡ |
BML |
BML-EI348-0010 |
URB-602 ¡ÚBiphenyl-3-ylcarbamic Acid Cyclohexyl Ester¡Û |
10mg |
¡ï8,000 |
|
565460-15-3 |
|
|
|
¡¡ |
BML |
BML-EI348-0050 |
URB-602 ¡ÚBiphenyl-3-ylcarbamic Acid Cyclohexyl Ester¡Û |
50mg |
¡ï34,000 |
|
565460-15-3 |
|
|
|
¡¡ |
BML |
BML-EI349-0010 |
URB-754 ¡Ú6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazine-4-one¡Û |
10mg |
¡ï8,000 |
|
86672-58-4 |
|
|
|
¡¡ |
BML |
BML-EI349-0050 |
URB-754 ¡Ú6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazine-4-one¡Û |
50mg |
¡ï34,000 |
|
86672-58-4 |
|
|
|
¡¡ |
BML |
BML-EI350-0005 |
HET-0016 ¡ÚN-Hydroxy-N'-(4-butyl-2-methylphenyl)formamidine¡Û |
5mg |
¡ï10,000 |
|
339068-25-6 |
|
|
|
¡¡ |
BML |
BML-EI350-0025 |
HET-0016 ¡ÚN-Hydroxy-N'-(4-butyl-2-methylphenyl)formamidine¡Û |
25mg |
¡ï42,000 |
|
339068-25-6 |
|
|
|
¡¡ |
BML |
BML-EI351-0001 |
STA-21 ¡Ú(S)-Ochromycinone¡Û¡ÚDeoxytetrangomycin¡Û |
1mg |
¡ï24,000 |
|
28882-53-3 |
|
|
|
¡¡ |
BML |
BML-EI352-0001 |
QNZ ¡Ú6-Amino-4-(4-phenoxyphenylethylamino)quinazoline¡Û |
1mg |
¡ï14,000 |
|
545380-34-5 |
|
|
|
¡¡ |
BML |
BML-EI353-0001 |
ZM-306416 ¡Ú4-[(4'-Chloro-2'-fluoro)phenylamino]-6,7-dimethoxyquinazoline¡Û |
1mg |
¡ï9,000 |
|
690206-97-4 |
|
|
|
¡¡ |
BML |
BML-EI353-0010 |
ZM-306416 ¡Ú4-[(4'-Chloro-2'-fluoro)phenylamino]-6,7-dimethoxyquinazoline¡Û |
10mg |
¡ï19,000 |
|
690206-97-4 |
|
|
|
¡¡ |
BML |
BML-EI354-0001 |
L-JNKi1 ¡ÚJNK Inhibitor 1(L-stereoisomer)¡Û¡Úc-Jun N-terminal Kinase Peptide Inhibitor 1, L-stereoisomer¡Û |
1mg* |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI356-0010 |
PD 146176 ¡Ú6,11-Dihydro[1]benzothiopyrano[4,3-b]indole¡Û |
10mg |
¡ï11,000 |
|
4079-26-9 |
|
|
|
¡¡ |
BML |
BML-EI356-0050 |
PD 146176 ¡Ú6,11-Dihydro[1]benzothiopyrano[4,3-b]indole¡Û |
50mg |
¡ï46,000 |
|
4079-26-9 |
|
|
|
¡¡ |
BML |
BML-EI358-0005 |
DuP-697 ¡Ú5-Bromo-2[4-fluorophenyl]-3-[4-methylsulfonylphenyl]thiophene¡Û |
5mg |
¡ï15,000 |
|
88149-94-4 |
|
|
|
¡¡ |
BML |
BML-EI358-0025 |
DuP-697 ¡Ú5-Bromo-2[4-fluorophenyl]-3-[4-methylsulfonylphenyl]thiophene¡Û |
25mg |
¡ï60,000 |
|
88149-94-4 |
|
|
|
¡¡ |
BML |
BML-EI360-0005 |
PD 98059 ¡ÚMEK Inhibitor¡Û¡Ú2'-Amino-3'-methoxyflavone¡Û |
5mg |
¡ï10,000 |
|
167869-21-8 |
|
|
|
¡¡ |
BML |
BML-EI361-0001 |
Geldanamycin-FITC |
1mg |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI363-0100 |
GERI-BP002-A ¡Ú2,2'-Methylenebis(6-tert-butyl-4-methylphenol)¡Û |
100mg |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI363-1000 |
GERI-BP002-A ¡Ú2,2'-Methylenebis(6-tert-butyl-4-methylphenol)¡Û |
1g |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI364-0010 |
GW-441756 ¡Ú1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one¡Û |
10mg |
¡ï18,000 |
|
504433-23-3 |
|
|
|
¡¡ |
BML |
BML-EI364-0050 |
GW-441756 ¡Ú1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one¡Û |
50mg |
¡ï74,000 |
|
504433-23-3 |
|
|
|
·àʪ |
BML |
BML-EI365-0001 |
SL-327 ¡Úa-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile¡Û |
1mg |
¡ï7,000 |
|
305350-87-2 |
|
|
|
·àʪ |
BML |
BML-EI365-0010 |
SL-327 ¡Úa-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile¡Û |
10mg |
¡ï23,000 |
|
305350-87-2 |
|
|
|
¡¡ |
BML |
BML-EI366-0001 |
JX-401 ¡Ú1-[2-Methoxy-4-(methylthio)benzoyl]-4-(phenylmethyl)piperidine¡Û |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI366-0010 |
JX-401 ¡Ú1-[2-Methoxy-4-(methylthio)benzoyl]-4-(phenylmethyl)piperidine¡Û |
10mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI367-0005 |
AAL-993 ¡Ú2-[(4-Pyridyl)methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide¡Û |
5mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI367-0025 |
AAL-993 ¡Ú2-[(4-Pyridyl)methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide¡Û |
25mg |
¡ï72,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI368-0010 |
Stattic ¡Ú6-Nitro[b]thiophene-1,1-dioxide¡Û |
10mg |
¡ï6,000 |
|
19983-44-9 |
|
|
|
¡¡ |
BML |
BML-EI368-0050 |
Stattic ¡Ú6-Nitro[b]thiophene-1,1-dioxide¡Û |
50mg |
¡ï26,000 |
|
19983-44-9 |
|
|
|
¡¡ |
BML |
BML-EI369-0005 |
BML-275 ¡ÚDorsomorphin¡Û¡ÚCompound C¡Û¡Ú6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrrazolo[1,5-a]pyrimidine¡Û |
5mg |
¡ï10,000 |
|
866405-64-3 |
|
|
|
¡¡ |
BML |
BML-EI369-0025 |
BML-275 ¡ÚDorsomorphin¡Û¡ÚCompound C¡Û¡Ú6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrrazolo[1,5-a]pyrimidine¡Û |
25mg |
¡ï43,000 |
|
866405-64-3 |
|
|
|
¡¡ |
BML |
BML-EI370-0001 |
PKC-412 ¡Ú4'-N-Benzoylstaurosporine¡Û¡ÚMidostaurin¡Û¡ÚCGP 41251¡Û |
1mg |
¡ï14,000 |
|
120685-11-2 |
|
|
|
¡¡ |
BML |
BML-EI370-0005 |
PKC-412 ¡Ú4'-N-Benzoylstaurosporine¡Û¡ÚMidostaurin¡Û¡ÚCGP 41251¡Û |
5mg |
¡ï58,000 |
|
120685-11-2 |
|
|
|
¡¡ |
BML |
BML-EI371-0010 |
SD-169 ¡Ú1H-Indole-5-carboxamide¡Û |
10mg |
¡ï7,000 |
|
1670-87-7 |
|
|
|
¡¡ |
BML |
BML-EI371-0050 |
SD-169 ¡Ú1H-Indole-5-carboxamide¡Û |
50mg |
¡ï21,000 |
|
1670-87-7 |
|
|
|
¡¡ |
BML |
BML-EI372-0001 |
Picropodophyllin |
1mg |
¡ï20,000 |
|
447-47-4 |
|
|
|
¡¡ |
BML |
BML-EI373-0001 |
ZM-447439 ¡Ú4-(4-Benzoylaminophenylamino)-7-(3-morpholin-4-ylpropoxy)-6-methoxyquinazoline¡Û |
1mg |
¡ï8,000 |
|
331771-20-1 |
|
|
|
¡¡ |
BML |
BML-EI373-0010 |
ZM-447439 ¡Ú4-(4-Benzoylaminophenylamino)-7-(3-morpholin-4-ylpropoxy)-6-methoxyquinazoline¡Û |
10mg |
¡ï37,000 |
|
331771-20-1 |
|
|
|
¡¡ |
BML |
BML-EI377-0010 |
1,4-DPCA ¡Ú4-Oxo-1,4-dihydro-[1,10]phenanthroline-3-carboxylic Acid¡Û |
10mg |
¡ï4,000 |
|
331830-20-7 |
|
|
|
¡¡ |
BML |
BML-EI377-0050 |
1,4-DPCA ¡Ú4-Oxo-1,4-dihydro-[1,10]phenanthroline-3-carboxylic Acid¡Û |
50mg |
¡ï18,000 |
|
331830-20-7 |
|
|
|
¡¡ |
BML |
BML-EI378-0010 |
Ozagrel ¡Ú(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid¡Û |
10mg |
¡ï7,000 |
|
82571-53-7 |
|
|
|
¡¡ |
BML |
BML-EI378-0050 |
Ozagrel ¡Ú(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid¡Û |
50mg |
¡ï30,000 |
|
82571-53-7 |
|
|
|
¡¡ |
BML |
BML-EI379-0005 |
N-Arachidonyl Maleimide ¡ÚNAM¡Û |
5mg |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI379-0025 |
N-Arachidonyl Maleimide ¡ÚNAM¡Û |
25mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI384-0001 |
(D-Pro1,2)-retro-(D-HIV-TAT(48-57)) |
1mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI385-0001 |
ZM-323881 ¡Ú5-[(7-Benzyloxyquinazolin-4-yl)amino]-4-fluoro-2-methylphenol¡Û |
1mg |
¡ï9,000 |
|
324077-30-7 |
|
|
|
¡¡ |
BML |
BML-EI385-0005 |
ZM-323881 ¡Ú5-[(7-Benzyloxyquinazolin-4-yl)amino]-4-fluoro-2-methylphenol¡Û |
5mg |
¡ï36,000 |
|
324077-30-7 |
|
|
|
¡¡ |
BML |
BML-EI386-0005 |
DAPH ¡Ú4,5-Dianilinophthalimide¡Û¡ÚCGP-52411¡Û |
5mg |
¡ï20,000 |
|
145915-58-8 |
|
|
|
¡¡ |
BML |
BML-EI387-0001 |
DAPH-7 ¡ÚCGP 53353¡Û¡Ú4,5-bis[(4-Fluorophenyl)amino]phthalimide¡Û |
1mg |
¡ï4,000 |
|
145915-60-2 |
|
|
|
¡¡ |
BML |
BML-EI388-0010 |
BML-277 ¡ÚChk2 Inhibitor II¡Û¡Ú2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide¡Û |
10mg |
¡ï13,000 |
|
516480-79-8 |
|
|
|
¡¡ |
BML |
BML-EI388-0050 |
BML-277 ¡ÚChk2 Inhibitor II¡Û¡Ú2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide¡Û |
50mg |
¡ï52,000 |
|
516480-79-8 |
|
|
|
¡¡ |
BML |
BML-EI389-0005 |
STO-609 ¡Ú7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid, Acetate salt¡Û |
5mg |
¡ï10,000 |
|
52029-86-4 |
|
|
|
¡¡ |
BML |
BML-EI389-0025 |
STO-609 ¡Ú7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid, acetate salt¡Û |
25mg |
¡ï40,000 |
|
52029-86-4 |
|
|
|
¡¡ |
BML |
BML-EI390-0010 |
AS-041164 ¡ÚNSC31098¡Û¡Ú5-Benzo[1,3]dioxol-5-ylmethylenethiazolidine-2,4-dione¡Û |
10mg |
¡ï9,000 |
|
6318-41-8 |
|
|
|
¡¡ |
BML |
BML-EI390-0050 |
AS-041164 ¡ÚNSC31098¡Û¡Ú5-Benzo[1,3]dioxol-5-ylmethylenethiazolidine-2,4-dione¡Û |
50mg |
¡ï39,000 |
|
6318-41-8 |
|
|
|
¡¡ |
BML |
BML-EI391-0010 |
JZL-184 ¡Ú4-Nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate¡Û |
10mg |
¡ï8,000 |
|
1101854-58-3 |
|
|
|
¡¡ |
BML |
BML-EI391-0050 |
JZL-184 ¡Ú4-Nitrophenyl-4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate¡Û |
50mg |
¡ï35,000 |
|
1101854-58-3 |
|
|
|
¡¡ |
BML |
BML-EI392-0010 |
AUDA ¡Ú12-(3-Adamantan-1-ylureido)dodecanoic Acid¡Û |
10mg |
¡ï7,000 |
|
479413-70-2 |
|
|
|
¡¡ |
BML |
BML-EI392-0050 |
AUDA ¡Ú12-(3-Adamantan-1-ylureido)dodecanoic Acid¡Û |
50mg |
¡ï32,000 |
|
479413-70-2 |
|
|
|
¡¡ |
BML |
BML-EI394-0010 |
CCG-1423 ¡ÚN-(2-(4-Chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide¡Û |
10mg |
¡ï8,000 |
|
285986-88-1 |
|
|
|
¡¡ |
BML |
BML-EI394-0050 |
CCG-1423 ¡ÚN-(2-(4-Chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide¡Û |
50mg |
¡ï33,000 |
|
285986-88-1 |
|
|
|
¡¡ |
BML |
BML-EI395-0010 |
VAS-2870 ¡Ú3-Benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine¡Û |
10mg |
¡ï13,000 |
|
722456-31-7 |
|
|
|
¡¡ |
BML |
BML-EI395-0050 |
VAS-2870 ¡Ú3-Benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine¡Û |
50mg |
¡ï52,000 |
|
722456-31-7 |
|
|
|
¡¡ |
BML |
BML-EI396-0005 |
Ko143 ¡Ú(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino-[1¡Ç,2¡Ç:1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl Ester¡Û |
5mg |
¡ï16,000 |
|
461054-93-3 |
|
|
|
¡¡ |
BML |
BML-EI396-0025 |
Ko143 ¡Ú(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino-[1¡Ç,2¡Ç:1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl Ester¡Û |
25mg |
¡ï63,000 |
|
461054-93-3 |
|
|
|
¡¡ |
BML |
BML-EI397-0005 |
SMER28 ¡Ú6-Bromo-4-allylaminoquinazoline¡Û |
5mg |
¡ï10,000 |
|
307538-42-7 |
|
|
|
¡¡ |
BML |
BML-EI397-0025 |
SMER28 ¡Ú6-Bromo-4-allylaminoquinazoline¡Û |
25mg |
¡ï40,000 |
|
307538-42-7 |
|
|
|
¡¡ |
BML |
BML-EI398-0005 |
Src I1 ¡Ú6,7-Dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine¡Û |
5mg |
¡ï9,000 |
|
179248-59-0 |
|
|
|
¡¡ |
BML |
BML-EI398-0025 |
Src I1 ¡Ú6,7-Dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine¡Û |
25mg |
¡ï37,000 |
|
179248-59-0 |
|
|
|
¡¡ |
BML |
BML-EI399-0010 |
TCID ¡Ú4,5,6,7-Tetrachloroindan-1,3-dione¡Û |
10mg |
¡ï12,000 |
|
30675-13-9 |
|
|
|
¡¡ |
BML |
BML-EI399-0050 |
TCID ¡Ú4,5,6,7-Tetrachloroindan-1,3-dione¡Û |
50mg |
¡ï51,000 |
|
30675-13-9 |
|
|
|
¡¡ |
BML |
BML-EI400-0005 |
BML-282 ¡ÚN-(3,4-Dichlorobenzyl)-5-bromoisatin O-Acetyloxime¡Û |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI400-0025 |
BML-282 ¡ÚN-(3,4-Dichlorobenzyl)-5-bromoisatin O-Acetyloxime¡Û |
25mg |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI401-0010 |
Tesmilifene ¡ÚDPPE¡Û¡ÚN,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine, HCl¡Û |
10mg |
¡ï9,000 |
|
92981-78-7 |
|
|
|
¡¡ |
BML |
BML-EI401-0050 |
Tesmilifene ¡ÚDPPE¡Û¡ÚN,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine, HCl¡Û |
50mg |
¡ï39,000 |
|
92981-78-7 |
|
|
|
¡¡ |
BML |
BML-EI402-0005 |
PF-622 ¡ÚN-Phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide¡Û |
5mg |
¡ï13,000 |
|
898235-65-9 |
|
|
|
¡¡ |
BML |
BML-EI402-0025 |
PF-622 ¡ÚN-Phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide¡Û |
25mg |
¡ï53,000 |
|
898235-65-9 |
|
|
|
¡¡ |
BML |
BML-EI404-0005 |
BML-283 ¡ÚNCGC00030335¡Û¡Ú1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylsulfonyl)-4-(4-methoxyphenylsulfonyl)piperazine¡Û |
5mg |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI404-0025 |
BML-283 ¡ÚNCGC00030335¡Û¡Ú1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylsulfonyl)-4-(4-methoxyphenylsulfonyl)piperazine¡Û |
25mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI405-0100 |
PAP-AMC, Tyrosinase Substrate ¡Ú1-(4-Methyl-coumarin-7-yl)-3-(4-hydroxyphenyl)urea¡Û |
0.1mg |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EI406-0010 |
SKI-II ¡Ú4-{[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]amino}phenol¡Û |
10mg |
¡ï8,000 |
|
312636-16-1 |
|
|
|
¡¡ |
BML |
BML-EI406-0050 |
SKI-II ¡Ú4-{[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]amino}phenol¡Û |
50mg |
¡ï36,000 |
|
312636-16-1 |
|
|
|
¡¡ |
BML |
BML-EI407-0001 |
BI-D1870 ¡Ú2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone¡Û |
1mg |
¡ï6,000 |
|
501437-28-1 |
|
|
|
¡¡ |
BML |
BML-EI407-0005 |
BI-D1870 ¡Ú2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone¡Û |
5mg |
¡ï24,000 |
|
501437-28-1 |
|
|
|
¡¡ |
BML |
BML-EI408-0001 |
SU11652 ¡Ú5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid(2-Diethylaminoethyl)amide¡Û |
1mg |
¡ï22,000 |
|
326914-10-7 |
|
|
|
¡¡ |
BML |
BML-EI409-0010 |
Adaphostin ¡ÚAG 957 Adamantyl Ester¡Û¡ÚNSC 680410¡Û |
10mg |
¡ï18,000 |
|
241127-58-2 |
|
|
|
¡¡ |
BML |
BML-EI409-0050 |
Adaphostin ¡ÚAG 957 Adamantyl Ester¡Û¡ÚNSC 680410¡Û |
50mg |
¡ï78,000 |
|
241127-58-2 |
|
|
|
¡¡ |
BML |
BML-EI410-0100 |
Ibuproxam ¡Ú2-(4-Isobutylphenyl)propiohydroxamic Acid¡Û |
100mg |
¡ï3,000 |
|
53648-05-8 |
|
|
|
¡¡ |
BML |
BML-EI411-0005 |
SK1-I ¡Ú(2R,3S,4E)-N-methyl-5-(4'-pentylphenyl)-2-aminopent-4-ene-1,3-diol, HCl¡Û |
5mg |
¡ï17,000 |
-20¡î |
1072443-89-0 |
|
HARMFUL, Protect from light and air.
|
|
¡¡ |
BML |
BML-EI411-0025 |
SK1-I ¡Ú(2R,3S,4E)-N-methyl-5-(4'-pentylphenyl)-2-aminopent-4-ene-1,3-diol, HCl¡Û |
25mg |
¡ï54,000 |
-20¡î |
1072443-89-0 |
|
HARMFUL, Protect from light and air.
|
|
¡¡ |
BML |
BML-EM56-0050 |
(¡Þ)-5,6-EET Methyl Ester ¡Ú(¡Þ)5,6-Epoxyeicosa-8Z,11Z,14Z-trienoic Acid Methyl Ester¡Û¡Ú5(6)-EpETrE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EM56-1000 |
(¡Þ)-5,6-EET Methyl Ester ¡Ú(¡Þ)5,6-Epoxyeicosa-8Z,11Z,14Z-trienoic Acid Methyl Ester¡Û¡Ú5(6)-EpETrE¡Û |
1mg |
¡ï100,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ET003-0001 |
5,8,11-Eicosatriynoic Acid ¡ÚETI ¡Û |
1mg |
¡ï10,000 |
|
13488-22-7 |
|
|
|
¡¡ |
BML |
BML-ET003-0010 |
5,8,11-Eicosatriynoic Acid ¡ÚETI ¡Û |
10mg |
¡ï78,000 |
|
13488-22-7 |
|
|
|
¡¡ |
BML |
BML-ET004-0020 |
5,8,11,14-Eicosatetraynoic Acid ¡ÚETYA¡Û |
20mg |
¡ï8,000 |
|
1191-85-1 |
|
|
|
¡¡ |
BML |
BML-ET004-0100 |
5,8,11,14-Eicosatetraynoic Acid ¡ÚETYA¡Û |
100mg |
¡ï37,000 |
|
1191-85-1 |
|
|
|
¡¡ |
BML |
BML-EW9805-0100 |
Mg2+/ATP Activating Solution ¡ÚATP Activating Solution, Mg2+¡Û |
100ul |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-EW9810-0100 |
ATP(Energy)Regeneration Solution |
100ul |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA001-0100 |
Eicosapentaenoic Acid ¡ÚEicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid(20:5, n-3)¡Û |
100mg |
¡ï10,000 |
|
10417-94-4 |
|
|
|
¡¡ |
BML |
BML-FA001-1000 |
Eicosapentaenoic Acid ¡ÚEicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid(20:5, n-3)¡Û |
1g |
¡ï44,000 |
|
10417-94-4 |
|
|
|
¡¡ |
BML |
BML-FA002-0100 |
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid |
100mg |
¡ï7,000 |
|
6217-54-5 |
|
|
|
¡¡ |
BML |
BML-FA002-1000 |
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid |
1g |
¡ï25,000 |
|
6217-54-5 |
|
|
|
¡¡ |
BML |
BML-FA003-0100 |
Arachidonic Acid(20:4, n-6)¡Ú5Z,8Z,11Z,14Z-Eicosatetraenoic Acid¡Û |
100mg |
¡ï11,000 |
|
506-32-1 |
|
|
|
¡¡ |
BML |
BML-FA003-1000 |
Arachidonic Acid(20:4, n-6)¡Ú5Z,8Z,11Z,14Z-Eicosatetraenoic Acid¡Û |
1g |
¡ï29,000 |
|
506-32-1 |
|
|
|
¡¡ |
BML |
BML-FA004-0001 |
Mead Acid ¡ÚEicosa-5Z,8Z,11Z-trienoic Acid¡Û |
1mg |
¡ï10,000 |
|
20590-32-3 |
|
|
|
¡¡ |
BML |
BML-FA004-0010 |
Mead Acid ¡ÚEicosa-5Z,8Z,11Z-trienoic Acid¡Û |
10mg |
¡ï62,000 |
|
20590-32-3 |
|
|
|
¡¡ |
BML |
BML-FA005-1000 |
Linolenic Acid(18:3, n-3)¡ÚOctadeca-9Z,12Z,15Z-trienoic Acid¡Û |
1g |
¡ï12,000 |
|
463-40-1 |
|
|
|
¡¡ |
BML |
BML-FA006-0100 |
¦Ã-Linolenic Acid ¡ÚOctadeca-6Z,9Z,12Z-trienoic Acid¡Û |
100mg |
¡ï3,000 |
|
506-26-3 |
|
|
|
¡¡ |
BML |
BML-FA006-1000 |
¦Ã-Linolenic Acid ¡ÚOctadeca-6Z,9Z,12Z-trienoic Acid¡Û |
1g |
¡ï20,000 |
|
506-26-3 |
|
|
|
¡¡ |
BML |
BML-FA007-0100 |
Eicosa-11Z,14Z-dienoic Acid |
100mg |
¡ï3,000 |
|
2091-39-6 |
|
|
|
¡¡ |
BML |
BML-FA007-1000 |
Eicosa-11Z,14Z-dienoic Acid |
1g |
¡ï20,000 |
|
2091-39-6 |
|
|
|
¡¡ |
BML |
BML-FA008-0100 |
Eicosa-11Z,14Z,17Z-trienoic Acid |
100mg |
¡ï3,000 |
|
2091-27-2 |
|
|
|
¡¡ |
BML |
BML-FA008-1000 |
Eicosa-11Z,14Z,17Z-trienoic Acid |
1g |
¡ï20,000 |
|
2091-27-2 |
|
|
|
¡¡ |
BML |
BML-FA009-0100 |
Dihomo-¦Ã-linolenic Acid(20:3, n-6)¡ÚEicosa-8Z,11Z,14Z-trienoic Acid¡Û |
100mg |
¡ï12,000 |
|
1783-84-2 |
|
|
|
¡¡ |
BML |
BML-FA009-1000 |
Dihomo-¦Ã-linolenic Acid(20:3, n-6)¡ÚEicosa-8Z,11Z,14Z-trienoic Acid¡Û |
1g |
¡ï77,000 |
|
1783-84-2 |
|
|
|
¡¡ |
BML |
BML-FA010-0020 |
Docosa-13Z,16Z,19Z-trienoic Acid |
20mg |
¡ï5,000 |
|
28845-86-5 |
|
|
|
¡¡ |
BML |
BML-FA011-0020 |
Adrenic Acid(22:4, n-6)¡ÚDocosa-7Z,10Z,13Z,16Z-tetraenoic Acid¡Û |
20mg |
¡ï5,000 |
|
28874-58-0 |
|
|
|
¡¡ |
BML |
BML-FA011-0100 |
Adrenic Acid(22:4, n-6)¡ÚDocosa-7Z,10Z,13Z,16Z-tetraenoic Acid¡Û |
100mg |
¡ï21,000 |
|
28874-58-0 |
|
|
|
¡¡ |
BML |
BML-FA012-0010 |
Docosa-7Z,10Z,13Z,16Z,19Z-pentaenoic Acid |
10mg |
¡ï7,000 |
|
24880-45-3 |
|
|
|
¡¡ |
BML |
BML-FA014-0100 |
Linoleic Acid ¡ÚOctadeca-9Z,12Z-dienoic Acid¡Û |
100mg |
¡ï3,000 |
|
60-33-3 |
|
|
|
¡¡ |
BML |
BML-FA014-1000 |
Linoleic Acid ¡ÚOctadeca-9Z,12Z-dienoic Acid¡Û |
1g |
¡ï6,000 |
|
60-33-3 |
|
|
|
¡¡ |
BML |
BML-FA017-0005 |
Anandamide ¡ÚAEA¡Û¡ÚN-Arachidonoylethanolamine¡Û¡Ú(all-Z)-N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide¡Û |
5mg |
¡ï7,000 |
|
94421-68-8 |
|
|
|
¡¡ |
BML |
BML-FA017-0025 |
Anandamide ¡ÚAEA¡Û¡ÚN-Arachidonoylethanolamine¡Û¡Ú(all-Z)-N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide¡Û |
25mg |
¡ï21,000 |
|
94421-68-8 |
|
|
|
¡¡ |
BML |
BML-FA018-0010 |
Palmitylethanolamide ¡ÚPEA¡Û |
10mg |
¡ï5,000 |
|
544-31-0 |
|
|
|
¡¡ |
BML |
BML-FA018-0050 |
Palmitylethanolamide ¡ÚPEA¡Û |
50mg |
¡ï19,000 |
|
544-31-0 |
|
|
|
¡¡ |
BML |
BML-FA019-0005 |
Anandamide(20:3, n-6)¡ÚDihomo-¦Ã-linolenylethanolamide¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA020-0005 |
Anandamide(22:4, n-6)¡ÚDocosatetraenylethanolamide¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA020-0025 |
Anandamide(22:4, n-6)¡ÚDocosatetraenylethanolamide¡Û |
25mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA021-0005 |
Methanandamide ¡ÚAM 356¡Û¡Ú(R)-(+)-Arachidonyl-1'-hydroxy-2'-propylamide¡Û¡ÚN-(2-Hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide¡Û |
5mg |
¡ï7,000 |
|
157182-49-5 |
|
|
|
¡¡ |
BML |
BML-FA021-0025 |
Methanandamide ¡ÚAM 356¡Û¡Ú(R)-(+)-Arachidonyl-1'-hydroxy-2'-propylamide¡Û¡ÚN-(2-Hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide¡Û |
25mg |
¡ï22,000 |
|
157182-49-5 |
|
|
|
¡¡ |
BML |
BML-FA022-0010 |
Arachidonamide |
10mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA022-0050 |
Arachidonamide |
50mg |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA023-0010 |
Linoleamide |
10mg |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA023-0050 |
Linoleamide |
50mg |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA024-0001 |
Eicosa-5Z,8Z-dienoic Acid |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA024-0005 |
Eicosa-5Z,8Z-dienoic Acid |
5mg |
¡ï65,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA025-0050 |
9,10-Octadecenoamide |
50mg |
¡ï25,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA026-0005 |
Anandamide(18:2, n-6)¡ÚLinoleylethanolamide¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA026-0025 |
Anandamide(18:2, n-6)¡ÚLinoleylethanolamide¡Û |
25mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA027-0001 |
Mead Acid Ethanolamide ¡Ú(Z,Z,Z)-5,8,11-Eicosatrienoic Acid, N-(2-hydroxyethyl)-¡Û¡ÚEicosa-5Z,8Z,11Z-trienylethanolamide¡Û |
1mg |
¡ï11,000 |
|
169232-04-6 |
|
|
|
¡¡ |
BML |
BML-FA027-0010 |
Mead Acid Ethanolamide ¡Ú(Z,Z,Z)-5,8,11-Eicosatrienoic Acid, N-(2-hydroxyethyl)-¡Û¡ÚEicosa-5Z,8Z,11Z-trienylethanolamide¡Û |
10mg |
¡ï72,000 |
|
169232-04-6 |
|
|
|
¡¡ |
BML |
BML-FA028-0005 |
2-Arachidonoylglycerol ¡Ú2-AG¡Û |
5mg |
¡ï14,000 |
|
53847-30-6 |
|
|
|
¡¡ |
BML |
BML-FA029-0005 |
N-Arachidonylglycine ¡ÚNAGly¡Û |
5mg |
¡ï10,000 |
|
179113-91-8 |
|
|
|
¡¡ |
BML |
BML-FA029-0025 |
N-Arachidonylglycine ¡ÚNAGly¡Û |
25mg |
¡ï39,000 |
|
179113-91-8 |
|
|
|
¡¡ |
BML |
BML-FA030-0005 |
N-Linoleoylglycine |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA030-0025 |
N-Linoleoylglycine |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA031-0010 |
Arachidonylcyclopropylamide ¡ÚACPA¡Û |
10mg |
¡ï8,000 |
|
229021-64-1 |
|
|
|
¡¡ |
BML |
BML-FA031-0050 |
Arachidonylcyclopropylamide ¡ÚACPA¡Û |
50mg |
¡ï31,000 |
|
229021-64-1 |
|
|
|
¡¡ |
BML |
BML-FA032-0010 |
Arachidonyl-2-chloroethylamide ¡ÚACEA¡Û¡ÚN-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide¡Û |
10mg |
¡ï8,000 |
|
220556-69-4 |
|
|
|
¡¡ |
BML |
BML-FA032-0050 |
Arachidonyl-2-chloroethylamide ¡ÚACEA¡Û¡ÚN-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide¡Û |
50mg |
¡ï32,000 |
|
220556-69-4 |
|
|
|
¡¡ |
BML |
BML-FA033-0001 |
Noladin Ether ¡Ú2-Arachidonyl Glycerol Ether¡Û¡Ú2-AG Ether¡Û¡Ú5Z,8Z,11Z,14Z-Eicosatetraen-2-glyceryl Ether¡Û |
1mg |
¡ï4,000 |
|
222723-55-9 |
|
|
|
¡¡ |
BML |
BML-FA033-0005 |
Noladin Ether ¡Ú2-Arachidonyl Glycerol Ether¡Û¡Ú2-AG Ether¡Û¡Ú5Z,8Z,11Z,14Z-Eicosatetraen-2-glyceryl Ether¡Û |
5mg |
¡ï18,000 |
|
222723-55-9 |
|
|
|
¡¡ |
BML |
BML-FA034-0005 |
N-Arachidonyl-L-alanine ¡ÚNA-Ala¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA034-0025 |
N-Arachidonyl-L-alanine ¡ÚNA-Ala¡Û |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA035-0005 |
N-Arachidonyl-GABA ¡ÚNA-GABA¡Û¡Ú4-(1-oxo-5Z,8Z,11Z,14Z-Eicosatetraenyl)aminobutanoic Acid¡Û¡ÚN-Arachidonoyl-¦Ã-aminobutyric Acid¡Û |
5mg |
¡ï10,000 |
|
128201-89-8 |
|
|
|
¡¡ |
BML |
BML-FA035-0025 |
N-Arachidonyl-GABA ¡ÚNA-GABA¡Û¡Ú4-(1-oxo-5Z,8Z,11Z,14Z-Eicosatetraenyl)aminobutanoic Acid¡Û¡ÚN-Arachidonoyl-¦Ã-aminobutyric Acid¡Û |
25mg |
¡ï37,000 |
|
128201-89-8 |
|
|
|
¡¡ |
BML |
BML-FA036-0005 |
Virodhamine ¡ÚO-AEA¡Û¡ÚO-Arachidonoylethanolamine¡Û¡ÚArachidonic Acid(2-Aminoethyl)Ester¡Û |
5mg |
¡ï16,000 |
|
443129-35-9 |
|
|
|
¡¡ |
BML |
BML-FA036-0025 |
Virodhamine ¡ÚO-AEA¡Û¡ÚO-Arachidonoylethanolamine¡Û¡ÚArachidonic Acid(2-Aminoethyl)Ester¡Û |
25mg |
¡ï68,000 |
|
443129-35-9 |
|
|
|
¡¡ |
BML |
BML-FA037-0010 |
N-Arachidonoyl-L-serine |
10mg |
¡ï9,000 |
|
187224-29-9 |
|
|
|
¡¡ |
BML |
BML-FA037-0050 |
N-Arachidonoyl-L-serine |
50mg |
¡ï34,000 |
|
187224-29-9 |
|
|
|
¡¡ |
BML |
BML-FA039-0005 |
N-Arachidonoyl-L-tyrosine |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA039-0025 |
N-Arachidonoyl-L-tyrosine |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA040-0005 |
N-Arachidonoyl-L-phenylalanine |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA040-0025 |
N-Arachidonoyl-L-phenylalanine |
25mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA041-0005 |
N-Arachidonoyl-L-methionine |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA041-0025 |
N-Arachidonoyl-L-methionine |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA045-0010 |
Oleic Acid ¡Úcis-9-Octadecenoic Acid 18:1¡Û |
10g |
¡ï9,000 |
|
112-80-1 |
|
|
|
¡¡ |
BML |
BML-FA046-0005 |
N-Oleoyl-L-serine |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA046-0025 |
N-Oleoyl-L-serine |
25mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FA047-0005 |
Eicosapentaenoyl Ethanolamide ¡ÚEPEA¡Û |
5mg |
¡ï5,000 |
|
109001-03-8 |
|
|
|
¡¡ |
BML |
BML-FA047-0025 |
Eicosapentaenoyl Ethanolamide ¡ÚEPEA¡Û |
25mg |
¡ï21,000 |
|
109001-03-8 |
|
|
|
¡¡ |
BML |
BML-FA1155-0025 |
FMRFamide(Phe-Met-Arg-Phe.amide), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-FA1155-0100 |
FMRFamide(Phe-Met-Arg-Phe.amide), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-FG6010-0100 |
Fibronectin(cellular)¡ÚcFn¡Û(A8387 fibrosarcoma cells)[DH1], mouse mAb, Affinity-purified(specificity: human) |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DH1 | human | WB(250kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-FG6020-0100 |
Fibronectin(plasma)¡ÚpFn¡Û(A8387 fibrosarcoma cells)[BF12], mouse mAb, Affinity-purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | BF12 | human | WB(225-250 kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-FG6090-0100 |
a-Fodrin ¡ÚaII-spectrin¡Û(chicken blood cell membranes)[AA6], mouse mAb, purified |
100ul |
¡ï26,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | AA6 | mammalian¡¢ chicken | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-FG6090-0500 |
a-Fodrin ¡ÚaII-spectrin¡Û(chicken blood cell membranes)[AA6], mouse mAb, purified |
500ul |
¡ï90,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | AA6 | mammalian¡¢ chicken | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-FM004-0001 |
Mead Acid Methyl Ester ¡ÚMethyl 5,8,11-Eicosatrienoate¡Û |
1mg |
¡ï9,000 |
|
14602-39-2 |
|
|
|
¡¡ |
BML |
BML-FM004-0010 |
Mead Acid Methyl Ester ¡ÚMethyl 5,8,11-Eicosatrienoate¡Û |
10mg |
¡ï61,000 |
|
14602-39-2 |
|
|
|
¡¡ |
BML |
BML-FR100-0100 |
U-74389G ¡Ú21-(4-(2,6-di-1-Pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)pregna-1,4,9(11)-triene-3,20-dione(Z)-2-Butenedioate¡Û |
100mg |
¡ï14,000 |
|
153190-29-5 |
|
|
|
¡¡ |
BML |
BML-FR101-0100 |
U-83836E ¡Ú(-)2-{[4-(2,6-di-1-Pyrrolidinyl-4-pyrimidinyl]-1-piperazinyl)methyl}-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol, 2HCl¡Û |
100mg |
¡ï14,000 |
|
122003-11-6 |
|
|
|
¡¡ |
BML |
BML-FR103-0050 |
MCI-186 ¡Ú3-Methyl-1-phenyl-2-pyrazolin-5-one¡Û |
50mg |
¡ï6,000 |
|
89-25-8 |
|
|
|
¡¡ |
BML |
BML-FR103-0250 |
MCI-186 ¡Ú3-Methyl-1-phenyl-2-pyrazolin-5-one¡Û |
250mg |
¡ï19,000 |
|
89-25-8 |
|
|
|
¡¡ |
BML |
BML-FR104-0100 |
Resveratrol ¡Útrans-3,4¡Ç,5-Trihydroxystilbene¡Û |
100mg |
¡ï6,000 |
|
501-36-0 |
|
|
|
¡¡ |
BML |
BML-FR104-0500 |
Resveratrol ¡Útrans-3,4¡Ç,5-Trihydroxystilbene¡Û |
500mg |
¡ï28,000 |
|
501-36-0 |
|
|
|
¡¡ |
BML |
BML-FR106-0001 |
Procysteine ¡ÚL-2-Oxothiazolidine-4-carboxylic Acid¡Û |
1g |
¡ï3,000 |
|
19771-63-2 |
|
|
|
¡¡ |
BML |
BML-FR110-0050 |
Hinokitiol ¡Ú2-Hydroxy-4-isopropyl-2,4,6-cycloheptatriene¡Û |
50mg |
¡ï8,000 |
|
499-44-5 |
|
|
|
¡¡ |
BML |
BML-FR110-0250 |
Hinokitiol ¡Ú2-Hydroxy-4-isopropyl-2,4,6-cycloheptatriene¡Û |
250mg |
¡ï24,000 |
|
499-44-5 |
|
|
|
¡¡ |
BML |
BML-FR111-0010 |
L-Ergothioneine ¡Ú(S)-a-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-1H-imidazole-4-ethanaminium inner salt¡Û |
10mg |
¡ï13,000 |
|
497-30-3 |
|
|
|
¡¡ |
BML |
BML-FR111-0050 |
L-Ergothioneine ¡Ú(S)-a-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-1H-imidazole-4-ethanaminium inner salt¡Û |
50mg |
¡ï55,000 |
|
497-30-3 |
|
|
|
¡¡ |
BML |
BML-FR112-0001 |
Ambroxol ¡Útrans-4-(2-Amino-3,5-dibromobenzylamino)cyclohexane, HCl¡Û |
1g |
¡ï6,000 |
|
18683-91-5 |
|
|
|
¡¡ |
BML |
BML-FR113-0050 |
HBED ¡ÚN,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic Acid, HCl¡Û |
50mg |
¡ï6,000 |
|
35369-53-0 |
|
|
|
¡¡ |
BML |
BML-FR113-0250 |
HBED ¡ÚN,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic Acid, HCl¡Û |
250mg |
¡ï26,000 |
|
35369-53-0 |
|
|
|
¡¡ |
BML |
BML-FR114-0020 |
Idebenone ¡Ú6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone¡Û |
20mg |
¡ï10,000 |
|
58186-27-9 |
|
|
|
¡¡ |
BML |
BML-FR114-0100 |
Idebenone ¡Ú6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone¡Û |
100mg |
¡ï40,000 |
|
58186-27-9 |
|
|
|
¡¡ |
BML |
BML-FR115-0020 |
Tocopherylquinone, D-a- |
20mg |
¡ï8,000 |
|
7559-04-8 |
|
|
|
¡¡ |
BML |
BML-FR115-0100 |
Tocopherylquinone, D-a- |
100mg |
¡ï17,000 |
|
7559-04-8 |
|
|
|
¡¡ |
BML |
BML-FR116-0100 |
Ethyl Ferulate ¡ÚEthyl 4-Hydroxy-3-methoxycinnamate¡Û |
100mg |
¡ï7,000 |
|
4046-02-0 |
|
|
|
¡¡ |
BML |
BML-FR117-0500 |
Buthionine Sulfoximine ¡ÚBSO¡Û |
500mg |
¡ï19,000 |
|
83730-53-4 |
|
|
|
¡¡ |
BML |
BML-FR119-0010 |
Triacetylresveratrol |
10mg |
¡ï8,000 |
|
42206-94-0 |
|
|
|
¡¡ |
BML |
BML-FR119-0050 |
Triacetylresveratrol |
50mg |
¡ï31,000 |
|
42206-94-0 |
|
|
|
¡¡ |
BML |
BML-FW8820-0020 |
p53(human)(recombinant)with His-Tag |
20ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-FW9370-0050 |
p53(human)(recombinant)with GST-Tag |
50ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G100-0050 |
Pertussis Toxin(Bordetella pertussis)¡ÚPTX¡Û¡ÚIslet-Activating Protein¡Û¡ÚHolotoxin¡Û |
50ug |
¡ï45,000 |
|
82248-93-9 |
|
|
|
¡¡ |
BML |
BML-G101-0050 |
Bordetella pertussis toxin ¡ÚIslet-activating protein¡Û¡ÚPTX¡Û |
50ug |
¡ï35,000 |
+4¡î |
70323-44-3 |
|
TOXIC.
|
|
¡¡ |
BML |
BML-G105-0010 |
Pertussis Toxin A Protomer(Bordetella pertussis)¡ÚIslet-Activating Protein A Protomer¡Û¡ÚPTX A Protomer¡Û |
10ug |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G110-0040 |
Pertussis Toxin B Oligomer(Bordetella pertussis)¡ÚIslet-Activating Protein B Oligomer¡Û¡ÚPTX B Oligomer¡Û |
40ug |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G120-0250 |
Cholera Toxin A Subunit(Vibrio Cholerae) |
250ug |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G125-0500 |
Cholera Toxin B Subunit(Vibrio Cholerae) |
500ug |
¡ï41,000 |
|
131096-89-4 |
|
|
|
¡¡ |
BML |
BML-G130-0010 |
C3 Exoenzyme(Clostridium botulinum) |
10ug |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G130-0050 |
C3 Exoenzyme(Clostridium botulinum) |
50ug |
¡ï69,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G135-0500 |
Diphtheria Toxin(Corynebacterium diphtheriae) |
500ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G140-0050 |
C. difficile toxin A ¡ÚClostridium difficile toxin A¡Û |
50ug |
¡ï39,000 |
+4¡î |
none |
|
TOXIC.
|
|
¡¡ |
BML |
BML-G145-0050 |
C. difficile toxoid A ¡ÚClostridium difficile toxoid A¡Û |
50ug |
¡ï43,000 |
+4¡î |
none |
|
Purity: ¡ä99%, Application: antibody capture, ELISA, LINE assay, cytotoxicity studies, immunogen
|
|
¡¡ |
BML |
BML-G150-0050 |
C. difficile toxin B ¡ÚClostridium difficile toxin B¡Û |
50ug |
¡ï74,000 |
+4¡î |
none |
|
TOXIC.
|
|
¡¡ |
BML |
BML-G155-0050 |
C. difficile toxoid B ¡ÚClostridium difficile toxoid B¡Û |
50ug |
¡ï76,000 |
+4¡î |
none |
|
Purity: ¡ä99%, Application: antibody capture, ELISA, LINE assay, cytotoxicity studies, immunogen
|
|
¡¡ |
BML |
BML-G200-0005 |
N-Acetyl-S-farnesyl-L-cysteine ¡ÚAFC¡Û |
5mg |
¡ï9,000 |
|
135304-07-3 |
|
|
|
¡¡ |
BML |
BML-G200-0025 |
N-Acetyl-S-farnesyl-L-cysteine ¡ÚAFC¡Û |
25mg |
¡ï38,000 |
|
135304-07-3 |
|
|
|
¡¡ |
BML |
BML-G201-0005 |
S-Farnesyl-L-cysteine Methyl Ester |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G201-0025 |
S-Farnesyl-L-cysteine Methyl Ester |
25mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G210-0100 |
Perillic Acid ¡ÚS(-)-4-Isopropenyl-1-cyclohexene-1-carboxylic Acid¡Û¡ÚL(-)-4-Isopropenyl-1-cyclohexene-1-carboxylic Acid¡Û |
100mg |
¡ï5,000 |
|
7694-45-3 |
|
|
|
¡¡ |
BML |
BML-G210-0500 |
Perillic Acid ¡ÚS(-)-4-Isopropenyl-1-cyclohexene-1-carboxylic Acid¡Û¡ÚL(-)-4-Isopropenyl-1-cyclohexene-1-carboxylic Acid¡Û |
500mg |
¡ï25,000 |
|
7694-45-3 |
|
|
|
¡¡ |
BML |
BML-G220-0005 |
N-Acetyl-S-geranylgeranyl-L-cysteine ¡ÚAGGC¡Û |
5mg |
¡ï10,000 |
|
139332-94-8 |
|
|
|
¡¡ |
BML |
BML-G220-0025 |
N-Acetyl-S-geranylgeranyl-L-cysteine ¡ÚAGGC¡Û |
25mg |
¡ï42,000 |
|
139332-94-8 |
|
|
|
¡¡ |
BML |
BML-G221-0005 |
N-Acetyl-S-geranyl-L-cysteine ¡ÚAGC¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G221-0025 |
N-Acetyl-S-geranyl-L-cysteine ¡ÚAGC¡Û |
25mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G222-0005 |
Farnesylthioacetic Acid ¡ÚFTA¡Û |
5mg |
¡ï9,000 |
|
135784-48-4 |
|
|
|
¡¡ |
BML |
BML-G222-0025 |
Farnesylthioacetic Acid ¡ÚFTA¡Û |
25mg |
¡ï35,000 |
|
135784-48-4 |
|
|
|
¡¡ |
BML |
BML-G224-0200 |
Farnesylpyrophosphate ¡ÚFPP, 3NH4¡Û |
200ug |
¡ï8,000 |
|
13058-04-3 |
|
|
|
¡¡ |
BML |
BML-G224-5000 |
Farnesylpyrophosphate ¡ÚFPP, 3NH4¡Û |
5mg |
¡ï133,000 |
|
13058-04-3 |
|
|
|
¡¡ |
BML |
BML-G225-0200 |
Geranylgeranylpyrophosphate, 3NH3 |
200ug |
¡ï4,000 |
|
6699-20-3 |
|
|
|
¡¡ |
BML |
BML-G226-0010 |
Lovastatin ¡ÚMevinolin¡Û¡Ú6-a-Methylcompactin¡Û |
10mg |
¡ï6,000 |
|
75330-75-5 |
|
|
|
¡¡ |
BML |
BML-G226-0050 |
Lovastatin ¡ÚMevinolin¡Û¡Ú6-a-Methylcompactin¡Û |
50mg |
¡ï26,000 |
|
75330-75-5 |
|
|
|
¡¡ |
BML |
BML-G228-0001 |
a-Hydroxyfarnesylphosphonic Acid |
1mg |
¡ï17,000 |
|
140633-12-1 |
|
|
|
¡¡ |
BML |
BML-G229-0005 |
Chaetomellic Acid A |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G229-0025 |
Chaetomellic Acid A |
25mg |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G230-0050 |
2-Hydroxymyristic Acid ¡Ú2-Hydroxy-tetradecanoic Acid¡Û |
50mg |
¡ï6,000 |
|
2507-55-3 |
|
|
|
¡¡ |
BML |
BML-G230-0250 |
2-Hydroxymyristic Acid ¡Ú2-Hydroxy-tetradecanoic Acid¡Û |
250mg |
¡ï27,000 |
|
2507-55-3 |
|
|
|
¡¡ |
BML |
BML-G231-0005 |
2-Fluoropalmitic Acid |
5mg |
¡ï5,000 |
|
89270-22-4 |
|
|
|
¡¡ |
BML |
BML-G231-0025 |
2-Fluoropalmitic Acid |
25mg |
¡ï24,000 |
|
89270-22-4 |
|
|
|
¡¡ |
BML |
BML-G232-0010 |
4-Oxatetradecanoic Acid |
10mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G232-0050 |
4-Oxatetradecanoic Acid |
50mg |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G233-0010 |
Mevastatin ¡ÚCompactin¡Û |
10mg |
¡ï9,000 |
|
73573-88-3 |
|
|
|
¡¡ |
BML |
BML-G233-0050 |
Mevastatin ¡ÚCompactin¡Û |
50mg |
¡ï21,000 |
|
73573-88-3 |
|
|
|
¡¡ |
BML |
BML-G234-0010 |
12-Methoxydodecanoic Acid |
10mg |
¡ï8,000 |
|
92169-28-3 |
|
|
|
¡¡ |
BML |
BML-G234-0050 |
12-Methoxydodecanoic Acid |
50mg |
¡ï31,000 |
|
92169-28-3 |
|
|
|
¡¡ |
BML |
BML-G235-0001 |
B581 ¡ÚN-(2(S)-(2(R)-Amino-3-mercaptopropylamino)-3-methylbutyl)-Phe-Met-OH¡Û |
1mg |
¡ï12,000 |
|
149759-96-6 |
|
|
|
¡¡ |
BML |
BML-G235-0005 |
B581 ¡ÚN-(2(S)-(2(R)-Amino-3-mercaptopropylamino)-3-methylbutyl)-Phe-Met-OH¡Û |
5mg |
¡ï68,000 |
|
149759-96-6 |
|
|
|
¡¡ |
BML |
BML-G237-0005 |
Cerulenin ¡Ú2,3-Epoxy-4-oxo-7,10-dodecadienamide¡Û |
5mg |
¡ï11,000 |
|
17397-89-6 |
|
|
|
¡¡ |
BML |
BML-G237-0025 |
Cerulenin ¡Ú2,3-Epoxy-4-oxo-7,10-dodecadienamide¡Û |
25mg |
¡ï47,000 |
|
17397-89-6 |
|
|
|
¡¡ |
BML |
BML-G238-0005 |
Mevastatin Sodium |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G238-0025 |
Mevastatin Sodium |
25mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G242-0005 |
L-744,832 |
5mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G242-0025 |
L-744,832 |
25mg |
¡ï87,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G243-0020 |
Geranylgeraniol |
20mg |
¡ï10,000 |
|
24034-73-9 |
|
|
|
¡¡ |
BML |
BML-G243-0100 |
Geranylgeraniol |
100mg |
¡ï40,000 |
|
24034-73-9 |
|
|
|
¡¡ |
BML |
BML-G244-0050 |
Simvastatin ¡ÚZocor¡Û |
50mg |
¡ï15,000 |
|
79902-63-9 |
|
|
|
¡¡ |
BML |
BML-G244-0250 |
Simvastatin ¡ÚZocor¡Û |
250mg |
¡ï62,000 |
|
79902-63-9 |
|
|
|
¡¡ |
BML |
BML-G245-0005 |
Lovastatin, Na salt ¡ÚMevinolin, Na salt¡Û¡Ú6-a-Methylcompactin, Na salt¡Û |
5mg |
¡ï9,000 |
|
75225-50-2 |
|
|
|
¡¡ |
BML |
BML-G245-0025 |
Lovastatin, Na salt ¡ÚMevinolin, Na salt¡Û¡Ú6-a-Methylcompactin, Na salt¡Û |
25mg |
¡ï36,000 |
|
75225-50-2 |
|
|
|
¡¡ |
BML |
BML-G310-0005 |
Guanylylimidodiphosphate, 4Li salt ¡ÚGpp(NH)p¡Û |
5mg |
¡ï23,000 |
|
74812-64-9 |
|
|
|
¡¡ |
BML |
BML-G405-0005 |
Brefeldin A ¡ÚBFA¡Û¡ÚAscotoxin¡Û¡ÚDecumbin¡Û |
5mg |
¡ï11,000 |
|
20350-15-6 |
|
|
|
¡¡ |
BML |
BML-G405-0025 |
Brefeldin A ¡ÚBFA¡Û¡ÚAscotoxin¡Û¡ÚDecumbin¡Û |
25mg |
¡ï39,000 |
|
20350-15-6 |
|
|
|
¡¡ |
BML |
BML-G405-0100 |
Brefeldin A ¡ÚBFA¡Û¡ÚAscotoxin¡Û¡ÚDecumbin¡Û |
100mg |
¡ï112,000 |
|
20350-15-6 |
|
|
|
¡¡ |
BML |
BML-G410-0001 |
Mastoparan |
1mg |
¡ï13,000 |
|
72093-21-1 |
|
|
|
¡¡ |
BML |
BML-G415-0001 |
Mastoparan X |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G420-0001 |
Mas 7 |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G421-0001 |
Mas 17 |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G425-0001 |
Mastoparan(Polistes) |
1mg |
¡ï12,000 |
|
74129-19-4 |
|
|
|
¡¡ |
BML |
BML-G435-0100 |
Ilimaquinone ¡Ú3-[(Decahydro-1B,2B,4aB-trimethyl-5-methylene-1-naphthyl)methyl]-2-hydroxy-5-methoxybenzoquinone¡Û |
100ug |
¡ï16,000 |
|
71678-03-0 |
|
|
|
¡¡ |
BML |
BML-G440-0010 |
M-Iodobenzylguanidine |
10mg |
¡ï25,000 |
|
80663-95-2 |
|
|
|
¡¡ |
BML |
BML-G445-0001 |
ARF Inhibitory Peptide(P-13)¡ÚADP-ribosylation Factor¡Û |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G510-0001 |
GP Antagonist-2 ¡ÚG Protein Antagonist-2¡Û |
1mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G515-0001 |
GP Antagonist-2A ¡ÚG Protein Antagonist-2A¡Û |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-G520-0001 |
Isotetrandrine ¡ÚBerbamine Methyl Ether¡Û¡Ú6,6¡Ç,7,12-Tetramethoxy-2,2¡Ç-dimethylberbaman¡Û |
1mg |
¡ï8,000 |
|
477-57-6 |
|
|
|
¡¡ |
BML |
BML-G520-0005 |
Isotetrandrine ¡ÚBerbamine Methyl Ether¡Û¡Ú6,6¡Ç,7,12-Tetramethoxy-2,2¡Ç-dimethylberbaman¡Û |
5mg |
¡ï32,000 |
|
477-57-6 |
|
|
|
¡¡ |
BML |
BML-G521-0010 |
SCH-202676 ¡ÚN-(2,3-Diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene)methanamine, HBr¡Û |
10mg |
¡ï14,000 |
|
70375-43-8 |
|
|
|
¡¡ |
BML |
BML-G521-0050 |
SCH-202676 ¡ÚN-(2,3-Diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene)methanamine, HBr¡Û |
50mg |
¡ï55,000 |
|
70375-43-8 |
|
|
|
¡¡ |
BML |
BML-GA1159-0025 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û, rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-GA1159-0100 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û, rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-GA1160-0025 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û [5A9], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 5A9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-GA1160-0100 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û [5A9], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 5A9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-GA1161-0025 |
Galanin(pig), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1161-0100 |
Galanin(pig), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1164-0025 |
Peptide Serine Asparagine ¡ÚPSN¡Û¡ÚC-POG¡Û¡ÚC-terminal flanking peptide of pro-gastrin¡Û(Synthetic peptide(H-Ser-Ala-Glu-Asp-Glu-Asn-OH)of gastrin)(CT), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC |
|
|
¡¡ |
BML |
BML-GA1164-0100 |
Peptide Serine Asparagine ¡ÚPSN¡Û¡ÚC-POG¡Û¡ÚC-terminal flanking peptide of pro-gastrin¡Û(Synthetic peptide(H-Ser-Ala-Glu-Asp-Glu-Asn-OH)of gastrin)(CT), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC |
|
|
¡¡ |
BML |
BML-GA1166-0025 |
Gastrin Releasing Peptide ¡ÚGRP¡Û, rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC(FS) |
|
|
¡¡ |
BML |
BML-GA1166-0100 |
Gastrin Releasing Peptide ¡ÚGRP¡Û, rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC(FS) |
|
|
¡¡ |
BML |
BML-GA1167-0025 |
Gastrin(peptide, aa 18-34), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-GA1170-0100 |
Glial Fibrillary Acidic Protein ¡ÚGFAP¡Û(human)[EB4], mouse mAb, purified |
100ul |
¡ï17,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | BE4 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-GA1173-0025 |
Glucose-dependent Insulinotropic Peptide ¡ÚGIP¡Û(pig, natural), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1173-0100 |
Glucose-dependent Insulinotropic Peptide ¡ÚGIP¡Û(pig, natural), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1176-0025 |
Glucagon Like Peptide 1 ¡ÚGLP 1¡Û(human, aa 1-19), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1176-0100 |
Glucagon Like Peptide 1 ¡ÚGLP 1¡Û(human, aa 1-19), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1178-0250 |
Glucagon Like Peptide 1(7-36)Amide ¡ÚGLP 1(7-36)amide¡Û(human, aa 7-36), rabbit pAb |
250tb |
¡ï32,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ mammalian | RIA |
|
|
¡¡ |
BML |
BML-GA1179-0025 |
Glucagon Like Peptide 2 ¡ÚGLP 2¡Û(human, aa 1-33), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GA1181-0025 |
Glucagon(pig pancreatic, natural), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-GC3008-0025 |
Glutamic Acid Decarboxylase ¡ÚGAD¡Û(rat, aa 572-585), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ cat | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-GC3008-0100 |
Glutamic Acid Decarboxylase ¡ÚGAD¡Û(rat, aa 572-585), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ cat | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-GC3208-0025 |
Glutamic Acid Decarboxylase ¡ÚGAD¡Û(streptozotocin)[11], mouse mAb, purified |
25ul |
¡ï15,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 11 | human¡¢ mouse¡¢ rat¡¢ monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-GC3208-0100 |
Glutamic Acid Decarboxylase ¡ÚGAD¡Û(streptozotocin)[11], mouse mAb, purified |
100ul |
¡ï44,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 11 | human¡¢ mouse¡¢ rat¡¢ monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-GP100-0005 |
AR231453 ¡Ú2-Fluoro-4-methanesulfonylphenyl)-{6-[4-(3-isopropyl[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl}amine¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP100-0025 |
AR231453 ¡Ú2-Fluoro-4-methanesulfonylphenyl)-{6-[4-(3-isopropyl[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl}amine¡Û |
25mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP102-0010 |
GW9508 ¡Ú4-{[(3-Phenoxyphenyl)methyl]amino}benzenepropanoic Acid¡Û |
10mg |
¡ï8,000 |
|
885101-89-3 |
|
|
|
¡¡ |
BML |
BML-GP102-0050 |
GW9508 ¡Ú4-{[(3-Phenoxyphenyl)methyl]amino}benzenepropanoic Acid¡Û |
50mg |
¡ï35,000 |
|
885101-89-3 |
|
|
|
¡¡ |
BML |
BML-GP1432-0100 |
Glucagon Peptide(human, aa 51-81), Blocking peptide for Glucagon pAb(Prod. No. BML-GA1181) |
100ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP1434-0100 |
Glucose Dependent Insulinotropic Peptide ¡ÚGIP¡Û, Blocking peptide for Glucose-dependent insulinotropic peptide pAb(Prod. No. BML-GA1173) |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP1436-0100 |
Glucagon Like Peptide 1(human, aa 1-19)¡ÚGLP 1(1-19)¡Û¡Úpro-Glucagon(92-110)¡Û, Blocking peptide for Glucagon like peptide 1 pAb(Prod. No. BML-GA1176) |
100ug |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP1437-0100 |
Glucagon Like Peptide 1(human)(1-36)Amide ¡ÚGLP 1(1-36)amide¡Û, Blocking peptide for Glucagon like peptide 1 pAb(Prod. No. BML-GA1176) |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP1438-0100 |
Glucagon Like Peptide 1(human)(7-36)Amide ¡ÚGLP 1(7-36)amide¡Û, Blocking peptide for Glucagon like peptide 1(7-36)amide pAb(Prod. No. BML-GA1178) |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP1439-0100 |
Glucagon Like Peptide 2(human)¡ÚGLP2¡Û |
100ug |
¡ï17,000 |
|
99120-49-7 |
|
|
|
¡¡ |
BML |
BML-GP3009-0050 |
Glutamic Acid Decarboxylase ¡ÚGAD65/67 C-terminal¡Û Peptide, Blocking peptide for Glutamic acid decarboxylase pAb(Prod. No. BML-GC3008) |
50ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP3209-0050 |
Glutamic Acid Decarboxylase ¡ÚGAD 65(4-17)¡Û Peptide(NT), Blocking peptide for Glutamic acid decarboxylase mAb(11)(Prod. No. BML-GC3208) |
50ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GP9106-0100 |
Vesicular Glutamate Transporter-2 Peptide ¡ÚVGLUT2(human, aa 533-542)¡Û, Blocking peptide for Vesicular glutamate transporter-2 pAbs(Prod. No. BML-GZ1060 & BML-GZ1065) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR100-0500 |
Retinoic Acid, all trans |
500mg |
¡ï7,000 |
|
302-79-4 |
|
|
|
¡¡ |
BML |
BML-GR100-5000 |
Retinoic Acid, all trans |
5g |
¡ï40,000 |
|
302-79-4 |
|
|
|
¡¡ |
BML |
BML-GR101-0005 |
9-cis-Retinoic Acid |
5mg |
¡ï13,000 |
|
5300-03-8 |
|
|
|
¡¡ |
BML |
BML-GR101-0025 |
9-cis-Retinoic Acid |
25mg |
¡ï56,000 |
|
5300-03-8 |
|
|
|
¡¡ |
BML |
BML-GR102-0100 |
13-cis-Retinoic Acid |
100mg |
¡ï4,000 |
|
4759-48-2 |
|
|
|
¡¡ |
BML |
BML-GR102-0500 |
13-cis-Retinoic Acid |
500mg |
¡ï20,000 |
|
4759-48-2 |
|
|
|
¡¡ |
BML |
BML-GR103-0005 |
4-Hydroxyphenylretinamide |
5mg |
¡ï13,000 |
|
65646-68-6 |
|
|
|
¡¡ |
BML |
BML-GR103-0025 |
4-Hydroxyphenylretinamide |
25mg |
¡ï54,000 |
|
65646-68-6 |
|
|
|
¡¡ |
BML |
BML-GR104-0005 |
AM-580 ¡Ú4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic Acid¡Û |
5mg |
¡ï11,000 |
|
102121-60-8 |
|
|
|
¡¡ |
BML |
BML-GR104-0025 |
AM-580 ¡Ú4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic Acid¡Û |
25mg |
¡ï48,000 |
|
102121-60-8 |
|
|
|
¡¡ |
BML |
BML-GR105-0005 |
TTNPB ¡ÚRo 13-7410¡Û¡Ú4-[E-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetra-methyl-2-naphthalenyl)-1-propenyl]benzoic Acid¡Û |
5mg |
¡ï12,000 |
|
71441-28-6 |
|
|
|
¡¡ |
BML |
BML-GR105-0025 |
TTNPB ¡ÚRo 13-7410¡Û¡Ú4-[E-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetra-methyl-2-naphthalenyl)-1-propenyl]benzoic Acid¡Û |
25mg |
¡ï54,000 |
|
71441-28-6 |
|
|
|
¡¡ |
BML |
BML-GR106-0005 |
Methoprene Acid ¡Ú11-Methoxy-3,7,11-trimethyl-2E,4E-dodecadienoic Acid¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR106-0025 |
Methoprene Acid ¡Ú11-Methoxy-3,7,11-trimethyl-2E,4E-dodecadienoic Acid¡Û |
25mg |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR107-0010 |
Methoprene ¡Ú11-Methoxy-3,7,11-trimethyl-2E,4E-dodecadienoic Acid, Isopropyl Ester¡Û |
10mg |
¡ï8,000 |
|
40596-69-8 |
|
|
|
¡¡ |
BML |
BML-GR108-0010 |
Acitretin |
10mg |
¡ï14,000 |
|
55079-83-9 |
|
|
|
¡¡ |
BML |
BML-GR110-0005 |
Ro 41-5253 |
5mg |
¡ï10,000 |
|
144092-31-9 |
|
|
|
¡¡ |
BML |
BML-GR110-0025 |
Ro 41-5253 |
25mg |
¡ï41,000 |
|
144092-31-9 |
|
|
|
¡¡ |
BML |
BML-GR111-0020 |
Adapalene ¡Ú6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic Acid CD271¡Û |
20mg |
¡ï13,000 |
|
106685-40-9 |
|
|
|
¡¡ |
BML |
BML-GR111-0100 |
Adapalene ¡Ú6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic Acid CD271¡Û |
100mg |
¡ï54,000 |
|
106685-40-9 |
|
|
|
¡¡ |
BML |
BML-GR112-0010 |
AC-55469 ¡Ú4'-Octyl-4-biphenylcarboxylic Acid¡Û |
10mg |
¡ï8,000 |
|
59662-49-6 |
|
|
|
¡¡ |
BML |
BML-GR112-0050 |
AC-55469 ¡Ú4'-Octyl-4-biphenylcarboxylic Acid¡Û |
50mg |
¡ï34,000 |
|
59662-49-6 |
|
|
|
¡¡ |
BML |
BML-GR200-0050 |
WY-14643 ¡ÚPirinixic Acid¡Û¡Ú4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid¡Û |
50mg |
¡ï11,000 |
|
50892-23-4 |
|
|
|
¡¡ |
BML |
BML-GR200-0250 |
WY-14643 ¡ÚPirinixic Acid¡Û¡Ú4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid¡Û |
250mg |
¡ï44,000 |
|
50892-23-4 |
|
|
|
¡¡ |
BML |
BML-GR205-0005 |
Ciglitizone ¡ÚU-63287¡Û¡Ú(¡Þ)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione¡Û |
5mg |
¡ï13,000 |
|
74772-77-3 |
|
|
|
¡¡ |
BML |
BML-GR205-0025 |
Ciglitizone ¡ÚU-63287¡Û¡Ú(¡Þ)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione¡Û |
25mg |
¡ï54,000 |
|
74772-77-3 |
|
|
|
¡¡ |
BML |
BML-GR206-0100 |
6-Formylindolo[3,2-b]carbazole ¡ÚFICZ¡Û¡ÚIndolo[3,2-b]carbazole-6-carboxaldehyde-5,11-dihydro¡Û |
100ug |
¡ï11,000 |
|
172922-91-7 |
|
|
|
¡¡ |
BML |
BML-GR207-0050 |
Diindolylmethane |
50mg |
¡ï8,000 |
|
1968-05-4 |
|
|
|
¡¡ |
BML |
BML-GR207-0250 |
Diindolylmethane |
250mg |
¡ï33,000 |
|
1968-05-4 |
|
|
|
¡¡ |
BML |
BML-GR210-0005 |
Troglitazone ¡Ú(¡Þ)-5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]-benzyl]-2,4-thiazolidinedione¡Û |
5mg |
¡ï13,000 |
|
97322-87-7 |
|
|
|
¡¡ |
BML |
BML-GR210-0025 |
Troglitazone ¡Ú(¡Þ)-5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]-benzyl]-2,4-thiazolidinedione¡Û |
25mg |
¡ï54,000 |
|
97322-87-7 |
|
|
|
¡¡ |
BML |
BML-GR211-0001 |
Bezafibrate ¡Ú2-(4-{2-[(4-Chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic Acid¡Û |
1g |
¡ï6,000 |
|
41859-67-0 |
|
|
|
¡¡ |
BML |
BML-GR212-0010 |
T0070907 ¡Ú2-Chloro-5-nitro-N-4-pyridinylbenzamide¡Û |
10mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR212-0050 |
T0070907 ¡Ú2-Chloro-5-nitro-N-4-pyridinylbenzamide¡Û |
50mg |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR230-0001 |
24(S)-Hydroxycholesterol |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR230-0005 |
24(S)-Hydroxycholesterol |
5mg |
¡ï51,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR231-0001 |
24(S),25-Epoxycholesterol |
1mg |
¡ï24,000 |
|
77058-74-3 |
|
|
|
¡¡ |
BML |
BML-GR231-0005 |
24(S),25-Epoxycholesterol |
5mg |
¡ï110,000 |
|
77058-74-3 |
|
|
|
¡¡ |
BML |
BML-GR233-0005 |
CITCO ¡Ú6-(4-Chlorophenyl)imidazo[2,1-b] [1,3]thiazole-5-carbaldehyde O-3,4-Dichlorobenzyl)Oxime¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR233-0025 |
CITCO ¡Ú6-(4-Chlorophenyl)imidazo[2,1-b] [1,3]thiazole-5-carbaldehyde O-3,4-Dichlorobenzyl)Oxime¡Û |
25mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR234-0010 |
GW-9662 ¡Ú2-Chloro-5-nitrobenzanilide¡Û |
10mg |
¡ï10,000 |
|
22978-25-2 |
|
|
|
¡¡ |
BML |
BML-GR234-0050 |
GW-9662 ¡Ú2-Chloro-5-nitrobenzanilide¡Û |
50mg |
¡ï40,000 |
|
22978-25-2 |
|
|
|
¡¡ |
BML |
BML-GR235-0005 |
Z-Guggulsterone ¡Ú4,17(20)-Pregnadien-3,16-dione¡Û |
5mg |
¡ï10,000 |
|
39025-23-5 |
|
|
|
¡¡ |
BML |
BML-GR235-0025 |
Z-Guggulsterone ¡Ú4,17(20)-Pregnadien-3,16-dione¡Û |
25mg |
¡ï40,000 |
|
39025-23-5 |
|
|
|
¡¡ |
BML |
BML-GR236-0010 |
Tetradecylthioacetic Acid |
10mg |
¡ï8,000 |
|
2921-20-2 |
|
|
|
¡¡ |
BML |
BML-GR236-0050 |
Tetradecylthioacetic Acid |
50mg |
¡ï31,000 |
|
2921-20-2 |
|
|
|
¡¡ |
BML |
BML-GR239-0010 |
3-Methylcholanthrene |
10mg |
¡ï8,000 |
|
56-49-5 |
|
|
|
¡¡ |
BML |
BML-GR239-0050 |
3-Methylcholanthrene |
50mg |
¡ï32,000 |
|
56-49-5 |
|
|
|
¡¡ |
BML |
BML-GR242-0010 |
SR-12813 ¡ÚTetraethyl 2-(3,5-Di-tert-Butyl-4-hydroxyphenyl)ethenyl-1,1-bisphosphonate¡Û |
10mg |
¡ï10,000 |
|
126411-39-0 |
|
|
|
¡¡ |
BML |
BML-GR242-0050 |
SR-12813 ¡ÚTetraethyl 2-(3,5-Di-tert-Butyl-4-hydroxyphenyl)ethenyl-1,1-bisphosphonate¡Û |
50mg |
¡ï39,000 |
|
126411-39-0 |
|
|
|
¡¡ |
BML |
BML-GR243-0050 |
Raloxifene, HCI ¡Ú[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperdinyl)ethoxy]phenyl]methanone, HCl¡Û |
50mg |
¡ï9,000 |
|
84449-90-1 |
|
|
|
¡¡ |
BML |
BML-GR243-0500 |
Raloxifene, HCI ¡Ú[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperdinyl)ethoxy]phenyl]methanone, HCl¡Û |
500mg |
¡ï39,000 |
|
84449-90-1 |
|
|
|
¡¡ |
BML |
BML-GR245-0005 |
TCPOBOP ¡Ú3,3',5,5'-Tetrachloride-bispyridyloxybenzene¡Û |
5mg |
¡ï5,000 |
|
76150-91-9 |
|
|
|
¡¡ |
BML |
BML-GR245-0025 |
TCPOBOP ¡Ú3,3',5,5'-Tetrachloride-bispyridyloxybenzene¡Û |
25mg |
¡ï17,000 |
|
76150-91-9 |
|
|
|
¡¡ |
BML |
BML-GR246-0005 |
6-ECDCA ¡Ú6-Ethylchenodeoxycholic Acid¡Û¡Ú3a,7a-Dihydroxy-6a-ethyl-5B-cholan-24-oic Acid¡Û |
5mg |
¡ï11,000 |
|
459789-99-2 |
|
|
|
¡¡ |
BML |
BML-GR246-0025 |
6-ECDCA ¡Ú6-Ethylchenodeoxycholic Acid¡Û¡Ú3a,7a-Dihydroxy-6a-ethyl-5B-cholan-24-oic Acid¡Û |
25mg |
¡ï46,000 |
|
459789-99-2 |
|
|
|
¡¡ |
BML |
BML-GR247-0010 |
WAY-200070 ¡Ú7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol¡Û |
10mg |
¡ï14,000 |
|
440122-66-7 |
|
|
|
¡¡ |
BML |
BML-GR247-0050 |
WAY-200070 ¡Ú7-Bromo-2-(4-hydroxyphenyl)-1,3-benzoxazol-5-ol¡Û |
50mg |
¡ï56,000 |
|
440122-66-7 |
|
|
|
·àʪ |
BML |
BML-GR248-0010 |
DPN ¡ÚDiarylpropionitrile¡Û¡Ú2,3-bis(4-Hydroxyphenyl)propionitrile¡Û |
10mg |
¡ï12,000 |
|
1428-67-7 |
|
|
|
·àʪ |
BML |
BML-GR248-0050 |
DPN ¡ÚDiarylpropionitrile¡Û¡Ú2,3-bis(4-Hydroxyphenyl)propionitrile¡Û |
50mg |
¡ï52,000 |
|
1428-67-7 |
|
|
|
¡¡ |
BML |
BML-GR300-0005 |
Actinomycin D(Isolated from Streptomyces parvulus) |
5mg |
¡ï8,000 |
|
50-76-0 |
|
|
|
¡¡ |
BML |
BML-GR302-0010 |
Chromomycin A3(Isolated from Streptomyces griseus) |
10mg |
¡ï27,000 |
|
7059-24-7 |
|
|
|
¡¡ |
BML |
BML-GR303-0100 |
HOE-33342, 3HCl ¡ÚBisbenzimide¡Û¡Ú2¡Ç-(4-Ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2¡Ç,5¡Ç-bi-1H-benzimidazole¡Û |
100mg |
¡ï24,000 |
|
23491-52-3 |
|
|
|
¡¡ |
BML |
BML-GR305-0001 |
Mithramycin A(Isolated from Streptomyces argillaceus) |
1mg |
¡ï6,000 |
|
18378-89-7 |
|
|
|
¡¡ |
BML |
BML-GR307-0100 |
Etoposide ¡Ú4-Desmethylepipodophyllotoxin 9-(4,6-O-Ethylidene)-B-D-glucopyranoside¡Û¡ÚVP-16-213¡Û |
100mg |
¡ï10,000 |
|
33419-42-0 |
|
|
|
¡¡ |
BML |
BML-GR307-0500 |
Etoposide ¡Ú4-Desmethylepipodophyllotoxin 9-(4,6-O-Ethylidene)-B-D-glucopyranoside¡Û¡ÚVP-16-213¡Û |
500mg |
¡ï42,000 |
|
33419-42-0 |
|
|
|
¡¡ |
BML |
BML-GR308-0005 |
B-Lapachone |
5mg |
¡ï9,000 |
|
4707-32-8 |
|
|
|
¡¡ |
BML |
BML-GR308-0025 |
B-Lapachone |
25mg |
¡ï38,000 |
|
4707-32-8 |
|
|
|
¡¡ |
BML |
BML-GR309-0001 |
Trichostatin A ¡Ú[R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide¡Û(Isolated from Streptomyces hygroscopicus) |
1mg |
¡ï17,000 |
|
58880-19-6 |
|
|
|
¡¡ |
BML |
BML-GR309-0005 |
Trichostatin A ¡Ú[R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide¡Û(Isolated from Streptomyces hygroscopicus) |
5mg |
¡ï59,000 |
|
58880-19-6 |
|
|
|
¡¡ |
BML |
BML-GR311-0002 |
Mitomycin C |
2mg |
¡ï8,000 |
|
50-07-7 |
|
|
|
¡¡ |
BML |
BML-GR311-0010 |
Mitomycin C |
10mg |
¡ï35,000 |
|
50-07-7 |
|
|
|
¡¡ |
BML |
BML-GR312-0050 |
Puromycin, 2HCl ¡Ú3'-[[2-Amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl-adenosine, 2HCl¡Û¡Ú3'-(a-Amino-p-methoxy-hydrocinnamamido-3'-deoxy-N,N-dimethyl-adenosine, 2HCl¡Û |
50mg |
¡ï7,000 |
|
58-58-2 |
|
|
|
¡¡ |
BML |
BML-GR312-0250 |
Puromycin, 2HCl ¡Ú3'-[[2-Amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl-adenosine, 2HCl¡Û¡Ú3'-(a-Amino-p-methoxy-hydrocinnamamido-3'-deoxy-N,N-dimethyl-adenosine, 2HCl¡Û |
250mg |
¡ï27,000 |
|
58-58-2 |
|
|
|
¡¡ |
BML |
BML-GR313-0010 |
Lycorine, HCl |
10mg |
¡ï9,000 |
|
476-28-8 |
|
|
|
¡¡ |
BML |
BML-GR313-0050 |
Lycorine, HCl |
50mg |
¡ï39,000 |
|
476-28-8 |
|
|
|
¡¡ |
BML |
BML-GR314-0050 |
Delavirdine ¡Ú1-{3-[(1-Methylethyl)amino]-2-pyridinyl}-4-{5-[(methylsulfonyl)amino-1Hindol-2-yl]carbonyl}piperazine, Mesylate¡Û |
50mg |
¡ï11,000 |
|
147221-93-0 |
|
|
|
¡¡ |
BML |
BML-GR314-0250 |
Delavirdine ¡Ú1-{3-[(1-Methylethyl)amino]-2-pyridinyl}-4-{5-[(methylsulfonyl)amino-1Hindol-2-yl]carbonyl}piperazine, Mesylate¡Û |
250mg |
¡ï43,000 |
|
147221-93-0 |
|
|
|
¡¡ |
BML |
BML-GR315-0010 |
Ellipticine ¡Ú5,11-Dimethyl-6H-pyrido[4,3-b]carbazole¡Û |
10mg |
¡ï12,000 |
|
519-23-3 |
|
|
|
¡¡ |
BML |
BML-GR315-0050 |
Ellipticine ¡Ú5,11-Dimethyl-6H-pyrido[4,3-b]carbazole¡Û |
50mg |
¡ï49,000 |
|
519-23-3 |
|
|
|
¡¡ |
BML |
BML-GR316-0020 |
10-Hydroxycamptothecin |
20mg |
¡ï9,000 |
|
64439-81-2 |
|
|
|
¡¡ |
BML |
BML-GR316-0100 |
10-Hydroxycamptothecin |
100mg |
¡ï39,000 |
|
64439-81-2 |
|
|
|
¡¡ |
BML |
BML-GR317-0005 |
Coumermycin A1 |
5mg |
¡ï17,000 |
|
4434-05-3 |
|
|
|
¡¡ |
BML |
BML-GR317-0025 |
Coumermycin A1 |
25mg |
¡ï68,000 |
|
4434-05-3 |
|
|
|
¡¡ |
BML |
BML-GR319-0005 |
Doxorubicin, HCl ¡ÚDXR, HCl¡Û¡Ú14-Hydroxydaunomycin, HCl¡Û¡ÚAdriamycin, HCl¡Û |
5mg |
¡ï10,000 |
|
25316-40-9 |
|
|
|
¡¡ |
BML |
BML-GR319-0025 |
Doxorubicin, HCl ¡ÚDXR, HCl¡Û¡Ú14-Hydroxydaunomycin, HCl¡Û¡ÚAdriamycin, HCl¡Û |
25mg |
¡ï40,000 |
|
25316-40-9 |
|
|
|
¡¡ |
BML |
BML-GR320-0001 |
HC Toxin ¡ÚCyclo-(D-Pro-L-Ala-D-Ala-L-2-amino-8-oxo-9,10-epoxydecanoic Acid)¡Û |
1mg |
¡ï25,000 |
|
83209-65-8 |
|
|
|
¡¡ |
BML |
BML-GR321-0005 |
BPPA ¡Ú2,6-bis(3-Piperidinopropionamido)anthraquinone Diacetate¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR321-0025 |
BPPA ¡Ú2,6-bis(3-Piperidinopropionamido)anthraquinone Diacetate¡Û |
25mg |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR322-0005 |
Monastrol ¡Ú4-(3-Hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydro-4H-pyrimidin-5-carboxylic Acid Ethyl Ester¡Û |
5mg |
¡ï16,000 |
|
329689-23-8 |
|
|
|
¡¡ |
BML |
BML-GR322-0025 |
Monastrol ¡Ú4-(3-Hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydro-4H-pyrimidin-5-carboxylic Acid Ethyl Ester¡Û |
25mg |
¡ï63,000 |
|
329689-23-8 |
|
|
|
¡¡ |
BML |
BML-GR323-0100 |
Suberoyl bis-Hydroxamic Acid |
100mg |
¡ï6,000 |
|
38937-66-5 |
|
|
|
¡¡ |
BML |
BML-GR323-0500 |
Suberoyl bis-Hydroxamic Acid |
500mg |
¡ï13,000 |
|
38937-66-5 |
|
|
|
¡¡ |
BML |
BML-GR324-0100 |
DIF-1 ¡Ú1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one¡Û |
100ug |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR324-0500 |
DIF-1 ¡Ú1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one¡Û |
500ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR325-0005 |
Pifithrin-a ¡ÚPFT-a¡Û¡Ú1-(4-Methylphenyl)-2-(4,5,6,7-tetrahydro-2-imino-3(2H)-benzothiazoyl)ethanone, HBr¡Û |
5mg |
¡ï9,000 |
|
63208-82-2 |
|
|
|
¡¡ |
BML |
BML-GR325-0025 |
Pifithrin-a ¡ÚPFT-a¡Û¡Ú1-(4-Methylphenyl)-2-(4,5,6,7-tetrahydro-2-imino-3(2H)-benzothiazoyl)ethanone, HBr¡Û |
25mg |
¡ï37,000 |
|
63208-82-2 |
|
|
|
¡¡ |
BML |
BML-GR326-0001 |
Scriptaid ¡Ú6-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-N-hydroxyhexanamide¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR326-0005 |
Scriptaid ¡Ú6-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-N-hydroxyhexanamide¡Û |
5mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR327-0001 |
Nullscript ¡Ú4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-N-hydroxybutanamide¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR327-0005 |
Nullscript ¡Ú4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-N-hydroxybutanamide¡Û |
5mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR330-0001 |
BML-210 ¡ÚN-(2-Aminophenyl)-N'-phenyloctanediamide¡Û |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR330-0005 |
BML-210 ¡ÚN-(2-Aminophenyl)-N'-phenyloctanediamide¡Û |
5mg |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR331-0005 |
Splitomicin ¡Ú1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one¡Û |
5mg |
¡ï12,000 |
|
5690-03-9. |
|
|
|
¡¡ |
BML |
BML-GR331-0025 |
Splitomicin ¡Ú1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one¡Û |
25mg |
¡ï51,000 |
|
5690-03-9. |
|
|
|
¡¡ |
BML |
BML-GR332-0001 |
ICRF-193 ¡ÚMeso-4,4'-(2,3-butanediyl)-bis(2,6-piperazinedione)¡Û |
1mg |
¡ï15,000 |
|
21416-68-2 |
|
|
|
¡¡ |
BML |
BML-GR332-0005 |
ICRF-193 ¡ÚMeso-4,4'-(2,3-butanediyl)-bis(2,6-piperazinedione)¡Û |
5mg |
¡ï61,000 |
|
21416-68-2 |
|
|
|
¡¡ |
BML |
BML-GR333-0005 |
PRIMA-1 ¡Ú2,2-bis(Hydroxymethyl)-3-quinuclidinone¡Û¡Ú2,2-bis(Hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one¡Û |
5mg |
¡ï8,000 |
|
5608-24-2 |
|
|
|
¡¡ |
BML |
BML-GR333-0025 |
PRIMA-1 ¡Ú2,2-bis(Hydroxymethyl)-3-quinuclidinone¡Û¡Ú2,2-bis(Hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one¡Û |
25mg |
¡ï32,000 |
|
5608-24-2 |
|
|
|
¡¡ |
BML |
BML-GR334-0001 |
Cyclopamine |
1mg |
¡ï13,000 |
|
4449-51-8 |
|
|
|
¡¡ |
BML |
BML-GR334-0005 |
Cyclopamine |
5mg |
¡ï54,000 |
|
4449-51-8 |
|
|
|
¡¡ |
BML |
BML-GR335-0025 |
Tomatidine, HCl |
25mg |
¡ï6,000 |
|
6192-62-7 |
|
|
|
¡¡ |
BML |
BML-GR336-0005 |
Tanshinone IIA |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR336-0025 |
Tanshinone IIA |
25mg |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR339-0010 |
Dimethyl-Bisphenol A |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR339-0050 |
Dimethyl-Bisphenol A |
50mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR340-0001 |
Apicidin ¡ÚCyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)¡Û¡Úcyclo-L-(2-Amino-8-oxodecanoyl)-L-(N-methoxytryptophan)-L-isoleucyl-D-pipecolinyl¡Û |
1mg |
¡ï8,000 |
|
183506-66-3 |
|
|
|
¡¡ |
BML |
BML-GR340-0005 |
Apicidin ¡ÚCyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)¡Û¡Úcyclo-L-(2-Amino-8-oxodecanoyl)-L-(N-methoxytryptophan)-L-isoleucyl-D-pipecolinyl¡Û |
5mg |
¡ï33,000 |
|
183506-66-3 |
|
|
|
¡¡ |
BML |
BML-GR341-0010 |
Amifostine ¡ÚWR-2721¡Û¡ÚS-2[3-Aminopropylamino]ethylphosphothioic Acid¡Û |
10mg |
¡ï8,000 |
|
20537-88-6 |
|
|
|
¡¡ |
BML |
BML-GR341-0050 |
Amifostine ¡ÚWR-2721¡Û¡ÚS-2[3-Aminopropylamino]ethylphosphothioic Acid¡Û |
50mg |
¡ï37,000 |
|
20537-88-6 |
|
|
|
¡¡ |
BML |
BML-GR343-0010 |
Garcinol |
10mg |
¡ï11,000 |
|
78824-30-3 |
|
|
|
¡¡ |
BML |
BML-GR343-0050 |
Garcinol |
50mg |
¡ï44,000 |
|
78824-30-3 |
|
|
|
¡¡ |
BML |
BML-GR344-0010 |
Zebularine ¡Ú1-(B-D-Ribofuranosyl)-1,2-dihydropyrimidin-2-one¡Û¡Ú2-Pyrimidone-1-B-D-riboside¡Û |
10mg |
¡ï14,000 |
|
3690-10-6. |
|
|
|
¡¡ |
BML |
BML-GR346-0010 |
BML-266 ¡Ú1,4-Di[(4-hydroxyphenethyl)amino]-9,10-dihydroanthracene-9,10-dione¡Û |
10mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR346-0050 |
BML-266 ¡Ú1,4-Di[(4-hydroxyphenethyl)amino]-9,10-dihydroanthracene-9,10-dione¡Û |
50mg |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR349-0200 |
Chaetocin |
200ug |
¡ï10,000 |
|
28097-03-2 |
|
|
|
¡¡ |
BML |
BML-GR350-0025 |
ITSA-1 ¡ÚN-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide¡Û |
25mg |
¡ï10,000 |
|
200626-61-5 |
|
|
|
¡¡ |
BML |
BML-GR350-0100 |
ITSA-1 ¡ÚN-(1H-Benzotriazol-1-yl)-2,4-dichlorobenzamide¡Û |
100mg |
¡ï29,000 |
|
200626-61-5 |
|
|
|
¡¡ |
BML |
BML-GR357-0005 |
Mirin ¡Ú6-(4-Hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR357-0025 |
Mirin ¡Ú6-(4-Hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone¡Û |
25mg |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR359-0005 |
BML-278 ¡ÚN-Benzyl-3,5-dicarbethoxy-4-phenyl-1,4-dihydropyridine¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR359-0025 |
BML-278 ¡ÚN-Benzyl-3,5-dicarbethoxy-4-phenyl-1,4-dihydropyridine¡Û |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR360-0010 |
CP-31398 ¡ÚN¡Ç-{2-[2-(4-Methoxyphenyl)ethenyl]-4-quinazolinyl}-N,N-dimethyl-1,3-propanediamine, 2HCl¡Û |
10mg |
¡ï13,000 |
|
259199-65-0 |
|
|
|
¡¡ |
BML |
BML-GR360-0050 |
CP-31398 ¡ÚN¡Ç-{2-[2-(4-Methoxyphenyl)ethenyl]-4-quinazolinyl}-N,N-dimethyl-1,3-propanediamine, 2HCl¡Û |
50mg |
¡ï52,000 |
|
259199-65-0 |
|
|
|
¡¡ |
BML |
BML-GR361-0001 |
BML-281 ¡ÚN-Hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-3-isoxazolecarboxamido]heptanamide¡Û |
1mg |
¡ï10,000 |
|
1045792-66-2 |
|
|
|
¡¡ |
BML |
BML-GR361-0005 |
BML-281 ¡ÚN-Hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-3-isoxazolecarboxamido]heptanamide¡Û |
5mg |
¡ï42,000 |
|
1045792-66-2 |
|
|
|
¡¡ |
BML |
BML-GR362-0100 |
Tubacin ¡ÚN-(4-{(2R,4R,6S)-4-{[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanyl]methyl}-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl}phenyl)-N'-hydroxyoctanediamide¡Û |
100ug |
¡ï11,000 |
|
537049-40-4 |
|
|
|
¡¡ |
BML |
BML-GR362-0500 |
Tubacin ¡ÚN-(4-{(2R,4R,6S)-4-{[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanyl]methyl}-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl}phenyl)-N'-hydroxyoctanediamide¡Û |
500ug |
¡ï48,000 |
|
537049-40-4 |
|
|
|
¡¡ |
BML |
BML-GR363-0100 |
Niltubacin ¡Ú7-(4-((2R,4R,6S)-4-((4,5-dipenyloxazol-2-ylthio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-dioxan-2-yl)phenylcarbamoyl)heptanoic Acid¡Û |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GR363-0500 |
Niltubacin ¡Ú7-(4-((2R,4R,6S)-4-((4,5-dipenyloxazol-2-ylthio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-dioxan-2-yl)phenylcarbamoyl)heptanoic Acid¡Û |
500ug |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-GZ1031-0025 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û(GABA glutaraldehyde-haemocyanin complex), rat pAb |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-GZ1060-0025 |
Vesicular Glutamate Transporter-2 ¡ÚVGLUT2¡Û(human, aa 533-542), rabbit pAb, purified |
25ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-GZ1065-0025 |
Vesicular Glutamate Transporter-2 ¡ÚVGLUT2¡Û(human, aa 533-542), guinea pig pAb, purified |
25ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
guinea pig | - | human¡¢ mouse¡¢ rat | IHC |
|
|
¡¡ |
BML |
BML-GZ1081-0025 |
¦Ã-Aminobutyric Acid ¡ÚGABA¡Û(GABA glutaraldehyde-haemocyanin complex), guinea pig pAb |
25ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
guinea pig | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-GZ1092-0025 |
Gonadotropin Releasing Hormone ¡ÚGnRH¡Û [BML], mouse mAb, purified |
25ul |
¡ï43,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | BML | human¡¢ rat¡¢ guinea pig¡¢ bovine | IHC |
|
|
¡¡ |
BML |
BML-GZ1110-0025 |
Gonadotropin Releasing Hormone ¡ÚGnRH¡Û, guinea pig pAb, purified |
25ul |
¡ï27,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
guinea pig | - | human¡¢ mouse¡¢ rat¡¢ bovine | IHC |
|
|
¡¡ |
BML |
BML-H005-0050 |
5(S)-Hydroxyeicosa-6E,8Z,11Z,14Z-tetraenoic Acid ¡Ú5(S)-HETE¡Û |
50ug |
¡ï28,000 |
|
70608-72-9 |
|
|
|
¡¡ |
BML |
BML-H008-0050 |
8(S)-Hydroxyeicosa-5Z,9E,11Z,14Z-tetraenoic Acid ¡Ú8(S)-HETE¡Û |
50ug |
¡ï29,000 |
|
98462-03-4 |
|
|
|
¡¡ |
BML |
BML-H009-0050 |
9(S)-Hydroxyeicosa-5Z,7E,11Z,14Z-tetraenoic Acid ¡Ú9(S)-HETE¡Û |
50ug |
¡ï33,000 |
|
79495-85-5 |
|
|
|
¡¡ |
BML |
BML-H015-0050 |
15(S)-Hydroxyeicosa-5Z,8Z,11Z,13E-tetraenoic Acid ¡Ú15(S)-HETE¡Û |
50ug |
¡ï9,000 |
|
54845-95-3 |
|
|
|
¡¡ |
BML |
BML-H015-1000 |
15(S)-Hydroxyeicosa-5Z,8Z,11Z,13E-tetraenoic Acid ¡Ú15(S)-HETE¡Û |
1mg |
¡ï108,000 |
|
54845-95-3 |
|
|
|
¡¡ |
BML |
BML-H112-0050 |
12(R)-Hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic Acid ¡Ú12-(R)-HETE¡Û |
50ug |
¡ï29,000 |
|
82337-46-0 |
|
|
|
¡¡ |
BML |
BML-H112-1000 |
12(R)-Hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic Acid ¡Ú12-(R)-HETE¡Û |
1mg |
¡ï357,000 |
|
82337-46-0 |
|
|
|
¡¡ |
BML |
BML-H215-0050 |
15(S)-Hydroxyeicosa-11Z,13E-dienoic Acid ¡Ú15(S)-HEDE¡Û |
50ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-H305-0050 |
(¡Þ)-5-Hydroxyeicosa-6E,8Z,11Z-trienoic Acid ¡Ú(¡Þ)5-HETrE¡Û |
50ug |
¡ï11,000 |
|
88053-46-7 |
|
|
|
¡¡ |
BML |
BML-H312-0050 |
Tetranor-12(R)-HETE ¡Ú8(R)-Hydroxy-4Z, 6E, 10Z-hexadecatrienoic Acid¡Û |
50ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-H515-0050 |
15(S)-Hydroxyeicosa-5Z,8Z,11Z,13E,17Z-pentaenoic Acid ¡Ú15(S)-HEPE¡Û |
50ug |
¡ï10,000 |
|
86282-92-0 |
|
|
|
¡¡ |
BML |
BML-HA004-0001 |
(¡Þ)-4-Hydroxynon-2-enal |
1mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HA004-0010 |
(¡Þ)-4-Hydroxynon-2-enal |
10mg |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HA005-0020 |
Decadienal ¡Ú2(E),4(E)-Decadienal¡Û |
20mg |
¡ï8,000 |
|
25152-84-5 |
|
|
|
¡¡ |
BML |
BML-HC3001-0025 |
Heme Oxygenase 1 ¡ÚHO 1¡Û(human, aa 12-25), rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-HC3001-0100 |
Heme Oxygenase 1 ¡ÚHO 1¡Û(human, aa 12-25), rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-HC3002-0025 |
Heme Oxygenase 2 ¡ÚHO 2¡Û(human, 246-264 ), rabbit pAb, purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-HC3002-0100 |
Heme Oxygenase 2 ¡ÚHO 2¡Û(human, 246-264 ), rabbit pAb, purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-HE008-0050 |
Hepoxilin A3 ¡Ú8,11(12)-HEpETrE¡Û |
50ug |
¡ï31,000 |
|
85589-24-8 |
|
|
|
¡¡ |
BML |
BML-HE008-1000 |
Hepoxilin A3 ¡Ú8,11(12)-HEpETrE¡Û |
1mg |
¡ï403,000 |
|
85589-24-8 |
|
|
|
¡¡ |
BML |
BML-HE010-0050 |
Hepoxilin B3 ¡Ú10,11(12)-HEpETrE¡Û |
50ug |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HE010-1000 |
Hepoxilin B3 ¡Ú10,11(12)-HEpETrE¡Û |
1mg |
¡ï391,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HL005-0050 |
(¡Þ)-5-HETE Lactone |
50ug |
¡ï13,000 |
|
73279-37-5 |
|
|
|
¡¡ |
BML |
BML-HL005-1000 |
(¡Þ)-5-HETE Lactone |
1mg |
¡ï149,000 |
|
73279-37-5 |
|
|
|
¡¡ |
BML |
BML-HLB004-0050 |
20-Hydroxy-Leukotriene B4 ¡Ú20-Hydroxy-LTB4¡Û |
50ug |
¡ï44,000 |
|
79516-82-8 |
|
|
|
¡¡ |
BML |
BML-HLB004-1000 |
20-Hydroxy-Leukotriene B4 ¡Ú20-Hydroxy-LTB4¡Û |
1mg |
¡ï521,000 |
|
79516-82-8 |
|
|
|
¡¡ |
BML |
BML-HO013-0050 |
13(S)-Hydroxyoctadeca-9Z,11E-dienoic Acid ¡Ú13(S)-HODE¡Û |
50ug |
¡ï9,000 |
|
29623-28-7 |
|
|
|
¡¡ |
BML |
BML-HO013-1000 |
13(S)-Hydroxyoctadeca-9Z,11E-dienoic Acid ¡Ú13(S)-HODE¡Û |
1mg |
¡ï105,000 |
|
29623-28-7 |
|
|
|
¡¡ |
BML |
BML-HO309-0050 |
(¡Þ)9-Hydroxyoctadeca-10E,12Z-dienoic Acid ¡Ú(¡Þ)9-HODE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HO309-1000 |
(¡Þ)9-Hydroxyoctadeca-10E,12Z-dienoic Acid ¡Ú(¡Þ)9-HODE¡Û |
1mg |
¡ï108,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HO313-0050 |
13(S)-Hydroxyoctadeca-6Z,9Z,11E-trienoic Acid ¡Ú13(S)-HOTE¡Û |
50ug |
¡ï11,000 |
|
74784-20-6 |
|
|
|
¡¡ |
BML |
BML-HO313-1000 |
13(S)-Hydroxyoctadeca-6Z,9Z,11E-trienoic Acid ¡Ú13(S)-HOTE¡Û |
1mg |
¡ï126,000 |
|
74784-20-6 |
|
|
|
¡¡ |
BML |
BML-HO409-0050 |
9(S)-Hydroxyoctadeca-10E,12Z-dienoic Acid ¡Ú9(S)-HODE¡Û |
50ug |
¡ï9,000 |
|
73543-67-6 |
|
|
|
¡¡ |
BML |
BML-HO409-1000 |
9(S)-Hydroxyoctadeca-10E,12Z-dienoic Acid ¡Ú9(S)-HODE¡Û |
1mg |
¡ï100,000 |
|
73543-67-6 |
|
|
|
¡¡ |
BML |
BML-HP005-0050 |
5(S)-Hydroperoxyeicosa-6E,8Z,11Z,14Z-tetraenoic Acid(HPETE)¡Ú5(S)-HPETE¡Û |
50ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HP005-1000 |
5(S)-Hydroperoxyeicosa-6E,8Z,11Z,14Z-tetraenoic Acid(HPETE)¡Ú5(S)-HPETE¡Û |
1mg |
¡ï253,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HP012-0050 |
12(S)-Hydroperoxyeicosa-5Z,8Z,10E,14Z-tetraenoic Acid(HPETE)¡Ú12(S)-HPETE¡Û |
50ug |
¡ï33,000 |
|
71774-10-2 |
|
|
|
¡¡ |
BML |
BML-HP013-0050 |
13(S)-Hydroperoxyoctadeca-9Z,11E-dienoic Acid ¡Ú13(S)-HPODE¡Û |
50ug |
¡ï9,000 |
|
33964-75-9 |
|
|
|
¡¡ |
BML |
BML-HP013-1000 |
13(S)-Hydroperoxyoctadeca-9Z,11E-dienoic Acid ¡Ú13(S)-HPODE¡Û |
1mg |
¡ï105,000 |
|
33964-75-9 |
|
|
|
¡¡ |
BML |
BML-HP015-0050 |
15(S)-Hydroperoxyeicosa-5Z,8Z,11Z,13E-tetraenoic Acid(HPETE)¡Ú15(S)-HPETE¡Û |
50ug |
¡ï9,000 |
|
70981-96-3 |
|
|
|
¡¡ |
BML |
BML-HP015-1000 |
15(S)-Hydroperoxyeicosa-5Z,8Z,11Z,13E-tetraenoic Acid(HPETE)¡Ú15(S)-HPETE¡Û |
1mg |
¡ï105,000 |
|
70981-96-3 |
|
|
|
¡¡ |
BML |
BML-HP019-0050 |
9(S)-Hydroperoxyoctadeca-10E,12Z-dienoic Acid ¡Ú9(S)-HPODE¡Û |
50ug |
¡ï11,000 |
|
29774-12-7 |
|
|
|
¡¡ |
BML |
BML-HP125-0050 |
15(S)-Hydroperoxyeicosa-11Z,13E-dienoic Acid ¡Ú15(S)-HPEDE¡Û |
50ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HP125-1000 |
15(S)-Hydroperoxyeicosa-11Z,13E-dienoic Acid ¡Ú15(S)-HPEDE¡Û |
1mg |
¡ï133,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HP515-0050 |
15(S)-Hydroperoxyeicosa-5Z,8Z,11Z,13E,17Z-pentaenoic Acid ¡Ú15(S)-HPEPE¡Û |
50ug |
¡ï9,000 |
|
125992-60-1 |
|
|
|
¡¡ |
BML |
BML-HP9301-0100 |
Heme Oxygenase 1 Peptide, Blocking Peptide for Heme Oxygenase 1 pAb(Prod. No. BML-HC3001) |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HP9302-0100 |
Heme Oxygenase 2 Peptide, Blocking Peptide for Heme Oxygenase 2 pAb(Prod. No. BML-HC3002) |
100ug |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HR005-0050 |
(¡Þ)5-Hydroxyeicosa-6E,8Z,11Z,14Z-tetraenoic Acid ¡Ú(¡Þ)-5-HETE¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HR005-1000 |
(¡Þ)5-Hydroxyeicosa-6E,8Z,11Z,14Z-tetraenoic Acid ¡Ú(¡Þ)-5-HETE¡Û |
1mg |
¡ï105,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HR012-0050 |
(¡Þ)12-Hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic Acid(HETE)¡Ú(¡Þ)-12-HETE¡Û |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HR013-0050 |
(¡Þ)13-Hydroxyoctadeca-9Z,11E-dienoic Acid ¡Ú(¡Þ)13-HODE¡Û |
50ug |
¡ï9,000 |
|
73804-64-5 |
|
|
|
¡¡ |
BML |
BML-HR013-1000 |
(¡Þ)13-Hydroxyoctadeca-9Z,11E-dienoic Acid ¡Ú(¡Þ)13-HODE¡Û |
1mg |
¡ï100,000 |
|
73804-64-5 |
|
|
|
¡¡ |
BML |
BML-HR505-0050 |
(¡Þ)5-Hydroxyeicosa-6E,8Z,11Z,14Z,17Z-pentaenoic Acid ¡Ú(¡Þ)13-HODE¡Û |
50ug |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HRT012-0050 |
12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic Acid ¡Ú12(S)-HHT¡Û |
50ug |
¡ï30,000 |
|
54397-84-1 |
|
|
|
¡¡ |
BML |
BML-HRT012-1000 |
12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic Acid ¡Ú12(S)-HHT¡Û |
1mg |
¡ï368,000 |
|
54397-84-1 |
|
|
|
¡¡ |
BML |
BML-HW8600-0001 |
Fraction I(HeLa)¡ÚFrI¡Û(Isolated from HeLa S3 cell lysate) |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-HW8605-0001 |
Fraction II(HeLa)¡ÚFrII¡Û(Isolated from HeLa S3 cell lysate) |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-IG6060-0100 |
B1-Integrin ¡ÚCD29¡Û(human fibroblasts)[DF5], mouse mAb, purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DF5 | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-IG6061-0100 |
B1-Integrin ¡ÚCD29¡Û(human fibroblasts)[DF7], mouse mAb, purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DF7 | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-IG6065-0100 |
aIIb Integrin ¡ÚCD41b¡Û(human platelets)[DB10], mouse mAb(CA3), purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DB10 | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-IM100-0010 |
Cycloheximide-N-ethylethanoate |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-IM100-0050 |
Cycloheximide-N-ethylethanoate |
50mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-IM101-0020 |
Mycophenolate Mofetil(Isolated from Penicillium brevicompactum) |
20mg |
¡ï8,000 |
|
128794-94-5 |
|
|
|
¡¡ |
BML |
BML-IM101-0100 |
Mycophenolate Mofetil(Isolated from Penicillium brevicompactum) |
100mg |
¡ï24,000 |
|
128794-94-5 |
|
|
|
¡¡ |
BML |
BML-J100-0001 |
Norfentanyl ¡ÚN-Phenyl-N-(4-piperidinyl)propanamide¡Û |
1mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J100-0010 |
Norfentanyl ¡ÚN-Phenyl-N-(4-piperidinyl)propanamide¡Û |
10mg |
¡ï69,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J110-0001 |
Despropionylfentanyl ¡Ú1-Phenethyl-N-phenylpiperidin-4-amine¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J110-0010 |
Despropionylfentanyl ¡Ú1-Phenethyl-N-phenylpiperidin-4-amine¡Û |
10mg |
¡ï69,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J115-0001 |
Despropionyl-3-methylfentanyl |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J115-0010 |
Despropionyl-3-methylfentanyl |
10mg |
¡ï102,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J116-0005 |
Imipramine N-Oxide |
5mg |
¡ï11,000 |
|
6829-98-7 |
|
|
|
¡¡ |
BML |
BML-J116-0025 |
Imipramine N-Oxide |
25mg |
¡ï44,000 |
|
6829-98-7 |
|
|
|
¡¡ |
BML |
BML-J120-0005 |
(S)-Mephenytoin ¡Ú(S)-5-Ethyl-3-methyl-5-phenylhydantoin¡Û |
5mg |
¡ï9,000 |
|
70989-04-7 |
|
|
|
¡¡ |
BML |
BML-J120-0025 |
(S)-Mephenytoin ¡Ú(S)-5-Ethyl-3-methyl-5-phenylhydantoin¡Û |
25mg |
¡ï38,000 |
|
70989-04-7 |
|
|
|
¡¡ |
BML |
BML-J125-0005 |
a-Hydroxy-Alprazolam ¡Ú4H-s-Triazolo[4,3-a][1,4]benzodiazepine-1-methanol¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J126-0005 |
4-Hydroxy-Alprazolam ¡Ú8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepin-4-ol¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J130-0001 |
a-Hydroxy-Triazolam ¡Ú8-Chloro-6-(o-chlorophenyl)-4H-s-Triazolo[4,3-a][1,4]-benzodiazepine-1-methanol¡Û |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J131-0005 |
4-Hydroxy-Triazolam ¡Ú8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepin-4-ol¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J135-0010 |
PNU-88822 ¡Ú2-[4-(5-Hydroxy-1H-indol-2-ylcarbonyl)-1-piperazinyl]-N-(1-methylethyl)-3-pyridineamine¡Û |
10mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-J135-0050 |
PNU-88822 ¡Ú2-[4-(5-Hydroxy-1H-indol-2-ylcarbonyl)-1-piperazinyl]-N-(1-methylethyl)-3-pyridineamine¡Û |
50mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-JW8695-0010 |
c-Jun(human)(recombinant) with His-Tag |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-K005-0050 |
5-Ketoeicosa-6E,8Z,11Z,14E-tetraenoic Acid ¡Ú5-KETE¡Û |
50ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-K015-0050 |
15-Ketoeicosa-6E,8Z,11Z,13E-tetraenoic Acid ¡Ú15-KETE¡Û¡Ú15-oxo-ETE¡Û |
50ug |
¡ï20,000 |
|
81416-72-0 |
|
|
|
¡¡ |
BML |
BML-K015-1000 |
15-Ketoeicosa-6E,8Z,11Z,13E-tetraenoic Acid ¡Ú15-KETE¡Û¡Ú15-oxo-ETE¡Û |
1mg |
¡ï238,000 |
|
81416-72-0 |
|
|
|
¡¡ |
BML |
BML-KC120-0001 |
Glyburide ¡ÚGlibenclamide¡Û |
1g |
¡ï4,000 |
|
10238-21-8 |
|
|
|
¡¡ |
BML |
BML-KC120-0005 |
Glyburide ¡ÚGlibenclamide¡Û |
5g |
¡ï6,000 |
|
10238-21-8 |
|
|
|
¡¡ |
BML |
BML-KC125-0100 |
Minoxidil ¡ÚU-10858¡Û |
100mg |
¡ï8,000 |
|
38304-91-5 |
|
|
|
¡¡ |
BML |
BML-KC125-0500 |
Minoxidil ¡ÚU-10858¡Û |
500mg |
¡ï36,000 |
|
38304-91-5 |
|
|
|
¡¡ |
BML |
BML-KC127-0005 |
NS-1619 ¡Ú1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-trifluoromethyl-2Hbenzimidazol-2-one¡Û |
5mg |
¡ï15,000 |
|
153587-01-0 |
|
|
|
¡¡ |
BML |
BML-KC130-0005 |
Minoxidil Sulfate ¡ÚU-58838¡Û |
5mg |
¡ï10,000 |
|
83701-22-8 |
|
|
|
¡¡ |
BML |
BML-KC130-0025 |
Minoxidil Sulfate ¡ÚU-58838¡Û |
25mg |
¡ï40,000 |
|
83701-22-8 |
|
|
|
·àʪ |
BML |
BML-KC131-0020 |
PCO 400 ¡Ú(-)-(3S,4R)-3,4-Dihydro-3-hydroxy-2,2-dimethyl-4-(3-oxocyclopent-1-enyl-1-oxy)-2H-1-benzpyran-6-carbonitrile¡Û |
20mg |
¡ï6,000 |
|
121055-10-5 |
|
|
|
·àʪ |
BML |
BML-KC131-0100 |
PCO 400 ¡Ú(-)-(3S,4R)-3,4-Dihydro-3-hydroxy-2,2-dimethyl-4-(3-oxocyclopent-1-enyl-1-oxy)-2H-1-benzpyran-6-carbonitrile¡Û |
100mg |
¡ï27,000 |
|
121055-10-5 |
|
|
|
¡¡ |
BML |
BML-KC140-0025 |
Valinomycin(Isolated from Streptomyces fulvissimus) |
25mg |
¡ï9,000 |
|
2001-95-8 |
|
|
|
¡¡ |
BML |
BML-KC141-0100 |
5-Hydroxydecanoate, Na salt |
100mg |
¡ï9,000 |
|
624-00-0 |
|
|
|
¡¡ |
BML |
BML-KC141-0500 |
5-Hydroxydecanoate, Na salt |
500mg |
¡ï36,000 |
|
624-00-0 |
|
|
|
¡¡ |
BML |
BML-KC152-0050 |
Nicorandil ¡ÚN-[2-(Nitrooxy)ethyl]-3-pyridinecarboxamide¡Û |
50mg |
¡ï6,000 |
|
65141-46-0 |
|
|
|
¡¡ |
BML |
BML-KC155-0005 |
Paxilline |
5mg |
¡ï11,000 |
|
57186-25-1 |
|
|
|
¡¡ |
BML |
BML-KC155-0025 |
Paxilline |
25mg |
¡ï53,000 |
|
57186-25-1 |
|
|
|
¡¡ |
BML |
BML-KC156-0002 |
Paxillinol |
2mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KC157-0001 |
Penitrem A ¡ÚTremortin A¡Û¡ÚNSC 354845¡Û |
1mg |
¡ï6,000 |
|
12627-35-9 |
|
|
|
¡¡ |
BML |
BML-KC157-0005 |
Penitrem A ¡ÚTremortin A¡Û¡ÚNSC 354845¡Û |
5mg |
¡ï19,000 |
|
12627-35-9 |
|
|
|
¡¡ |
BML |
BML-KC158-0005 |
E-4031, 2HCl , 2H2O ¡Ú4¡Ç-[[1-[2-(6-Methyl-2-pyridyl)ethyl]-4-piperidinyl]carbonyl]methanesulfonanilide, 2HCl, 2H2O¡Û |
5mg |
¡ï20,000 |
|
113558-89-7 |
|
|
|
¡¡ |
BML |
BML-KC158-0025 |
E-4031, 2HCl, 2H2O ¡Ú4¡Ç-[[1-[2-(6-Methyl-2-pyridyl)ethyl]-4-piperidinyl]carbonyl]methanesulfonanilide, 2HCl, 2H2O¡Û |
25mg |
¡ï81,000 |
|
113558-89-7 |
|
|
|
¡¡ |
BML |
BML-KC159-0005 |
U-37883A ¡ÚN-(1-Adamantyl)-N'-cyclohexyl-4-morpholinecarboxamidine, HCl¡Û |
5mg |
¡ï9,000 |
|
57568-80-6 |
|
|
|
¡¡ |
BML |
BML-KC159-0025 |
U-37883A ¡ÚN-(1-Adamantyl)-N'-cyclohexyl-4-morpholinecarboxamidine, HCl¡Û |
25mg |
¡ï39,000 |
|
57568-80-6 |
|
|
|
¡¡ |
BML |
BML-KC160-0050 |
Gabapentin-Lactam ¡Ú3-Azaspiro[4,5]decan-2-one¡Û |
50mg |
¡ï8,000 |
|
64744-50-9 |
|
|
|
¡¡ |
BML |
BML-KC160-0250 |
Gabapentin-Lactam ¡Ú3-Azaspiro[4,5]decan-2-one¡Û |
250mg |
¡ï25,000 |
|
64744-50-9 |
|
|
|
¡¡ |
BML |
BML-KC161-0005 |
TRAM-34 ¡Ú1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole¡Û |
5mg |
¡ï11,000 |
|
289905-88-0 |
|
|
|
¡¡ |
BML |
BML-KC161-0025 |
TRAM-34 ¡Ú1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole¡Û |
25mg |
¡ï47,000 |
|
289905-88-0 |
|
|
|
¡¡ |
BML |
BML-KC163-0140 |
Dendrotoxin-I(Dendroaspis p. polylepis), purified |
140ug |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KC164 |
Dendrotoxin-K(Dendroaspis p. polylepis), purified |
70ug |
¡ï58,000 |
|
119128-61-9 |
|
|
|
¡¡ |
BML |
BML-KC166-0010 |
Margatoxin ¡ÚMgTx¡Û(recombinant) |
10ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KC167-0140 |
a-Dendrotoxin |
140ug |
¡ï58,000 |
|
74504-53-3 |
|
|
|
¡¡ |
BML |
BML-KC168-0100 |
Charybdotoxin(recombinant) |
100ug |
¡ï44,000 |
|
95751-30-7 |
|
|
|
¡¡ |
BML |
BML-KC169-0010 |
NS-1643 ¡ÚN,N¡Ç-Bis[2-hydroxy-5-(trifluoromethyl)phenyl] Urea¡Û |
10mg |
¡ï11,000 |
|
448895-37-2 |
|
|
|
¡¡ |
BML |
BML-KC169-0050 |
NS-1643 ¡ÚN,N¡Ç-Bis[2-hydroxy-5-(trifluoromethyl)phenyl] Urea¡Û |
50mg |
¡ï46,000 |
|
448895-37-2 |
|
|
|
¡¡ |
BML |
BML-KC170-0010 |
ZM-226600 ¡ÚN-(4-Phenylsulfonylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide¡Û |
10mg |
¡ï11,000 |
|
147695-92-9 |
|
|
|
¡¡ |
BML |
BML-KC170-0050 |
ZM-226600 ¡ÚN-(4-Phenylsulfonylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide¡Û |
50mg |
¡ï45,000 |
|
147695-92-9 |
|
|
|
¡¡ |
BML |
BML-KC171-0010 |
Iberiotoxin(synthetic) |
10ug |
¡ï21,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI100-0001 |
Desalting Column and Resin |
Set |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI101-0001 |
96 Well Plates |
Pack |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI102-0001 |
1mL Phosphate Standard(800uM)for BIOMOL GREEN ¡ÚPhosphate Standard¡Û |
1mL |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI103-0001 |
Protease Inhibitor Cocktail |
Set |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI104-0050 |
Fluor-de-Lys Deacetylase Substrate ¡ÚDeacetylase Substrate¡Û |
50ul |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI105 |
Fluor-de-Lys Developer I Concentrate ¡ÚDeveloper I Concentrate¡Û |
300ul |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI106-0001 |
p-Nitroaniline ¡ÚpNA¡Û Standard |
1mL |
¡ï4,000 |
|
100-01-6 |
|
|
|
¡¡ |
BML |
BML-KI107-0001 |
AMC ¡Ú7-Amino-4-methylcoumarin¡Û Standard |
1mL |
¡ï4,000 |
|
26093-31-2 |
|
|
|
¡¡ |
BML |
BML-KI108-0001 |
AFC ¡Ú7-Amino-4-trifluoromethylcoumarin¡Û Standard |
1mg |
¡ï4,000 |
|
53518-15-3 |
|
|
|
¡¡ |
BML |
BML-KI110-0001 |
1/2 Volume White Microplates ¡ÚMicroplates(1/2 Volume White)¡Û(5 plates) |
1set |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI111-0020 |
Caspase Assay Buffer |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI115-0020 |
MMP-3 Colorimetric Assay Buffer ¡ÚMatrix Metalloproteinase-3 Colorimetric Assay Buffer¡Û¡ÚStromelysin-1 Colorimetric Assay Buffer¡Û¡ÚTransin Colorimetric Assay Buffer¡Û |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI117-0030 |
Caspase Cell Lysis Buffer |
30ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI120-0020 |
Proteasome 20S Assay Buffer |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI127-0020 |
MMP-3 Fluorescent Assay Buffer ¡ÚMatrix Metalloproteinase-3 Fluorescent Assay Buffer¡Û¡ÚStromelysin-1 Fluorescent Assay Buffer¡Û¡ÚTransin Fluorescent Assay Buffer¡Û |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI128-0020 |
Calcineurin Assay Buffer(2x) |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI131-0020 |
PTP1B 2x Assay Buffer ¡ÚProtein Tyrosine Phosphatase 2x Assay Buffer¡Û |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI134-0020 |
Caspase-14 Assay Buffer |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI136-0001 |
EGTA(2x)Buffer |
1mL |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI137-0500 |
Nuclear Extract for Colorimetric HDAC Assays |
500ul |
¡ï19,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI138-0050 |
Color-de-Lys Deacetylase Substrate ¡ÚDeacetylase Substrate¡Û |
50ul |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI139 |
Color-de-Lys Developer |
300ul |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI140-0100 |
Nuclear Extract from HeLa cells |
100ul |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI141-0030 |
Color-de-Lys Deacetylated Standard ¡ÚDeacetylated Standard¡Û |
30ul |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI142-0030 |
Fluor-de-Lys Deacetylated Standard ¡ÚDeacetylated Standard¡Û |
30ul |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI143-0020 |
HDAC Assay Buffer ¡ÚHistone Deacetylase Assay Buffer¡Û |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI144-0001 |
AMC ¡Ú7-Amino-4-methylcoumarin¡Û Calibration Standard |
1mg |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI145-0001 |
pNA ¡Úp-Nitroaniline¡Û Calibration Standard |
1mg |
¡ï3,000 |
|
7300-59-6 |
|
|
|
¡¡ |
BML |
BML-KI164-0001 |
SR-VAD-fluoromethylketone |
1vial |
¡ï22,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI170-0012 |
5X Wash Buffer(from the AK120 Kit) |
12ml |
¡ï3,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI171-0001 |
Sterile 96-well Microplate ¡Ú96 Well Microplate, Sterile-¡Û |
96wells |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI173-0020 |
MMP-1 Colorimetric Assay Buffer ¡ÚMatrix Metalloproteinase-1 Colorimetric Assay Buffer¡Û |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI174-0005 |
Fluor-de-Lys -H4-AcK16 Deacetylase Substrate ¡ÚH4-AcK16 Deacetylase Substrate¡Û |
0.5umol |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI175-0020 |
MMP-1 Assay Buffer ¡ÚMatrix Metalloproteinase-1Assay Buffer¡Û |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI176-1250 |
Fluor-de-Lys Developer II Concentrate ¡ÚDeveloper II Concentrate¡Û |
1.25mL |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI177-0005 |
Fluor-de-Lys -SIRT1 Deacetylase Substrate ¡ÚSIRT1 Deacetylase Substrate¡Û |
0.5umol |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI178-0005 |
Fluor-de-Lys -HDAC8 Deacetylase Substrate ¡ÚHDAC8 Deacetylase Substrate¡Û |
0.5umol |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI179-0005 |
Fluor-de-Lys-SIRT2 Deacetylase Substrate ¡ÚSIRT2 Deacetylase Substrate¡Û |
0.5umol |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI180-0002 |
3',5'-cAMP Substrate |
2ml |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI181-0040 |
PDE Assay Buffer |
2x20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI182-0001 |
5'-GMP Standard |
1mL |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI184-0001 |
5'-AMP Standard |
1mL |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI190-0002 |
3',5'-cGMP Substrate |
2ml |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI282-0500 |
NAD+(SIRT Substrate)¡ÚB-Nicotinamide Adenine Dinucleotide, Oxidized form¡Û |
500ul |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI283-0500 |
Nicotinamide |
500ul |
¡ï4,000 |
|
98-92-0 |
|
|
|
¡¡ |
BML |
BML-KI285-0010 |
Suramin Sodium |
10mg |
¡ï3,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI286-0020 |
SIRT Assay Buffer |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI307-5000 |
5'-Nucleotidase(from Crotalus atrox venom) |
5000kU |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI311-0020 |
HDAC8 Assay Buffer ¡ÚHistone Deacetylase 8 Assay Buffer¡Û |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI340-0020 |
Proteasome Assay Buffer |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI341-0012 |
Sodium Dodecyl Sulfate ¡ÚSDS¡Û |
12mg |
¡ï4,000 |
|
151-21-3 |
|
|
|
¡¡ |
BML |
BML-KI346-0020 |
HDAC Cell Lysis Buffer ¡ÚHistone Deacetylase Cell Lysis Buffer¡Û |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI347-0001 |
Sterile 1/2 Volume Microplate with Lid ¡ÚMicroplate(Sterile 1/2 Volume)with Lid¡Û(1 set of 5 plates¡Ë |
1set |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI422-0020 |
HDAC Assay Buffer II ¡ÚHistone Deacetylase Assay Buffer II¡Û |
20ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI431-0020 |
Cathepsin S Assay Buffer |
20ml |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI432-0020 |
Cathepsin K assay buffer |
20ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI456-0020 |
PDE Enzyme(from bovine brain) |
20U |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI468-0005 |
BIOMOL RED Reagent |
5ml |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI572-0050 |
Fluor-de-Lys-Green substrate ¡ÚGreen substrate¡Û |
50ul |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI576-0020 |
Assay buffer |
20ml |
¡ï3,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI579-0050 |
Fluor-de-Lys-Propionyl Substrate ¡ÚPropionyl Substrate¡Û |
50ul |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI580-0050 |
Fluor-de-Lys-Butyryl Substrate ¡ÚButyryl Substrate¡Û |
50ul |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI581-0020 |
Neutrophil Elastase Assay Buffer |
20ml |
¡ï3,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI584-0001 |
1/2 Volume White Microplates(non-binding surface)(for 96 wells) |
1set |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KI590-0050 |
Fluor-de-Lys-Succinyl, Desuccinylase Substrate ¡ÚDesuccinylase Substrate, Fluor-de-Lys-Succinyl-¡Û |
50ul |
¡ï21,000 |
-80¡î |
none |
|
Purity: ¡ä95% Application: Study of desuccinylase kinetics, regulation, and inhibitor sensitivity. Ideal for drug discovery and HTS applications
|
|
¡¡ |
BML |
BML-KI597-0400 |
DMSO |
400ul |
¡ï3,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI604-0001 |
1/2 Volume Black Microplate, Non-binding surface |
5plates |
¡ï7,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KI605-0030 |
Fluor de Lys Green Standard |
30ul |
¡ï8,000 |
|
|
|
|
|
¡¡ |
BML |
BML-KO013-0050 |
13-Keto-octadeca-9Z,11E-dienoic Acid |
50ug |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KO013-1000 |
13-Keto-octadeca-9Z,11E-dienoic Acid |
1mg |
¡ï238,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KW9885-0005 |
10x Ubiquitinylation Buffer(packaged as 5 x 1 ml)
|
5ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-KW9890-0005 |
10x SUMOylation Buffer(packaged as 5 x 1 ml)
|
5ml |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L100-0005 |
1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine ¡ÚPAF C-16¡Û |
5mg |
¡ï7,000 |
|
74389-68-7 |
|
|
|
¡¡ |
BML |
BML-L100-0025 |
1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine ¡ÚPAF C-16¡Û |
25mg |
¡ï29,000 |
|
74389-68-7 |
|
|
|
¡¡ |
BML |
BML-L102-0005 |
1-O-Hexadecyl-2-O-arachidonoyl-sn-glycero-3-phosphorylcholine ¡Ú2-AA-PAF¡Û |
5mg |
¡ï24,000 |
|
86288-11-1 |
|
|
|
¡¡ |
BML |
BML-L102-0025 |
1-O-Hexadecyl-2-O-arachidonoyl-sn-glycero-3-phosphorylcholine ¡Ú2-AA-PAF¡Û |
25mg |
¡ï94,000 |
|
86288-11-1 |
|
|
|
¡¡ |
BML |
BML-L103-0005 |
CV-3988 ¡Úrac-3-(N-Octadecylcarbamoyl)-2-Methoxy)propyl-(2-thiazolioethyl)Phosphate¡Û |
5mg |
¡ï19,000 |
|
85703-73-7] |
|
|
|
¡¡ |
BML |
BML-L103-0025 |
CV-3988 ¡Úrac-3-(N-Octadecylcarbamoyl)-2-Methoxy)propyl-(2-thiazolioethyl)Phosphate¡Û |
25mg |
¡ï78,000 |
|
85703-73-7] |
|
|
|
¡¡ |
BML |
BML-L106-0005 |
(¡Þ)-1-O-Hexadecyl-2-O-methylglycero-3-phosphorylcholine ¡Ú2-O-Methyl PAF¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L106-0025 |
(¡Þ)-1-O-Hexadecyl-2-O-methylglycero-3-phosphorylcholine ¡Ú2-O-Methyl PAF¡Û |
25mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L107-0005 |
1-Oleoyl-2-acetyl-sn-glycero-3-phosphorylcholine ¡ÚPAF C-18:1¡Û |
5mg |
¡ï8,000 |
|
85966-90-1 |
|
|
|
¡¡ |
BML |
BML-L107-0025 |
1-Oleoyl-2-acetyl-sn-glycero-3-phosphorylcholine ¡ÚPAF C-18:1¡Û |
25mg |
¡ï36,000 |
|
85966-90-1 |
|
|
|
¡¡ |
BML |
BML-L108-0005 |
1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine ¡Ú2-O-Methyl-PAF-C-18¡Û¡Úsn-ET-18-OCH3¡Û¡ÚEdelfosine¡Û |
5mg |
¡ï9,000 |
|
77286-66-9 |
|
|
|
¡¡ |
BML |
BML-L108-0025 |
1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine ¡Ú2-O-Methyl-PAF-C-18¡Û¡Úsn-ET-18-OCH3¡Û¡ÚEdelfosine¡Û |
25mg |
¡ï38,000 |
|
77286-66-9 |
|
|
|
¡¡ |
BML |
BML-L115-0005 |
1-O-Hexadecyl-2-O-eicosapentaenoyl-sn-glycero-3-phosphorylcholine |
5mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L115-0025 |
1-O-Hexadecyl-2-O-eicosapentaenoyl-sn-glycero-3-phosphorylcholine |
25mg |
¡ï94,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L116-0005 |
1-O-Hexadecyl-2-O-dihomo-¦Ã-linolenoyl-sn-glycero-3-phosphorylcholine |
5mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L116-0025 |
1-O-Hexadecyl-2-O-dihomo-¦Ã-linolenoyl-sn-glycero-3-phosphorylcholine |
25mg |
¡ï94,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L117-0005 |
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine |
5mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L117-0025 |
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine |
25mg |
¡ï94,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L119-0005 |
2-O-Ethyl-PAF ¡ÚE-PAF¡Û¡Ú1-O-Hexadecyl-2-O-ethyl-sn-glycero-3-phosphorylcholine¡Û |
5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L120-0005 |
Carbamyl-PAF ¡ÚC-PAF¡Û¡Ú1-O-Hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphorylcholine¡Û |
5mg |
¡ï19,000 |
|
91575-58-5 |
|
|
|
¡¡ |
BML |
BML-L120-0025 |
Carbamyl-PAF ¡ÚC-PAF¡Û¡Ú1-O-Hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphorylcholine¡Û |
25mg |
¡ï78,000 |
|
91575-58-5 |
|
|
|
¡¡ |
BML |
BML-L122-0001 |
bis(Methylthio)gliotoxin ¡ÚFR-49175¡Û |
1mg |
¡ï11,000 |
|
74149-38-5 |
|
|
|
¡¡ |
BML |
BML-L122-0005 |
bis(Methylthio)gliotoxin ¡ÚFR-49175¡Û |
5mg |
¡ï44,000 |
|
74149-38-5 |
|
|
|
¡¡ |
BML |
BML-L123-0001 |
(¡Þ)-trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane |
1mg |
¡ï10,000 |
|
116673-45-1 |
|
|
|
¡¡ |
BML |
BML-L123-0005 |
(¡Þ)-trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane |
5mg |
¡ï40,000 |
|
116673-45-1 |
|
|
|
¡¡ |
BML |
BML-L124-0001 |
(¡Þ)-cis-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane |
1mg |
¡ï6,000 |
|
116673-47-3 |
|
|
|
¡¡ |
BML |
BML-L124-0005 |
(¡Þ)-cis-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane |
5mg |
¡ï27,000 |
|
116673-47-3 |
|
|
|
¡¡ |
BML |
BML-L131-0005 |
Octylonium Bromide |
5mg |
¡ï10,000 |
|
26095-59-0 |
|
|
|
¡¡ |
BML |
BML-L131-0025 |
Octylonium Bromide |
25mg |
¡ï39,000 |
|
26095-59-0 |
|
|
|
¡¡ |
BML |
BML-L133-0010 |
PCA-4248 ¡ÚMethyl 2-(Phenylthio)ethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate¡Û |
10mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L133-0050 |
PCA-4248 ¡ÚMethyl 2-(Phenylthio)ethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate¡Û |
50mg |
¡ï76,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L134-0001 |
1-O-Palmitoyl-2-O-acetyl-sn-glycero-3-phosphorylcholine ¡Ú1-Acyl-PAF¡Û |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L134-0005 |
1-O-Palmitoyl-2-O-acetyl-sn-glycero-3-phosphorylcholine ¡Ú1-Acyl-PAF¡Û |
5mg |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-L135-0010 |
Ginkgolide B ¡ÚBN 52021¡Û |
10mg |
¡ï7,000 |
|
15291-77-7 |
|
|
|
¡¡ |
BML |
BML-L135-0050 |
Ginkgolide B ¡ÚBN 52021¡Û |
50mg |
¡ï29,000 |
|
15291-77-7] |
|
|
|
¡¡ |
BML |
BML-L137-0001 |
WEB-2086 ¡Ú4-(2-Chlorophenyl)-9-methyl-2-(3-morpholino-3-oxo-propyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine¡Û |
1mg |
¡ï10,000 |
|
105219-56-5 |
|
|
|
¡¡ |
BML |
BML-L137-0005 |
WEB-2086 ¡Ú4-(2-Chlorophenyl)-9-methyl-2-(3-morpholino-3-oxo-propyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine¡Û |
5mg |
¡ï42,000 |
|
105219-56-5 |
|
|
|
¡¡ |
BML |
BML-LA004-0050 |
Leukotriene A4 Methyl Ester ¡ÚLTA4-ME¡Û |
50ug |
¡ï23,000 |
|
73466-12-3 |
|
|
|
¡¡ |
BML |
BML-LA004-1000 |
Leukotriene A4 Methyl Ester ¡ÚLTA4-ME¡Û |
1mg |
¡ï306,000 |
|
73466-12-3 |
|
|
|
¡¡ |
BML |
BML-LB003-0050 |
Leukotriene B3 ¡ÚLTB3¡Û |
50ug |
¡ï38,000 |
|
88099-35-8 |
|
|
|
¡¡ |
BML |
BML-LB004-0050 |
Leukotriene B4 ¡ÚLTB4¡Û¡Ú5,12-Dihydroxy-[S-[R*,S*-(E,Z,Z,E)]]-6,8,10,14-eicosatetraenoic Acid¡Û |
50ug |
¡ï33,000 |
|
71160-24-2 |
|
|
|
¡¡ |
BML |
BML-LB004-1000 |
Leukotriene B4 ¡ÚLTB4¡Û¡Ú5,12-Dihydroxy-[S-[R*,S*-(E,Z,Z,E)]]-6,8,10,14-eicosatetraenoic Acid¡Û |
1mg |
¡ï430,000 |
|
71160-24-2 |
|
|
|
¡¡ |
BML |
BML-LB005-0050 |
Leukotriene B5 ¡ÚLTB5¡Û |
50ug |
¡ï42,000 |
|
88763-92-9 |
|
|
|
¡¡ |
BML |
BML-LB014-0050 |
14,15-Dehydro-Leukotriene B4 ¡Ú14,15-Dehydro-LTB4¡Û |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LB504-0050 |
Leukotriene B4-6,7,14,15-d4 ¡ÚLTB4-d4¡Û |
50ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LB704-0050 |
Leukotriene B4-3-Aminopropylamide ¡ÚLTB4-APA¡Û |
50ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LC004-0050 |
Leukotriene C4 ¡ÚLTC4¡Û¡Ú5S-Hydroxy-6R-(S-glutathionyl)-7E,9E,11Z,14Z-eicosatetraenoic Acid¡Û |
50ug |
¡ï31,000 |
|
72025-60-6 |
|
|
|
¡¡ |
BML |
BML-LD004-0050 |
Leukotriene D4 ¡ÚLTD4¡Û |
50ug |
¡ï30,000 |
|
73836-78-9 |
|
|
|
¡¡ |
BML |
BML-LD004-1000 |
Leukotriene D4 ¡ÚLTD4¡Û |
1mg |
¡ï372,000 |
|
73836-78-9 |
|
|
|
¡¡ |
BML |
BML-LE004-0050 |
Leukotriene E4 ¡ÚLTE4¡Û |
50ug |
¡ï26,000 |
|
75715-89-8 |
|
|
|
¡¡ |
BML |
BML-LE004-1000 |
Leukotriene E4 ¡ÚLTE4¡Û |
1mg |
¡ï340,000 |
|
75715-89-8 |
|
|
|
¡¡ |
BML |
BML-LE009-0050 |
Leukotoxin A ¡Ú9,10-EODE¡Û¡Ú9(10)-EpOME¡Û¡Ú(¡Þ)9,10-Epoxyoctadec-12Z-enoic Acid¡Û |
50ug |
¡ï9,000 |
|
6814-52-4 |
|
|
|
¡¡ |
BML |
BML-LE009-1000 |
Leukotoxin A ¡Ú9,10-EODE¡Û¡Ú9(10)-EpOME¡Û¡Ú(¡Þ)9,10-Epoxyoctadec-12Z-enoic Acid¡Û |
1mg |
¡ï105,000 |
|
6814-52-4 |
|
|
|
¡¡ |
BML |
BML-LE012-0050 |
Leukotoxin B ¡Ú12,13-EODE¡Û¡Ú12(13)-EpOME¡Û¡Ú(¡Þ)12,13-Epoxyoctadec-9Z-enoic Acid¡Û |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LE504-0050 |
Leukotriene E4-20,20,20-d3 ¡ÚLTE4-d3¡Û |
50ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LEA004-0050 |
N-Acetyl-Leukotriene E4 ¡ÚN-Ac-LTE4¡Û |
50ug |
¡ï31,000 |
|
80115-95-3 |
|
|
|
¡¡ |
BML |
BML-LG6030-0100 |
Laminin B chain(human placenta)[DG10], mouse mAb, purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DG10 | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-LP100-0005 |
Lysophosphatidic Acid ¡Ú1-Oleoyl-2-hydroxy-sn-glycerol-3-phosphate, Na salt¡Û |
5mg |
¡ï8,000 |
|
22556-62-3 |
|
|
|
¡¡ |
BML |
BML-LP100-0025 |
Lysophosphatidic Acid ¡Ú1-Oleoyl-2-hydroxy-sn-glycerol-3-phosphate, Na salt¡Û |
25mg |
¡ï30,000 |
|
22556-62-3 |
|
|
|
¡¡ |
BML |
BML-LP101-0001 |
L-NASPA ¡ÚN-Palmitoyl-L-serine Phosphoric Acid¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP101-0005 |
L-NASPA ¡ÚN-Palmitoyl-L-serine Phosphoric Acid¡Û |
5mg |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP102-0010 |
(¡Þ)-Lisofylline ¡Ú(¡Þ)-1-(5-Hydroxyhexyl)-3,7-dimethylxanthine¡Û |
10mg |
¡ï10,000 |
|
6493-06-7 |
|
|
|
¡¡ |
BML |
BML-LP102-0050 |
(¡Þ)-Lisofylline ¡Ú(¡Þ)-1-(5-Hydroxyhexyl)-3,7-dimethylxanthine¡Û |
50mg |
¡ï40,000 |
|
6493-06-7 |
|
|
|
¡¡ |
BML |
BML-LP103-0100 |
Phosphatidic Acid, Dipalmitoyl ¡ÚDipalmitoylphosphatidic Acid¡Û¡Ú1,2-Dipalmitoyl-sn-glycero-3-phosphate, Na salt¡Û¡ÚDPPA¡Û |
100mg |
¡ï12,000 |
|
71065-87-7 |
|
|
|
¡¡ |
BML |
BML-LP103-0500 |
Phosphatidic Acid, Dipalmitoyl ¡ÚDipalmitoylphosphatidic Acid¡Û¡Ú1,2-Dipalmitoyl-sn-glycero-3-phosphate, Na salt¡Û¡ÚDPPA¡Û |
500mg |
¡ï51,000 |
|
71065-87-7 |
|
|
|
¡¡ |
BML |
BML-LP104-0010 |
Phosphatidic Acid, Dioleoyl ¡ÚDioleoylphosphatidic Acid¡Û¡Ú1,2-Dioleyoyl-sn-glycero-3-phosphate, Na salt¡Û |
10mg |
¡ï11,000 |
|
108392-02-5 |
|
|
|
¡¡ |
BML |
BML-LP105-0005 |
Dodecylphosphate |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP105-0025 |
Dodecylphosphate |
25mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP106-0010 |
SEW-2871 ¡Ú5-[4-Phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole¡Û |
10mg |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP106-0050 |
SEW-2871 ¡Ú5-[4-Phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole¡Û |
50mg |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP107-0001 |
N-Arachidonoyl Phosphatidylethanolamine ¡ÚDipalmitoyl-N-arachidonoyl Phosphatidylethanolamine¡Û¡ÚNAPE¡Û¡ÚNARPE¡Û |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP107-0005 |
N-Arachidonoyl Phosphatidylethanolamine ¡ÚDipalmitoyl-N-arachidonoyl Phosphatidylethanolamine¡Û¡ÚNAPE¡Û¡ÚNARPE¡Û |
5mg |
¡ï60,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP108-0001 |
N-Palmitoyl Phosphatidylethanolamine ¡ÚC16:0 NAPE¡Û¡ÚNPPE¡Û |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LP108-0005 |
N-Palmitoyl Phosphatidylethanolamine ¡ÚC16:0 NAPE¡Û¡ÚNPPE¡Û |
5mg |
¡ï59,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LPA004-0050 |
14,15-Leukotriene A4 Methyl Ester ¡Ú14,15-LTA4 ME¡Û |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LPA004-1000 |
14,15-Leukotriene A4 Methyl Ester ¡Ú14,15-LTA4 ME¡Û |
1mg |
¡ï297,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LPC004-0050 |
14,15-Leukotriene C4 ¡Ú14,15-LTC4¡Û |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LPD004-0050 |
14,15-Leukotriene D4 ¡Ú14,15-LTD4¡Û |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-LPE004-0050 |
14,15-Leukotriene E4 ¡Ú14,15-LTE4¡Û |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-MA1198-0025 |
Motilin(pig, natural), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-MA1366-0025 |
ERK1/ERK2(phosphorylated)¡ÚMAP Kinases¡Û¡ÚExtracellular Signal-Regulated Kinases¡Û(peptide, motif pThr-Glu-pTyr)[AMK1], mouse mAb, purified |
25ug |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | AMK1 | activated mammalian | WB |
|
|
¡¡ |
BML |
BML-MZ1111-0050 |
a-Melanocyte Stimulating Hormone ¡Úa-MSH¡Û(synthetic peptide), rabbit pAb, purified |
50ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | IHC(PS) |
|
|
¡¡ |
BML |
BML-N110-0005 |
ENMD-1068 |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N110-0025 |
ENMD-1068 |
25mg |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N140-0010 |
Bilobalide |
10mg |
¡ï8,000 |
|
33570-04-6 |
|
|
|
¡¡ |
BML |
BML-N140-0050 |
Bilobalide |
50mg |
¡ï35,000 |
|
33570-04-6 |
|
|
|
¡¡ |
BML |
BML-N155-0001 |
MMTC ¡Ú1-Methyl-6-methoxy-1,2,3,4-tetrahydro-B-carboline¡Û |
1mg |
¡ï8,000 |
|
1210-56-6 |
|
|
|
¡¡ |
BML |
BML-N156-0005 |
Bourgeonal ¡Ú4-tert-Butylbenzenepropionaldehyde¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N156-0025 |
Bourgeonal ¡Ú4-tert-Butylbenzenepropionaldehyde¡Û |
25mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N157-0001 |
Fipexide, HCI ¡Ú1-(1,3-Benzodioxol-5-yl-methyl)-4-[(4-chlorophenoxy)acetyl]piperazine, HCl¡Û |
1g |
¡ï3,000 |
|
34161-23-4 |
|
|
|
¡¡ |
BML |
BML-N158-0001 |
Clioquinol ¡Ú5-Chloro-7-iodo-8-quinolinol¡Û |
1g |
¡ï5,000 |
|
130-26-7 |
|
|
|
¡¡ |
BML |
BML-N158-0005 |
Clioquinol ¡Ú5-Chloro-7-iodo-8-quinolinol¡Û |
5g |
¡ï14,000 |
|
130-26-7 |
|
|
|
¡¡ |
BML |
BML-N159-0001 |
Gambogic Amide |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N159-0005 |
Gambogic Amide |
5mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-N160-0005 |
P7C3 ¡Ú1-(3,6-Dibromocarbazol-9-yl)-3-phenylaminopropan-2-ol Dihydrate¡Û |
5mg |
¡ï9,000 |
|
301353-96-8 |
|
|
|
¡¡ |
BML |
BML-N701-0050 |
U-50488 ¡Útrans-(¡Þ)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide, HCl¡Û |
50mg |
¡ï25,000 |
|
67198-13-4 |
|
|
|
¡¡ |
BML |
BML-N705-0005 |
U-69593 ¡ÚN-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-, [5a,7a,8b]-(+)-benzeneacetamide¡Û |
5mg |
¡ï11,000 |
|
96744-75-1 |
|
|
|
¡¡ |
BML |
BML-N705-0025 |
U-69593 ¡ÚN-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-, [5a,7a,8b]-(+)-benzeneacetamide¡Û |
25mg |
¡ï47,000 |
|
96744-75-1 |
|
|
|
¡¡ |
BML |
BML-NA103-0050 |
Benzamyl, HCl ¡ÚBenzylamiloride, HCl¡Û¡ÚN-(Benzylamidino)-3,5-diamino-6-chloropyrazinecarboxamide, HCl¡Û |
50mg |
¡ï19,000 |
|
2898-76-2 |
|
|
|
¡¡ |
BML |
BML-NA106-0050 |
ATX II(recombinant) |
50ug |
¡ï39,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-NA116-0020 |
SDZ-201 106(+/-)¡Ú4-(3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy)-1H-indol-2-carbonitrile¡Û¡ÚDPI-201106¡Û |
20mg |
¡ï5,000 |
|
97730-95-5 |
|
|
|
·àʪ |
BML |
BML-NA116-0100 |
SDZ-201 106(+/-)¡Ú4-(3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy)-1H-indol-2-carbonitrile¡Û¡ÚDPI-201106¡Û |
100mg |
¡ï25,000 |
|
97730-95-5 |
|
|
|
·àʪ |
BML |
BML-NA117-0005 |
SDZ-201 106(+)¡Ú(R)-4-(3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy)-1H-indol-2-carbonitrile¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-NA118-0005 |
SDZ-201 106(-)¡Ú(S)-4-(3-(4-Diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy)-1H-indol-2-carbonitrile¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NA120-0001 |
Tetrodotoxin ¡ÚTTX¡Û¡ÚFugu poison¡Û |
1mg |
¡ï26,000 |
|
4368-28-9 |
|
|
|
¡¡ |
BML |
BML-NA1215-0050 |
Neurofilament H ¡ÚNF H¡Û(human)[BE8], mouse mAb, purified |
50ul |
¡ï19,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | BE8 | human¡¢ rat¡¢ monkey¡¢ pig | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1216-0050 |
Neurofilament M ¡ÚNF M¡Û(primate, 150kDa), rabbit pAb(neat serum) |
50ul |
¡ï18,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1216-0100 |
Neurofilament M ¡ÚNF M¡Û(primate, 150kDa), rabbit pAb(neat serum) |
100ul |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1223-0100 |
Neurofilament Triplet Proteins ¡Úpan-Neurofilaments¡Û(human spinal cord) [13AA], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 13AA | human¡¢ mouse¡¢ rat¡¢ other mammalian | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1225-0100 |
Neurofilament L&H ¡ÚNF L & NF-H¡Û(human spinal cord) [14BA], mouse mAb, purified |
100ul |
¡ï24,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 14BA | human¡¢ mouse¡¢ rat¡¢ other mammalian | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1230-0025 |
Neurotensin(peptide), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-NA1230-0100 |
Neurotensin(peptide), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-NA1233-0025 |
Neuropeptide Tyrosine ¡ÚNeuropeptide Y¡Û¡ÚNPY¡Û(pig, peptide), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1233-0100 |
Neuropeptide Tyrosine ¡ÚNeuropeptide Y¡Û¡ÚNPY¡Û(pig, peptide), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1235-0025 |
Neuropeptide Tyrosine Precursor ¡ÚNeuropeptide Y Precursor¡Û¡ÚNPY Precursor¡Û(peptide)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ baboon¡¢ cat | IHC |
|
|
¡¡ |
BML |
BML-NA1235-0100 |
Neuropeptide Tyrosine Precursor ¡ÚNeuropeptide Y Precursor¡Û¡ÚNPY Precursor¡Û(peptide)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ baboon¡¢ cat | IHC |
|
|
¡¡ |
BML |
BML-NA1247-0025 |
Neuron Specific Enolase ¡Ú¦Ã,¦Ã'-enolase¡Û¡ÚNSE¡Û(human, aa 269-286), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1247-0100 |
Neuron Specific Enolase ¡Ú¦Ã,¦Ã'-enolase¡Û¡ÚNSE¡Û(human, aa 269-286), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA125-0010 |
Veratridine |
10mg |
¡ï16,000 |
|
71-62-5 |
|
|
|
¡¡ |
BML |
BML-NA1300-0025 |
Neurogranin ¡ÚBICKS¡Û¡ÚRC3¡Û¡Úp17¡Û¡ÚNg¡Û(rat, aa 9-25), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ goat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA1300-0100 |
Neurogranin ¡ÚBICKS¡Û¡ÚRC3¡Û¡Úp17¡Û¡ÚNg¡Û(rat, aa 9-25), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ goat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA134-0100 |
QX-314 ¡ÚN-(2,6-Dimethylphenyl)acetamide-2-triethylammonium Bromide¡Û |
100mg |
¡ï8,000 |
|
21306-56-9 |
|
|
|
¡¡ |
BML |
BML-NA135-0001 |
Grayanotoxin III ¡ÚAndromedol¡Û |
1mg |
¡ï9,000 |
|
4678-45-9 |
|
|
|
¡¡ |
BML |
BML-NA136-0050 |
Kavain(+/-)¡Ú(¡Þ)-4-Methoxy-6-styryl-5,6-dihydro-a-pyrone¡Û |
50mg |
¡ï8,000 |
|
500-64-1 |
|
|
|
¡¡ |
BML |
BML-NA136-0250 |
Kavain(+/-)¡Ú(¡Þ)-4-Methoxy-6-styryl-5,6-dihydro-a-pyrone¡Û |
250mg |
¡ï32,000 |
|
500-64-1 |
|
|
|
¡¡ |
BML |
BML-NA138-0020 |
Riluzole ¡Ú2-Amino-6-(trifluoromethoxy)benzothiazole¡Û¡Ú6-(Trifluoromethoxy)-2-benzothiazolamine¡Û |
20mg |
¡ï7,000 |
|
1744-22-5 |
|
|
|
¡¡ |
BML |
BML-NA138-0100 |
Riluzole ¡Ú2-Amino-6-(trifluoromethoxy)benzothiazole¡Û¡Ú6-(Trifluoromethoxy)-2-benzothiazolamine¡Û |
100mg |
¡ï30,000 |
|
1744-22-5 |
|
|
|
¡¡ |
BML |
BML-NA139-0001 |
Bupivacaine ¡Ú1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, HCl¡Û |
1g |
¡ï7,000 |
|
14252-80-3 |
|
|
|
¡¡ |
BML |
BML-NA140-0005 |
PD 85639 ¡Úa-Phenyl-N-(3-(2,6-dimethyl-1-piperizinyl)alphapropyl)benzeneacetamide¡Û |
5mg |
¡ï13,000 |
|
150034-24-5 |
|
|
|
¡¡ |
BML |
BML-NA140-0025 |
PD 85639 ¡Úa-Phenyl-N-(3-(2,6-dimethyl-1-piperizinyl)alphapropyl)benzeneacetamide¡Û |
25mg |
¡ï45,000 |
|
150034-24-5 |
|
|
|
¡¡ |
BML |
BML-NA141-0010 |
Batrachotoxin ¡ÚBTX¡Û |
10ug |
¡ï30,000 |
|
23509-16-2 |
|
|
|
¡¡ |
BML |
BML-NA142-0010 |
A-803467 ¡Ú5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide¡Û |
10mg |
¡ï10,000 |
|
944261-79-4 |
|
|
|
¡¡ |
BML |
BML-NA142-0050 |
A-803467 ¡Ú5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide¡Û |
50mg |
¡ï43,000 |
|
944261-79-4 |
|
|
|
¡¡ |
BML |
BML-NA143-0010 |
Lorcainide, HCl ¡ÚN-(4-Chlorophenyl)-N-[1-(1-isopropyl)-4-piperidinyl]phenylacetamide, HCl¡Û |
10mg |
¡ï10,000 |
|
58934-46-6 |
|
|
|
¡¡ |
BML |
BML-NA143-0050 |
Lorcainide, HCl ¡ÚN-(4-Chlorophenyl)-N-[1-(1-isopropyl)-4-piperidinyl]phenylacetamide, HCl¡Û |
50mg |
¡ï39,000 |
|
58934-46-6 |
|
|
|
¡¡ |
BML |
BML-NA144-0005 |
Tetracaine, HCl ¡Ú4-(Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester, HCl ¡Û |
5g |
¡ï4,000 |
|
136-47-0 |
|
|
|
¡¡ |
BML |
BML-NA144-0025 |
Tetracaine, HCl ¡Ú4-(Butylamino)benzoic Acid 2-(Dimethylamino)ethyl Ester, HCl ¡Û |
25g |
¡ï7,000 |
|
136-47-0 |
|
|
|
¡¡ |
BML |
BML-NA1501-0100 |
Neuron Specific Enolase ¡ÚNSE¡Û¡Ú¦Ã,¦Ã¡Ç-enolase¡Û [NSE47], mouse mAb, purified |
100ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | NSE47 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB(~76kDa)¡¢ ELISA |
|
|
¡¡ |
BML |
BML-NA1501-0500 |
Neuron Specific Enolase ¡ÚNSE¡Û¡Ú¦Ã,¦Ã¡Ç-enolase¡Û [NSE47], mouse mAb, purified |
500ul |
¡ï40,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | NSE47 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB(~76kDa)¡¢ ELISA |
|
|
¡¡ |
BML |
BML-NA4300-0025 |
Neurokinin-1 Receptor ¡ÚNK1R¡Û¡ÚSubstance P Receptor¡Û(rat, aa 393-407)(CT), rabbit pAb(antiserum)(specificity: rat) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC |
|
|
¡¡ |
BML |
BML-NA4400-0025 |
Neurokinin-1 Receptor ¡ÚNK1r¡Û¡ÚSubstance P Receptor¡Û(human, aa 393-407), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NA4400-0100 |
Neurokinin-1 Receptor ¡ÚNK1r¡Û¡ÚSubstance P Receptor¡Û(human, aa 393-407), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-NG1931-0100 |
N-Ethylmaleimide-Sensitive Fusion Protein ¡ÚNSF¡Û(human)(recombinant)[NSF1], mouse mAb, Affinity-purified |
100ug |
¡ï35,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | NSF1 | human¡¢ mouse¡¢ rat¡¢ bovine | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NH100-0005 |
Amthamine ¡Ú2-Amino-4-methylthiazole-5-ethanamine, 2HBr¡Û |
5mg |
¡ï11,000 |
|
142437-67-0 |
|
|
|
¡¡ |
BML |
BML-NH101-0010 |
Astemizole ¡Ú1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine¡Û |
10mg |
¡ï9,000 |
|
68844-77-9 |
|
|
|
¡¡ |
BML |
BML-NH101-0050 |
Astemizole ¡Ú1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine¡Û |
50mg |
¡ï36,000 |
|
68844-77-9 |
|
|
|
¡¡ |
BML |
BML-NH102-0100 |
Dimaprit ¡ÚS-(3-Dimethylaminopropyl)isothiourea, 2HCl¡Û |
100mg |
¡ï22,000 |
|
23256-33-9 |
|
|
|
¡¡ |
BML |
BML-NH103-0010 |
HTMT ¡Ú6-[2-(4-Imidazolyl)ethylamino]-N-(4-trifluoromethylphenyl)heptanecarboxamide, Dimaleate¡Û |
10mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NH104-0010 |
R(-)-a-Methylhistamine, 2HBr ¡ÚHistamine,(R)-(-)-a-Methyl-, 2HBr¡Û |
10mg |
¡ï21,000 |
|
75614-87-8 |
|
|
|
¡¡ |
BML |
BML-NH105-0010 |
Thioperamide, Maleate ¡ÚN-Cyclohexyl-4-(imidazol-4-yl)-1-piperidinecarbothioamide, Maleate¡Û |
10mg |
¡ï12,000 |
|
106243-16-7 |
|
|
|
¡¡ |
BML |
BML-NH105-0050 |
Thioperamide, Maleate ¡ÚN-Cyclohexyl-4-(imidazol-4-yl)-1-piperidinecarbothioamide, Maleate¡Û |
50mg |
¡ï50,000 |
|
106243-16-7 |
|
|
|
¡¡ |
BML |
BML-NH106-0001 |
Ketotifen, Fumarate ¡Ú4-(1-Methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-10(9H)-one Fumarate¡Û |
1g |
¡ï8,000 |
|
34580-14-8 |
|
|
|
·àʪ |
BML |
BML-NH107-0010 |
Levocabastine, HCI |
10mg |
¡ï24,000 |
|
79547-78-7 |
|
|
|
¡¡ |
BML |
BML-NH108-0100 |
Azelastine, HCl ¡Ú4-(p-Chlorobenzyl)-2-(N-methylperhydroazepin-4-yl)-1(2H)-phthalazinone¡Û |
100mg |
¡ï9,000 |
|
79307-93-0 |
|
|
|
¡¡ |
BML |
BML-NH112-0010 |
Dimebon, 2HCl ¡Ú2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole, 2HCl¡Û |
10mg |
¡ï22,000 |
|
97657-92-6 |
|
|
|
¡¡ |
BML |
BML-NH112-0050 |
Dimebon, 2HCl ¡Ú2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole, 2HCl¡Û |
50mg |
¡ï87,000 |
|
97657-92-6 |
|
|
|
¡¡ |
BML |
BML-NK100-0001 |
Resiniferatoxin ¡ÚRTX¡Û(Isolated from Euphorbia poisonii) |
1mg |
¡ï15,000 |
|
57444-62-9 |
|
|
|
¡¡ |
BML |
BML-NK100-0005 |
Resiniferatoxin ¡ÚRTX¡Û(Isolated from Euphorbia poisonii) |
5mg |
¡ï58,000 |
|
57444-62-9 |
|
|
|
¡¡ |
BML |
BML-NK103-0010 |
L-732,138 ¡ÚN-Acetyl-L-tryptophan-3,5-bis(trifluoromethyl)Benzyl Ester¡Û |
10mg |
¡ï14,000 |
|
148451-96-1 |
|
|
|
¡¡ |
BML |
BML-NK103-0050 |
L-732,138 ¡ÚN-Acetyl-L-tryptophan-3,5-bis(trifluoromethyl)Benzyl Ester¡Û |
50mg |
¡ï54,000 |
|
148451-96-1 |
|
|
|
¡¡ |
BML |
BML-NK104-0001 |
HOE-140 ¡ÚIcatibant¡Û |
1mg |
¡ï29,000 |
|
130308-48-4 |
|
|
|
¡¡ |
BML |
BML-NL3720-0025 |
N-Ethylmaleimide-Sensitive Fusion Protein ¡ÚNSF¡Û(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ bovine | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NL3720-0100 |
N-Ethylmaleimide-Sensitive Fusion Protein ¡ÚNSF¡Û(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ bovine | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NL3750-0025 |
Neuronal Ca2+ Sensor-1 ¡ÚNCS-1¡Û¡ÚFrequenin¡Û(rat)(recombinant), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NL3750-0100 |
Neuronal Ca2+ Sensor-1 ¡ÚNCS-1¡Û¡ÚFrequenin¡Û(rat)(recombinant), rabbit pAb(neat serum) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NL3770-0025 |
Neurocalcin ¦Ä ¡ÚNCALD¡Û¡ÚVILIP-3¡Û(rat)(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NL3770-0100 |
Neurocalcin ¦Ä ¡ÚNCALD¡Û¡ÚVILIP-3¡Û(rat)(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-NO102-0010 |
Naloxonazine, 2HCl ¡Úbis-[5-a-4,5-Epoxy-3-14-dihydroxy-17-(2-propenyl)morphan-6-ylidene]hydrazine, 2HCl¡Û |
10mg |
¡ï12,000 |
|
82824-01-9 |
|
|
|
¡¡ |
BML |
BML-NO103-0100 |
Carbetapentane, Citrate ¡ÚPentoxyverine¡Û |
100mg |
¡ï5,000 |
|
77-23-6 |
|
|
|
¡¡ |
BML |
BML-NO103-0500 |
Carbetapentane, Citrate ¡ÚPentoxyverine¡Û |
500mg |
¡ï23,000 |
|
77-23-6 |
|
|
|
¡¡ |
BML |
BML-NO104-0010 |
4-Phenyl-1-(4-phenylbutyl)piperidine, Maleate |
10mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NO105-0010 |
BD 1008 ¡ÚN-[2-(3,4-Dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine, 2HBr¡Û |
10mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NO107-0010 |
PRE-084 ¡Ú2-(4-Morpholinethyl)-1-phenylcyclohexanecarboxylate, HCl¡Û |
10mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NO110-0100 |
Nalmefene, HCl ¡Ú(5a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol¡Û |
100mg |
¡ï11,000 |
|
58895-64-0 |
|
|
|
¡¡ |
BML |
BML-NO110-0500 |
Nalmefene, HCl ¡Ú(5a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol¡Û |
500mg |
¡ï45,000 |
|
58895-64-0 |
|
|
|
¡¡ |
BML |
BML-NO490-0010 |
1-(4-Iodophenyl)-3-(1-adamantyl)guanidine |
10mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NP1413-0100 |
Neurogranin Peptide, Blocking Peptide for Neurogranin pAb(Prod. No. BML-NA1300) |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NP1442-0100 |
Neurokinin-1 Receptor(rat, aa 393-407)C-terminal Pentadecapeptide, Blocking Peptide for Neurokinin-1 receptor pAb(Prod. No. BML-NA4200) |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NP1444-0100 |
Neurokinin-1 Receptor Peptide ¡ÚNK1r¡Û(human, aa 393-407), Blocking Peptide for Neurokinin-1 receptor(human)pAb(Prod. No. BML-NA4400) |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NP1450-0050 |
Neuron Specific Enolase ¡ÚNSE¡Û¡Ú¦Ã,¦Ã'-Enolase¡Û(human), purified |
50ug |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NS085-0010 |
CGS 12066B, Dimaleate ¡Ú7-Trifluoromethyl-4-(4-methyl-1-piperazinyl)pyrrolo-(1,2-a)quinoxaline, Maleate¡Û |
10mg |
¡ï14,000 |
|
109028-10-6 |
|
|
|
¡¡ |
BML |
BML-NS100-0005 |
Anpirtoline ¡ÚD-16949¡Û¡Ú6-Chloro-2-[piperidinyl-4-thio]pyridine, HCl¡Û |
5mg |
¡ï15,000 |
|
98330-05-3 |
|
|
|
¡¡ |
BML |
BML-NS100-0025 |
Anpirtoline ¡ÚD-16949¡Û¡Ú6-Chloro-2-[piperidinyl-4-thio]pyridine, HCl¡Û |
25mg |
¡ï59,000 |
|
98330-05-3 |
|
|
|
·àʪ |
BML |
BML-NS101-0005 |
3-(4-Allylpiperazin-1-yl)-2-quinoxalinecarbonitrile |
5mg |
¡ï12,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-NS101-0025 |
3-(4-Allylpiperazin-1-yl)-2-quinoxalinecarbonitrile |
25mg |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NS102-0010 |
Cinanserin ¡ÚN-[2-[[3-(Dimethylamino)propyl]thio]phenyl]-3-phenyl-2-propenamide¡Û |
10mg |
¡ï17,000 |
|
1166-34-3 |
|
|
|
¡¡ |
BML |
BML-NS104-0010 |
AMI-193 ¡Ú8-[3-(4-Fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one¡Û |
10mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NS105-0005 |
Clozapine N-Oxide |
5mg |
¡ï11,000 |
|
34233-69-7 |
|
|
|
¡¡ |
BML |
BML-NS105-0025 |
Clozapine N-Oxide |
25mg |
¡ï44,000 |
|
34233-69-7 |
|
|
|
¡¡ |
BML |
BML-NS106-0005 |
N-Desmethyl Clozapine |
5mg |
¡ï10,000 |
|
6104-71-8 |
|
|
|
¡¡ |
BML |
BML-NS106-0025 |
N-Desmethyl Clozapine |
25mg |
¡ï42,000 |
|
6104-71-8 |
|
|
|
¡¡ |
BML |
BML-NS107-0100 |
Dibenzepine, HCl |
100mg |
¡ï7,000 |
|
315-80-0 |
|
|
|
¡¡ |
BML |
BML-NS107-0500 |
Dibenzepine, HCl |
500mg |
¡ï30,000 |
|
315-80-0 |
|
|
|
¡¡ |
BML |
BML-NS108-0200 |
Dihydroergocristine, Mesylate |
200mg |
¡ï6,000 |
|
24730-10-7 |
|
|
|
¡¡ |
BML |
BML-NS108-1000 |
Dihydroergocristine, Mesylate |
1g |
¡ï27,000 |
|
24730-10-7 |
|
|
|
¡¡ |
BML |
BML-NS109-0020 |
Fluperlapine ¡Ú3-Fluoro-6-(4-methyl-1-piperazinyl)-11H-dibenz[b,e]azepine¡Û |
20mg |
¡ï14,000 |
|
67121-76-0 |
|
|
|
¡¡ |
BML |
BML-NS109-0100 |
Fluperlapine ¡Ú3-Fluoro-6-(4-methyl-1-piperazinyl)-11H-dibenz[b,e]azepine¡Û |
100mg |
¡ï32,000 |
|
67121-76-0 |
|
|
|
¡¡ |
BML |
BML-NS111-0050 |
Bupropion, HCl ¡Ú(¡Þ)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone, HCl¡Û |
50mg |
¡ï8,000 |
|
31677-93-7 |
|
|
|
¡¡ |
BML |
BML-NS111-0250 |
Bupropion, HCl ¡Ú(¡Þ)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone, HCl¡Û |
250mg |
¡ï36,000 |
|
31677-93-7 |
|
|
|
¡¡ |
BML |
BML-NS112-0010 |
Citalopram, HBr ¡Ú1-[3-Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, HBr¡Û |
10mg |
¡ï10,000 |
|
59729-32-7 |
|
|
|
¡¡ |
BML |
BML-NS112-0050 |
Citalopram, HBr ¡Ú1-[3-Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, HBr¡Û |
50mg |
¡ï40,000 |
|
59729-32-7 |
|
|
|
¡¡ |
BML |
BML-NS114-0010 |
Venlafaxine, HCl ¡ÚWY-45030¡Û¡Ú(¡Þ)-1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, HCl¡Û |
10mg |
¡ï8,000 |
|
99300-78-4 |
|
|
|
¡¡ |
BML |
BML-NS114-0050 |
Venlafaxine, HCl ¡ÚWY-45030¡Û¡Ú(¡Þ)-1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, HCl¡Û |
50mg |
¡ï35,000 |
|
99300-78-4 |
|
|
|
¡¡ |
BML |
BML-NS115-0010 |
Sertraline, HCl ¡ÚCP-51974¡Û¡Ú(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine, HCl¡Û |
10mg |
¡ï8,000 |
|
79559-97-0 |
|
|
|
¡¡ |
BML |
BML-NS115-0050 |
Sertraline, HCl ¡ÚCP-51974¡Û¡Ú(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine, HCl¡Û |
50mg |
¡ï33,000 |
|
79559-97-0 |
|
|
|
¡¡ |
BML |
BML-NS140-0050 |
Fluoxetine, HCl ¡Ú(¡Þ)-N-Methyl-¦Ã-[4-(trifluoromethyl)phenoxy]benzenepropanamine, HCl¡Û |
50mg |
¡ï8,000 |
|
56296-78-7 |
|
|
|
¡¡ |
BML |
BML-NS140-0250 |
Fluoxetine, HCl ¡Ú(¡Þ)-N-Methyl-¦Ã-[4-(trifluoromethyl)phenoxy]benzenepropanamine, HCl¡Û |
250mg |
¡ï25,000 |
|
56296-78-7 |
|
|
|
¡¡ |
BML |
BML-NS145-0010 |
Ondansteron ¡Ú1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1Himidazol-1-ylmethyl]-4H-carbazol-4-one¡Û |
10mg |
¡ï10,000 |
|
99614-02-5 |
|
|
|
¡¡ |
BML |
BML-NS145-0050 |
Ondansteron ¡Ú1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-ylmethyl]-4H-carbazol-4-one¡Û |
50mg |
¡ï41,000 |
|
99614-02-5 |
|
|
|
¡¡ |
BML |
BML-NS515-0050 |
Ketanserin, Tartrate |
50mg |
¡ï13,000 |
|
74050-98-9 |
|
|
|
¡¡ |
BML |
BML-NS520-0001 |
Melatonin ¡ÚN-Acetyl-5-methoxytryptamine¡Û |
1g |
¡ï6,000 |
|
73-31-4 |
|
|
|
¡¡ |
BML |
BML-NS530-0050 |
MDL-72222 ¡Ú3-Tropanyl-3,5-dichlorobenzoate¡Û |
50mg |
¡ï22,000 |
|
40796-97-2 |
|
|
|
¡¡ |
BML |
BML-NS531-1000 |
Mesoridazine, Besylate ¡Ú10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine Benzenesulfonate¡Û |
1g |
¡ï3,000 |
|
32672-69-8 |
|
|
|
¡¡ |
BML |
BML-NS550-0020 |
N-Methylquipazine, Dimaleate ¡Ú2-[1-(4-Methyl)piperazinyl]quinoline, Dimaleates¡Û |
20mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NS560-0010 |
(¡Þ)-a-Methylserotonin, Maleate |
10mg |
¡ï14,000 |
|
304-52-9 |
|
|
|
¡¡ |
BML |
BML-NS560-0050 |
(¡Þ)-a-Methylserotonin, Maleate |
50mg |
¡ï55,000 |
|
304-52-9 |
|
|
|
¡¡ |
BML |
BML-NS570-0010 |
2-Methylserotonin, HCl |
10mg |
¡ï13,000 |
|
78263-90-8 |
|
|
|
¡¡ |
BML |
BML-NS570-0050 |
2-Methylserotonin, HCl |
50mg |
¡ï66,000 |
|
78263-90-8 |
|
|
|
¡¡ |
BML |
BML-NS640-0050 |
NAN-190 ¡Ú1-(2-Methoxyphenyl)-4-(4-phthalimidobutyl)piperazine, HBr¡Û |
50mg |
¡ï15,000 |
|
115338-32-4 |
|
|
|
¡¡ |
BML |
BML-NS660-0020 |
1-(1-Naphthyl)piperazine, HCl |
20mg |
¡ï6,000 |
|
57536-86-4 |
|
|
|
¡¡ |
BML |
BML-NS660-0100 |
1-(1-Naphthyl)piperazine, HCl |
100mg |
¡ï27,000 |
|
57536-86-4 |
|
|
|
¡¡ |
BML |
BML-NS705-0010 |
ORG-12962 ¡Ú1-[6-Chloro-5-trifluoromethyl)-2-pyridinyl]piperazine¡Û |
10mg |
¡ï11,000 |
|
210821-63-9 |
|
|
|
¡¡ |
BML |
BML-NS705-0050 |
ORG-12962 ¡Ú1-[6-Chloro-5-trifluoromethyl)-2-pyridinyl]piperazine¡Û |
50mg |
¡ï45,000 |
|
210821-63-9 |
|
|
|
¡¡ |
BML |
BML-NS710-0020 |
Paroxetine, HCl |
20mg |
¡ï9,000 |
|
110429-49-8 |
|
|
|
¡¡ |
BML |
BML-NS710-0100 |
Paroxetine, HCl |
100mg |
¡ï39,000 |
|
110429-49-8 |
|
|
|
¡¡ |
BML |
BML-NS740-0100 |
Pizotifen, Maleate |
100mg |
¡ï7,000 |
|
5189-11-7 |
|
|
|
¡¡ |
BML |
BML-NS740-0500 |
Pizotifen, Maleate |
500mg |
¡ï28,000 |
|
5189-11-7 |
|
|
|
¡¡ |
BML |
BML-NS830-0010 |
Spiroxatrine ¡ÚR 5188¡Û¡Ú(¡Þ)-8-[(2,3-Dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one¡Û |
10mg |
¡ï21,000 |
|
1054-88-2 |
|
|
|
¡¡ |
BML |
BML-NS835-0005 |
Thioridazine, HCl ¡Ú10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine, HCl¡Û |
5g |
¡ï3,000 |
|
130-61-0 |
|
|
|
¡¡ |
BML |
BML-NS901-0005 |
Y-25130 ¡ÚN-(1-Azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide, HCl¡Û |
5mg |
¡ï12,000 |
|
123040-16-4 |
|
|
|
¡¡ |
BML |
BML-NW8780-0500 |
NIP-(Leu)3-vinyl Sulfone ¡Ú4-Hydroxy-5-iodo-3-nitrophenylacetyl-L-leucyl-L-leucyl-L-leucinyl Vinyl Sulphone¡Û¡ÚNLVS¡Û |
500ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-NZ1112-0025 |
Neurotensin(peptide), rat pAb |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-NZ1113-0025 |
Neurotensin(peptide), rabbit pAb |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-NZ1115-0025 |
Neuropeptide Tyrosine ¡ÚNPY¡Û¡ÚNeuropeptide Y¡Û(pig, peptide 36aa), rat pAb, purified |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-P100-0001 |
CaM Kinase IV Substrate ¡ÚCa2+/Calmodulin-dependent Protein Kinase II¦Ã(345-358)¡Û¡ÚPeptide ¦Ã¡Û¡ÚCa2+/Calmodulin-dependent Protein Kinase IV Substrate¡Û¡ÚCAMKIV Substrate¡Û |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P101-0001 |
Autocamtide-2 [CaMK Substrates] |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P102-0001 |
Syntide-2 [CaMK Substrates] |
1mg |
¡ï19,000 |
|
108334-68-5 |
|
|
|
¡¡ |
BML |
BML-P103-0001 |
Casein Kinase II B(198-215)¡ÚCdk Substrate¡Û¡ÚCell-cycle Dependent Kinase Substrate¡Û |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P104-0500 |
CSH103 Substrate ¡Úp34cdc2(CDK1)Protein Kinase Substrate¡Û |
500ug |
¡ï11,000 |
|
135546-44-0 |
|
|
|
¡¡ |
BML |
BML-P106-0001 |
H1-7 ¡ÚHistone H1 Phosphorylation site¡Û¡ÚPKA Substrate¡Û¡ÚArg-Arg-Lys-Ala-Ser-Gly-Pro¡Û¡ÚRRKASGP¡Û |
1mg |
¡ï7,000 |
|
65189-70-0 |
|
|
|
¡¡ |
BML |
BML-P107-0001 |
Kemptide [Protein Kinase Substrate] |
1mg |
¡ï5,000 |
|
65189-71-1 |
|
|
|
¡¡ |
BML |
BML-P108-0001 |
Malantide [Protein Kinase Substrate] |
1mg |
¡ï13,000 |
|
86555-35-3 |
|
|
|
¡¡ |
BML |
BML-P109-0001 |
EGF Receptor Fragment(651-658)¡ÚEpidermal Growth Factor Receptor¡Û¡ÚEGFR¡Û [Protein Kinase Substrate] |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P110-0001 |
MBP(4-14)(N-Acetylated)¡ÚMyelin Basic Protein(4-14)(N-Acetylated)¡Û |
1mg |
¡ï10,000 |
|
126768-94-3 |
|
|
|
¡¡ |
BML |
BML-P111-0001 |
[Ser25]-Protein Kinase C(19-31)¡ÚProtein Kinase C, [Ser25]-¡Û¡Ú[Ser25]-PKC(19-31)¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P112-0001 |
BPDEtide ¡ÚcGMP-dependent Protein Kinase Substrate¡Û¡ÚcGMP-dependent PK Substrate¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P113-0001 |
Casein Kinase II Substrate ¡ÚArg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu¡Û¡ÚCKII Substrate¡Û |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P114-0001 |
MLCK Substrate(Skeletal and smooth muscle)¡ÚMyosin Light Chain Kinase Substrate¡Û¡ÚLys-Lys-Arg-Ala-Ala-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ala-NH2¡Û |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P115-0001 |
MLCK Substrate(skeletal muscle)¡ÚMyosin Light Chain Kinase Substrate¡Û¡ÚAla-Lys-Arg-Pro-Gln-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ser-NH2¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P118-0500 |
[Ala97]-RII(81-99)¡ÚRII(81-99), Ala97]-¡Û¡ÚDLDVPIPGRFDRRVSVAAE¡Û |
0.5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P120-0005 |
Ac-Leu-Leu-Nle-al ¡ÚAc-Leu-Leu-Nle-CHO¡Û¡ÚCalpain Inhibitor I¡Û¡ÚALLN¡Û¡ÚAc-LL-norleucinal¡Û |
5mg |
¡ï10,000 |
|
110044-82-1 |
|
|
|
¡¡ |
BML |
BML-P120-0025 |
Ac-Leu-Leu-Nle-al ¡ÚAc-Leu-Leu-Nle-CHO¡Û¡ÚCalpain Inhibitor I¡Û¡ÚALLN¡Û¡ÚAc-LL-norleucinal¡Û |
25mg |
¡ï41,000 |
|
110044-82-1 |
|
|
|
¡¡ |
BML |
BML-P121-0001 |
Epidermal Growth Factor Receptor(661-681)¡ÚEGF Receptor(661-681)¡Û [MAP Kinase Substrate] |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P122-0001 |
MBP(95-98)S5 Peptide ¡ÚMyelin Basic Protein(95-98)S5 Peptide¡Û¡ÚMBP(95-98)¡Û¡ÚAla-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg¡Û [MAP Kinase Substrate] |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P123-0001 |
Tyrosine Hydroxylase(rat)(24-33)Peptide ¡ÚTH(24-33)¡Û¡ÚLys-Gln-Ala-Glu-Ala-Val-Thr-Ser-Pro-Arg¡Û [MAP Kinase Substrate] |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P124-0001 |
ERK1/ERK2 Peptide(172-190)[MAP Kinase Kinase Substrate] |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P125-0005 |
MMP Substrate(chromogenic)¡ÚMatrix Metalloproteinase Substrate¡Û¡ÚAc-Pro-Leu-Gly-[2-mercapto-4-methylpentanoyl]-Leu-Gly-OC2H5¡Û |
5mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P126-0001 |
OmniMMP Fluorogenic Substrate ¡ÚMca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 . AcOH¡Û¡ÚMatrix Metalloproteinase Substrate¡Û |
1mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P127-0001 |
OmniMMP Fluorogenic Control Peptide ¡ÚMca-Pro-Leu-OH¡Û¡ÚMatrix Metalloproteinase Fluorogenic Control¡Û |
1mg* |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P128-0001 |
MMP Substrate(Fluorogenic)¡ÚMatrix Metalloproteinase Substrate¡Û¡ÚDnp-Pro-B-cyclohexyl-Ala-Gly-Cys(Me)-His-Ala-Lys(Nma)-NH2¡Û |
1mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P129-0001 |
Akt Substrate ¡ÚProtein Kinase B substrate¡Û¡ÚPKB Substrate¡Û¡ÚArg-Pro-Arg-Ala-Ala-Thr-Phe¡Û |
1mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P131-0001 |
Matrix Metalloproteinase Substrate a(Fluorescent)¡ÚMMP Substrate a(Fluorogenic)¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P132-0500 |
ADAM17(TACE)Substrate(Fluorescent)¡ÚTACE Substrate(Fluorogenic)¡Û¡ÚADAM17 Substrate¡Û |
0.5mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P133-0005 |
Ac-IEPD-pNA ¡ÚCaspase-8 Substrate(Chromogenic)¡Û¡ÚGranzyme B Substrate(Chromogenic)¡Û |
5mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P134-0005 |
Ac-IEPD-AMC ¡ÚCaspase-8 Substrate(Fluorogenic)¡Û¡ÚGranzyme B Substrate(Fluorogenic)¡Û |
5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P135-0025 |
H-Arg-AMC, 2HCl |
25mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P136-0025 |
H-Arg-Pna, 2HCl |
25mg |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P137-0010 |
Z-RR-AMC ¡ÚZ-Arg-Arg-AMC¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P137-0050 |
Z-RR-AMC ¡ÚZ-Arg-Arg-AMC¡Û |
50mg |
¡ï49,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P138-0025 |
Z-RR-pNA ¡ÚZ-Arg-Arg-pNA¡Û |
25mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P139-0010 |
OmniCathepsin Fluorogenic Substrate ¡ÚZ-FR-AMC¡Û¡ÚZ-Phe-Arg-AMC¡Û |
10mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P139-0050 |
OmniCathepsin Fluorogenic Substrate ¡ÚZ-FR-AMC¡Û¡ÚZ-Phe-Arg-AMC¡Û |
50mg |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P141-0025 |
Suc-AAPF-pNA ¡ÚSuc-Ala-Ala-Pro-Phe-pNA¡Û |
25mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P142-0005 |
Z-GPR-AMC ¡ÚZ-Gly-Pro-Arg-AMC¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P142-0020 |
Z-GPR-AMC ¡ÚZ-Gly-Pro-Arg-AMC¡Û |
20mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P144-0001 |
S6 Ribosomal Protein/Peptide ¡ÚRibosomal Protein S6(rat)(229-239)¡Û [Protein Kinase Substrate] |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P145-0001 |
Cathepsin D&E Fluorogenic Substrate |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P146-0001 |
Casein Kinase I Peptide Substrate ¡ÚCKI Peptide Substrate¡Û |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P147-0001 |
Casein Kinase II Peptide Substrate ¡ÚCKII Peptide Substrate¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P148-0001 |
IkB Kinase Substrate, Biotinylated |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P149-0001 |
Crosstide ¡ÚH-Gly-Arg-Pro-Arg-Thr-Ser-Ser-Phe-Ala-Glu-Gly-OH¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P150-0500 |
Protein Kinase C(19-36)Pseudosubstrate ¡ÚPKC¡Û |
0.5mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P151-0001 |
GSK3 Peptide Substrate ¡ÚGlycogen Synthase Kinase 3 Substrate¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P152-0001 |
Protein Phosphatase 2 Peptide Substrate ¡ÚPP2 Substrate¡Û¡ÚProtein Serine/Threonine Phosphatase Peptide Substrate¡Û |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P153-0001 |
Protein Tyrosine Phosphatase Peptide Substrate ¡ÚPTP Substrate¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P154-0001 |
PKC¦Ä Peptide Substrate ¡ÚProtein Kinase C¦Ä Substrate¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P155-0500 |
PKC¦Å Substrate ¡Ú[Ser159]-PKC¦Å(149-164)¡Û¡ÚPKC¦Å Substrate, [Ser159]-¡Û¡ÚProtein Kinase C¦Å Substrate¡Û |
0.5mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P156-0001 |
PKC¦Æ Peptide Substrate ¡ÚProtein Kinase C¦Æ Substrate¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P157-0001 |
Shp-1 & -2 Peptide Substrate |
1mg* |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P158-0001 |
Chk 1 & 2 Peptide Substrate ¡ÚCDC25C(206-225)¡Û |
1mg* |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P160-0500 |
RII Phosphopeptide ¡Ú[pSer95, Ala97]-RII(81-99)¡Û¡ÚAsp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-pSer-Val-Ala-Ala-Glu¡Û¡ÚDLDVPIPGRFDRRVpSVAAE¡Û |
0.5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P161-0001 |
Abz-FRK(Dnp)-P ¡ÚACE1 Substrate(Fluorogenic)¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P162-0001 |
Abz-SDK(Dnp)-P ¡ÚACE1(N-domain)Substrate(Fluorogenic)¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P163-0001 |
Mca-APK(Dnp)(Fluorogenic Substrate)¡ÚMca-Ala-Pro-Lys(Dnp)-OH¡Û |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P164-0001 |
MAP(177-189)Phosphorylated Peptide ¡Ú[pThr183, pTyr185] MAP kinase(177-189)¡Û¡ÚMAP Kinase(177-189), [pThr183, pTyr185] -¡Û¡ÚMAP(177-189)pT/pY Peptide¡Û |
1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P165-0001 |
Z-AAD-CMK ¡ÚGranzyme B Inhibitor¡Û |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P188-0025 |
GP-pNA(Chromogenic Substrate)¡ÚGly-Pro-pNA¡Û¡ÚDipeptidyl Peptidase Substrate(Chromogenic)¡Û |
25mg |
¡ï9,000 |
|
103213-34-9 |
|
|
|
¡¡ |
BML |
BML-P189-0005 |
GP-AMC(Fluorogenic Substrate)¡ÚGly-Pro-AMC¡Û |
5mg |
¡ï10,000 |
|
115035-46-6 |
|
|
|
¡¡ |
BML |
BML-P191-0001 |
Crosstide, Biotinylated |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P193-0001 |
GSK-3 Peptide Substrate II ¡ÚGlycogen Synthase Kinase 3 Substrate II¡Û |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P194-0001 |
PAK4 / Akt Peptide Substrate ¡ÚCys-Lys-Arg-Pro-Arg-Ala-Ala-Ser-Phe-Ala-Glu¡Û¡Úp21-Activated Kinase 4 Substrate¡Û¡ÚProtein Kinase B Substrate¡Û¡ÚPKB Substrate¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P195-0001 |
CREBitde Protein Kinase Substrate |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P196-0001 |
MAPKAPK2 Peptide Substrate ¡ÚMAP Kinase-Activated Protein Kinase 2 Substrate¡Û¡ÚLys-Lys-Leu-Asn-Arg-Thr-Leu-Ser-Val-Ala¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P197-0001 |
src Peptide Substrate ¡Úcdc2(6-20)¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P198-2500 |
p53(368-386)¡Úp300 & CBP Substrate¡Û |
2.5mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P199-0010 |
Z-VVR-AMC(Fluorogenic Substrate)¡ÚCathepsin S & L Substrate(Fluorogenic)¡Û |
10mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P200-0500 |
CaM Kinase II(290-309)[Calmodulin Antagonist] ¡ÚCaMKII(290-309)¡Û¡ÚCa2+/Calmodulin-dependent Protein Kinase II(290-309)¡Û |
0.5mg |
¡ï15,000 |
|
115044-69-4 |
|
|
|
¡¡ |
BML |
BML-P201-0500 |
CaM Kinase II(281-309)¡ÚCaMKII(281-309)¡Û¡ÚCa2+/Calmodulin-dependent Protein Kinase II(281-309)¡Û [Calmodulin Antagonist] |
0.5mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P202-0500 |
CaM Kinase II(Ala286)(281-302)¡Ú[Ala286]-CaM Kinase II(281-302)¡Û¡ÚCaM Kinase II(281-302), [Ala286]-¡Û¡Ú[Ala286]-CaMKII(281-302)¡Û¡ÚAla286]-Ca2+/Calmodulin-dependent Protein Kinase II(281-302)¡Û [Calm |
0.5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P203-0500 |
PKI(5-24)¡ÚcAMP-dependent Protein Kinase Inhibitor(5-24)¡Û¡ÚPKA Inhibitor¡Û¡ÚProtein Kinase A Inhibitor¡Û |
0.5mg |
¡ï13,000 |
|
99534-03-9 |
|
|
|
¡¡ |
BML |
BML-P204-0001 |
PKI(6-22)Amide ¡ÚcAMP-dependent Protein Kinase Inhibitor(6-22)Amide¡Û¡ÚPKA Inhibitor¡Û¡ÚProtein Kinase A Inhibitor¡Û |
1mg |
¡ï15,000 |
|
121932-06-7 |
|
|
|
¡¡ |
BML |
BML-P205-0500 |
Myristoylated Protein Kinase C(20-28)¡ÚProtein Kinase C(20-28)(Myristoylated)¡Û¡ÚPKC(20-28)(Myristoylated)¡Û [Cell-permeable PKC Inhibitor] |
0.5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P206-0001 |
Protein Kinase C(19-31)¡ÚPKC(19-31)¡Û [Pseudosubstrate Inhibitor] |
1mg |
¡ï16,000 |
|
121545-65-1 |
|
|
|
¡¡ |
BML |
BML-P207-0500 |
Myristoylated EGF-R(651-658)¡ÚEGF Receptor(651-658)(Myristoylated)¡Û¡ÚEGFR(651-658)(Myristoylated)¡Û¡ÚEpidermal Growth Factor Receptor(651-658)(Myristoylated)¡Û [PKC Inhibitor] |
0.5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P208-0001 |
PKG Inhibitor ¡ÚProtein Kinase G Inhibitor¡Û¡Ú[Ala32]-Histone H2B(29-35)¡Û |
1mg |
¡ï9,000 |
|
82801-73-8 |
|
|
|
¡¡ |
BML |
BML-P209-0001 |
MLCK Inhibitor ¡ÚMLCK(342-352)Amide¡Û¡ÚMyosin Light Chain Kinase(342-352)Amide¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P210-0500 |
Myristoylated PKI(14-22)Amide ¡ÚPKI(14-22)Amide(Myristoylated)¡Û¡ÚcAMP-dependent Protein Kinase Inhibitor(14-22)Amide(Myristoylated)¡Û¡Úmyr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2¡Û¡ÚMyr-GRTGRRNAI-NH2 |
0.5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P211-0001 |
AIP ¡ÚAutocamtide-2-related Inhibitory Peptide¡Û[CaM Kinase II Inhibitory Peptide] |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P212-0500 |
Myristoylated AIP ¡ÚAIP(Myristoylated)¡Û¡ÚAutocamtide-2-related Inhibitory Peptide(Myristoylated)¡Û[CaM Kinase II Inhibitory Peptide] |
0.5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P213-0005 |
MeOSuc-AAPV-pNA(Chromogenic Substrate) |
5mg |
¡ï10,000 |
|
70967-90-7 |
|
|
|
¡¡ |
BML |
BML-P214-0001 |
R18 Peptide |
1mg* |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P215-0001 |
Fyn Kinase Peptide Substrate |
1mg* |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P216-0001 |
Abl Kinase Peptide Substrate |
1mg* |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P217-0001 |
Lyn and Syk Kinase Peptide Substrate |
1mg* |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P219-0500 |
Myristoylated PKC¦Æ ¡ÚPKC¦Æ(113-125)(Myristoylated)¡Û¡ÚProtein Kinase C ¦Æ(113-125)(Myristoylated)¡Û¡ÚPKC¦Æ Pseudosubstrate¡Û |
0.5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P224-0005 |
MeOSuc-AAPV-AMC(Fluorogenic Substrate)¡ÚNeutrophil Elastase Substrate(Fluorogenic)¡Û |
5mg |
¡ï10,000 |
|
72252-90-5 |
|
|
|
¡¡ |
BML |
BML-P225-0001 |
R18 Peptide, Biotinylated |
1mg* |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P226-0001 |
IKK Peptide Substrate ¡ÚI¦ÊB Kinase Substrate¡Û |
1mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P227-0001 |
Mca-RPPGFSAFK(Dnp)(Fluorogenic Substrate) |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P228-0100 |
ADAM17(TACE)Substrate II(Fluorogenic)¡ÚTACE Substrate II(Fluorogenic)¡Û¡ÚADAM17 Substrate II(Fluorogenic)¡Û |
100ug |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P229-0010 |
Z-LR-AMC(Fluorogenic Substrate)¡ÚZ-Leu-Arg-AMC¡Û¡ÚCathepsin K Substrate(Fluorogenic)¡Û |
10mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P230-0100 |
Leu-pNA(Chromogenic Substrate)¡ÚAminopeptidase Substrate(Chromogenic)¡Û |
100mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P231-0001 |
SAMS Peptide [AMPK Peptide Substrate] |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P232-0001 |
SAMS Peptide [AMPK Peptide Substrate], Biotinylated |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P233-0001 |
SAMS Peptide [AMPK Peptide Substrate](Phosphorylated), Biotinylated |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P234-0001 |
Enterostatin(human) |
1mg |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P234-0005 |
Enterostatin(human) |
5mg |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P235-0001 |
ADAM Substrate(Fluorogenic)¡ÚA Disintegrin And Metalloproteinase¡Û |
1mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P236-0025 |
Met-AMC(Fluorogenic Substrate) |
25mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P237-0005 |
Boc-Gln-Ala-Arg-AMC(Fluorogenic Substrate)¡ÚBoc-QAR-AMC¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P238-0001 |
NP-M2tide |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P239-0001 |
P-M2tide |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P240-0001 |
KDR/VEGFR2 Peptide Substrate ¡ÚVEGFR-2 Substrate¡Û¡ÚKDR Substrate¡Û |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P241-0001 |
KDR/VEGFR Peptide Substrate, -Biotinylated, TFA salt ¡ÚVEGFR-2 Substrate(Biotinylated)¡Û¡ÚKDR Substrate(Biotinylated)¡Û |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P242-0001 |
HER2 Peptide Substrate ¡ÚGlu-Gly-Met-Glu-Asp-Ile-Tyr-Phe-Glu-Phe-Met-Gly-Gly-Lys-Lys-Lys¡Û |
1mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P243-0001 |
HER2 Peptide Substrate, -Biotinylated, TFA salt ¡ÚBiotin-Ahx-Gly-Gly-Met-Glu-Asp-Ile-Tyr-Phe-Glu-Phe-Met-Gly-Gly-Lys-Lys-Lys¡Û |
1mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P244-0001 |
FGFR Peptide Substrate ¡ÚFibroblast Growth Factor Receptor Substrate¡Û |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P245-0001 |
FGFR Peptide Substrate, -Biotinylated, TFA salt ¡ÚFibroblast Growth Factor Receptor Substrate(Biotinylated)¡Û |
1mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P246-0001 |
Hsp27tide Peptide Substrate |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P247-0001 |
Hsp27tide Peptide Substrate, Biotinylated |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P248-0001 |
Axl-tide Peptide Substrate |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P249-0001 |
Axl-tide Peptide Substrate, -Biotinylated, TFA salt |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P250-0100 |
PDKtide Peptide Substrate ¡ÚPhosphoinositide-dependent Protein Kinase Substrate¡Û |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P251-0100 |
PDKtide Peptide Substrate, -Biotinylated |
100ug |
¡ï20,000 |
|
¡¡ |
|
|
|
¡¡ |
BML |
BML-P256-0500 |
Histone H3 Dimethyl Lysine-4 Peptide |
0.5mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P257-0001 |
IGF 1Rtide Peptide Substrate |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P258-0001 |
IGF 1Rtide Peptide Substrate, Biotinylated |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P259-0001 |
src Peptide Substrate II ¡ÚTyr-Ile-Tyr-Gly-Ser-Phe-Lys¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P260-0001 |
src Peptide Substrate, Biotinylated ¡ÚBiotin-Ahx-Tyr-Ile-Tyr-Gly-Ser-Phe-Lys¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P261-0001 |
DYRK Kinase Peptide Substrate ¡ÚWoodtide¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P262-0001 |
DYRK Kinase Peptide Substrate, Biotinylated ¡ÚWoodtide(Biotinylated)¡Û |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P263-0001 |
CDK5 Peptide Substrate ¡ÚCyclin-Dependent Kinase 5 Substrate¡Û |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P264-0001 |
CDK5 Peptide Substrate, Biotinylated ¡ÚCyclin-Dependent Kinase 5 Substrate, Biotinylated¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P265-0001 |
CDK2 Peptide Substrate ¡ÚCyclin-Dependent Kinase 2 Substrate¡Û¡ÚHis-His-Ala-Ser-Pro-Arg-Lys¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P266-0001 |
CDK2 Peptide Substrate, Biotinylated ¡ÚCyclin-Dependent Kinase 2 Substrate, Biotinylated¡Û¡ÚBiotin-Ahx-His-His-Ala-Ser-Pro-Arg-Lys¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P267-0001 |
LRRKtide Peptide Substrate |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P268-0001 |
LRRKtide Peptide Substrate, Biotinylated |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P270-0001 |
AMARA Peptide Substrate |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P271-0500 |
Histone H3 Peptide ¡ÚHistone H3(human)(5-23)Amide¡Û |
0.5mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P272-0001 |
CDC2 Peptide Substrate, Biotinylated |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P275-0100 |
FA-Phe-Gly-Gly-OH(ACE substrate)¡ÚFA-Phe-Gly-Gly-OH¡Û¡ÚFAPGG¡Û¡ÚN-[3-(2-Furylacryloyl)]-L-phenyalanyl-glycyl-glycine¡Û |
100mg |
¡ï17,000 |
|
64967-39-1 |
|
|
|
¡¡ |
BML |
BML-P276-0001 |
Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2(Fluorogenic Substrate)¡ÚFS-6¡Û |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P277-0100 |
OmniMMP RED Fluorogenic Substrate |
0.1mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P278-0100 |
MMP-3 Fuorogenic Substrate |
0.1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P300-0001 |
YEEI Peptide |
1mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P301-0001 |
pp60c-Src C-terminal Phosphoregulatory Peptide ¡ÚAc-Thr-Ser-Thr-Glu-Pro-Gln-pTyr-Gln-Pro-Gly-Glu-Asn-Leu¡Û |
1mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P302-0200 |
YEEI Peptide, Biotinylated |
200ug |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P303-0005 |
Boc-Ala-Ala-Nva-SBzl(Chromogenic Substrate) |
5mg |
¡ï12,000 |
|
¡¡ |
|
|
|
¡¡ |
BML |
BML-P304-0001 |
pp60c-Src C-terminal Peptide |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P305-0001 |
hSOS(1149-1158)N10 SH3 Binding Domain ¡ÚSOS-1(human)(1149-1158)¡Û¡ÚSOS-1(human)N10 SH3 Binding Domain¡Û¡ÚRas Inhibitory Peptide¡Û |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P306-0500 |
Peptide A ¡Úpp60v-src(137-157)¡Û [Pprotein Tyrosine Kinase Inhibitor] |
0.5mg |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P307-0001 |
pp60v-src Autophosphorylation site |
1mg |
¡ï11,000 |
|
81493-98-3 |
|
|
|
¡¡ |
BML |
BML-P308-0001 |
RR-Src(Protein Tyrosine Kinase Inhibitor)¡Úv-Src Autophosphorylation site¡Û |
1mg |
¡ï12,000 |
|
81156-93-6 |
|
|
|
¡¡ |
BML |
BML-P311-0001 |
PI3K SH3 Domain Binding Peptide ¡ÚPhosphoinositol 3-Kinase SH3 Domain Binding Peptide¡Û |
1mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P312-0001 |
pp60v-Src Autophosphorylation Site(pY Substrate) |
1mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P314-0500 |
Insulin Receptor(1142-1153)Peptide |
0.5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P315-0500 |
Insulin Receptor(1142-1153)(pTyr1146)Peptide ¡Ú[pTyr1146] Insulin Receptor(1142-1153)¡Û |
0.5mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P316-0500 |
Insulin Receptor(1142-1153)(pTyr1150)Peptide ¡Ú[pTyr1150] Insulin Receptor(1142-1153)¡Û |
0.5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P317-0500 |
Insulin Receptor(1142-1153)(pTyr1151)Peptide ¡Ú[pTyr1151] Insulin Receptor(1142-1153)¡Û |
0.5mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P318-0500 |
Insulin Receptor(1142-1153)(pTyr1146, pTyr1150 &(pTyr1151)Peptide ¡Ú[pTyr1146/1150/1151] Insulin Receptor(1142-1153)¡Û |
0.5mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P320-0001 |
IRS-1(pTyr608)Peptide ¡ÚInsulin Receptor Substrate(Tyr608)Peptide¡Û |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P321-0500 |
Insulin Receptor(1142-1153)(pTyr1146/1150)Peptide ¡Ú[pTyr1146/1150] Insulin Receptor(1142-1153)¡Û |
0.5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P323-0001 |
EGFR(988-998), PTP1B Substrate ¡Ú[pTyr992] EGF Receptor(988-998)¡Û¡ÚPTP1B substrate¡Û¡Ú[pTyr992] Epidermal Growth Factor Receptor(988-998)¡Û |
1mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P400-0001 |
ICE Substrate ¡ÚIL-1B Precursor(110-123)¡Û¡ÚCaspase-1 substrate¡Û¡ÚIL-1B-Converting Enzyme¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P402-0001 |
PSTAIRE Peptide |
1mg |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P404-0005 |
Cell permeable YVAD-CHO ¡ÚAc-AAVALLPAVLLALLAPYVAD-CHO¡Û¡ÚCaspase-1 Inhibitor(Aldehyde)¡Û¡ÚYVAD-CHO¡Û¡ÚCaspase ¡ÚICE¡Û Inhibitor¡Û(cell permeable) |
0.5mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P416-0001 |
Z-VAD-FMK ¡ÚZ-VAD(OMe)-FMK¡Û¡ÚCaspase Family Inhibitor(Fluoromethylketone)¡Û [Caspase Inhibitor] |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P420-0001 |
Calcitonin(salmon) |
1mg |
¡ï13,000 |
|
47931-85-1 |
|
|
|
¡¡ |
BML |
BML-P420-0005 |
Calcitonin(salmon) |
5mg |
¡ï54,000 |
|
47931-85-1 |
|
|
|
¡¡ |
BML |
BML-P437-0005 |
Ac-VEID-pNA ¡ÚCaspase-6 Substrate(Chromogenic)¡Û [Caspase Chromogenic Substrate] |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P442-0005 |
Ac-REQD-pNA ¡ÚCaspase-1 Substrate(Chromogenic)¡Û [Caspase Chromogenic Substrate] |
5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P448-0005 |
VP-AMC(Fluorogenic Substrate)¡ÚVal-Pro-AMC¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P449-0005 |
DP-AMC(Fluorogenic Substrate)¡ÚAsp-Pro-AMC¡Û |
5mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P450-0005 |
WP-AMC(Fluorogenic Substrate)¡ÚTrp-Pro-AMC¡Û |
5mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P502-0001 |
(Sar9, Met(02)11)Substance P |
1mg |
¡ï20,000 |
|
110880-55-2 |
|
|
|
¡¡ |
BML |
BML-P503-0001 |
Spantide II [Substance P Antagonist] |
1mg |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P504-0001 |
Spantide III [Substance P Antagonist] |
1mg |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P504-0005 |
Spantide III [Substance P Antagonist] |
5mg |
¡ï94,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P505-0001 |
Neurokinin A ¡ÚNeuromedin L¡Û¡ÚSubstance K¡Û |
1mg |
¡ï15,000 |
|
86933-74-6 |
|
|
|
¡¡ |
BML |
BML-P506-0001 |
(B-Ala8)Neurokinin A(4-10) |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P507-0001 |
MEN 10376 [Highly Selective NK-2 Neurokinin Receptor Antagonist] |
1mg |
¡ï18,000 |
|
135306-85-3 |
|
|
|
¡¡ |
BML |
BML-P508-0001 |
Neurokinin B ¡ÚNeuromedin K¡Û |
1mg |
¡ï19,000 |
|
86933-75-7 |
|
|
|
¡¡ |
BML |
BML-P509-0001 |
Senktide ¡Ú [Succinyl-Asp6, N-Me-Phe8]-Substance P(6-11)¡Û [Highly selective NK-3 Neurokinin Receptor Agonist] |
1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P510-0001 |
Sendide ¡Ú [Tyr6, D-Phe7, D-His9]-Substance P(6-11)¡Û [Potent NK-1 Neurokinin Receptor Antagonist] |
1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P600-0005 |
NF-¦ÊB SN50 Cell Permeable Inhibitory Peptide |
0.5mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P601-0500 |
NF-¦ÊB SN50M Cell Permeable Control Peptide |
0.5mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P603-0500 |
p53 Activator ¡ÚFusion Peptide 46¡Û |
0.5mg |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P605-0500 |
Int-H1-S6A F8 c-myc Inhibitor |
0.5mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P606-0500 |
Int-H1-S6A F8 Control Peptide |
0.5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P607-0500 |
IKK-NBD Peptide ¡ÚIKKB¡?NEMO Binding Domain Peptide¡Û |
0.5mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P608-0500 |
IKK-NBD Control Peptide ¡ÚIKKB¡?NEMO Binding Domain Control Peptide¡Û |
0.5mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P700-0005 |
RGD Peptide ¡ÚGRGDNP¡Û |
5mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P701-0005 |
RGD Control Peptide ¡ÚGRADSP¡Û |
5mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P801-0005 |
Z-Leu-Arg-Gly-Gly-AMC ¡ÚZ-LRGG-AMC¡Û¡ÚUbiquitin C-terminal Hydrolase Substrate(Fluorogenic)¡Û |
5mg |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-P802-0005 |
Suc-Leu-Leu-Val-Tyr-AMC ¡ÚSuc-LLVY-AMC¡Û¡ÚProteasome Substrate(Fluorogenic)¡Û¡ÚCalpain Substrate(Fluorogenic)¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PA1243-0025 |
Pancreastatin(pig, aa 1-49), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig¡¢ other mammalian | IHC |
|
|
¡¡ |
BML |
BML-PA1246-0025 |
Peptide Histidine Isoleucine ¡ÚPHI¡Û(pig), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-PA1246-0100 |
Peptide Histidine Isoleucine ¡ÚPHI¡Û(pig), rabbit pAb(antiserum) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-PA1249-0025 |
Peptide Histidine Methionine ¡ÚPHM¡Û(human, synthetic), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-PA1249-0100 |
Peptide Histidine Methionine ¡ÚPHM¡Û(human, synthetic), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC |
|
|
¡¡ |
BML |
BML-PA1254-0100 |
Peptide Tyrosine Tyrosine ¡ÚPeptide YY¡Û¡ÚPYY¡Û(pig), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢WB |
|
|
¡¡ |
BML |
BML-PD120-0010 |
BRL-50481 ¡Ú3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene¡Û |
10mg |
¡ï9,000 |
|
433695-36-4 |
|
|
|
¡¡ |
BML |
BML-PD120-0050 |
BRL-50481 ¡Ú3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene¡Û |
50mg |
¡ï35,000 |
|
433695-36-4 |
|
|
|
¡¡ |
BML |
BML-PD125-0005 |
Cilostamide ¡ÚOPS 3689¡Û¡ÚOCP 3689¡Û¡ÚN-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide¡Û |
5mg |
¡ï8,000 |
|
68550-75-4 |
|
|
|
¡¡ |
BML |
BML-PD125-0025 |
Cilostamide ¡ÚOPS 3689¡Û¡ÚOCP 3689¡Û¡ÚN-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide¡Û |
25mg |
¡ï33,000 |
|
68550-75-4 |
|
|
|
¡¡ |
BML |
BML-PD127-0010 |
Cilostazol ¡Ú6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinoline¡Û |
10mg |
¡ï8,000 |
|
73963-72-1 |
|
|
|
¡¡ |
BML |
BML-PD127-0050 |
Cilostazol ¡Ú6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinoline¡Û |
50mg |
¡ï33,000 |
|
73963-72-1 |
|
|
|
¡¡ |
BML |
BML-PD129-0010 |
EHNA ¡ÚErythro-9-(2-hydroxy-3-nonyl)adenine, HCl¡Û |
10mg |
¡ï7,000 |
|
51350-19-7 |
|
|
|
¡¡ |
BML |
BML-PD129-0050 |
EHNA ¡ÚErythro-9-(2-hydroxy-3-nonyl)adenine, HCl¡Û |
50mg |
¡ï29,000 |
|
51350-19-7 |
|
|
|
¡¡ |
BML |
BML-PD130-0005 |
SQ 20009 ¡ÚEtazolate¡Û |
5mg |
¡ï7,000 |
|
51022-77-6 |
|
|
|
¡¡ |
BML |
BML-PD130-0025 |
SQ 20009 ¡ÚEtazolate¡Û |
25mg |
¡ï32,000 |
|
51022-77-6 |
|
|
|
¡¡ |
BML |
BML-PD140-0200 |
3-Isobutyl-1-methylxanthine ¡ÚIBMX¡Û |
200mg |
¡ï6,000 |
|
28822-58-4 |
|
|
|
¡¡ |
BML |
BML-PD140-1000 |
3-Isobutyl-1-methylxanthine ¡ÚIBMX¡Û |
1g |
¡ï27,000 |
|
28822-58-4 |
|
|
|
¡¡ |
BML |
BML-PD141-0050 |
Irsogladine, Maleate |
50mg |
¡ï7,000 |
|
84504-69-8 |
|
|
|
¡¡ |
BML |
BML-PD141-0250 |
Irsogladine, Maleate |
250mg |
¡ï30,000 |
|
84504-69-8 |
|
|
|
¡¡ |
BML |
BML-PD149-0005 |
MBCQ ¡Ú4-[[3,4-(Methylenedioxy)benzyl]amino]-6-chloroquinazoline¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PD149-0025 |
MBCQ ¡Ú4-[[3,4-(Methylenedioxy)benzyl]amino]-6-chloroquinazoline¡Û |
25mg |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PD150-0010 |
8-Methoxymethyl-IBMX ¡Ú8-Methoxymethyl-1-methyl-3-(2-methylpropyl)xanthine¡Û |
10mg |
¡ï22,000 |
|
78033-08-6 |
|
|
|
¡¡ |
BML |
BML-PD155-0010 |
MY-5445 ¡Ú1-(3-Chlorophenylamino)-4-phenylphthalazine¡Û |
10mg |
¡ï19,000 |
|
78351-75-4 |
|
|
|
¡¡ |
BML |
BML-PD170-0010 |
Quazinone ¡ÚRo 13-6438¡Û¡Ú(R)-6-Chloro-1,5-dihydro-3-methylimidazo[2,1-b]quinazolin-2-one¡Û |
10mg |
¡ï11,000 |
|
70018-51-8 |
|
|
|
¡¡ |
BML |
BML-PD170-0050 |
Quazinone ¡ÚRo 13-6438¡Û¡Ú(R)-6-Chloro-1,5-dihydro-3-methylimidazo[2,1-b]quinazolin-2-one¡Û |
50mg |
¡ï42,000 |
|
70018-51-8 |
|
|
|
¡¡ |
BML |
BML-PD175-0010 |
Rolipram ¡Ú(¡Þ)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone¡Û |
10mg |
¡ï8,000 |
|
61413-54-5 |
|
|
|
¡¡ |
BML |
BML-PD175-0050 |
Rolipram ¡Ú(¡Þ)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone¡Û |
50mg |
¡ï34,000 |
|
61413-54-5 |
|
|
|
¡¡ |
BML |
BML-PD177-0005 |
R-(-)-Rolipram ¡ÚR-(-)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone¡Û |
5mg |
¡ï20,000 |
|
85416-75-7 |
|
|
|
¡¡ |
BML |
BML-PD178-0005 |
S-(+)-Rolipram ¡ÚS-(+)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone¡Û |
5mg |
¡ï20,000 |
|
85416-75-7 |
|
|
|
¡¡ |
BML |
BML-PD179-0005 |
Siguazodan ¡ÚSK&F-94836¡Û¡ÚN-Cyano-N'-methyl-N"-[4-(1,4,5,6 -tetrahydro-4-Methyl-6-oxo-3-pyridazinyl)phenyl]guanidine¡Û |
5mg |
¡ï13,000 |
|
115344-47-3 |
|
|
|
¡¡ |
BML |
BML-PD179-0025 |
Siguazodan ¡ÚSK&F-94836¡Û¡ÚN-Cyano-N'-methyl-N"-[4-(1,4,5,6 -tetrahydro-4-Methyl-6-oxo-3-pyridazinyl)phenyl]guanidine¡Û |
25mg |
¡ï50,000 |
|
115344-47-3 |
|
|
|
¡¡ |
BML |
BML-PD180-0010 |
Trequinsin ¡ÚHL-725¡Û¡Ú9,10-Dimethoxy-2-mesitylimino-3-methyl-2,3,6,7-tetrahydro-4H-pyrimidoisoquinoline-4-one, HCl¡Û |
10mg |
¡ï33,000 |
|
78416-81-6 |
|
|
|
¡¡ |
BML |
BML-PD185-0020 |
Vinpocetine |
20mg |
¡ï7,000 |
|
42971-09-5 |
|
|
|
¡¡ |
BML |
BML-PD185-0100 |
Vinpocetine |
100mg |
¡ï27,000 |
|
42971-09-5 |
|
|
|
¡¡ |
BML |
BML-PD190-0020 |
Zaprinast ¡ÚM&B 22948¡Û¡Ú2-(2-Propoxyphenyl)-8-azahypoxanthine¡Û¡Ú1,4-Dihydro-5-[2-propoxyphenyl]-7H-1,2,3-triazolo[4,5-d]pyrimidine-7-one¡Û |
20mg |
¡ï5,000 |
|
37762-06-4 |
|
|
|
¡¡ |
BML |
BML-PD190-0100 |
Zaprinast ¡ÚM&B 22948¡Û¡Ú2-(2-Propoxyphenyl)-8-azahypoxanthine¡Û¡Ú1,4-Dihydro-5-[2-propoxyphenyl]-7H-1,2,3-triazolo[4,5-d]pyrimidine-7-one¡Û |
100mg |
¡ï25,000 |
|
37762-06-4 |
|
|
|
¡¡ |
BML |
BML-PD195-0005 |
Zardaverine ¡Ú6-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone¡Û |
5mg |
¡ï10,000 |
|
101975-10-4 |
|
|
|
¡¡ |
BML |
BML-PD195-0025 |
Zardaverine ¡Ú6-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone¡Û |
25mg |
¡ï43,000 |
|
101975-10-4 |
|
|
|
¡¡ |
BML |
BML-PD200-0005 |
BML-288 ¡Ú5-Methyl-6-oxo-N-(1,3,4-thiadiazol-2-yl)-7H-furo[2,3-f]indole-7-carboxamide¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PD200-0025 |
BML-288 ¡Ú5-Methyl-6-oxo-N-(1,3,4-thiadiazol-2-yl)-7H-furo[2,3-f]indole-7-carboxamide¡Û |
25mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PE135-0001 |
Phorbol 12,13-Dibutyrate |
1mg |
¡ï5,000 |
|
37558-16-0 |
|
|
|
¡¡ |
BML |
BML-PE135-0005 |
Phorbol 12,13-Dibutyrate |
5mg |
¡ï23,000 |
|
37558-16-0 |
|
|
|
¡¡ |
BML |
BML-PE140-0001 |
4a-Phorbol 12,13-Dibutyrate |
1mg |
¡ï14,000 |
|
93781-54-5 |
|
|
|
¡¡ |
BML |
BML-PE145-0001 |
Phorbol 12,13-Didecanoate |
1mg |
¡ï8,000 |
|
24928-17-4 |
|
|
|
¡¡ |
BML |
BML-PE145-0005 |
Phorbol 12,13-Didecanoate |
5mg |
¡ï35,000 |
|
24928-17-4 |
|
|
|
¡¡ |
BML |
BML-PE147-0001 |
4a-Phorbol 12,13-Didecanoate ¡Ú4aPDD¡Û |
1mg |
¡ï14,000 |
|
27536-56-7 |
|
|
|
¡¡ |
BML |
BML-PE147-0005 |
4a-Phorbol 12,13-Didecanoate ¡Ú4aPDD¡Û |
5mg |
¡ï59,000 |
|
27536-56-7 |
|
|
|
¡¡ |
BML |
BML-PE160-0001 |
Phorbol 12-Myristate 13-Acetate ¡ÚPMA¡Û¡ÚTPA¡Û |
1mg |
¡ï4,000 |
|
16561-29-8 |
|
|
|
¡¡ |
BML |
BML-PE160-0005 |
Phorbol 12-Myristate 13-Acetate ¡ÚPMA¡Û¡ÚTPA¡Û |
5mg |
¡ï14,000 |
|
16561-29-8 |
|
|
|
¡¡ |
BML |
BML-PE162-0001 |
4a-Phorbol 12-Myristate 13-Acetate ¡Ú4a-PMA¡Û |
1mg |
¡ï8,000 |
|
63597-44-4 |
|
|
|
¡¡ |
BML |
BML-PE176-0100 |
(+)-7-Octylindolactam V |
100ug |
¡ï8,000 |
|
123597-54-6 |
|
|
|
¡¡ |
BML |
BML-PE180-0001 |
Thapsigargin |
1mg |
¡ï8,000 |
|
67526-95-8 |
|
|
|
¡¡ |
BML |
BML-PE180-0005 |
Thapsigargin |
5mg |
¡ï33,000 |
|
67526-95-8 |
|
|
|
¡¡ |
BML |
BML-PE182-0001 |
12-Deoxyphorbol 13-Phenylacetate 20-Acetate ¡ÚdPPA¡Û¡ÚDOPPA¡Û |
1mg |
¡ï15,000 |
|
54662-31-5 |
|
|
|
¡¡ |
BML |
BML-PE186-0001 |
Ingenol 3,20-Dibenzoate ¡ÚIDB¡Û |
1mg |
¡ï23,000 |
|
59086-90-7 |
|
|
|
¡¡ |
BML |
BML-PE187-0001 |
12-Deoxyphorbol 13-Acetate ¡ÚProstratin¡Û |
1mg |
¡ï14,000 |
|
60857-08-1 |
|
|
|
¡¡ |
BML |
BML-PE190-0010 |
Farnesyl Thiotrazole ¡ÚFTT¡Û |
10mg |
¡ï9,000 |
|
156604-45-4 |
|
|
|
¡¡ |
BML |
BML-PE190-0050 |
Farnesyl Thiotrazole ¡ÚFTT¡Û |
50mg |
¡ï37,000 |
|
156604-45-4 |
|
|
|
¡¡ |
BML |
BML-PG001-0001 |
Prostaglandin A1 ¡ÚPGA1¡Û |
1mg |
¡ï5,000 |
|
14152-28-4 |
|
|
|
¡¡ |
BML |
BML-PG001-0010 |
Prostaglandin A1 ¡ÚPGA1¡Û |
10mg |
¡ï30,000 |
|
14152-28-4 |
|
|
|
¡¡ |
BML |
BML-PG002-0001 |
Prostaglandin A2 ¡ÚPGA2¡Û¡ÚMedullin¡Û¡ÚProsta-5,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-,(5Z,13E,15S)-¡Û |
1mg |
¡ï4,000 |
|
13345-50-1 |
|
|
|
¡¡ |
BML |
BML-PG002-0010 |
Prostaglandin A2 ¡ÚPGA2¡Û¡ÚMedullin¡Û¡ÚProsta-5,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-,(5Z,13E,15S)-¡Û |
10mg |
¡ï25,000 |
|
13345-50-1 |
|
|
|
¡¡ |
BML |
BML-PG003-0001 |
Prostaglandin B1 ¡ÚPGB1¡Û |
1mg |
¡ï4,000 |
|
13345-51-2 |
|
|
|
¡¡ |
BML |
BML-PG003-0010 |
Prostaglandin B1 ¡ÚPGB1¡Û |
10mg |
¡ï27,000 |
|
13345-51-2 |
|
|
|
¡¡ |
BML |
BML-PG004-0001 |
Prostaglandin B2 ¡ÚPGB2¡Û |
1mg |
¡ï5,000 |
|
13367-85-6 |
|
|
|
¡¡ |
BML |
BML-PG004-0010 |
Prostaglandin B2 ¡ÚPGB2¡Û |
10mg |
¡ï33,000 |
|
13367-85-6 |
|
|
|
¡¡ |
BML |
BML-PG005-0001 |
Prostaglandin D2 ¡ÚPGD2¡Û |
1mg |
¡ï5,000 |
|
41598-07-6 |
|
|
|
¡¡ |
BML |
BML-PG005-0010 |
Prostaglandin D2 ¡ÚPGD2¡Û |
10mg |
¡ï42,000 |
|
41598-07-6 |
|
|
|
¡¡ |
BML |
BML-PG006-0001 |
Prostaglandin E1 ¡ÚPGE1¡Û |
1mg |
¡ï2,000 |
|
745-65-3 |
|
|
|
¡¡ |
BML |
BML-PG006-0010 |
Prostaglandin E1 ¡ÚPGE1¡Û |
10mg |
¡ï17,000 |
|
745-65-3 |
|
|
|
¡¡ |
BML |
BML-PG007-0001 |
Prostaglandin E2 ¡ÚPGE2¡Û |
1mg |
¡ï3,000 |
|
363-24-6 |
|
|
|
¡¡ |
BML |
BML-PG007-0010 |
Prostaglandin E2 ¡ÚPGE2¡Û |
10mg |
¡ï23,000 |
|
363-24-6 |
|
|
|
¡¡ |
BML |
BML-PG008-0001 |
Prostaglandin F2a ¡ÚPGF2a¡Û Dinoprost¡Û¡Ú9a,11a,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic Acid¡Û |
1mg |
¡ï4,000 |
|
551-11-1 |
|
|
|
¡¡ |
BML |
BML-PG008-0010 |
Prostaglandin F2a ¡ÚPGF2a¡Û Dinoprost¡Û¡Ú9a,11a,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic Acid¡Û |
10mg |
¡ï31,000 |
|
551-11-1 |
|
|
|
¡¡ |
BML |
BML-PG009-0001 |
Prostaglandin F2a, Tromethamine ¡ÚPGF2a, THAM¡Û |
1mg |
¡ï4,000 |
|
38562-01-5 |
|
|
|
¡¡ |
BML |
BML-PG009-0010 |
Prostaglandin F2a, Tromethamine ¡ÚPGF2a, THAM¡Û |
10mg |
¡ï32,000 |
|
38562-01-5 |
|
|
|
¡¡ |
BML |
BML-PG010-0001 |
Prostaglandin F1a ¡ÚPGF1a¡Û |
1mg |
¡ï8,000 |
|
745-62-0 |
|
|
|
¡¡ |
BML |
BML-PG011-0001 |
Prostaglandin I2, Na ¡ÚPGI2, Na¡Û¡ÚProstacyclin¡Û |
1mg |
¡ï10,000 |
|
61849-14-7 |
|
|
|
¡¡ |
BML |
BML-PG011-0010 |
Prostaglandin I2, Na ¡ÚPGI2, Na¡Û¡ÚProstacyclin¡Û |
10mg |
¡ï80,000 |
|
61849-14-7 |
|
|
|
¡¡ |
BML |
BML-PG013-0001 |
15-KetoProstaglandin E2 ¡Ú15-Keto-PGE2¡Û |
1mg |
¡ï16,000 |
|
26441-05-4 |
|
|
|
¡¡ |
BML |
BML-PG016-0001 |
13,14-Dihydro-15-ketoProstaglandin F2a ¡Ú13,14-Dihydro-15-keto-PGF2a¡Û |
1mg |
¡ï13,000 |
|
27376-76-7 |
|
|
|
¡¡ |
BML |
BML-PG016-0010 |
13,14-Dihydro-15-ketoProstaglandin F2a ¡Ú13,14-Dihydro-15-keto-PGF2a¡Û |
10mg |
¡ï93,000 |
|
27376-76-7 |
|
|
|
¡¡ |
BML |
BML-PG017-0001 |
6-KetoProstaglandin F1a ¡Ú6-Keto-PGF1a¡Û |
1mg |
¡ï13,000 |
|
58962-34-8 |
|
|
|
¡¡ |
BML |
BML-PG017-0010 |
6-KetoProstaglandin F1a ¡Ú6-Keto-PGF1a¡Û |
10mg |
¡ï93,000 |
|
58962-34-8 |
|
|
|
¡¡ |
BML |
BML-PG023-0001 |
U-46619 ¡Ú9,11-Dideoxy-9a,11a-methanoepoxy PGF2a¡Û |
1mg |
¡ï11,000 |
|
56985-40-1 |
|
|
|
¡¡ |
BML |
BML-PG023-0010 |
U-46619 ¡Ú9,11-Dideoxy-9a,11a-methanoepoxy PGF2a¡Û |
10mg |
¡ï90,000 |
|
56985-40-1 |
|
|
|
¡¡ |
BML |
BML-PG030-0001 |
9B,11a-Prostaglandin F2 ¡Ú9B,11a-PGF2¡Û |
1mg |
¡ï11,000 |
|
4510-16-1 |
|
|
|
¡¡ |
BML |
BML-PG031-0001 |
9a,11B-Prostaglandin F2 ¡Ú9a,11B-PGF2¡Û |
1mg |
¡ï25,000 |
|
38432-87-0 |
|
|
|
¡¡ |
BML |
BML-PG033-0001 |
Prostaglandin J2 ¡ÚPGJ2¡Û |
1mg |
¡ï21,000 |
|
60203-57-8 |
|
|
|
¡¡ |
BML |
BML-PG033-0010 |
Prostaglandin J2 ¡ÚPGJ2¡Û |
10mg |
¡ï156,000 |
|
60203-57-8 |
|
|
|
¡¡ |
BML |
BML-PG035-0001 |
Carbacyclin ¡ÚCarbocyclic PGI2¡Û |
1mg |
¡ï21,000 |
|
69552-46-1 |
|
|
|
¡¡ |
BML |
BML-PG035-0010 |
Carbacyclin ¡ÚCarbocyclic PGI2¡Û |
10mg |
¡ï147,000 |
|
69552-46-1 |
|
|
|
¡¡ |
BML |
BML-PG036-0001 |
(¡Þ)-13-Azaprostanoic Acid ¡Ú13-APA¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PG036-0010 |
(¡Þ)-13-Azaprostanoic Acid ¡Ú13-APA¡Û |
10mg |
¡ï70,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PG038-0050 |
19(R)-HydroxyProstaglandin E2 ¡Ú19(R)-Hydroxy-PGE2¡Û |
50ug |
¡ï13,000 |
|
64625-54-3 |
|
|
|
¡¡ |
BML |
BML-PG038-1000 |
19(R)-HydroxyProstaglandin E2 ¡Ú19(R)-Hydroxy-PGE2¡Û |
1mg |
¡ï169,000 |
|
64625-54-3 |
|
|
|
¡¡ |
BML |
BML-PG039-0050 |
19(R)-HydroxyProstaglandin F2a ¡Ú19(R)-Hydroxy-PGF2a¡Û |
50ug |
¡ï13,000 |
|
64625-53-2 |
|
|
|
¡¡ |
BML |
BML-PG040-0050 |
2,3-Dinor-6-ketoProstaglandin F1a-20,20,20-d3 ¡Ú2,3-Dinor-6-keto-PGF1a-d3¡Û |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PG042-0001 |
17-Phenyl-trinor-Prostaglandin E2 ¡Ú17-Phenyl-trinor-PGE2¡Û |
1mg |
¡ï9,000 |
|
38315-43-4 |
|
|
|
¡¡ |
BML |
BML-PG042-0010 |
17-Phenyl-trinor-Prostaglandin E2 ¡Ú17-Phenyl-trinor-PGE2¡Û |
10mg |
¡ï74,000 |
|
38315-43-4 |
|
|
|
¡¡ |
BML |
BML-PG048-0001 |
13,14-DihydroProstaglandin E1 ¡Ú13,14-Dihydro-PGE1¡Û¡ÚPGE0¡Û |
1mg |
¡ï12,000 |
|
19313-28-1 |
|
|
|
¡¡ |
BML |
BML-PG048-0010 |
13,14-DihydroProstaglandin E1 ¡Ú13,14-Dihydro-PGE1¡Û¡ÚPGE0¡Û |
10mg |
¡ï81,000 |
|
19313-28-1 |
|
|
|
¡¡ |
BML |
BML-PG049-0001 |
8-epi-Prostaglandin F2a ¡Ú8-epi-PGF2a¡Û¡Ú8-iso Prostaglandin F2a¡Û¡Ú8-Isoprostane¡Û |
1mg |
¡ï17,000 |
|
27415-26-5 |
|
|
|
¡¡ |
BML |
BML-PG050-0001 |
15-Deoxy-¦Ä12,14-prostaglandin J2 ¡Ú15-Deoxy-PGJ2¡Û¡Ú15d-PGJ2¡Û |
1mg |
¡ï13,000 |
|
87893-55-8 |
|
|
|
¡¡ |
BML |
BML-PG050-0005 |
15-Deoxy-¦Ä12,14-prostaglandin J2 ¡Ú15-Deoxy-PGJ2¡Û¡Ú15d-PGJ2¡Û |
5mg |
¡ï58,000 |
|
87893-55-8 |
|
|
|
¡¡ |
BML |
BML-PG051-0010 |
Misoprostol ¡ÚSC-29333¡Û¡Ú(¡Þ)-15-Deoxy-(16R,S)-16-hydroxy-16-methyl-prostaglandin E1, Methyl Ester¡Û |
10mg |
¡ï12,000 |
|
59122-46-2 |
|
|
|
¡¡ |
BML |
BML-PG051-0100 |
Misoprostol ¡ÚSC-29333¡Û¡Ú(¡Þ)-15-Deoxy-(16R,S)-16-hydroxy-16-methyl-prostaglandin E1, Methyl Ester¡Û |
100mg |
¡ï82,000 |
|
59122-46-2 |
|
|
|
¡¡ |
BML |
BML-PG052-0001 |
Misoprostol, free Acid ¡Ú(¡Þ)-15-Deoxy-(16R,S)-16-hydroxy-16-methyl-prostaglandin E1¡Û |
1mg |
¡ï9,000 |
|
112137-89-0 |
|
|
|
¡¡ |
BML |
BML-PG052-0010 |
Misoprostol, free Acid ¡Ú(¡Þ)-15-Deoxy-(16R,S)-16-hydroxy-16-methyl-prostaglandin E1¡Û |
10mg |
¡ï65,000 |
|
112137-89-0 |
|
|
|
¡¡ |
BML |
BML-PG9500-0025 |
UCH-L1 ¡ÚUbiquitin C-terminal Hydrolase L1¡Û¡ÚPGP9.5¡Û(human brain), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PG9500-0100 |
UCH-L1 ¡ÚUbiquitin C-terminal Hydrolase L1¡Û¡ÚPGP9.5¡Û(human brain), rabbit pAb(antiserum) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PH002-0050 |
Prostaglandin H2 ¡ÚPGH2¡Û |
50ug |
¡ï11,000 |
|
42935-17-1 |
|
|
|
¡¡ |
BML |
BML-PH002-1000 |
Prostaglandin H2 ¡ÚPGH2¡Û |
1mg |
¡ï154,000 |
|
42935-17-1 |
|
|
|
¡¡ |
BML |
BML-PH100-0010 |
L-a-Phosphatidylinositol ¡Ú1,2-Diacyl-sn-glycero-3-phospho-1-D-myo-inositol, Na¡Û |
10mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PH102-0001 |
L-a-Phosphatidylinositol-4,5-bisphosphate, 5Na salt ¡ÚPtdIns-4,5-P2¡Û¡Ú1,2-Diacyl-sn-glycero-3-phospho-1-D-myo-inositol-4,5-bisphosphate, 5Na¡Û |
1mg |
¡ï65,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PH105-0100 |
L-a-Phosphatidylinositol-3-P ¡ÚPtdIns-3-P¡Û¡Ú1,2-Dipalmitoyl-sn-glycero-3-phospho-1-D-myo-inositol-3-phosphate, 3NH3¡Û |
100ug |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PH106-0100 |
L-a-Phosphatidylinositol-3,4-P2 ¡ÚPtdIns-3,4-P2¡Û¡Ú1,2-Dipalmitoyl-sn-glycero-3-phospho-1-D-myo-inositol-3,4-bisphosphate, 5NH3¡Û |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PH107-0100 |
L-a-Phosphatidylinositol-3,4,5-P3 ¡ÚPtdIns-3,4,5-P3¡Û¡Ú1,2-Dipalmitoyl-sn-glycero-3-phospho-1-D-myo-inositol-3,4,5-trisphosphate, 7Na¡Û |
100ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI100-0005 |
Ac-Leu-Leu-Met-al ¡ÚN-Acetyl-Leu-Leu-Methional¡Û¡ÚALLM¡Û¡ÚAc-LLM-CHO¡Û¡ÚCalpain Inhibitor II¡Û |
5mg |
¡ï10,000 |
|
136632-32-1 |
|
|
|
¡¡ |
BML |
BML-PI100-0025 |
Ac-Leu-Leu-Met-al ¡ÚN-Acetyl-Leu-Leu-Methional¡Û¡ÚALLM¡Û¡ÚAc-LLM-CHO¡Û¡ÚCalpain Inhibitor II¡Û |
25mg |
¡ï42,000 |
|
136632-32-1 |
|
|
|
¡¡ |
BML |
BML-PI101-0010 |
Calpeptin ¡ÚZ-Leu-norleucinal¡Û¡ÚN-Benzyloxycarbonyl-L-leucyl-norleucinal¡Û |
10mg |
¡ï13,000 |
|
117591-20-5 |
|
|
|
¡¡ |
BML |
BML-PI101-0050 |
Calpeptin ¡ÚZ-Leu-norleucinal¡Û¡ÚN-Benzyloxycarbonyl-L-leucyl-norleucinal¡Û |
50mg |
¡ï54,000 |
|
117591-20-5 |
|
|
|
¡¡ |
BML |
BML-PI102-0005 |
MG-132 ¡ÚZ-Leu-Leu-Leu-CHO¡Û¡ÚZ-LLL-CHO¡Û |
5mg |
¡ï10,000 |
|
133407-82-6 |
|
|
|
¡¡ |
BML |
BML-PI102-0025 |
MG-132 ¡ÚZ-Leu-Leu-Leu-CHO¡Û¡ÚZ-LLL-CHO¡Û |
25mg |
¡ï38,000 |
|
133407-82-6 |
|
|
|
¡¡ |
BML |
BML-PI103-0005 |
Elastatinal ¡ÚN-[(S)-1-Carboxyisopentyl]carbamoyl-a-[2-iminohexahydro-4(S)-pyrimidyl]-(S)-glycyl-(S)-glutaminyl-(S)-alaninal¡Û |
5mg |
¡ï9,000 |
|
51798-45-9 |
|
|
|
¡¡ |
BML |
BML-PI103-0025 |
Elastatinal ¡ÚN-[(S)-1-Carboxyisopentyl]carbamoyl-a-[2-iminohexahydro-4(S)-pyrimidyl]-(S)-glycyl-(S)-glutaminyl-(S)-alaninal¡Û |
25mg |
¡ï40,000 |
|
51798-45-9 |
|
|
|
¡¡ |
BML |
BML-PI104-0200 |
Lactacystin |
200ug |
¡ï16,000 |
|
133343-34-7 |
|
|
|
¡¡ |
BML |
BML-PI104-1000 |
Lactacystin |
1mg |
¡ï73,000 |
|
133343-34-7 |
|
|
|
¡¡ |
BML |
BML-PI106-0001 |
E-64-C ¡Ú2S,3S-trans-(Carboxyoxirane-2-carbonyl)-L-leucine-(3-methylbutyl)amide¡Û¡Ú(2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane¡Û |
1mg |
¡ï8,000 |
|
76684-89-4 |
|
|
|
¡¡ |
BML |
BML-PI106-0005 |
E-64-C ¡Ú2S,3S-trans-(Carboxyoxirane-2-carbonyl)-L-leucine-(3-methylbutyl)amide¡Û¡Ú(2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane¡Û |
5mg |
¡ï34,000 |
|
76684-89-4 |
|
|
|
¡¡ |
BML |
BML-PI107-0001 |
E-64-D ¡Ú2S,3S-trans-(Ethoxycarbonyloxirane-2-carbonyl)-L-leucine-(3-methylbutyl)amide¡Û¡Ú(2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane Ethyl Ester¡Û |
1mg |
¡ï8,000 |
|
88321-09-9 |
|
|
|
¡¡ |
BML |
BML-PI107-0005 |
E-64-D ¡Ú2S,3S-trans-(Ethoxycarbonyloxirane-2-carbonyl)-L-leucine-(3-methylbutyl)amide¡Û¡Ú(2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane Ethyl Ester¡Û |
5mg |
¡ï34,000 |
|
88321-09-9 |
|
|
|
¡¡ |
BML |
BML-PI108-0100 |
clasto-Lactacystin B-Lactone ¡ÚOmuralide¡Û |
100ug |
¡ï29,000 |
|
155975-72-7 |
|
|
|
¡¡ |
BML |
BML-PI109-0100 |
Z-Leu-Leu-Leu-B(OH)2 ¡ÚMG-262¡Û¡ÚZ-LLL-B(OH)2¡Û¡ÚProteasome Inhibitor III¡Û |
100ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI110-0010 |
3,4-Dichloroisocoumarin |
10mg |
¡ï28,000 |
|
51050-59-0 |
|
|
|
¡¡ |
BML |
BML-PI111-0005 |
Phosphoramidon ¡ÚN-(a-Rhamnopyranosyloxyhydroxyphosphinyl)-L-leucyl-L-tryptophan¡Û¡ÚN-(a-Rhamnopyranosyloxyhydroxyphosphinyl)-Leu-Trp-OH, 2Na¡Û |
5mg |
¡ï19,000 |
|
119942-99-3 |
|
|
|
¡¡ |
BML |
BML-PI111-0025 |
Phosphoramidon ¡ÚN-(a-Rhamnopyranosyloxyhydroxyphosphinyl)-L-leucyl-L-tryptophan¡Û¡ÚN-(a-Rhamnopyranosyloxyhydroxyphosphinyl)-Leu-Trp-OH, 2Na¡Û |
25mg |
¡ï79,000 |
|
119942-99-3 |
|
|
|
¡¡ |
BML |
BML-PI112-0005 |
Z-Prolyl-prolinal ¡ÚZ-Pro-Pro-CHO¡Û¡ÚZ-PP-CHO¡Û |
5mg |
¡ï8,000 |
|
86925-97-5 |
|
|
|
¡¡ |
BML |
BML-PI112-0025 |
Z-Prolyl-prolinal ¡ÚZ-Pro-Pro-CHO¡Û¡ÚZ-PP-CHO¡Û |
25mg |
¡ï33,000 |
|
86925-97-5 |
|
|
|
¡¡ |
BML |
BML-PI113-0005 |
Thiorphan ¡ÚDL-Thiorphan¡Û¡ÚDL-3-Mercapto-2-benzylpropanoylglycine¡Û |
5mg |
¡ï10,000 |
|
76721-89-6 |
|
|
|
¡¡ |
BML |
BML-PI113-0025 |
Thiorphan ¡ÚDL-Thiorphan¡Û¡ÚDL-3-Mercapto-2-benzylpropanoylglycine¡Û |
25mg |
¡ï41,000 |
|
76721-89-6 |
|
|
|
¡¡ |
BML |
BML-PI115-0005 |
NNGH ¡ÚN-Isobutyl-N-(4-methoxyphenylsulfonyl)glycylhydroxamic Acid¡Û¡ÚBML-205¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI115-0025 |
NNGH ¡ÚN-Isobutyl-N-(4-methoxyphenylsulfonyl)glycylhydroxamic Acid¡Û¡ÚBML-205¡Û |
25mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI116-0005 |
Z-Leu-Leu-CHO(Calpain Inhibitor) |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI116-0025 |
Z-Leu-Leu-CHO(Calpain Inhibitor) |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI117-0005 |
PPACK ¡ÚD-Phe-Pro-Arg-CMK¡Û(Potent Irreversible Thrombin Inhibitor) |
5mg |
¡ï17,000 |
|
71142-71-7 |
|
|
|
¡¡ |
BML |
BML-PI117-0025 |
PPACK ¡ÚD-Phe-Pro-Arg-CMK¡Û(Potent Irreversible Thrombin Inhibitor) |
25mg |
¡ï73,000 |
|
71142-71-7 |
|
|
|
¡¡ |
BML |
BML-PI121-0200 |
TLCK ¡ÚNa-Tosyl-Lys-chloromethylketone, HCl¡Û |
200mg |
¡ï11,000 |
|
4238-41-9 |
|
|
|
¡¡ |
BML |
BML-PI122-0001 |
TPCK ¡ÚNa-Tosyl-Phe-chloromethylketone, HCl¡Û |
1g |
¡ï18,000 |
|
402-71-1 |
|
|
|
¡¡ |
BML |
BML-PI123-0005 |
AAF-CMK ¡ÚAla-Ala-Phe-chloromethylketone, TFA ¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI123-0025 |
AAF-CMK ¡ÚAla-Ala-Phe-chloromethylketone, TFA ¡Û |
25mg |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI124-0005 |
Z-AAF-CMK ¡ÚZ-Ala-Ala-Phe-CMK¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI125-0001 |
NapSul-Ile-Trp-CHO ¡ÚCathepsin L inhibitor¡Û¡Ú1-Napthalenesulfonyl-Ile-Trp-Aldehyde¡Û |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI125-0005 |
NapSul-Ile-Trp-CHO ¡ÚCathepsin L inhibitor¡Û¡Ú1-Napthalenesulfonyl-Ile-Trp-Aldehyde¡Û |
5mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI126-0001 |
CA-074 Me ¡ÚN-(L-3-trans-Propylcarbonyloxirane-2-carbonyl)-L-isoleucyl-L-proline Methyl Ester¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI127-0100 |
Epoxomicin |
100ug |
¡ï26,000 |
|
134381-21-8 |
|
|
|
¡¡ |
BML |
BML-PI128-0005 |
Boc-Gly-Val-Val-CHO ¡ÚBoc-GVV-CHO¡Û¡Ú¦Ã-secretase Inhibitor¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI128-0025 |
Boc-Gly-Val-Val-CHO ¡ÚBoc-GVV-CHO¡Û¡Ú¦Ã-secretase Inhibitor¡Û |
25mg |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI129-0002 |
Gliotoxin ¡Ú[3R-(3a, 5aB,6B,10aa)]-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epi-dithiopyrazino[1,2-a]indole-1,4-dione¡Û |
2mg |
¡ï16,000 |
|
67-99-2 |
|
|
|
¡¡ |
BML |
BML-PI129-0010 |
Gliotoxin ¡Ú[3R-(3a, 5aB,6B,10aa)]-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epi-dithiopyrazino[1,2-a]indole-1,4-dione¡Û |
10mg |
¡ï49,000 |
|
67-99-2 |
|
|
|
¡¡ |
BML |
BML-PI130-0010 |
MDL-28170 ¡ÚZ-Val-Phe-CHO¡Û(Potent, selective, Cell Permeable Calpain Inhibitor) |
10mg |
¡ï7,000 |
|
88191-84-8 |
|
|
|
¡¡ |
BML |
BML-PI130-0050 |
MDL-28170 ¡ÚZ-Val-Phe-CHO¡Û(Potent, selective, Cell Permeable Calpain Inhibitor) |
50mg |
¡ï29,000 |
|
88191-84-8 |
|
|
|
¡¡ |
BML |
BML-PI133-0001 |
TAPI-0 ¡ÚIC1¡Û¡ÚN-(R)-(2-(Hydroxyaminocarbonyl)Methyl)-4-Methylpentanoyl-L-Naphthylalanyl-L-Alanine Amide¡Û |
1mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI134-0001 |
TAPI-1 ¡ÚIC2¡Û¡ÚN-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4-methylpentanoyl-L-naphthylalanyl-L-alanine 2-aminoethyl Amide¡Û |
1mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI135-0001 |
TAPI-2 ¡ÚIC3¡Û¡ÚN-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4-methylpentanoyl-L-tert-butyl-glycine-L-alanine 2-Aminoethyl Amide¡Û |
1mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI136-0001 |
CTT ¡ÚGelatinase Inhibitor¡Û |
1mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI136-0005 |
CTT ¡ÚGelatinase Inhibitor¡Û |
5mg |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI137-0001 |
STT Negative Control for Gelatinase |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI137-0005 |
STT Negative Control for Gelatinase |
5mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI138-0001 |
Z-Phe-Ala-FMK |
1mg |
¡ï14,000 |
|
197855-65-5 |
|
|
|
¡¡ |
BML |
BML-PI138-0005 |
Z-Phe-Ala-FMK |
5mg |
¡ï59,000 |
|
197855-65-5 |
|
|
|
¡¡ |
BML |
BML-PI139-0100 |
Z-Pro-Leu-Gly-NHOH ¡ÚBenzyloxycarbonyl-prolyl-leucyl-glycyl-hydroxamate¡Û |
100mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI140-0005 |
BML-244 ¡ÚBoc-L-Norleucinal¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI140-0025 |
BML-244 ¡ÚBoc-L-Norleucinal¡Û |
25mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI142-0010 |
P32/98 ¡Ú3-N-[((2S,3S)-2-Amino-3-methylpentanoyl]-1,3-thiazolidine Hemifumarate¡Û |
10mg |
¡ï14,000 |
|
136259-20-6 |
|
|
|
¡¡ |
BML |
BML-PI142-0050 |
P32/98 ¡Ú3-N-[((2S,3S)-2-Amino-3-methylpentanoyl]-1,3-thiazolidine Hemifumarate¡Û |
50mg |
¡ï68,000 |
|
136259-20-6 |
|
|
|
¡¡ |
BML |
BML-PI143-0010 |
Nafamostat, Mesylate |
10mg |
¡ï9,000 |
|
82956-11-4 |
|
|
|
¡¡ |
BML |
BML-PI143-0050 |
Nafamostat, Mesylate |
50mg |
¡ï37,000 |
|
82956-11-4 |
|
|
|
¡¡ |
BML |
BML-PI144-0010 |
Gabexate, Mesylate ¡Ú4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic Acid Ethyl Ester, Mesylate¡Û¡ÚEthyl 4-(6-Guanidinohexanoyloxy)benzoate Methanesulfonate¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI144-0050 |
Gabexate, Mesylate ¡Ú4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic Acid Ethyl Ester, Mesylate¡Û¡ÚEthyl 4-(6-Guanidinohexanoyloxy)benzoate Methanesulfonate¡Û |
50mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI145-0001 |
Apstatin ¡ÚN-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-prolyl-L-prolyl-L-alaninamide¡Û |
1mg |
¡ï10,000 |
|
160470-73-5 |
|
|
|
¡¡ |
BML |
BML-PI146-0010 |
Argatroban ¡Ú(2R,4R)-4-Methyl-1-[N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic Acid¡Û |
10mg |
¡ï13,000 |
|
74863-84-6 |
|
|
|
¡¡ |
BML |
BML-PI146-0050 |
Argatroban ¡Ú(2R,4R)-4-Methyl-1-[N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic Acid¡Û |
50mg |
¡ï55,000 |
|
74863-84-6 |
|
|
|
¡¡ |
BML |
BML-PI147-0005 |
PKSI-527 ¡Útrans-4-Aminomethylcyclohexanecarbonylphenylalanyl-4-carboxymethylanilide¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI147-0025 |
PKSI-527 ¡Útrans-4-Aminomethylcyclohexanecarbonylphenylalanyl-4-carboxymethylanilide¡Û |
25mg |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI153-0010 |
Cilastatin Sodium ¡Ú[R-[R*,S*-(Z)]]-7-[(2-Amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-2-heptenoic Acid, Na salt¡Û |
10mg |
¡ï8,000 |
|
81129-83-1 |
|
|
|
¡¡ |
BML |
BML-PI153-0050 |
Cilastatin Sodium ¡Ú[R-[R*,S*-(Z)]]-7-[(2-Amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-2-heptenoic Acid, Na salt¡Û |
50mg |
¡ï37,000 |
|
81129-83-1 |
|
|
|
¡¡ |
BML |
BML-PI155-0001 |
PF-356231 ¡Ú(3R)-3-Phenyl-[[(4-pyridin-4-ylphenyl)thiophene-2-carbonyl]amino]propanoic Acid¡Û |
1mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI155-0005 |
PF-356231 ¡Ú(3R)-3-Phenyl-[[(4-pyridin-4-ylphenyl)thiophene-2-carbonyl]amino]propanoic Acid¡Û |
5mg |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PI156-0005 |
H-Glu-Gly-Arg-chloromethylketone ¡ÚH-Glu-Gly-Arg-CMK¡Û¡ÚEGR-CMK¡Û |
5mg |
¡ï23,000 |
|
65113-67-9 |
|
|
|
¡¡ |
BML |
BML-PI157-0010 |
Sivelestat Sodium ¡ÚONO-5046¡Û¡ÚN-[2-({4-(2,2-Dimethylpropanoyl)oxy]phenyl}sulfonyl}amino)benzoyl]glycine, Na salt¡Û |
10mg |
¡ï11,000 |
|
201677-61-4 |
|
|
|
¡¡ |
BML |
BML-PI157-0050 |
Sivelestat Sodium ¡ÚONO-5046¡Û¡ÚN-[2-({4-(2,2-Dimethylpropanoyl)oxy]phenyl}sulfonyl}amino)benzoyl]glycine, Na salt¡Û |
50mg |
¡ï46,000 |
|
201677-61-4 |
|
|
|
¡¡ |
BML |
BML-PL005-0001 |
5-Lipoxygenase(potato)(Isolated from potato) |
1mg |
¡ï101,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PL012-0100 |
12-Lipoxygenase(porcine)(Isolated from pig leukocytes) |
100U |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PL015-5000 |
15-Lipoxygenase(rabbit)(Isolated from rabbit reticulocytes) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9350-0100 |
Valosin-containing Protein ¡ÚVCP¡Û, Blocking peptide for Valosin-containing protein pAb(Prod. No. BML-PW9335) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9360-0100 |
aB-Crystallin Peptide, Blocking Peptide for aB-Crystallin(human)pAb(Prod. No. BML-CA9360) |
100ug |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9365-0100 |
Parkin, Blocking Peptide for Parkin(human)pAb(Prod. No. BML-PW9365) |
100ug |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9470-0100 |
SUMO-1(NT), Blocking peptide for SUMO-1(human)(NT)pAb(Prod. No. BML-PW8330) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9475-0100 |
SUMO-1(CT), Blocking peptide for SUMO-1(human)(CT)pAb(Prod. No. BML-PW9460) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9480-0100 |
SUMO-2/3 ¡ÚSmall Ubiquitin-related Modifier 2/3¡Û(NT), Blocking Peptide for SUMO-2/3(human)(NT)pAb(Prod. No. BML-PW9465) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9543-0100 |
N-Acetyl-Peptide YY(3-36)amide(porcine/rat) |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9580-0100 |
FAT10, Blocking Peptide for FAT10 pAb(Prod. No. BML-PW9585) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9590-0100 |
ISG15, Blocking Peptide for ISG15(human)pAb(Prod. No. BML-PW9575) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9600-0100 |
Urm1 ¡ÚUbiquitin-related Modifier 1¡Û, Blocking Peptide for Urm1(human)pAb(Prod. No. BML-PW9595) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9610-0100 |
Ubl5 ¡ÚUbiquitin-Like Protein 5¡Û, Blocking Peptide for Ubl5(human)pAb(Prod. No. BML-PW9605) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9620-0100 |
Fub1, Blocking Peptide for Fub1(human)pAb(Prod. No. BML-PW9615) |
100ug |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PP9630-0100 |
Rpn11, Blocking Peptide for Proteasome 19S Rpn11/S13 subunit(human)pAb(Prod. No. BML-PW9625) |
100ug |
¡ï6,000 |
|
none |
|
|
|
·àʪ |
BML |
BML-PR100-0010 |
Cypermethrin ¡ÚAlphamethrine¡Û¡ÚPestanal¡Û¡Ú(R,S)-a-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
10mg |
¡ï6,000 |
|
52315-07-8 |
|
|
|
·àʪ |
BML |
BML-PR100-0050 |
Cypermethrin ¡ÚAlphamethrine¡Û¡ÚPestanal¡Û¡Ú(R,S)-a-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
50mg |
¡ï26,000 |
|
52315-07-8 |
|
|
|
·àʪ |
BML |
BML-PR101-0010 |
Deltamethrin ¡Ú(S)-a-Cyano-(3-phenoxybenzyl(1R)-cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
10mg |
¡ï8,000 |
|
52918-63-5 |
|
|
|
·àʪ |
BML |
BML-PR101-0050 |
Deltamethrin ¡Ú(S)-a-Cyano-(3-phenoxybenzyl(1R)-cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
50mg |
¡ï33,000 |
|
52918-63-5 |
|
|
|
·àʪ |
BML |
BML-PR102-0020 |
Fenvalerate ¡Úa-Cyano-3-phenoxybenzyl a-(4-Chlorophenyl)isovalerate¡Û |
20mg |
¡ï4,000 |
|
51630-58-1 |
|
|
|
·àʪ |
BML |
BML-PR102-0100 |
Fenvalerate ¡Úa-Cyano-3-phenoxybenzyl a-(4-Chlorophenyl)isovalerate¡Û |
100mg |
¡ï19,000 |
|
51630-58-1 |
|
|
|
¡¡ |
BML |
BML-PR103-0010 |
Permethrin ¡Ú3-Phenoxybenzyl(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
10mg |
¡ï4,000 |
|
52645-53-1 |
|
|
|
¡¡ |
BML |
BML-PR103-0050 |
Permethrin ¡Ú3-Phenoxybenzyl(1R,S)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate¡Û |
50mg |
¡ï19,000 |
|
52645-53-1 |
|
|
|
¡¡ |
BML |
BML-PR104-0500 |
Calcineurin Inhibitory Peptide ¡ÚCN412¡Û |
0.5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR106-0010 |
Cantharidic Acid ¡Úexo-1,6-Dicarboxy-endo-1,6-dimethyl-7-oxabicyclo[2.2.1]heptane¡Û |
10mg |
¡ï7,000 |
|
28874-45-5 |
|
|
|
¡¡ |
BML |
BML-PR106-0050 |
Cantharidic Acid ¡Úexo-1,6-Dicarboxy-endo-1,6-dimethyl-7-oxabicyclo[2.2.1]heptane¡Û |
50mg |
¡ï31,000 |
|
28874-45-5 |
|
|
|
·àʪ |
BML |
BML-PR107-0020 |
Endothall ¡Ú7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid¡Û |
20mg |
¡ï4,000 |
|
145-73-3 |
|
|
|
·àʪ |
BML |
BML-PR107-0100 |
Endothall ¡Ú7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid¡Û |
100mg |
¡ï19,000 |
|
145-73-3 |
|
|
|
¡¡ |
BML |
BML-PR108-0010 |
1,4-Dimethylendothall ¡Ú1,4-Dimethyl-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid¡Û |
10mg |
¡ï7,000 |
|
109282-27-1 |
|
|
|
¡¡ |
BML |
BML-PR108-0050 |
1,4-Dimethylendothall ¡Ú1,4-Dimethyl-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid¡Û |
50mg |
¡ï28,000 |
|
109282-27-1 |
|
|
|
¡¡ |
BML |
BML-PR109-0005 |
RWJ-60475 ¡Ú2-(4-Bromophenoxy)-5-nitrophenylhydroxymethylphosphonic Acid¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR110-0001 |
RWJ-60475,(AM)3 ¡Ú2-(4-Bromophenoxy)-5-nitrophenylhydroxymethylphosphonic Acid, tris(Acetoxymethyl Ester)¡Û |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR112-0200 |
RK-682(Novel Tyrosine Phosphatase Inhibitor) |
200ug |
¡ï14,000 |
|
154639-24-4 |
|
|
|
¡¡ |
BML |
BML-PR112-1000 |
RK-682(Novel Tyrosine Phosphatase Inhibitor) |
1mg |
¡ï56,000 |
|
154639-24-4 |
|
|
|
·àʪ |
BML |
BML-PR113-0010 |
Tyrphostin 8 ¡Úa-Cyano-(4-hydroxy)cinnamonitrile¡Û¡ÚAG-10¡Û |
10mg |
¡ï9,000 |
|
3785-90-8 |
|
|
|
¡¡ |
BML |
BML-PR114-0001 |
CinnGEL(Novel Peptoid Inhibitor) |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR115-0001 |
CinnGEL 2-Methyl Ester(Novel Peptoid Inhibitor) |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR117-0010 |
Artesunate ¡Ú4-(5-Benzylidene-4-oxo-2-thioxothiazolidine-3yl)benzoic Acid¡Û |
10mg |
¡ï9,000 |
|
88495-63-0 |
|
|
|
¡¡ |
BML |
BML-PR117-0050 |
Artesunate ¡Ú4-(5-Benzylidene-4-oxo-2-thioxothiazolidine-3yl)benzoic Acid¡Û |
50mg |
¡ï37,000 |
|
88495-63-0 |
|
|
|
¡¡ |
BML |
BML-PR119-0010 |
BML-260 ¡Ú4-(5-Benzylidene-4-oxo-2-thioxothiazolidine-3yl)benzoic Acid¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR119-0050 |
BML-260 ¡Ú4-(5-Benzylidene-4-oxo-2-thioxothiazolidine-3yl)benzoic Acid¡Û |
50mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR121-0010 |
BML-267 ¡Ú6-Methyl-2-(oxalylamino)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic Acid, TFA salt¡Û |
10mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR121-0050 |
BML-267 ¡Ú6-Methyl-2-(oxalylamino)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic Acid, TFA salt¡Û |
50mg |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PR131-0050 |
BMOV ¡ÚBis(maltolato)oxovanadium(IV)¡Û |
50mg |
¡ï7,000 |
|
38213-69-3 |
|
|
|
¡¡ |
BML |
BML-PR131-0250 |
BMOV ¡ÚBis(maltolato)oxovanadium(IV)¡Û |
250mg |
¡ï28,000 |
|
38213-69-3 |
|
|
|
¡¡ |
BML |
BML-PW0150-0025 |
Mono- and Polyubiquitinated Conjugates(polyubiquitinylated-lysozyme)[FK2H], mouse mAb, -HRP conj. |
25ug |
¡ï11,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW0150-0100 |
Mono- and Polyubiquitinated Conjugates(polyubiquitinylated-lysozyme)[FK2H], mouse mAb, -HRP conj. |
100ug |
¡ï39,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW0190-0025 |
CUL1(Arabidopsis thaliana)¡ÚAtCUL1¡Û(full length, recombinant), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis CUL1 | WB |
|
|
¡¡ |
BML |
BML-PW0190-0100 |
CUL1(Arabidopsis thaliana)¡ÚAtCUL1¡Û(full length, recombinant), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis CUL1 | WB |
|
|
¡¡ |
BML |
BML-PW0325-0025 |
Sp100(human, aa 292-304), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0325-0100 |
Sp100(human, aa 292-304), rabbit pAb, purified(specificity: human) |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0330-0025 |
Sp100(SUMO modified)(human, aa 292-304), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | ICC |
|
|
¡¡ |
BML |
BML-PW0330-0100 |
Sp100(SUMO modified)(human, aa 292-304), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | ICC |
|
|
¡¡ |
BML |
BML-PW0365-0025 |
SENP5 ¡ÚSentrin-specific protease 5¡Û(human, aa 60-77), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0365-0100 |
SENP5 ¡ÚSentrin-specific protease 5¡Û(human, aa 60-77), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0370-0025 |
SENP6 ¡ÚSentrin-specific Protease 6¡Û¡ÚSUSP1¡Û¡ÚSUMO-1-specific Protease 1¡Û(human, aa 635-1112)(recombinant), sheep pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0370-0100 |
SENP6 ¡ÚSentrin-specific Protease 6¡Û¡ÚSUSP1¡Û¡ÚSUMO-1-specific Protease 1¡Û(human, aa 635-1112)(recombinant), sheep pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0430-0025 |
PBA1(Arabidopsis thaliana)¡ÚProteasome 20S(PBA1/B1 Subunit)¡Û¡Ú20S Proteasome B subunit A1¡Û¡ÚPBA1¡Û(full-length, Arabidopsis PBA1), rabbit pAb(neat serum) |
25ul |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 20S (PBA1/¦Â1 subunit) | WB |
|
|
¡¡ |
BML |
BML-PW0430-0100 |
PBA1(Arabidopsis thaliana)¡ÚProteasome 20S(PBA1/B1 Subunit)¡Û¡Ú20S Proteasome B subunit A1¡Û¡ÚPBA1¡Û(full-length, Arabidopsis PBA1), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 20S (PBA1/¦Â1 subunit) | WB |
|
|
¡¡ |
BML |
BML-PW0435-0025 |
PBF1(Arabidopsis thaliana)¡ÚProteasome 20S(PBF1/B6 Subunit)¡Û¡Ú20S Proteasome B subunit F1¡Û¡ÚPBF1¡Û(Full-length Arabidopsis B6 subunit), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 20S (PBF1/¦Â6 subunit) | WB |
|
|
¡¡ |
BML |
BML-PW0435-0100 |
PBF1(Arabidopsis thaliana)¡ÚProteasome 20S(PBF1/B6 Subunit)¡Û¡Ú20S Proteasome B subunit F1¡Û¡ÚPBF1¡Û(Full-length Arabidopsis B6 subunit), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 20S (PBF1/¦Â6 subunit) | WB |
|
|
¡¡ |
BML |
BML-PW0440-0025 |
Proteasome 19S Rpn12/S14 subunit(full-length Arabidopsis proteasome 26S), rabbit pAb(serum) |
25ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 26S | WB |
|
|
¡¡ |
BML |
BML-PW0445-0025 |
Proteasome 19S Rpt2/S4 subunit(full-length Arabidopsis proteasome 26S), rabbit pAb |
25ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 26S | WB |
|
|
¡¡ |
BML |
BML-PW0445-0100 |
Proteasome 19S Rpt2/S4 subunit(full-length Arabidopsis proteasome 26S), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis proteasome 26S | WB |
|
|
¡¡ |
BML |
BML-PW0450-0025 |
Proteasome 19S Rpn5 subunit(full length A. thaliana protein), rabbit pAb(neat serum) |
25ul |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | A. thaliana | WB |
|
|
¡¡ |
BML |
BML-PW0455-0025 |
DDA1 ¡ÚPCIA1¡Û¡ÚDET1- and DDB1-Associated Protein 1¡Û¡ÚPlacenta Cross-immune Reaction Antigen 1¡Û(human, peptide), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0455-0100 |
DDA1 ¡ÚPCIA1¡Û¡ÚDET1- and DDB1-Associated Protein 1¡Û¡ÚPlacenta Cross-immune Reaction Antigen 1¡Û(human, peptide), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0460-0025 |
DDB1 ¡ÚDamage-specific DNA Binding protein 1¡Û(human, aa 756-1140)(recombinant)(CT), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW0465-0025 |
AtRbx1 ¡ÚRING-box Protein 1a¡Û¡ÚAtRoc1¡Û¡ÚProtein RING of Cullins 1¡Û(full length Arabidopsis AtRbx1), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis COP9 signalosome | WB |
|
|
¡¡ |
BML |
BML-PW0470-0025 |
AtCul3(Arabidopsis thaliana)¡ÚCullin 3-like Protein¡Û(Arabidopsis AtCUL3, aa 1-333)(recombinant)(NT), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis AtCUL3 | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0480-0025 |
PAC1 ¡ÚProteasome Assembling Chaperone-1¡Û¡ÚDSCR2¡Û¡ÚDown's Syndrome Critical Region Protein 2¡Û(human, full length)(recombinant)[EX-5], mouse mAb, purified(specificity: human) |
25ug |
¡ï14,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-5 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0480-0100 |
PAC1 ¡ÚProteasome Assembling Chaperone-1¡Û¡ÚDSCR2¡Û¡ÚDown's Syndrome Critical Region Protein 2¡Û(human, full length)(recombinant)[EX-5], mouse mAb, purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-5 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0485-0025 |
PAC2 ¡ÚProteasome Assembling Chaperone-2¡Û¡ÚHCCA3¡Û¡ÚHepatocellular Carcinoma Associated Gene 3¡Û(human, full length)(recombinant)[EX-6], mouse mAb, purified(specificity: human) |
25ug |
¡ï14,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-6 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0485-0100 |
PAC2 ¡ÚProteasome Assembling Chaperone-2¡Û¡ÚHCCA3¡Û¡ÚHepatocellular Carcinoma Associated Gene 3¡Û(human, full length)(recombinant)[EX-6], mouse mAb, purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-6 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0490-0025 |
PAC3 ¡ÚProteasome Assembling Chaperone-3¡Û(human, full length)(recombinant)[EX-7], mouse mAb, purified(specificity: human) |
25ug |
¡ï14,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-7 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0490-0100 |
PAC3 ¡ÚProteasome Assembling Chaperone-3¡Û(human, full length)(recombinant)[EX-7], mouse mAb, purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-7 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW0505-0025 |
SUMO-1 ¡ÚSentrin-1¡Û¡ÚSmall Ubiquitin-related Modifier-1¡Û(human, full length)(recombinant), sheep pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0505-0100 |
SUMO-1 ¡ÚSentrin-1¡Û¡ÚSmall Ubiquitin-related Modifier-1¡Û(human, full length)(recombinant), sheep pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0510-0025 |
SUMO-2 ¡ÚSentrin-2¡Û¡ÚSmall Ubiquitin-related Modifier-2¡Û(human, full length)(recombinant), sheep pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0510-0100 |
SUMO-2 ¡ÚSentrin-2¡Û¡ÚSmall Ubiquitin-related Modifier-2¡Û(human, full length)(recombinant), sheep pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0525-0025 |
UBA6 ¡Úubiquitin-Like Modifier Activating Enzyme-6¡Û¡ÚUbE1L2¡Û(human, aa 1034-1052), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0525-0100 |
UBA6 ¡Úubiquitin-Like Modifier Activating Enzyme-6¡Û¡ÚUbE1L2¡Û(human, aa 1034-1052)(CT), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0530-0025 |
Proteasome 19S Rpt2/S4 Subunit ¡Ú26S Proteasome Subunit ATPase 1¡Û¡Ú19S Regulator ATPase Subunit Rpt2(S4)¡Û(human, aa 368-383), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0530-0100 |
Proteasome 19S Rpt2/S4 Subunit ¡Ú26S Proteasome Subunit ATPase 1¡Û¡Ú19S Regulator ATPase Subunit Rpt2(S4)¡Û(human, aa 368-383), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0535-0025 |
E6AP ¡ÚUBE3A¡Û(human)(recombinant)[EX-8], mouse mAb, purified(specificity: human) |
25ug |
¡ï14,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-8 | human | WB |
|
|
¡¡ |
BML |
BML-PW0535-0100 |
E6AP ¡ÚUBE3A¡Û(human)(recombinant)[EX-8], mouse mAb, purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-8 | human | WB |
|
|
¡¡ |
BML |
BML-PW0540-0025 |
USP7 ¡ÚUbiquitin Thioesterase 7¡Û¡ÚUbiquitin-Specific-Processing Protease 7¡Û¡ÚHAUSP¡Û¡ÚHerpesvirus-Associated Ubiquitin-Specific Protease¡Û(human, aa 29-40), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0540-0100 |
USP7 ¡ÚUbiquitin Thioesterase 7¡Û¡ÚUbiquitin-Specific-Processing Protease 7¡Û¡ÚHAUSP¡Û¡ÚHerpesvirus-Associated Ubiquitin-Specific Protease¡Û(human, aa 29-40), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0570-0025 |
Blm10(Saccharomyces cerevisiae)¡ÚBlm3¡Û¡ÚPA200 Homolog¡Û(Saccharomyces cervisiae, aa 1-157)(recombinant)(NT), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Saccharomyces cervisiae | WB |
|
|
¡¡ |
BML |
BML-PW0575-0001 |
Proteasome ELISA Kit(96 wells(24 tests in triplicate)) |
96wells |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW0580-0025 |
Ubiquitin(synthesised polyubiquitin chains)[EX-9], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0580-0100 |
Ubiquitin(synthesised polyubiquitin chains)[EX-9], mouse mAb(purified) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0585-0025 |
USP21 ¡ÚUbiquitin Thioesterase 21¡Û¡ÚUbiquitin-Specific-Processing Protease 21¡Û¡ÚDeubiquitinating Enzyme 21¡Û¡ÚNEDD8-Specific Protease¡Û(human, aa 60-74), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0585-0100 |
USP21 ¡ÚUbiquitin Thioesterase 21¡Û¡ÚUbiquitin-Specific-Processing Protease 21¡Û¡ÚDeubiquitinating Enzyme 21¡Û¡ÚNEDD8-Specific Protease¡Û(human, aa 60-74), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0595A-0025 |
Huntingtin ¡ÚHtt¡Û¡ÚHD Protein¡Û(human, aa 2-17)(synthetic peptide), rabbit Pab, Affinity-purified |
25ul |
¡ï13,000 |
-20¡î |
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢rat | WB(~350kDa) |
Replaces Prod. #: BML-PW0595, 0.09% sodium azide
|
|
¡¡ |
BML |
BML-PW0595A-0100 |
Huntingtin ¡ÚHtt¡Û¡ÚHD Protein¡Û(human, aa 2-17)(synthetic peptide), rabbit Pab, Affinity-purified |
100ul |
¡ï43,000 |
-20¡î |
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢rat | WB(~350kDa) |
Replaces Prod. #: BML-PW0595, 0.09% sodium azide
|
|
¡¡ |
BML |
BML-PW0600-0025 |
Polyubiquitin(K63-Linkage-Specific)(synthetic peptide)[HWA4C4], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | HWA4C4 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW0600-0100 |
Polyubiquitin(K63-Linkage-Specific)(synthetic peptide)[HWA4C4], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | HWA4C4 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW0605-0025 |
Polyubiquitin(K63-Linkage-Specific)(synthetic peptide)[HWA4C4], mouse mAb, -HRP conj. |
25ug |
¡ï18,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | HWA4C4 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0605-0100 |
Polyubiquitin(K63-Linkage-Specific)(synthetic peptide)[HWA4C4], mouse mAb, -HRP conj. |
100ug |
¡ï61,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | HWA4C4 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0655-0025 |
AMSH ¡ÚSTAMBP¡Û¡ÚSTAM-Binding Protein¡Û¡ÚAssociated Molecule with the SH3-domain of STAM¡Û(human, full-length)(recombinant), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0655-0100 |
AMSH ¡ÚSTAMBP¡Û¡ÚSTAM-Binding Protein¡Û¡ÚAssociated Molecule with the SH3-domain of STAM¡Û(human, full-length)(recombinant), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0660-0025 |
MYSM1 ¡ÚMyb-Like, SWIRM and MPN Domain-containing Protein 1¡Û(human, aa 665-679), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0660-0100 |
MYSM1 ¡ÚMyb-Like, SWIRM and MPN Domain-containing Protein 1¡Û(human, aa 665-679), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0690-0025 |
Tripeptidyl Peptidase II ¡ÚTPPII¡Û(human, erythrocyte), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0690-0100 |
Tripeptidyl Peptidase II ¡ÚTPPII¡Û(human, erythrocyte), rabbit pAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0755-0025 |
Mono- and Polyubiquitinated conjugates(polyubiquitinylated-lysozyme)[FK2], mouse mAb, -Biotin conj. |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0755-0100 |
Mono- and Polyubiquitinated conjugates(polyubiquitinylated-lysozyme)[FK2], mouse mAb, -Biotin conj. |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0760-0025 |
CYLD(human, aa 336-353), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0760-0100 |
CYLD(human, aa 336-353), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0765-0025 |
FAT10(human)(recombinant)[4F1], mouse mAb, Affinity-purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | 4F1 | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0765-0100 |
FAT10(human)(recombinant)[4F1], mouse mAb, Affinity-purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | 4F1 | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-PW0770-0025 |
Use1(human, aa 231-242 ), rabbit pAb,(crude serum)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0770-0100 |
Use1(human, aa 231-242 ), rabbit pAb,(crude serum)(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0835-0025 |
Ubiquitin(synthesised Polyubiquitin Chains)[EX-9], mouse mAb, -HRP conj. |
25ul |
¡ï18,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0835-0100 |
Ubiquitin(synthesised Polyubiquitin Chains)[EX-9], mouse mAb, -HRP conj. |
100ul |
¡ï51,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0920-0025 |
Herc5(human, aa 402-414), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0920-0100 |
Herc5(human, aa 402-414), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0930-0100 |
Ubiquitin(bovine, denatured)[P4D1], mouse mAb, purified |
100ug |
¡ï19,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P4D1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0930-1000 |
Ubiquitin(bovine, denatured)[P4D1], mouse mAb, purified |
1mg |
¡ï118,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P4D1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0935-0025 |
Ubiquitin(bovine, denatured)[P4D1], mouse mAb, -HRP conj. |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P4D1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0935-0100 |
Ubiquitin(bovine, denatured)[P4D1], mouse mAb, -HRP conj. |
100ul |
¡ï40,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P4D1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW0945-0025 |
USP18 ¡ÚUBP43¡Û¡ÚISG15 Specific Protease¡Û(human, aa 89-100 ), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0945-0100 |
USP18 ¡ÚUBP43¡Û¡ÚISG15 Specific Protease¡Û(human, aa 89-100 ), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0950-0025 |
Huwe1 ¡ÚHECT, UBA and WWE Domain-containing Protein 1¡Û¡ÚUpstream Regulatory Element-binding Protein 1¡Û¡ÚURE-B1¡Û¡ÚMcl-1 Ubiquitin Ligase E3¡Û¡ÚMule¡Û¡ÚARF-binding Protein 1¡Û¡ÚLarge Structure of URE |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat¡¢ human | WB |
|
|
¡¡ |
BML |
BML-PW0950-0100 |
Huwe1 ¡ÚHECT, UBA and WWE Domain-containing Protein 1¡Û¡ÚUpstream Regulatory Element-binding Protein 1¡Û¡ÚURE-B1¡Û¡ÚMcl-1 Ubiquitin Ligase E3¡Û¡ÚMule¡Û¡ÚARF-binding Protein 1¡Û¡ÚLarge Structure of URE |
100ul |
¡ï44,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat¡¢ human | WB |
|
|
¡¡ |
BML |
BML-PW0975-0025 |
USP30(human, aa 170-185 ), rabbit pAb(crude serum)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW0975-0100 |
USP30(human, aa 170-185 ), rabbit pAb(crude serum)(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW1020-0025 |
Proteasome 20S B5t Subunit ¡Ú20S Proteasome Beta5t Subunit¡Û¡ÚProteasome 20S B8 Subunit¡Û(human)(recombinant)[b8-17], mouse mAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | b8-17 | human, mouse | WB |
|
|
¡¡ |
BML |
BML-PW1020-0100 |
Proteasome 20S B5t Subunit ¡Ú20S Proteasome Beta5t Subunit¡Û¡ÚProteasome 20S B8 Subunit¡Û(human)(recombinant)[b8-17], mouse mAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | b8-17 | human, mouse | WB |
|
|
¡¡ |
BML |
BML-PW1025-0025 |
USP19 ¡ÚZMYND9¡Û¡ÚZinc Finger MYND Domain-containing Protein 9¡Û(human, aa 1-129)(recombinant), rabbit pAb, Affinity-purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human, mouse, rat | WB |
|
|
¡¡ |
BML |
BML-PW1025-0100 |
USP19 ¡ÚZMYND9¡Û¡ÚZinc Finger MYND Domain-containing Protein 9¡Û(human, aa 1-129)(recombinant), rabbit pAb, Affinity-purified |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human, mouse, rat | WB |
|
|
¡¡ |
BML |
BML-PW1045-0025 |
S5a ¡ÚRpn10¡Û¡ÚMCB1¡Û¡ÚPSMD4¡Û¡Ú26S Proteasome Regulatory Subunit S5A¡Û¡ÚMbp1¡Û¡ÚSun1¡Û¡Úp54¡Û¡ÚAntisecretory Factor 1(ASF1)¡Û(human, full-length)(recombinant), rabbit pAb, purified(specificity: human |
25ul |
¡ï14,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW1045-0100 |
S5a ¡ÚRpn10¡Û¡ÚMCB1¡Û¡ÚPSMD4¡Û¡Ú26S Proteasome Regulatory Subunit S5A¡Û¡ÚMbp1¡Û¡ÚSun1¡Û¡Úp54¡Û¡ÚAntisecretory Factor 1(ASF1)¡Û(human, full-length)(recombinant), rabbit pAb, purified(specificity: human |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW1075-0001 |
Proteasome Purification Kit(10 binding assays) |
1Kit |
¡ï41,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW1075A-0001 |
Proteasome purification kit(10 binding assays) |
1Kit |
¡ï41,000 |
-80¡î |
none |
|
Application: for the isolation and enrichment of proteasome complexes. Kit Contents: Proteasome purification matrix, Control lysate, 20S ¡Æcore¡Ç proteasome antibody solution, Screw capped tube
|
|
¡¡ |
BML |
BML-PW1085-0025 |
p53(human, full-length)(recombinant)[PAb1801], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | PAb1801 | human(aa 46-55, NT) | IHC¡¢ WB¡¢ IP¡¢ FC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW1090-0025 |
p53(human, full length)(recombinant)[DO-1], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | DO-1 | human(aa 20-25, NT) | IHC¡¢ WB¡¢ IP¡¢ FC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW1095-0025 |
p53(human, full length)(recombinant)[DO-7], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | DO-7 | human(aa 20-25, NT) | IHC¡¢ WB¡¢ IP¡¢ FC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW1100-0025 |
p53(human, full length)(recombinant)[EX-2], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-2 | human(aa 40-60, NT) | WB |
|
|
¡¡ |
BML |
BML-PW1105-0025 |
p53(human, full length)(recombinant)[EX-1], mouse mAb, purified |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | EX-1 | human(CT) | WB |
|
|
¡¡ |
BML |
BML-PW1110-0025 |
p53(human, full length)(recombinant)[EX-4], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-4 | human(NT) | WB |
|
|
¡¡ |
BML |
BML-PW1115-0025 |
p53(human, full length)(recombinant)[EX-3], mouse mAb, purified(specificity: human) |
25ug |
¡ï22,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | EX-3 | human(NT) | WB |
|
|
¡¡ |
BML |
BML-PW1125-0025 |
Nbr1(human, aa 38-51), rabbit pAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW1125-0100 |
Nbr1(human, aa 38-51), rabbit pAb, purified(specificity: human) |
100ul |
¡ï43,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW1130-0025 |
Nbr1(human, aa 38-51), rabbit pAb, -FITC conj. |
25ul |
¡ï18,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | ICC |
|
|
¡¡ |
BML |
BML-PW1205-0025 |
LC3(human, peptide)(NT)[2G6], mouse mAb, -FITC conj. |
25ul |
¡ï30,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 2G6 | human | ICC |
|
|
¡¡ |
BML |
BML-PW1210-0025 |
Mono- and Polyubiquitinylated conjugates(Polyubiquitinylated-Lysozyme)[FK2], mouse mAb, -FITC conj. |
25ul |
¡ï17,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-PW1215-0025 |
Polyubiquitinylated conjugates(Polyubiquitinylated-Lysozyme)[FK1], mouse mAb, -FITC conj. |
25ul |
¡ï17,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgM | FK1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-PW1220-0025 |
Ubiquitin(denatured Glutaraldehyde Gross-linked Ubiquitin IgG Complex)[P4D1], mouse mAb, -FITC conj. |
25ul |
¡ï17,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P4D1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-PW1225-0025 |
Ubiquitin(enzymatically synthesised Polyubiquitin Chains)[EX-9], mouse mAb, -FITC conj. |
25ul |
¡ï19,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EX-9 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-PW1230-0025 |
p62 ¡ÚSQSTM1¡Û¡ÚSequestosome I¡Û(human, aa 387-436), rabbit pAb, -FITC conj.(specificity: human) |
25ul |
¡ï19,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | ICC |
|
|
¡¡ |
BML |
BML-PW1235-0025 |
Ubiquitin-Protein conjugates(Ubiquitin), rabbit pAb, -FITC conj. |
25ul |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-PW1335-0025 |
Mono- and polyubiquitinylated conjugates ¡Úubiquitinylated conjugates, Mono- and poly-¡Û(Poly-ubiquitinylated lysozyme)[FK2], mouse MAb, -affinity purified |
25ul |
¡ï17,000 |
-20¡î |
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢goat¡¢sheep¡¢dog¡¢pig¡¢monkey¡¢others | ICC |
0.01% sodium azide.
|
|
¡¡ |
BML |
BML-PW8100-0025 |
Proteasome 20S(a6 Subunit)¡ÚPROS30¡Û(human placenta)[MCP20], mouse mAb, purified ascites |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP20 | human¡¢ rabbit (not mouse¡¢ rat) | IHC¡¢ WB(33kDa)¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8100-0100 |
Proteasome 20S(a6 Subunit)¡ÚPROS30¡Û(human placenta)[MCP20], mouse mAb, purified ascites |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP20 | human¡¢ rabbit (not mouse¡¢ rat) | IHC¡¢ WB(33kDa)¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8105-0025 |
Proteasome 20S(a2 Subunit)(human placenta)[MCP21], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP21 | human¡¢ rabbit¡¢ bovine | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8105-0100 |
Proteasome 20S(a2 Subunit)(human placenta)[MCP21], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP21 | human¡¢ rabbit¡¢ bovine | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8110-0025 |
Proteasome 20S(a7 Subunit)(human placenta)[MCP72], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP72 | human¡¢ rat¡¢ rabbit¡¢ yeast¡¢ arthropod | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8110-0100 |
Proteasome 20S(a7 Subunit)(human placenta)[MCP72], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP72 | human¡¢ rat¡¢ rabbit¡¢ yeast¡¢ arthropod | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8115-0025 |
Proteasome 20S(a3 Subunit)(human placenta)[MCP257], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | MCP257 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8115-0100 |
Proteasome 20S(a3 Subunit)(human placenta)[MCP257], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | MCP257 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8120-0025 |
Proteasome 20S(a4 Subunit)(human placenta)[MCP34], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP34 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8120-0100 |
Proteasome 20S(a4 Subunit)(human placenta)[MCP34], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP34 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8125-0025 |
Proteasome 20S(a5 Subunit)(human placenta)[MCP196], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | MCP196 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8125-0100 |
Proteasome 20S(a5 Subunit)(human placenta)[MCP196], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | MCP196 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8130-0025 |
Proteasome 20S(B3 Subunit)(dinitrophenylated Proteasomes)[MCP102], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP102 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8130-0100 |
Proteasome 20S(B3 Subunit)(dinitrophenylated Proteasomes)[MCP102], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP102 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8135-0025 |
Proteasome 20S(B7 Subunit)(dinitrophenylated Proteasomes)[MCP205], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP205 | human¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8135-0100 |
Proteasome 20S(B7 Subunit)(dinitrophenylated Proteasomes)[MCP205], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP205 | human¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8140-0025 |
Proteasome 20S(B1 Subunit)(dinitrophenylated Proteasomes)[MCP421], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP421 | human¡¢ rabbit¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8140-0100 |
Proteasome 20S(B1 Subunit)(dinitrophenylated Proteasomes)[MCP421], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP421 | human¡¢ rabbit¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8145-0025 |
Proteasome 20S(B2 Subunit)(dinitrophenylated Proteasomes)[MCP168], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP168 | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8145-0100 |
Proteasome 20S(B2 Subunit)(dinitrophenylated Proteasomes)[MCP168], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP168 | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8150-0025 |
Proteasome 20S(B2i Subunit)(mouse, aa 218-236), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8150-0100 |
Proteasome 20S(B2i Subunit)(mouse, aa 218-236), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8155-0025 |
Proteasome 20S(core Subunits(a5/a7, B1, B5, B5i, B7))(human erythrocyte), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human, mouse¡¢ rat¡¢ rabbit¡¢ yeast | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8155-0100 |
Proteasome 20S(core Subunits(a5/a7, B1, B5, B5i, B7))(human erythrocyte), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human, mouse¡¢ rat¡¢ rabbit¡¢ yeast | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8160-0025 |
Proteasome 19S(Rpt2/S4(mts2)Subunit)(S. pombe mts2, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW8160-0100 |
Proteasome 19S(Rpt2/S4(mts2)Subunit)(S. pombe mts2, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW8165-0025 |
Proteasome 19S(Rpt1/S7 Subunit)(human MSS1, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | WB |
|
|
¡¡ |
BML |
BML-PW8165-0100 |
Proteasome 19S(Rpt1/S7 Subunit)(human MSS1, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | WB |
|
|
¡¡ |
BML |
BML-PW8175-0025 |
Proteasome 19S(Rpt3/S6b Subunit)(Manduca Sexta)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8175-0100 |
Proteasome 19S(Rpt3/S6b Subunit)(Manduca Sexta)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8180-0025 |
Proteasome 19S(Rpn8/S12 Subunit)(human, aa 1-205)(recombinant), sheep pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8185-0025 |
Proteasome Activator 11S(a Subunit)¡ÚPA28a¡Û(mouse, aa 5-19), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-PW8185-0100 |
Proteasome Activator 11S(a Subunit)¡ÚPA28a¡Û(mouse, aa 5-19), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-PW8190-0025 |
Proteasome Activator 11S(¦Ã Subunit)¡ÚProteasome activator complex subunit 3¡Û(human/mouse, aa 70-85), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8190-0100 |
Proteasome Activator 11S(¦Ã Subunit)¡ÚProteasome Activator Complex Subunit 3¡Û(human/mouse, aa 70-85), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8195-0025 |
Proteasome 20S(a1,2,3,5,6,& 7 Subunits)(dinitrophenylated Proteasomes)[MCP231], mouse mAb, P-purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP231 | human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ yeast¡¢ potato | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8195-0100 |
Proteasome 20S(a1,2,3,5,6,& 7 Subunits)(dinitrophenylated Proteasomes)[MCP231], mouse mAb, purified(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP231 | human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ yeast¡¢ potato | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8200-0025 |
Proteasome 20S(B5i Subunit)(mouse, aa 23-223)(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8200-0100 |
Proteasome 20S(B5i Subunit)(mouse, aa 23-223)(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8205-0025 |
Proteasome 20S(B1i Subunit)(mouse, full length)(recombinant)(NT), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8205-0100 |
Proteasome 20S(B1i Subunit)(mouse, full length)(recombinant)(NT), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8210-0025 |
Proteasome 20S(B2/2i Subunit)(mouse/human, aa 44-73), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8210-0100 |
Proteasome 20S(B2/2i Subunit)(mouse/human, aa 44-73), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8215-0025 |
Proteasome 19S(Rpt6/S8 Subunit)(human, p45, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8215-0100 |
Proteasome 19S(Rpt6/S8 Subunit)(human, p45, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8220-0025 |
Proteasome 19S(Rpt4/S10b Subunit)¡ÚProteasome Subunit p42¡Û(human, p42, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8220-0100 |
Proteasome 19S(Rpt4/S10b Subunit)¡ÚProteasome Subunit p42¡Û(human, p42, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8225-0025 |
Proteasome 19S(Rpn7/S10a Subunit)(human, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8225-0100 |
Proteasome 19S(Rpn7/S10a Subunit)(human, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8230-0025 |
COP9 Signalosome(Csn2 Subunit)¡ÚSgn2¡Û¡ÚTRIP15¡Û(recombinant)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8230-0100 |
COP9 Signalosome(Csn2 Subunit)¡ÚSgn2¡Û¡ÚTRIP15¡Û(recombinant)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8235-0025 |
COP9 Signalosome(Csn3 Subunit)(human, aa 115-345)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8235-0100 |
COP9 Signalosome(Csn3 Subunit)(human, aa 115-345)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8240-0025 |
Proteasome Activator 11S(B Subunit)(mouse, aa 15-31), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8240-0100 |
Proteasome Activator 11S(B Subunit)(mouse, aa 15-31), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8245-0025 |
Proteasome 19S(Rpt5/S6a Subunit)(Yta1, 100aa)(recombinant)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8245-0100 |
Proteasome 19S(Rpt5/S6a Subunit)(Yta1, 100aa)(recombinant)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8250-0025 |
Proteasome 19S(Rpt3/S6b Subunit)(YTA2 protein, 100aa)(recombinant)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8250-0100 |
Proteasome 19S(Rpt3/S6b Subunit)(YTA2 protein, 100aa)(recombinant)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ yeast | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8255-0025 |
Proteasome 19S(Rpt1/S7 Subunit)(YTA3, 100aa)(recombinant)(NT), rabbit pAb (specificity: yeast) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8255-0100 |
Proteasome 19S(Rpt1/S7 Subunit)(YTA3, 100aa)(recombinant)(NT), rabbit pAb (specificity: yeast) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8260-0025 |
Proteasome 19S(Rpt2/S4 Subunit)(yeast YTA5, 100aa)(recombinant)(NT), rabbit pAb(specificity: yeast) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8260-0100 |
Proteasome 19S(Rpt2/S4 Subunit)(yeast YTA5, 100aa)(recombinant)(NT), rabbit pAb(specificity: yeast) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW8265-0100 |
Proteasome 20S(a Subunit)(human erythrocyte)[HP810], mouse mAb, Affinity-purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | HP810 | human | IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8270-0100 |
Proteasome 20S(a5 Subunit)(human erythrocyte)[HP903], mouse mAb, purified(ascites)(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | HP903 | human | IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-PW8275-0100 |
Proteasome 20S(a Subunit)(human, native)[HP103], mouse mAb, Affinity-purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | HP103 | human | ICC |
|
|
¡¡ |
BML |
BML-PW8280-0100 |
Proteasome 20S(a Subunit)(human erythrocyte)[HP305], mouse mAb, Affinity-purified(specificity: human) |
100ug |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | HP305 | human | IHC |
|
|
¡¡ |
BML |
BML-PW8285-0025 |
COP9 Signalosome(Csn1 Subunit)(human, aa 230-500)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig¡¢ frog | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8285-0100 |
COP9 Signalosome(Csn1 Subunit)(human, aa 230-500)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig¡¢ frog | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8290-0025 |
COP9 Signalosome(Csn8 Subunit)(human, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig¡¢ Xenopus | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8290-0100 |
COP9 Signalosome(Csn8 Subunit)(human, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig¡¢ Xenopus | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8295-0025 |
COP9 Signalosome(Csn6 Subunit)(human, aa 283-297), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8295-0100 |
COP9 Signalosome(Csn6 Subunit)(human, aa 283-297), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8300-0025 |
COP9 Signalosome(Csn7 Subunit)(human, full length)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8300-0100 |
COP9 Signalosome(Csn7 Subunit)(human, full length)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8305-0025 |
Proteasome 19S(Rpt2/S4 Subunit)(human, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8305-0100 |
Proteasome 19S(Rpt2/S4 Subunit)(human, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8310-0025 |
Proteasome 19S(Rpt5/S6a Subunit)¡ÚTBP1¡Û(human, full length, His-FLAG-tagged)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8310-0100 |
Proteasome 19S(Rpt5/S6a Subunit)¡ÚTBP1¡Û(human, full length, His-FLAG-tagged)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB (not IHC¡¢ IP) |
|
|
¡¡ |
BML |
BML-PW8315-0025 |
Proteasome 19S(Rpt1/S7 Subunit)¡ÚS7¡Û¡ÚMSS1¡Û(human, full length)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8315-0100 |
Proteasome 19S(Rpt1/S7 Subunit)¡ÚS7¡Û¡ÚMSS1¡Û(human, full length)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8320-0025 |
Proteasome 19S(Rpt6/S8 Subunit)¡ÚTRIP1¡Û(human, full length)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB(~48kDa) |
|
|
¡¡ |
BML |
BML-PW8320-0100 |
Proteasome 19S(Rpt6/S8 Subunit)¡ÚTRIP1¡Û(human, full length)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB(~48kDa) |
|
|
¡¡ |
BML |
BML-PW8325-0025 |
Gankyrin(human, full length)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8330-0025 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier 1¡Û(human, aa 1-16)(NT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8330-0100 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier 1¡Û(human, aa 1-16)(NT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8335-0500 |
Proteasome 20S(a2 Subunit)(human placenta)[MCP21], mouse mAb, -Agarose conj. |
0.5mL |
¡ï52,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP21 | human¡¢ rabbit¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-PW8345-0025 |
Proteasome 20S(B1i Subunit)(human, aa 205-219), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8345-0100 |
Proteasome 20S(B1i Subunit)(human, aa 205-219), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8350-0025 |
Proteasome 20S(B2i Subunit)(human, aa 220-236), rabbit pAb(antiserum)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8350-0100 |
Proteasome 20S(B2i Subunit)(human, aa 220-236), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8355-0025 |
Proteasome 20S(B5i Subunit)(human, aa 262-276), rabbit pAb(antiserum)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8355-0100 |
Proteasome 20S(B5i Subunit)(human, aa 262-276), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8360-0025 |
COP9 Signalosome(Csn4 Subunit)(Arabidopsis thaliana, full length)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ arabidopsis thaliana¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8360-0100 |
COP9 Signalosome(Csn4 Subunit)(Arabidopsis thaliana, full length)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ arabidopsis thaliana¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8365-0025 |
COP9 Signalosome(Csn5 Subunit)(Arabidopsis thaliana, full length)(recombinant), rabbit pAb. |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ arabidopsis thaliana¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8365-0100 |
COP9 Signalosome(Csn5 Subunit)(Arabidopsis thaliana, full length)(recombinant), rabbit pAb. |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ arabidopsis thaliana¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8370-0025 |
Proteasome 19S(Rpn6/S9 Subunit)(Arabidopsis thaliana)(recombinant)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8370-0100 |
Proteasome 19S(Rpn6/S9 Subunit)(Arabidopsis thaliana)(recombinant)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis¡¢ cauliflower | WB |
|
|
¡¡ |
BML |
BML-PW8375-0025 |
Proteasome 19S ¡ÚATPase subunit Rpt5¡Û(Arabidopsis thaliana)(recombinant)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis¡¢ cauliflower | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8375-0100 |
Proteasome 19S ¡ÚATPase subunit Rpt5¡Û(Arabidopsis thaliana)(recombinant)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Arabidopsis¡¢ cauliflower | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8385-0025 |
Ubiquitin Activating Enzyme ¡ÚUb E1¡Û(human, aa 1-23)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ bovine¡¢ chicken | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8385-0100 |
Ubiquitin Activating Enzyme ¡ÚUb E1¡Û(human, aa 1-23)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ bovine¡¢ chicken | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8390-0025 |
Ubiquitin Activating Enzyme ¡ÚUb E1¡Û(human, aa 41-66)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ rabbit¡¢ bovine¡¢ chicken (not mouse¡¢ rat) | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8390-0100 |
Ubiquitin Activating Enzyme ¡ÚUb E1¡Û(human, aa 41-66)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ rabbit¡¢ bovine¡¢ chicken (not mouse¡¢ rat) | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8395-0025 |
Ubiquitin Activating Enzyme ¡ÚUb E1¡Û(human, aa 1040-1058)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-PW8720-0050 |
Proteasome 20S(human), purified(Isolated from human erythrocytes) |
50ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8765-0025 |
Proteasome 19S(Rpt3/S6b Subunit)(human, full-length)(recombinant)[TBP7-27], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | TBP7-27 | human¡¢ rabbit | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8765-0100 |
Proteasome 19S(Rpt3/S6b Subunit)(human, full-length)(recombinant)[TBP7-27], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | TBP7-27 | human¡¢ rabbit | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8770-0025 |
Proteasome 19S(Rpt5/S6a Subunit)(human, full-length)(recombinant)[TBP1-19], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | TBP1-19 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8770-0100 |
Proteasome 19S(Rpt5/S6a Subunit)(human, full-length)(recombinant)[TBP1-19], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | TBP1-19 | human¡¢ mouse¡¢ rat¡¢ rabbit | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8775-0050 |
Proteasome 20S(Saccharomyces cerevisiae)(purified from Saccharomyces cerevisiae) |
50ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8785-0025 |
RanGAP1 ¡ÚRanGTPase-Activating Protein 1¡Û(human, aa 241-360)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8785-0100 |
RanGAP1 ¡ÚRanGTPase-Activating Protein 1¡Û(human, aa 241-360)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW8805-0500 |
Polyubiquitinylated Conjugates(Poly ubiquitinylated Lysozyme)[FK1], mouse mAb, purified |
500ug |
¡ï47,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgM | FK1 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW8810-0500 |
Mono- and Polyubiquitinated Conjugates(Poly-ubiquitinylated-Lysozyme)[FK2], mouse mAb, purified |
500ug |
¡ï47,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FK2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-PW8815-0025 |
Proteasome 19S(Rpn12/S14 Subunit)(human, full length)(recombinant), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8815-0100 |
Proteasome 19S(Rpn12/S14 Subunit)(human, full length)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8825-0025 |
Proteasome 19S(Rpt1/S7 Subunit)(human)(recombinant)[MSS1-104], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MSS1-104 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW8825-0100 |
Proteasome 19S(Rpt1/S7 Subunit)(human)(recombinant)[MSS1-104], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MSS1-104 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW8830-0025 |
Proteasome 19S(Rpt4/S10b Subunit)(human)(recombinant)[p42-23], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | p42-23 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW8830-0100 |
Proteasome 19S(Rpt4/S10b Subunit)(human)(recombinant)[p42-23], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | p42-23 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW8835-0025 |
Proteasome 19S(Rpn12/S14 Subunit)(Rpn12 protein)(recombinant)[P31-27], mouse mAb, purified (specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P31-27 | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8835-0100 |
Proteasome 19S(Rpn12/S14 Subunit)(Rpn12 protein)(recombinant)[P31-27], mouse mAb, purified (specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | P31-27 | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8840-0025 |
Proteasome 20S(B1i Subunit)(human)(recombinant)[LMP2-13], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | LMP2-13 | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8840-0100 |
Proteasome 20S(B1i Subunit)(human)(recombinant)[LMP2-13], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | LMP2-13 | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8845-0025 |
Proteasome 20S(B5i Subunit)(human)(recombinant)[LMP7-1], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | LMP7-1 | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8845-0100 |
Proteasome 20S(B5i Subunit)(human)(recombinant)[LMP7-1], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | LMP7-1 | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8850-0100 |
PR39 Propeptide ¡ÚH-R-R-R-P-R-P-P-Y-L-P-R-P-R-P-P-P-F-F-P-P-R-L-P-P-R-I-P-P-G-F-P-P-R-F-P-P-R-F-P-OH¡Û |
0.1mg* |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8880-0025 |
Ornithine Decarboxylase ¡ÚODC¡Û(mouse, full length)(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse¡¢ rat¡¢ rabbit | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8880-0100 |
Ornithine Decarboxylase ¡ÚODC¡Û(mouse, full length)(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse¡¢ rat¡¢ rabbit | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8885-0025 |
Antizyme I ¡ÚAZ I¡Û(rat, aa 69-227)(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ rabbit | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8885-0100 |
Antizyme I ¡ÚAZ I¡Û(rat, aa 69-227)(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ rabbit | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW8890-0025 |
Proteasome 20S(B4 Subunit)(human, aa 72-85), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-PW8890-0100 |
Proteasome 20S(B4 Subunit)(human, aa 72-85), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-PW8895-0025 |
Proteasome 20S(B5 Subunit)(human, aa 194-207), rabbit pAb(antiserum)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8895-0100 |
Proteasome 20S(B5 Subunit)(human, aa 194-207), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW8900-0001 |
Proteasome 20S(a Subunits)Antibody Sampler Pack |
8x10ul |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8905-0001 |
Proteasome 20S(B Subunits)Antibody Sampler Pack |
13x10ul |
¡ï84,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8915-0001 |
Proteasome Activator 11S Subunit Antibody Sampler Pack |
3x10ul |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8925-0001 |
Proteasome 20S(a Subunits)Antibody Sampler Pack(for Immunofluorescence) |
4x25ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8935-0001 |
Proteasome 19S(ATPase Subunit)Antibody Sampler Pack(human) |
10x10ul |
¡ï68,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8940-0001 |
Proteasome 19S(ATPase Subunit)Antibody Sampler Pack(yeast) |
8x10ul |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8945-0001 |
COP9 Signalosome Subunits Antibody Sampler Pack |
8x10ul |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8950-0001 |
Proteasome 26S Degradation Kit(mammalian)(96 assays) |
Kit |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8960-0001 |
Ornithine Decarboxylase and Antizyme pAb Pack |
Pack |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW8965-0001 |
Proteasome 19S(Non-ATPase Subunit)Antibody Sampler Pack(human) |
7x10ul |
¡ï49,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9000-0025 |
Proteasome 20S(B6 Subunit)(human, aa 185-198), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9000-0100 |
Proteasome 20S(B6 Subunit)(human, aa 185-198), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9005-0500 |
Proteasome 20S(a4 Subunit)(human placenta)[MCP72], mouse mAb(MCP34), -Agarose conj.(specificity: human) |
0.5mL |
¡ï52,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP72 | human | WB |
|
|
¡¡ |
BML |
BML-PW9120-0100 |
Proteasome 11S(a Subunit)(human)(recombinant)with GST-Tag |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9125-0100 |
Proteasome 11S(B Subunit)(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9130-0100 |
Proteasome 11S(¦Ã Subunit)(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9140-0025 |
Proteasome 20S(a4 Subunit)(human placenta)[MCP79], mouse mAb(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP79 | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9140-0100 |
Proteasome 20S(a4 Subunit)(human placenta)[MCP79], mouse mAb(ascites) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP79 | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9150-0025 |
Proteasome 20S(B7 Subunit)(human placenta)[MCP444], mouse mAb, purified(ascites)(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP444 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9150-0100 |
Proteasome 20S(B7 Subunit)(human placenta)[MCP444], mouse mAb, purified(ascites)(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP444 | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9250-0025 |
Proteasome 19S(Rpn10/S5a Subunit)(human, full-length)(recombinant)[S5a-18], mouse mAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | S5a-18 | human | IHC¡¢WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9250-0100 |
Proteasome 19S(Rpn10/S5a Subunit)(human, full-length)(recombinant)[S5a-18], mouse mAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | S5a-18 | human | IHC¡¢WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9260-0025 |
Proteasome 19S(Rpn12/S14 Subunit)(human)(recombinant)[p31-38], mouse mAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | p31-38 | human | IP |
|
|
¡¡ |
BML |
BML-PW9260-0100 |
Proteasome 19S(Rpn12/S14 Subunit)(human)(recombinant)[p31-38], mouse mAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | p31-38 | human | IP |
|
|
¡¡ |
BML |
BML-PW9265-0025 |
Proteasome 19S(ATPase subunit Rpt6)(human)(recombinant)[p45-110], mouse mAb, purified |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | p45-110 | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9265-0100 |
Proteasome 19S(ATPase subunit Rpt6)(human)(recombinant)[p45-110], mouse mAb, purified |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | p45-110 | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9270-0025 |
Proteasome 19S(Rpn2/S1 Subunit)(human, full-length)(recombinant)[112-1], mouse mAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 112-1 | human | WB |
|
|
¡¡ |
BML |
BML-PW9270-0100 |
Proteasome 19S(Rpn2/S1 Subunit)(human, full-length)(recombinant)[112-1], mouse mAb, purified(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 112-1 | human | WB |
|
|
¡¡ |
BML |
BML-PW9300-0025 |
Proteasome 20S(B2 Subunit)(Dinitrophenylated proteasomes)[MCP165], mouse mAb, purified(ascites) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP165 | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9300-0100 |
Proteasome 20S(B2 Subunit)(Dinitrophenylated proteasomes)[MCP165], mouse mAb, purified(ascites) |
100ul |
¡ï40,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP165 | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9310-0050 |
Proteasome 26S(human), purified |
50ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9325-0100 |
PR11 ¡ÚN-terminal Undecapeptide of PR39¡Û¡Ú11-N-terminal Amino Acid of Proline-arginin-Rich 39¡Û |
0.1mg* |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9335-0025 |
Valosin-containing Protein ¡ÚVCP¡Û¡ÚTransitional Endoplasmic Reticulum ATPase¡Û¡ÚTER ATPase¡Û(human, aa 20-37), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ pig | WB |
|
|
¡¡ |
BML |
BML-PW9340-0025 |
NEDD8(protein, 81aa), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9340-0100 |
NEDD8(protein, 81aa), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9355-0025 |
Proteasome 20S(core subunits)(Saccharomyces cerevisiae), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW9355-0100 |
Proteasome 20S(core subunits)(Saccharomyces cerevisiae), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | yeast | WB |
|
|
¡¡ |
BML |
BML-PW9365-0025 |
Parkin(human, aa 399-415), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9365-0100 |
Parkin(human, aa 399-415), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9380-0100 |
MCMV pp89 Substrate Peptide |
100ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9385-0025 |
Proteasome 20S(a2 Subunit)(human placenta)[MCP236], mouse mAb(supernatant) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | MCP236 | human¡¢ mouse | IP (not WB) |
|
|
¡¡ |
BML |
BML-PW9390-0001 |
Proteasome 20S(a6 Subunit)(human placenta)[MCP106], mouse mAb(supernatant) |
1mL |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MCP106 | human¡¢ mouse¡¢ rabbit | WB |
|
|
¡¡ |
BML |
BML-PW9395-0025 |
Proteasome 20S(B7 Subunit)(dinitrophenylated Proteasomes)[MCP219], mouse mAb(supernatant) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | MCP219 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9395-0100 |
Proteasome 20S(B7 Subunit)(dinitrophenylated Proteasomes)[MCP219], mouse mAb(supernatant) |
100ul |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | MCP219 | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9400-0025 |
Proteasome 19S(Rpt1/S7 Subunit)(human)(recombinant)[MSS1-92], mouse mAb, purified(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | MSS1-92 | human | IP |
|
|
¡¡ |
BML |
BML-PW9420-0025 |
Proteasome Activator 11S Complex ¡ÚPA28¡Û(human), purified(Isolated from human erythrocytes) |
25ug |
¡ï48,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9425-0010 |
COP9 Signalosome ¡ÚCSN¡Û(human), purified(Isolated from human erythrocytes) |
10ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9460-0025 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier 1¡Û(human, aa 72-97)(CT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9460-0100 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier 1¡Û(human, aa 72-97)(CT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9465-0025 |
SUMO-2/3 ¡ÚSmall Ubiquitin-related Modifier 2/3¡Û(human, aa 1-15)(NT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9465-0100 |
SUMO-2/3 ¡ÚSmall Ubiquitin-related Modifier 2/3¡Û(human, aa 1-15)(NT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9575-0025 |
ISG15 ¡ÚUCRP¡Û¡ÚUbiquitin cross-Reactive Protein¡Û¡ÚInterferon Stimulated Gene 15¡Û(human, aa 85-101), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9575-0100 |
ISG15 ¡ÚUCRP¡Û¡ÚUbiquitin cross-Reactive Protein¡Û¡ÚInterferon Stimulated Gene 15¡Û(human, aa 85-101), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9585-0025 |
FAT10(human, aa 23-40), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9585-0100 |
FAT10(human, aa 23-40), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9595-0025 |
Urm1 ¡ÚUbiquitin-related Modifier 1¡Û(Saccharamyces cerevisiae, aa 50-64), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9605-0025 |
Ubl5 ¡ÚUbiquitin-Like Protein 5¡Û(human, aa 58-72), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9605-0100 |
Ubl5 ¡ÚUbiquitin-Like Protein 5¡Û(human, aa 58-72), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9615-0025 |
Fub1(human, aa 17-30), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9615-0100 |
Fub1(human, aa 17-30), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9625-0025 |
Proteasome 19S(Rpn11/S13 Subunit)(proteasome 26S, aa 19-32), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9625-0100 |
Proteasome 19S(Rpn11/S13 Subunit)(proteasome 26S, aa 19-32), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9645-0050 |
Immunoproteasome 20S(human), purified(Isolated from human spleen) |
50ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9660-0010 |
TPPII complex ¡ÚTripeptidyl Peptidase II¡Û(human), purified(Isolated from human erythrocytes) |
10ug |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9680-0025 |
FAT10(human)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9680-0100 |
FAT10(human)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9685-0025 |
NUB1 ¡ÚNUB1L¡Û¡ÚNEDD8 Ultimate Buster-1¡Û(human, aa 599-615), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9685-0100 |
NUB1 ¡ÚNUB1L¡Û¡ÚNEDD8 Ultimate Buster-1¡Û(human, aa 599-615), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-PW9705-0025 |
HERP ¡ÚHomocystein-Responsive Endoplasmic Reticulum-resident Ubiquitin-Like Domain Member 1 Protein¡Û(human, aa 1-240)(recombinant)(NT), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9705-0100 |
HERP ¡ÚHomocystein-Responsive Endoplasmic Reticulum-Resident Ubiquitin-Like Domain Member 1 Protein¡Û(human, aa 1-240)(recombinant)(NT), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9710-0025 |
PI31 ¡ÚProteasome Inhibitor 31¡Û(human, aa 241-271)(CT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9710-0100 |
PI31 ¡ÚProteasome Inhibitor 31¡Û(human, aa 241-271)(CT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9715-0025 |
POMP ¡ÚProteasome Maturation Protein ¡Û¡ÚUMP1 homolog¡Û(human, aa 129-141), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ monkey | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9715-0100 |
POMP ¡ÚProteasome Maturation Protein ¡Û¡ÚUMP1 homolog¡Û(human, aa 129-141), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ monkey | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9720-0025 |
COP9 Signalosome(Csn2 Subunit)(mouse, full length ), rabbit pAb(specificity: mouse) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9725-0025 |
COP1 ¡ÚConstitutive Photomorphogenic Protein 1¡Û(mouse, aa 71-210)(NT), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ hamster¡¢ monkey | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9725-0100 |
COP1 ¡ÚConstitutive Photomorphogenic Protein 1¡Û(mouse, aa 71-210)(NT), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ hamster¡¢ monkey | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-PW9780-0025 |
Ub+1 ¡ÚUbiquitin+1¡Û(human, aa 76-95), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9780-0100 |
Ub+1 ¡ÚUbiquitin+1¡Û(human, aa 76-95), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9790-0100 |
PR26 ¡Ú26-N-terminal Amino Acid of Proline-arginin-Rich 39¡Û |
0.1mg* |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9795-0025 |
USP15 ¡ÚUbiquitin-Specific Protease 15¡Û(human, aa 724-952)(recombinant), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9795-0100 |
USP15 ¡ÚUbiquitin-Specific Protease 15¡Û(human, aa 724-952)(recombinant), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9860-0025 |
p62 ¡ÚSQSTM1¡Û¡ÚSequestosome I¡Û(human, aa 387-436), rabbit pAb(specificity: human) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9860-0100 |
p62 ¡ÚSQSTM1¡Û¡ÚSequestosome I¡Û(human, aa 387-436), rabbit pAb(specificity: human) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-PW9865-0100 |
Proteasome Activator 11S(a Subunit)(human)(recombinant) |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9870-0100 |
Proteasome Activator 11S(B Subunit)(human)(recombinant) |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9875-0100 |
Proteasome Activator 11S(¦Ã Subunit)(human)(recombinant) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9901-0001 |
Proteasome Inhibitor Pack |
Pack |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9905-0001 |
Proteasome Substrate Pack |
Pack |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-PW9910-0025 |
19S Proteasome(ADRM1)(human)(recombinant), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PW9910-0100 |
19S Proteasome(ADRM1)(human)(recombinant), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-PZ1040-0050 |
Phenylethanolamine N-Methyltransferase ¡ÚPNMT¡Û(bovine adrenal), rabbit pAb, purified |
50ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ chicken¡¢ monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-RA101-0010 |
LY 171883 ¡Ú1-?[2-?Hydroxy-?3-?propyl-?4-?[4-?(1H-?tetrazol-?5-?yl)butoxy]phenyl]?ethanone¡Û |
10mg |
¡ï9,000 |
|
88107-10-2 |
|
|
|
¡¡ |
BML |
BML-RA101-0050 |
LY 171883 ¡Ú1-?[2-?Hydroxy-?3-?propyl-?4-?[4-?(1H-?tetrazol-?5-?yl)butoxy]phenyl]?ethanone¡Û |
50mg |
¡ï35,000 |
|
88107-10-2 |
|
|
|
¡¡ |
BML |
BML-RA102-0100 |
U-75302 ¡Ú6-?(6-?(3R-?Hydroxy-?1E,?5Z-?undecadien-?1-?yl)-?2-?pyridinyl)-?1,?5S-?hexanediol¡Û |
100ug |
¡ï17,000 |
|
119477-85-9 |
|
|
|
¡¡ |
BML |
BML-RA103-0001 |
SQ-29548 ¡Ú[1S-[1a,2a(Z),3a,4a]]-7-[3-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptanoic Acid]¡Û |
1mg |
¡ï10,000 |
|
98299-61-7 |
|
|
|
¡¡ |
BML |
BML-RA104-0010 |
Picotamide ¡Ú4-Methoxy-N,N'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide¡Û |
10mg |
¡ï10,000 |
|
32828-81-2 |
|
|
|
¡¡ |
BML |
BML-RA104-0050 |
Picotamide ¡Ú4-Methoxy-N,N'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide¡Û |
50mg |
¡ï40,000 |
|
32828-81-2 |
|
|
|
¡¡ |
BML |
BML-RA105-0001 |
Fluprostenol ¡Ú(¡Þ)-16-(3-Trifluoromethylphenoxy)tetranor-prostaglandin F2a¡Û |
1mg |
¡ï8,000 |
|
40666-16-8 |
|
|
|
¡¡ |
BML |
BML-RA105-0010 |
Fluprostenol ¡Ú(¡Þ)-16-(3-Trifluoromethylphenoxy)tetranor-prostaglandin F2a¡Û |
10mg |
¡ï66,000 |
|
40666-16-8 |
|
|
|
¡¡ |
BML |
BML-RA106-0001 |
Cloprostenol, Na salt ¡Ú16-(m-Chlorophenoxy)-tetranor-prostaglandin F2a, Na salt¡Û |
1mg |
¡ï6,000 |
|
55028-72-3 |
|
|
|
¡¡ |
BML |
BML-RA106-0010 |
Cloprostenol, Na salt ¡Ú16-(m-Chlorophenoxy)-tetranor-prostaglandin F2a, Na salt¡Û |
10mg |
¡ï53,000 |
|
55028-72-3 |
|
|
|
¡¡ |
BML |
BML-RA108-0001 |
BML-111 ¡Ú5(S),6(R),7-Trihydroxyheptanoic Acid, Methyl Ester¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA108-0005 |
BML-111 ¡Ú5(S),6(R),7-Trihydroxyheptanoic Acid, Methyl Ester¡Û |
5mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA109-0005 |
MK-571, Na salt ¡ÚL-660,711¡Û |
5mg |
¡ï8,000 |
|
115104-28-4 |
|
|
|
¡¡ |
BML |
BML-RA109-0025 |
MK-571, Na salt ¡ÚL-660,711¡Û |
25mg |
¡ï32,000 |
|
115104-28-4 |
|
|
|
¡¡ |
BML |
BML-RA110-0005 |
AH-6809 ¡Ú6-Isopropoxy-9-xanthone-2-carboxylic Acid¡Û |
5mg |
¡ï9,000 |
|
33458-93-4 |
|
|
|
¡¡ |
BML |
BML-RA110-0025 |
AH-6809 ¡Ú6-Isopropoxy-9-xanthone-2-carboxylic Acid¡Û |
25mg |
¡ï36,000 |
|
33458-93-4 |
|
|
|
¡¡ |
BML |
BML-RA112-0005 |
SC-51322 ¡Ú8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic Acid, 2-[3-[(2-FuranylMethyl)thio]-1-oxopropyl]hydrazide¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA112-0025 |
SC-51322 ¡Ú8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic Acid, 2-[3-[(2-FuranylMethyl)thio]-1-oxopropyl]hydrazide¡Û |
25mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA113-0005 |
SC-51089 ¡Ú8-Chlorodibenz(Z)[b,f][1,4]oxazepine-10(11H)-carboxylic Acid, 2-[1-Oxo-3-(4-pyridinyl)propyl]hydrazide, HCl¡Û |
5mg |
¡ï10,000 |
|
146033-02-5 |
|
|
|
¡¡ |
BML |
BML-RA113-0025 |
SC-51089 ¡Ú8-Chlorodibenz(Z)[b,f][1,4]oxazepine-10(11H)-carboxylic Acid, 2-[1-Oxo-3-(4-pyridinyl)propyl]hydrazide, HCl¡Û |
25mg |
¡ï39,000 |
|
146033-02-5 |
|
|
|
¡¡ |
BML |
BML-RA114-0100 |
BAY-u9773 ¡Ú4-?[[(1R,?2E,?4E,?6Z,?9Z)-?1-?[(1S)-?4-?Carboxy-?1-?hydroxybutyl]-?2,?4,?6,?9-?pentadecatetraenyl]thio]benzoic Acid¡Û |
100ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA114-1000 |
BAY-u9773 ¡Ú4-?[[(1R,?2E,?4E,?6Z,?9Z)-?1-?[(1S)-?4-?Carboxy-?1-?hydroxybutyl]-?2,?4,?6,?9-?pentadecatetraenyl]thio]benzoic Acid¡Û |
1mg |
¡ï188,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA115-0001 |
LY 255283 ¡Ú1-[5-Ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]ethanone¡Û |
1mg |
¡ï10,000 |
|
117690-79-6 |
|
|
|
¡¡ |
BML |
BML-RA115-0005 |
LY 255283 ¡Ú1-[5-Ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]ethanone¡Û |
5mg |
¡ï40,000 |
|
117690-79-6 |
|
|
|
¡¡ |
BML |
BML-RA116-0001 |
Sulprostone ¡Ú(5Z,11a, 13E, 15R)-11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic Acid Mmethanesulfonamide¡Û |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA116-0005 |
Sulprostone ¡Ú(5Z,11a, 13E, 15R)-11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic Acid Mmethanesulfonamide¡Û |
5mg |
¡ï70,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA117-0001 |
L-655,240 ¡Ú3-[1-(4-Chlorobenzyl)-5-fluoro-3-methylindol-2-yl]-2,2-dimethylpropanoic Acid¡Û |
1mg |
¡ï7,000 |
|
103253-15-2 |
|
|
|
¡¡ |
BML |
BML-RA117-0005 |
L-655,240 ¡Ú3-[1-(4-Chlorobenzyl)-5-fluoro-3-methylindol-2-yl]-2,2-dimethylpropanoic Acid¡Û |
5mg |
¡ï30,000 |
|
103253-15-2 |
|
|
|
¡¡ |
BML |
BML-RA118-0001 |
L-161-982 ¡ÚN-[[4'-[[3-Butyl-1,5-dihydro-5-oxo-1-[2-(trifluoromethy l)phenyl]-4H-1,2,4-triazol-4-yl]methyl][1,1'-biphenyl]- 2-yl]sulfonyl]-3-methyl-2-thiophenecarboxamide¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA118-0005 |
L-161-982 ¡ÚN-[[4'-[[3-Butyl-1,5-dihydro-5-oxo-1-[2-(trifluoromethy l)phenyl]-4H-1,2,4-triazol-4-yl]methyl][1,1'-biphenyl]- 2-yl]sulfonyl]-3-methyl-2-thiophenecarboxamide¡Û |
5mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-RA119-0010 |
Seratrodast ¡Ú7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid¡Û |
10mg |
¡ï11,000 |
|
112665-43-7 |
|
|
|
¡¡ |
BML |
BML-RA119-0050 |
Seratrodast ¡Ú7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic Acid¡Û |
50mg |
¡ï46,000 |
|
112665-43-7 |
|
|
|
¡¡ |
BML |
BML-RA120-0001 |
Latanoprost ¡Ú17-Phenyl-13,14-dihydroprostaglandin F2a Isopropyl Ester¡Û¡ÚIsopropyl 13,14-Dihydro-17-phenyl-18,19,20-trinor-prost-5-en-1-oate¡Û |
1mg |
¡ï7,000 |
|
130209-82-4 |
|
|
|
¡¡ |
BML |
BML-RA120-0005 |
Latanoprost ¡Ú17-Phenyl-13,14-dihydroprostaglandin F2a Isopropyl Ester¡Û¡ÚIsopropyl 13,14-Dihydro-17-phenyl-18,19,20-trinor-prost-5-en-1-oate¡Û |
5mg |
¡ï29,000 |
|
130209-82-4 |
|
|
|
¡¡ |
BML |
BML-RA121-0001 |
Bimatoprost ¡Ú(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide¡Û |
1mg |
¡ï7,000 |
|
155206-00-1 |
|
|
|
¡¡ |
BML |
BML-RA121-0010 |
Bimatoprost ¡Ú(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide¡Û |
10mg |
¡ï51,000 |
|
155206-00-1 |
|
|
|
¡¡ |
BML |
BML-S104-0005 |
Conduritol B Epoxide ¡ÚD,L-1,2-Anhydro-myo-inositol¡Û¡ÚCBE¡Û |
5mg |
¡ï6,000 |
|
6090-95-5 |
|
|
|
¡¡ |
BML |
BML-S104-0025 |
Conduritol B Epoxide ¡ÚD,L-1,2-Anhydro-myo-inositol¡Û¡ÚCBE¡Û |
25mg |
¡ï27,000 |
|
6090-95-5 |
|
|
|
¡¡ |
BML |
BML-S106-0010 |
Bromoconduritol ¡Ú6-Bromo-3,4,5-trihydroxycyclohex-1-ene¡Û |
10mg |
¡ï12,000 |
|
42014-74-4 |
|
|
|
¡¡ |
BML |
BML-S106-0050 |
Bromoconduritol ¡Ú6-Bromo-3,4,5-trihydroxycyclohex-1-ene¡Û |
50mg |
¡ï50,000 |
|
42014-74-4 |
|
|
|
¡¡ |
BML |
BML-S107-0100 |
Castanospermine |
100mg |
¡ï13,000 |
|
79831-76-8 |
|
|
|
¡¡ |
BML |
BML-S107-0500 |
Castanospermine |
500mg |
¡ï54,000 |
|
79831-76-8 |
|
|
|
¡¡ |
BML |
BML-S108-0001 |
Deoxyfuconojirimycin |
1mg |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S108-0005 |
Deoxyfuconojirimycin |
5mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S109-0005 |
Deoxymannojirimycin, HCl |
5mg |
¡ï17,000 |
|
84444-90-6 |
|
|
|
¡¡ |
BML |
BML-S110-0001 |
Deoxynojirimycin |
1mg |
¡ï4,000 |
|
19130-96-2 |
|
|
|
¡¡ |
BML |
BML-S110-0005 |
Deoxynojirimycin |
5mg |
¡ï16,000 |
|
19130-96-2 |
|
|
|
¡¡ |
BML |
BML-S112-0001 |
Swainsonine ¡Ú8a,B-Octahydroindolizidine-1a,2a,8B-triol¡Û |
1mg |
¡ï19,000 |
|
72741-87-8 |
|
|
|
¡¡ |
BML |
BML-S112-0005 |
Swainsonine ¡Ú8a,B-Octahydroindolizidine-1a,2a,8B-triol¡Û |
5mg |
¡ï78,000 |
|
72741-87-8 |
|
|
|
¡¡ |
BML |
BML-S113-0005 |
N-Ethyldeoxynojirimycin |
5mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S114-0001 |
Kifunensine |
1mg |
¡ï12,000 |
|
109944-15-2 |
|
|
|
¡¡ |
BML |
BML-S114-0005 |
Kifunensine |
5mg |
¡ï52,000 |
|
109944-15-2 |
|
|
|
¡¡ |
BML |
BML-S115-0001 |
Mannostatin A, HCl |
1mg |
¡ï65,000 |
|
102822-56-0 |
|
|
|
¡¡ |
BML |
BML-S180-0005 |
Coumestrol |
5mg |
¡ï10,000 |
|
479-13-0 |
|
|
|
¡¡ |
BML |
BML-S180-0025 |
Coumestrol |
25mg |
¡ï40,000 |
|
479-13-0 |
|
|
|
¡¡ |
BML |
BML-S200-0010 |
U-18666A ¡Ú3B-(2-Diethylaminoethoxy)androstenone, HCl¡Û |
10mg |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S200-0050 |
U-18666A ¡Ú3B-(2-Diethylaminoethoxy)androstenone, HCl¡Û |
50mg |
¡ï48,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S250-0005 |
6a-Fluorotestosterone ¡ÚU-11207¡Û |
5mg |
¡ï16,000 |
|
1597-68-8 |
|
|
|
¡¡ |
BML |
BML-S250-0025 |
6a-Fluorotestosterone ¡ÚU-11207¡Û |
25mg |
¡ï62,000 |
|
1597-68-8 |
|
|
|
¡¡ |
BML |
BML-S510-0025 |
Mifepristone ¡ÚRU 486¡Û¡Ú11B-[p-(Dimethylamino)phenyl]-17B-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one¡Û |
25mg |
¡ï10,000 |
|
84371-65-3 |
|
|
|
¡¡ |
BML |
BML-S510-0100 |
Mifepristone ¡ÚRU 486¡Û¡Ú11B-[p-(Dimethylamino)phenyl]-17B-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one¡Û |
100mg |
¡ï19,000 |
|
84371-65-3 |
|
|
|
¡¡ |
BML |
BML-S515-0001 |
Megestrol Acetate ¡Ú17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate¡Û |
1g |
¡ï15,000 |
|
595-33-5 |
|
|
|
¡¡ |
BML |
BML-S520-0200 |
Melengestrol Acetate ¡ÚU-21240¡Û |
200mg |
¡ï7,000 |
|
2919-66-6 |
|
|
|
¡¡ |
BML |
BML-S520-1000 |
Melengestrol Acetate ¡ÚU-21240¡Û |
1g |
¡ï29,000 |
|
2919-66-6 |
|
|
|
¡¡ |
BML |
BML-S540-0010 |
2-Methoxyestradiol ¡Ú2-Methoxy-3,17b-dihydroxyestra-1,3,5(10)-triene¡Û |
10mg |
¡ï9,000 |
|
362-07-2 |
|
|
|
¡¡ |
BML |
BML-S540-0050 |
2-Methoxyestradiol ¡Ú2-Methoxy-3,17b-dihydroxyestra-1,3,5(10)-triene¡Û |
50mg |
¡ï36,000 |
|
362-07-2 |
|
|
|
·àʪ |
BML |
BML-S620-0020 |
Pregnenolone-16a-carbonitrile ¡ÚU-14975¡Û |
20mg |
¡ï5,000 |
|
1434-54-4 |
|
|
|
·àʪ |
BML |
BML-S620-0100 |
Pregnenolone-16a-carbonitrile ¡ÚU-14975¡Û |
100mg |
¡ï21,000 |
|
1434-54-4 |
|
|
|
¡¡ |
BML |
BML-S701-0010 |
SDZ-089443 ¡Ú2,2-Di-(4-chlorophenyl)-2-(1H-imidazol-1-yl)-1-(4-chlorobenzoylamino)ethane¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-S701-0050 |
SDZ-089443 ¡Ú2,2-Di-(4-chlorophenyl)-2-(1H-imidazol-1-yl)-1-(4-chlorobenzoylamino)ethane¡Û |
50mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SA101-0100 |
Caspase-1(human, aa 104-124), rabbit pAb(specificity: human) |
100ul |
¡ï35,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA104-0100 |
Matrix Metalloproteinase-3 ¡ÚMMP-3¡Û¡ÚStromelysin-1¡Û¡ÚTransin¡Û(human, peptide), rabbit pAb |
100ug |
¡ï61,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ pig | IHC¡¢ WB¡¢ IP¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA109-0100 |
Vesicular Acetylcholine Transporter ¡ÚVAChT¡Û(rat, aa 511-530)(CT), goat pAb(neat serum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
goat | - | mouse¡¢ rat (not rabbit¡¢ cat¡¢ guinea pig) | IHC |
|
|
¡¡ |
BML |
BML-SA1100-0025 |
7B2 ¡ÚSecretogranin V¡Û¡ÚNeuroendocrine protein I¡Û(pig, aa 23-39), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA1100-0100 |
7B2 ¡ÚSecretogranin V¡Û¡ÚNeuroendocrine protein I¡Û(pig, aa 23-39), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA111-0200 |
EGF-Receptor ¡ÚEGFR¡Û¡ÚEpidermal Growth Factor Receptor¡Û(human, aa 985-996)[F4], mouse mAb, purified(specificity: human) |
200ug |
¡ï52,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | F4 | human | IHC¡¢ IP¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA113-0200 |
Na+/K+ ATPase(dog kidney), chicken pAb |
200ug |
¡ï30,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
chicken | - | mammalian | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA115-0010 |
Catalase(bovine liver), rabbit pAb |
10mg |
¡ï21,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | ELISA |
|
|
¡¡ |
BML |
BML-SA117-0010 |
Cu2+/Zn2+ Superoxide Dismutase ¡ÚCu2+/Zn2+ SOD ¡Û(bovine erythrocytes), rabbit pAb |
10mg |
¡ï21,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | ELISA |
|
|
¡¡ |
BML |
BML-SA119-0100 |
CDK1 ¡Úp34cdc2¡Û¡Úcyclin-dependent kinase 1¡Û(Xenopus, aa 85-302)(recombinant)(CT)[17], mouse mAb, purified |
100ug |
¡ï34,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | 17 | human¡¢ mouse¡¢ Xenopus | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA124-0100 |
Retinoblastoma Protein ¡Úp105 Rb¡Û(human retinoblastoma)(recombinant)[1F8], mouse mAb, purified(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 1F8 | human | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA125-0050 |
G Protein(B Subunit)(internal)¡ÚGB¡Û(human, aa 127-139), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA126-0050 |
G Protein(a Subunit)¡ÚGa¡Û(Gaz subunit , aa 40-54), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA1264-0025 |
Serotonin ¡Ú5-HT¡Û¡Ú5-hydroxytryptamine¡Û(Serotonin-glutaraldehyde-BSA conjugate), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SA1264-0100 |
Serotonin ¡Ú5-HT¡Û¡Ú5-hydroxytryptamine¡Û(Serotonin-glutaraldehyde-BSA conjugate), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SA1267-0025 |
Somatostatin 14 ¡ÚSOM-14¡Û(human, aa 15-28), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ mammalian | IHC¡¢ Immuno-EM |
|
|
¡¡ |
BML |
BML-SA1267-0100 |
Somatostatin 14 ¡ÚSOM-14¡Û(human, aa 15-28), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ mammalian | IHC¡¢ Immuno-EM |
|
|
¡¡ |
BML |
BML-SA1268-0100 |
Somatostatin 28 ¡ÚSOM-28¡Û(human, aa 1-14), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ mammalian | IHC¡¢ Immuno-EM |
|
|
¡¡ |
BML |
BML-SA1270-0025 |
Substance P(Synthetic substance P(H-RPKPQQFFGLM-NH2)), rabbit pAb(antiserum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig¡¢ guinea pig | IHC |
|
|
¡¡ |
BML |
BML-SA1270-0100 |
Substance P(Synthetic substance P(H-RPKPQQFFGLM-NH2)), rabbit pAb(antiserum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig¡¢ guinea pig | IHC |
|
|
¡¡ |
BML |
BML-SA127-0050 |
G Protein(ai1 Subunit)¡ÚGai1¡Û(human, aa 159-168), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ bovine | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA128-0050 |
G Protein(ai1 and ai2 Subunits)¡ÚGai1 and Gai2¡Û(human, aa 345-354), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ bovine | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA129-0050 |
G Protein(ai3 Subunit)¡ÚGai3¡Û(human, aa 345-354), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ bovine | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA130-0050 |
G Protein(ai3 and a0 Subunits)¡ÚGai3 and Ga0¡Û(human, aa 345-354), rabbit pAb |
50ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ bovine | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA131-0050 |
G Protein(a>sub>s subunit)¡ÚGas¡Û(human, aa 385-394)(CT), rabbit pAb |
50ul |
¡ï61,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ bovine | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA133-0100 |
Cyclophilin 40(human, aa 356-370)(CT), rabbit pAb(neat serum) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ yeast | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA134-0100 |
Cyclophilin 40(recombinant), rabbit pAb(neat serum) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA136-0100 |
FKBP59 ¡ÚFK506 Binding Protein 59¡Û¡ÚHSP56¡Û¡ÚHeat Shock Protein 56¡Û(FKBP59/ HSP56, peptide)(CT), rabbit pAb |
100ug |
¡ï57,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rabbit | WB |
|
|
¡¡ |
BML |
BML-SA144-0100 |
PKCa ¡ÚProtein Kinase C a¡Û, rabbit pAb(neat serum) |
100ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ mammalian | WB |
|
|
¡¡ |
BML |
BML-SA146-0001 |
PKCBII ¡ÚProtein Kinase CBII¡Û(human, aa 661-673), rabbit pAb(neat serum) |
1mL |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ mammalian | WB |
|
|
¡¡ |
BML |
BML-SA147-0001 |
PKC¦Ã ¡ÚProtein Kinase C¦Ã¡Û(human, aa 681-697), rabbit pAb(neat serum) |
1mL |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA148-0001 |
PKC¦Ä ¡ÚProtein Kinase C¦Ä¡Û(human, aa 658-676), rabbit pAb(neat serum) |
1mL |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA149-0100 |
PKC¦Å ¡ÚProtein Kinase C¦Å¡Û(human, aa 721-737), rabbit pAb(neat serum) |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA150-0100 |
PKC¦Æ ¡ÚProtein Kinase C¦Æ¡Û(human, aa 721-737), rabbit pAb(neat serum) |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA151-0100 |
PKC¦Ç ¡ÚProtein Kinase C¦Ç¡Û(human, aa 666-683), rabbit pAb(neat serum) |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA154-0100 |
Phosphotyrosine, rabbit pAb |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA158-0100 |
Retinoic Acid Receptor B ¡ÚRARB¡Û(mouse, aa 429-448)(CT), rabbit pAb(neat serum) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA163-0100 |
Casein Kinase II(a Subunit)¡ÚCKIIa¡Û(human)(recombinant)[1AD9], mouse mAb, purified |
100ug |
¡ï68,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 1AD9 | human | WB( |
|
|
¡¡ |
BML |
BML-SA170-0100 |
NF-¦ÊB(p50)(human, peptide)(NT), rabbit pAb)(neat serum(specificity: human) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP¡¢ ELISA¡¢ EMSA |
|
|
¡¡ |
BML |
BML-SA171-0100 |
NF-¦ÊB(p65)(human, peptide)(CT), rabbit pAb(neat serum) |
100ul |
¡ï76,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP¡¢ ELISA¡¢ EMSA |
|
|
¡¡ |
BML |
BML-SA172-0100 |
NF-¦ÊB c-rel(human, peptide)(CT), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not mouse) | WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA182-0001 |
G Protein Antibody Set |
Set |
¡ï94,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SA183-0001 |
Protein Kinase C Set ¡ÚPKC Set¡Û |
Kit |
¡ï131,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SA188-0100 |
Retinoblastoma Protein ¡ÚRb¡Û [mAb245], mouse mAb, purified |
100ug |
¡ï68,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | mAb245 | human¡¢ mouse(weak)¡¢ rat(weak)¡¢ primate | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA189-0100 |
Retinoblastoma Protein(under-phosphorylated)¡ÚRb¡Û [mAb549], mouse mAb, purified |
100ug |
¡ï68,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | mAb549 | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA193-0100 |
Cdk2 ¡ÚCyclin-dependent Kinase 2¡Û(human, peptide)(CT), rabbit pAb(antiserum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA195-0250 |
Protein kinase A(RII subunit)¡ÚPKA RII¡Û¡ÚcAMP-dependent Protein Kinase Regulatory Subunit RII¡Û(bovine brain)[R-30], mouse mAb, Affinity-purified |
250ug |
¡ï28,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | R-30 | pig (weakly human¡¢ mouse¡¢ rat) | WB¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA200-0025 |
Nitric Oxide Synthase(inducible)¡ÚiNOS¡Û¡ÚInducible Nitric Oxide Synthase¡Û¡ÚNOS 2¡Û(mouse macrophage, aa 1131-1144), rabbit pAb(neat serum) |
25ul |
¡ï18,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB(~130kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA200-0100 |
Nitric Oxide Synthase(inducible)¡ÚiNOS¡Û¡ÚInducible Nitric Oxide Synthase¡Û¡ÚNOS 2¡Û(mouse macrophage, aa 1131-1144), rabbit pAb(neat serum) |
100ul |
¡ï55,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB(~130kDa)¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA204-0100 |
IgG(mouse), goat pAb, -HRP conj. |
100ug |
¡ï10,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
goat | - | mouse IgG | secondary antibodies(WB¡¢ELISA) |
|
|
¡¡ |
BML |
BML-SA208-0100 |
CDK1 ¡ÚCyclin-dependent kinase 1¡Û¡Úp34cdc2¡Û(human, peptide)(CT), rabbit pAb(neat serum) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ELISA¡¢ IP |
|
|
¡¡ |
BML |
BML-SA210-0025 |
Aryl Hydrocarbon Receptor ¡ÚAhR¡Û(AhR, aa 1-402)(recombinant)(NT), rabbit pAb, Affinity-purified |
25ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse | WB(¡Á95kDa)¡¢ IP¡¢ Chromatin IP |
|
|
¡¡ |
BML |
BML-SA210-0100 |
Aryl Hydrocarbon Receptor ¡ÚAhR¡Û(AhR, aa 1-402)(recombinant)(NT), rabbit pAb, Affinity-purified |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse | WB(¡Á95kDa)¡¢ IP¡¢ Chromatin IP |
|
|
¡¡ |
BML |
BML-SA213-0100 |
Zip Kinase(human, aa 279-298), rabbit pAb |
100ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA214-0100 |
Smac/DIABLO ¡ÚDIABLO¡Û(human, aa 225-239), rabbit pAb |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA215-0050 |
Leptin ¡ÚOB Gene Product¡Û(mouse, aa 25-44), rabbit pAb |
50ul |
¡ï52,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA216-0100 |
Poly(ADP-Ribose)(polymer(chain length of 2-50 units)), mouse mAb, purified |
100ul |
¡ï44,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG3 | inquire | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB¡¢ IP¡¢ ICC¡¢ ELISA¡¢Immunopurification |
|
|
¡¡ |
BML |
BML-SA218-0100 |
FKBP 12(human, aa 1-13), rabbit pAb |
100ul |
¡ï57,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA219-0100 |
Smac/DIABLO ¡ÚDIABLO¡Û(mouse, aa 222-237 ), rabbit pAb |
100ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA225-0100 |
DR4 ¡ÚTRAIL-R1¡Û¡ÚDeath Receptor 4¡Û(human, aa 427-445), rabbit pAb |
100ug |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA226-0500 |
Cytochrome c(pigeon, aa 1-80, 81-104 and 66-104)(recombinant)[CTC05], mouse mAb, purified |
500ul |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | CTC05 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC(PS¡¢ FS)¡¢ WB |
|
|
¡¡ |
BML |
BML-SA227-0025 |
nNOS ¡ÚNOS1¡Û¡ÚbNOS¡Û¡ÚBrain Nitric Oxide Synthase¡Û(human brain, aa 1414-1434), rabbit pAb |
25ug |
¡ï14,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | WB¡¢ IF¡¢ICC¡¢ELISA |
|
|
¡¡ |
BML |
BML-SA227-0100 |
nNOS ¡ÚNOS1¡Û¡ÚbNOS¡Û¡ÚBrain Nitric Oxide Synthase¡Û(human brain, aa 1414-1434), rabbit pAb |
100ug |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | WB¡¢ IF¡¢ICC¡¢ELISA |
|
|
¡¡ |
BML |
BML-SA230-0100 |
Apoptosis-inducing Factor ¡ÚAIF¡Û(human, aa 109-122), rabbit pAb(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA232-0050 |
G Protein(aq/11 Subunit)¡ÚGaq/11¡Û(mouse, peptide)(CT), rabbit pAb |
50ul |
¡ï60,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ dog¡¢ hamster | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA235-0100 |
RAR¦Ã1 ¡ÚRetinoic Acid Receptor ¦Ã 1 ¡Û(human/mouse, aa 40-57)(NT), rabbit pAb(antiserum) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse | WB¡¢ IP¡¢ EMSA |
|
|
¡¡ |
BML |
BML-SA237-0025 |
COX-2 ¡ÚCyclooxygenase-2¡Û¡ÚProstaglandin H2 Synthase¡Û(mouse, peptide)(CT), pAb |
25ug |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ sheep | WB¡¢ IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-SA237-0100 |
COX-2 ¡ÚCyclooxygenase-2¡Û¡ÚProstaglandin H2 Synthase¡Û(mouse, peptide)(CT), pAb |
100ug |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ sheep | WB¡¢ IP¡¢ IHC |
|
|
¡¡ |
BML |
BML-SA239-0100 |
Bcl-2(human, aa 61-76)(recombinant)[4D7], mouse mAb, purified(specificity: human) |
100ug |
¡ï44,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 4D7 | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA240-1000 |
Phosphotyrosine [PY20], mouse mAb, purified |
1mg |
¡ï19,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | PY20 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA241-0500 |
Phosphotyrosine [PY20], mouse mAb -Agarose conj. |
0.5mL |
¡ï42,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | PY20 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IP¡¢ Immunoaffinity chromatography |
|
|
¡¡ |
BML |
BML-SA242-0100 |
Phosphotyrosine [PY20], mouse mAb, -FITC conj. |
100ug |
¡ï30,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | PY20 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | ICC |
|
|
¡¡ |
BML |
BML-SA243-0100 |
Phosphotyrosine [PY20], mouse mAb, -Biotin conj. |
100ug |
¡ï30,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | PY20 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA247-0100 |
Na+/K+ ATPase, a-3 Subunit(dog cardiac microsomes)[XVIF9-G10], mouse mAb(ascites)(fluid) |
100ug |
¡ï63,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | XVIF9-G10 | human¡¢ rat¡¢ monkey¡¢ sheep¡¢ rabbit¡¢ dog | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA249-0050 |
Poly(ADP-Ribose)Polymerase ¡ÚPoly(ADP-Ribose)Polymerase-1¡Û [C-2-10], mouse mAb, Affinity-purified |
50ug |
¡ï44,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | C-2-10 | human¡¢ mouse¡¢ rat¡¢ monkey¡¢ hamster¡¢ bovine | WB¡¢ICC¡¢ELISA |
|
|
¡¡ |
BML |
BML-SA250-0050 |
Poly(ADP-Ribose)Polymerase ¡ÚPARP¡Û(calf thymus)[C-2-10], mouse mAb(ascites) |
50ul |
¡ï36,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | C-2-10 | human¡¢ mouse¡¢ rat¡¢ monkey¡¢ hamster | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA253-0025 |
Poly(ADP-Ribose)Polymerase ¡ÚPARP¡Û(bovine, aa 509-524), rabbit pAb(neat serum) |
25ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA253-0100 |
Poly(ADP-Ribose)Polymerase ¡ÚPARP¡Û(bovine, aa 509-524), rabbit pAb(neat serum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA254-0100 |
IP3 Receptor Type 1 ¡ÚInositol 1,4,5-Triphosphate Receptor Type 1¡Û¡ÚIP3R1¡Û¡ÚITPR1¡Û(human, aa 1829-1848), rabbit pAb(neat serum) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ dog | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA255-0100 |
m-Calpain(domain III/IV)¡ÚCalpain II¡Û(bovine skeletal muscle)[107-82], mouse mAb(ascites)(fluid) |
100ul |
¡ï57,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 107-82 | human¡¢ rat¡¢ pig | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA259-0100 |
TRAIL ¡ÚApo2L¡Û(human, aa 261-277), rabbit pAb(specificity: human) |
100ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA261-0100 |
Cyclin D1(human)(recombinant)[DCS-11], mouse mAb, purified |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | DCS-11 | human¡¢ mouse¡¢ rat | IP |
|
|
¡¡ |
BML |
BML-SA262-0100 |
Cyclin D2(human)(recombinant)[DCS-3.1], mouse mAb, purified for blocking |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | DCS-3.1 | human¡¢ mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA263-0100 |
Cyclin D2(human)(recombinant)[DCS-5.2], mouse mAb, purified |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | DCS-5.2 | human¡¢ mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA265-0100 |
Cyclin D3(human)(recombinant)[DCS-28.1], mouse mAb, purified |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DCS-28.1 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA266-0020 |
[pThr180/pTyr182]p38 ¡Úp38, [pThr180/pTyr182]-¡Û¡Úp38 Kinase(phosphorylated)(pThr180/pThr182)¡Û(human phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ dog¡¢ carp | WB |
|
|
¡¡ |
BML |
BML-SA268-0100 |
Leptin ¡ÚOB gene product¡Û(human/mouse)(recombinant), rabbit pAb |
100ug |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA270-0100 |
PKA(RIIB Subunit)¡ÚProtein Kinase A RIIB Subunit¡Û(mouse, peptide)(NT), rabbit pAb(neat serum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA271-0100 |
PKA(RIIB Subunit)¡ÚProtein Kinase A RIIB Subunit¡Û(mouse, peptide)(NT), rabbit pAb |
100ug |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA272-0020 |
[pThr183/pTyr185]JNK1/2 ¡ÚJNK 1&2, [pThr183/pTyr185]-¡Û¡ÚSAP Kinase¡Û¡ÚSAPK¡Û(human, phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA272-0100 |
[pThr183/pTyr185]JNK1/2 ¡ÚJNK 1&2, [pThr183/pTyr185]-¡Û¡ÚSAP Kinase¡Û¡ÚSAPK¡Û(human, phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA273-0100 |
CDK4 ¡ÚCyclin-Dependent Kinase 4¡Û(human)(recombinant)[35.1], mouse mAb, purified |
100ug |
¡ï51,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 35.1 | human¡¢ mouse¡¢ rat | IF¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA275-0020 |
[pThr185/pTyr187]ERK1/2 ¡ÚERK1/2, [pThr185/pTyr187]-¡Û¡ÚMAP Kinase¡Û¡ÚMAPK¡Û(human, phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA275-0100 |
[pThr185/pTyr187]ERK1/2 ¡ÚERK1/2, [pThr185/pTyr187]-¡Û¡ÚMAP Kinase¡Û¡ÚMAPK¡Û(human, phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA277-0100 |
Nitric oxide synthase(universal)¡ÚNOS(universal)¡Û¡ÚUniversal Nitric Oxide Synthase¡Û(mouse iNOS and bNOS, aa 1113-1122), rabbit pAb |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit IgG | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ pig | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA278-0100 |
ERK1/2 ¡ÚMAP Kinase¡Û¡ÚMAPK¡Û(human, aa 317-339), rabbit pAb |
100ul |
¡ï57,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA279-0005 |
[pSer392]p53 ¡Úp53, [pSer392]-¡Û(mouse, phosphorylated peptide), rabbit pAb(preservative free) |
5ug |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA279-0025 |
[pSer392]p53 ¡Úp53, [pSer392]-¡Û(mouse, phosphorylated peptide), rabbit pAb(preservative free) |
25ug |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA280-0100 |
G Protein(a0 Subunit)(bovine brain)[2A.3], mouse mAb, purified |
100ug |
¡ï47,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 2A.3 | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ guinea pig | WB |
|
|
¡¡ |
BML |
BML-SA281-0100 |
G Protein(ai1 Subunit)¡ÚGai1¡Û(rat brain)[R4.5], mouse mAb, purified |
100ug |
¡ï44,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | R4.5 | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ guinea pig | WB |
|
|
¡¡ |
BML |
BML-SA285-0200 |
PKA(RIa Subunit)¡ÚProtein Kinase A RIa subunit¡Û(human, aa 4-18), chicken pAb |
200ug |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
chicken IgY | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA287-0250 |
Hif-1a ¡ÚHypoxia-inducible Factor 1a¡Û(human, aa 432-528)(recombinant)[H1a67], mouse mAb, purified |
250ul |
¡ï61,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | H1¦Á67 | human¡¢ mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA289-0100 |
Hif-1a ¡ÚHypoxia-inducible Factor 1a¡Û(human)(recombinant)[OZ12], mouse mAb, purified |
100ug |
¡ï51,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | OZ12 | human | Electrophoretic Mobility Shift Assay |
|
|
¡¡ |
BML |
BML-SA293-0050 |
p53(human, aa 371-380)[PAb421], mouse mAb(MAb421), purified |
50ug |
¡ï28,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | PAb421 | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA294-0500 |
c-myc(human pp62, aa 408-438)[9E10], mouse mAb, purified(specificity: human) |
0.5mg |
¡ï26,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 9E10. | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA296-0100 |
Cyclophilin A, rabbit pAb(neat serum) |
100ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA297-0100 |
Nitrotyrosine(Nitrated KLH), rabbit pAb(neat serum) |
100ul |
¡ï35,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA298-0050 |
Bak(human)(recombinant)(NT)[TC100], mouse mAb, purified(specificity: human) |
50ug |
¡ï26,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | TC100 | human | WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA304-0100 |
Caspase-14(human)(recombinant), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA320-0100 |
Caspase-3(human)(recombinant), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA321-0100 |
Caspase-9(human)(recombinant), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA322-0100 |
Caspase-8(human, aa 427-441), rabbit pAb(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA323-0100 |
Caspase-7(human, aa 24-46), rabbit pAb(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA324-0100 |
Caspase-11(mouse)(recombinant), rabbit pAb(antiserum)(specificity: mouse) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse | WB |
|
|
¡¡ |
BML |
BML-SA325-0100 |
Caspase-2(human)(recombinant), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA326-0100 |
Caspase-4(human)(recombinant), rabbit pAb(serum)(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA328-0020 |
[pTyr705]STAT3 ¡ÚSTAT3, [pTyr705]-¡Û¡ÚSTAT3(phosphorylated)(pTyr705)¡Û(human, phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA328-0100 |
[pTyr705]STAT3 ¡ÚSTAT3, [pTyr705]-¡Û¡ÚSTAT3(phosphorylated)(pTyr705)¡Û(human, phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA329-0040 |
[pTyr701]STAT1 ¡ÚSTAT1, [pTyr701]-¡Û¡ÚSTAT1(phosphorylated)(pTyr701)¡Û(mouse, phosphorylated peptide), rabbit pAb(specificity: mouse)(preservative free) |
40ul |
¡ï22,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ human (weak) | WB |
|
|
¡¡ |
BML |
BML-SA330-0010 |
[pTyr701]STAT1 ¡ÚSTAT1, [pTyr701]-¡Û¡ÚSTAT1(phosphorylated)(pTyr701)¡Û(human, phosphorylated peptide), rabbit pAb,(specificity: human)(preservative free) |
10ug |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse (weak) | WB |
|
|
¡¡ |
BML |
BML-SA331-0100 |
Caspase-5(human)(recombinant), rabbit pAb(serum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA3400-0025 |
a-Synuclein ¡ÚNACP¡Û(human, aa 117-131), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA3400-0100 |
a-Synuclein ¡ÚNACP¡Û(human, aa 117-131), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA3405-0025 |
B-Synuclein ¡ÚPNP14¡Û¡ÚPhosphoneuroprotein 14¡Û¡ÚSNCB¡Û(human, aa 97-111), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA3405-0100 |
B-Synuclein ¡ÚPNP14¡Û¡ÚPhosphoneuroprotein 14¡Û¡ÚSNCB¡Û(human, aa 97-111), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA342-0010 |
[pTyr407]Focal adhesion kinase ¡ÚFocal Adhesion Kinase, [pTyr407]-¡Û¡ÚFAK¡Û(phosphorylated peptide), rabbit pAb (preservative free) |
10ug |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ chicken¡¢ frog | WB |
|
|
¡¡ |
BML |
BML-SA342-0050 |
[pTyr407]Focal Adhesion Kinase ¡ÚFocal Adhesion Kinase, [pTyr407]-¡Û¡ÚFAK¡Û(phosphorylated peptide), rabbit pAb(preservative free) |
50ug |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ chicken¡¢ frog | WB |
|
|
¡¡ |
BML |
BML-SA343-0010 |
[pTyr576]Focal Adhesion Kinase ¡ÚFocal Adhesion Kinase, [pTyr576]-¡Û¡ÚFAK¡Û(phosphorylated peptide), rabbit pAb(preservative free) |
10ug |
¡ï17,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ chicken¡¢ frog | WB |
|
|
¡¡ |
BML |
BML-SA344-0010 |
[pTyr845]EGF Receptor ¡ÚEGF Receptor, [pTyr845]-¡Û¡ÚEpidermal Growth Factor Receptor¡Û¡ÚEGFR¡Û(phosphorylated peptide)[12A3], mouse mAb, purified |
10ug |
¡ï10,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 12A3 | human | IHC(PS¡¢FS)¡¢WB¡¢IP¡¢ICC¡¢ELISA¡¢Luminex |
|
|
¡¡ |
BML |
BML-SA344-0050 |
[pTyr845]EGF Receptor ¡ÚEGF Receptor, [pTyr845]-¡Û¡ÚEpidermal Growth Factor Receptor¡Û¡ÚEGFR¡Û(phosphorylated peptide)[12A3], mouse mAb, purified |
50ug |
¡ï38,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 12A3 | human | IHC(PS¡¢FS)¡¢WB¡¢IP¡¢ICC¡¢ELISA¡¢Luminex |
|
|
¡¡ |
BML |
BML-SA347-0010 |
MEK7 ¡ÚMKK7¡Û¡ÚMAP Kinase Kinase 7¡Û(synthetic peptide)[3F5], mouse mAb, purified(specificity: human) |
10ug |
¡ï10,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 3F5 | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA347-0050 |
MEK7 ¡ÚMKK7¡Û¡ÚMAP Kinase Kinase 7¡Û(synthetic peptide)[3F5], mouse mAb, purified(specificity: human) |
50ug |
¡ï38,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 3F5 | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA349-0010 |
[pTyr317]Shc ¡ÚShc, [pTyr317]-¡Û¡ÚShc(phosphorylated)(pTyr317)¡Û(phosphorylated peptide)[15E11], mouse mAb, purified |
10ug |
¡ï10,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 15E11. | human¡¢ mouse | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-SA354-0100 |
Cathepsin G(human), rabbit pAb(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA355-0100 |
Cathepsin H(human), rabbit pAb(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA356-0100 |
Peroxiredoxin-1 ¡ÚPrx 1¡Û(human, peptide), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA357-0100 |
Peroxiredoxin-2 ¡ÚPrx 2¡Û(human, peptide), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA358-0100 |
Peroxiredoxin-3 ¡ÚPrx 3¡Û(human)(recombinant), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA359-0100 |
Peroxiredoxin-4 ¡ÚPrx 4¡Û(human)(recombinant), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA360-0020 |
[pThr246]PRAS40 ¡ÚPRAS40, [pThr246]-¡Û¡ÚProline-Rich Akt Substrate 40¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA360-0100 |
[pThr246]PRAS40 ¡ÚPRAS40, [pThr246]-¡Û¡ÚProline-Rich Akt Substrate 40¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA361-0100 |
Cathepsin B(human), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA362-0100 |
Cathepsin L(human), rabbit pAb(antiserum)(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA363-0020 |
[pTyr1068]EGF Receptor ¡ÚEGF Receptor, [pTyr1068]-¡Û¡ÚEpidermal Growth Factor Receptor¡Û¡ÚEGFR¡Û(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA365-0020 |
[pTyr783]Phospholipase C¦Ã-1 ¡ÚPhospholipase C¦Ã-1, [pTyr783]-¡Û¡ÚPLC¦Ã1¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ bovine¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA365-0100 |
[pTyr783]Phospholipase C¦Ã-1 ¡ÚPhospholipase C¦Ã-1, [pTyr783]-¡Û¡ÚPLC¦Ã1¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ bovine¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA366-0020 |
[pTyr340/341]c-Raf-1 ¡Úc-Raf-1, [pTyr340/341]-¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA366-0100 |
[pTyr340/341]c-Raf-1 ¡Úc-Raf-1, [pTyr340/341]-¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA367-0020 |
[pSer249/pThr252]Retinoblastoma Protein ¡ÚRetinoblastoma Protein, [pSer249/pThr252]¡Û¡ÚRb¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA367-0100 |
[pSer249/pThr252]Retinoblastoma Protein ¡ÚRetinoblastoma Protein, [pSer249/pThr252]¡Û¡ÚRb¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA368-0020 |
[pThr821]Retinoblastoma Protein ¡ÚRetinoblastoma Protein, [pThr821]¡Û¡ÚRb¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA368-0100 |
[pThr821]Retinoblastoma Protein ¡ÚRetinoblastoma Protein, [pThr821]¡Û¡ÚRb¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA369-0100 |
Insulin-Like Growth Factor-1 Receptor ¡ÚIGF-1R ¡Û(human, aa 1323-1337)(CT)[1-2], mouse mAb, Affinity-purified |
100ug |
¡ï59,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2 | 1-2. | human¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA374-0100 |
TIMP-2 ¡ÚTissue Inhibitor of Matrix Metalloproteinases-2¡Û(human, peptide), rabbit pAb |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat¡¢ bovine¡¢ dog | WB |
|
|
¡¡ |
BML |
BML-SA375-0100 |
TIMP-3 ¡ÚTissue Inhibitor of Matrix Metalloproteinases 3¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
100ug |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA376-0100 |
ADAM9 ¡ÚA Disintegrin And Metalloproteinase 9¡Û¡ÚMeltrin ¦Ã¡Û¡ÚMDC9¡Û(human, peptide)(CT), rabbit pAb |
100ug |
¡ï32,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | WB |
|
|
¡¡ |
BML |
BML-SA377-0100 |
ADAM10 ¡ÚA Disintegrin And Metalloproteinase 10¡Û¡ÚMADM¡Û¡ÚKuzbanian¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA380-0100 |
TIMP-4 ¡ÚTissue Inhibitor of Matrix Metalloproteinases 4¡Û(human, peptide)(CT), rabbit pAb |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ rabbit | WB |
|
|
¡¡ |
BML |
BML-SA381-0020 |
[pSer383]Elk1 ¡ÚElk1, [pSer383]-¡Û¡ÚElk1(phosphorylated)(pSer383)¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA381-0100 |
[pSer383]Elk1 ¡ÚElk1, [pSer383]-¡Û¡ÚElk1(phosphorylated)(pSer383)¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï44,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA382-0020 |
[pSer152/156]MARCKS ¡ÚMARCKS, [pSer152/156]¡Û¡ÚMyristoylated Alanine-Rich C Kinase Substrate¡Û(rat)(phosphorylated), rabbit pAb |
20ul |
¡ï19,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | WB |
|
|
¡¡ |
BML |
BML-SA382-0100 |
[pSer152/156]MARCKS ¡ÚMARCKS, [pSer152/156]¡Û¡ÚMyristoylated Alanine-Rich C Kinase Substrate¡Û(rat)(phosphorylated), rabbit pAb |
100ul |
¡ï44,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | WB |
|
|
¡¡ |
BML |
BML-SA383-0020 |
[pSer218/222]MEK1/2 ¡ÚMEK1/2, [pSer218/222]-¡Û(human)(phosphorylated peptide), rabbit pAb (specificity: human) |
20ul |
¡ï14,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA383-0100 |
[pSer218/222]MEK1/2 ¡ÚMEK1/2, [pSer218/222]-¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï51,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA390-0100 |
[pTyr1158]Insulin Receptor and [pTyr1131]IGF-1 Receptor ¡ÚInsulin Receptor¡Û¡ÚIR and IGF-1R(Insulin-Like Growth Factor-1 receptor)¡Û¡ÚIGF-1R ¡Û¡ÚInsulin-Like Growth Factor-1 Receptor¡Û(human)(phosphor |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA392-0020 |
[pTyr1158/1162/1163]Insulin Receptor and [pTyr1131/1135/1136]IGF-1 Receptor ¡ÚInsulin Receptor¡Û¡ÚIR and IGF-1R(Insulin-Like Growth Factor-1 Receptor)¡Û¡ÚIGF-1R ¡Û¡ÚInsulin-Like Growth Factor-1 Recept |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA392-0100 |
[pTyr1158/1162/1163]Insulin Receptor and [pTyr1131/1135/1136]IGF-1 Receptor ¡ÚInsulin Receptor¡Û¡ÚIR and IGF-1R(Insulin-Like Growth Factor-1 Receptor)¡Û¡ÚIGF-1R ¡Û¡ÚInsulin-Like Growth Factor-1 Recept |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA393-0020 |
[pTyr1229]Insulin Receptor Substrate 1 ¡ÚInsulin Receptor Substrate-1, [pTyr1229]-¡Û¡ÚIRS-1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA393-0100 |
[pTyr1229]Insulin Receptor Substrate 1 ¡ÚInsulin Receptor Substrate-1, [pTyr1229]-¡Û¡ÚIRS-1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA394-0020 |
[pTyr941]Insulin Receptor Substrate 1 ¡ÚInsulin Receptor Substrate-1, [pTyr941]-¡Û¡ÚIRS-1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA396-0020 |
[pTyr896]Insulin Receptor Substrate 1 ¡ÚInsulin Receptor Substrate-1, [pTyr896]-¡Û¡ÚIRS-1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA396-0100 |
[pTyr896]Insulin Receptor Substrate 1 ¡ÚInsulin Receptor Substrate-1, [pTyr896]-¡Û¡ÚIRS-1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA398-0100 |
Cathepsin D(human)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA399-0020 |
[pThr71]Activating Transcription Factor 2 ¡ÚActivating Transcription Factor 2, [pThr71]-¡Û¡ÚATF2¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA399-0100 |
[pThr71]Activating Transcription Factor 2 ¡ÚActivating Transcription Factor 2, [pThr71]-¡Û¡ÚATF2¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA401-0100 |
HDAC1 ¡ÚHistone Deacetylase 1¡Û(human, aa 467-482)(CT), rabbit pAb |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ mouse¡¢ hamster¡¢ dog | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA402-0100 |
HDAC2 ¡ÚHistone Deacetylase 2¡Û(human, aa 475-488)(CT), rabbit pAb |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ mouse¡¢ hamster¡¢ dog | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA403-0100 |
HDAC3 ¡ÚHistone Deacetylase 3¡Û(human, aa 415-428)(CT), rabbit pAb |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ hamster¡¢ dog | WB |
|
|
¡¡ |
BML |
BML-SA404-0100 |
HDAC4 ¡ÚHistone Deacetylase 4¡Û(human, aa 1071-1084)(CT), rabbit pAb |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit IgG | - | human | WB(140kDa) |
|
|
¡¡ |
BML |
BML-SA405-0020 |
[pSer52]Eukaryotic Initiation Factor 2 a ¡ÚEukaryotic Initiation Factor 2 a, [pSer52]-¡Û¡ÚeIF2a¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ yeast | WB |
|
|
¡¡ |
BML |
BML-SA405-0100 |
[pSer52]Eukaryotic Initiation Factor 2 a ¡ÚEukaryotic Initiation Factor 2 a, [pSer52]-¡Û¡ÚeIF2a¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ yeast | WB |
|
|
¡¡ |
BML |
BML-SA411-0100 |
ADAMTS5 ¡ÚA Disintegrin and Metalloproteinase with Thrombospondin Motif 5¡Û¡ÚAggrecanase-2¡Û(human, peptide), rabbit pAb |
100ug |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA412-0020 |
[pSer32/36]I¦ÊBa ¡ÚI¦ÊBa, [pSer32/36]-¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig | WB |
|
|
¡¡ |
BML |
BML-SA412-0100 |
[pSer32/36]I¦ÊBa ¡ÚI¦ÊBa, [pSer32/36]-¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ pig | WB |
|
|
¡¡ |
BML |
BML-SA413-0020 |
[pTyr529]Src ¡ÚSrc, [pTyr529]-¡Û(human)(phosphorylated peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | WB |
|
|
¡¡ |
BML |
BML-SA413-0100 |
[pTyr529]Src ¡ÚSrc, [pTyr529]-¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken | WB |
|
|
¡¡ |
BML |
BML-SA415-0100 |
ADAM17(Catalytic Domain)¡ÚA Disintegrin and Metalloproteinase 17¡Û¡ÚTACE¡Û(human)(recombinant), rabbit pAb(neat serum) |
100ul |
¡ï32,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA416-0100 |
[pSer181]TAO2 ¡ÚTAO2, [pSer181]-¡Û¡ÚThousand and One Amino Acid 2 Protein Kinase¡Û(human)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï57,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA418-0100 |
[pTyr1472]NMDA Receptor NR2B Subunit ¡ÚNMDA Receptor(NR2B Subunit), [pTyr1472]-¡Û(rat)(phosphorylated peptide), rabbit pAb(specificity: rat) |
100ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA420-0050 |
GABA A Receptor ¦Ã2 ¡ÚGABRG2¡Û¡Úgamma-Aminobutyric Acid A Receptor¡Û(synthetic peptide), rabbit pAb(neat serum) |
50ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA422-0100 |
14-3-3¦Ã(human)(recombinant)[CG31], mouse mAb, purified(specificity: human) |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CG31 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA423-0500 |
Cyclin E(human, peptide)(CT), rabbit pAb |
500ug |
¡ï47,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA424-0100 |
GABAA receptor ¦Ã2(CT loop)¡ÚGABRG2¡Û¡ÚGamma-aminobutyric acid A Receptor ¦Ã2 ¡Û(rat)(recombinant)(cytosolic loop), rabbit pAb |
100ul |
¡ï53,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA425-0050 |
NMDA Receptor(NR2A Subunit)(rat)(recombinant)(CT), rabbit pAb |
50ul |
¡ï55,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA426-0050 |
NMDA Receptor(NR2B Subunit)(rat)(recombinant)(CT), rabbit pAb |
50ul |
¡ï55,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA427-0100 |
SIRT1 ¡ÚSirtuin 1¡Û(human)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA428-0100 |
ADAM15 ¡ÚA Disintegrin and Metalloproteinase 15¡Û¡ÚMetargidin¡Û¡ÚMDC15¡Û(human, peptide), rabbit pAb |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ other mammalian | WB |
|
|
¡¡ |
BML |
BML-SA429-0100 |
ZAP70(human, aa 1-254)(recombinant), rabbit pAb(specificity: human) |
100ug |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA430-0500 |
Focal Adhesion Kinase ¡ÚFAK¡Û(human, aa 853-1052)(recombinant), rabbit pAb |
500ug |
¡ï47,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit IgG | - | human¡¢ mouse¡¢ rat¡¢ dog¡¢ frog | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA432-0100 |
Insulin Receptor(B Subunit)¡ÚIR B subunit¡Û(human, 100aa)[CT-3], mouse mAb, purified |
100ug |
¡ï53,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | CT-3 | human¡¢ mouse¡¢ rat¡¢ monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA433-0020 |
[pTyr397]Focal Adhesion Kinase ¡ÚFocal Adhesion Kinase, [pTyr397]-¡Û¡ÚFAK¡Û(phosphorylated, peptide), rabbit pAb |
20ul |
¡ï15,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ chicken¡¢ frog | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA433-0100 |
[pTyr397]Focal Adhesion Kinase ¡ÚFocal Adhesion Kinase, [pTyr397]-¡Û¡ÚFAK¡Û(phosphorylated, peptide), rabbit pAb |
100ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ chicken¡¢ frog | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA434-0100 |
Matrix Metalloproteinase-10(Hinge Region)¡ÚMMP-10¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA435-0200 |
Ras(human, aa 31-43), rabbit pAb |
200ug |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | IHC |
|
|
¡¡ |
BML |
BML-SA436-0100 |
Janus Kinase 1 ¡ÚJAK1¡Û(human, peptide), rabbit pAb |
100ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA437-0100 |
Janus Kinase 2 ¡ÚJAK2¡Û(human, peptide), rabbit pAb |
100ug |
¡ï64,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA439-0020 |
[pThr98]Myelin Basic Protein ¡ÚMyelin Basic Protein, [pThr98]-¡Û¡ÚMBP¡Û(human myelin)(phosphorylated peptide)[P12], mouse mAb, purified |
20ug |
¡ï15,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | P12 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA439-0100 |
[pThr98]Myelin Basic Protein ¡ÚMyelin Basic Protein, [pThr98]-¡Û¡ÚMBP¡Û(human myelin)(phosphorylated peptide)[P12], mouse mAb, purified |
100ug |
¡ï60,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2a | P12 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ICC¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA444-0100 |
SIRT2 ¡ÚSirtuin 2¡Û(human)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA445-0100 |
ACE2 ¡ÚAngiotensin Converting Enzyme 2¡Û¡ÚSARS receptor¡Û¡ÚACEH¡Û(human, peptide), rabbit pAb |
100ug |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ mouse | WB |
|
|
¡¡ |
BML |
BML-SA447-0100 |
Kallikrein-1 ¡ÚKLK1¡Û¡ÚTissue Kallikrein¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA448-0100 |
Kallikrein-2 ¡ÚKLK2¡Û¡ÚGlandular Kallikrein¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA451-0100 |
DPPIV ¡ÚDipeptidyl Peptidase IV¡Û¡ÚDPP4¡Û¡ÚCD26¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA452-0100 |
[K(Ac)40]a-Tubulin ¡Úa-Tubulin, [K(Ac)40]-¡Û(human, aa 35-45)(synthetic acetylated peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | primate¡¢ rodent¡¢ chicken¡¢ Xenopus¡¢ zebrafish | WB |
|
|
¡¡ |
BML |
BML-SA461-0100 |
ACE1 ¡ÚAngiotensin Converting Enzyme 1¡Û¡ÚACE¡Û(human, peptide)(NT), rabbit pAb(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA462-0100 |
ACE1 ¡ÚAngiotensin Converting Enzyme 1¡Û¡ÚACE¡Û(human, peptide)(CT), rabbit pAb(specificity: human) |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA463-0100 |
SIRT3 ¡ÚSirtuin 3¡Û(human)(recombinant), rabbit pAb |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA464-0100 |
SIRT5 ¡ÚSirtuin 5¡Û(human)(recombinant), rabbit pAb |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA465-0100 |
BACE1 ¡ÚB-Secretase¡Û¡ÚB-Site APP Cleaving Enzyme 1¡Û¡ÚMemapsin-2¡Û¡ÚAspartyl protease 2¡Û(human, peptide), rabbit pAb |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA467-0100 |
MMP-12 ¡ÚMatrix Metalloproteinase-12¡Û¡ÚMetalloelastase¡Û¡ÚMacrophage Elastase¡Û(mouse, peptide)(CT), rabbit pAb |
100ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA468-0100 |
Nitrotyrosine(nitrated KLH)[HM11], mouse mAb, purified |
100ug |
¡ï73,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | HM11 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA469-0100 |
Neutrophil Elastase ¡ÚLeukocyte Elastase¡Û(human), rabbit pAb |
100ul |
¡ï23,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA470-0100 |
ADAM12(Catalytic Domain)¡ÚA Disintegrin And Metalloproteinase 12¡Û¡ÚMeltrin a¡Û(human)(recombinant), rabbit pAb(neat serum)(specificity: human) |
100ul |
¡ï28,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA474-0025 |
14-3-3B ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚProtein 1054¡Û¡Ú14-3-3a¡Û(acetylated N-terminal domain), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ ELISA¡¢Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA474-0100 |
14-3-3B ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚProtein 1054¡Û¡Ú14-3-3a¡Û(acetylated N-terminal domain), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ ELISA¡¢Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA475-0025 |
14-3-3¦Å ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3E¡Û(synthetic peptide, aa 239-255 )(CT), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ sheep¡¢ bovine¡¢ chicken | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA475-0100 |
14-3-3¦Å ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3E¡Û(synthetic peptide, aa 239-255 )(CT), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ rabbit¡¢ sheep¡¢ bovine¡¢ chicken | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA476-0025 |
14-3-3¦Ç ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚProtein AS1¡Û(acetylated N-terminal domain), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ cow¡¢ sheep | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA476-0100 |
14-3-3¦Ç ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚProtein AS1¡Û(acetylated N-terminal domain), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ cow¡¢ sheep | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA477-0025 |
14-3-3¦Ã ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û(human), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA477-0100 |
14-3-3¦Ã ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û(human), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA478-0025 |
14-3-3¦Å ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep¡¢ rabbit | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA478-0100 |
14-3-3¦Å ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep¡¢ rabbit | IHC¡¢ WB¡¢ ELISA¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA479-0025 |
[pSer185]14-3-3 ¡Ú14-3-3, [pSer185]-¡Û¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3B/¦Æ¡Û¡ÚProtein 1054¡Û(14-3-3 phosphorylated), sheep pAb. Affinity-purified |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | WB |
|
|
¡¡ |
BML |
BML-SA479-0100 |
[pSer185]14-3-3 ¡Ú14-3-3, [pSer185]-¡Û¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3B/¦Æ¡Û¡ÚProtein 1054¡Û(14-3-3 phosphorylated), sheep pAb, Affinity-purified |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | WB |
|
|
¡¡ |
BML |
BML-SA480-0025 |
14-3-3¦Ò ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚStratifin¡Û¡ÚSFN¡Û¡ÚEpithelial Cell Marker Protein 1¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | WB |
|
|
¡¡ |
BML |
BML-SA480-0100 |
14-3-3¦Ò ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚStratifin¡Û¡ÚSFN¡Û¡ÚEpithelial Cell Marker Protein 1¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | WB |
|
|
¡¡ |
BML |
BML-SA481-0025 |
14-3-3¦Ó/¦È ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚHS1 Protein¡Û¡ÚT Cell Protein¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA481-0100 |
14-3-3¦Ó/¦È ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡ÚHS1 Protein¡Û¡ÚT Cell Protein¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ sheep | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA482-0025 |
14-3-3¦Æ ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3¦Ä¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA482-0100 |
14-3-3¦Æ ¡ÚKCIP-1¡Û¡ÚProtein Kinase C Inhibitor Protein 1¡Û¡Ú14-3-3¦Ä¡Û(acetylated N-terminal epitope), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ bovine¡¢ sheep | IHC¡¢ WB¡¢ Affinity Chromatography |
|
|
¡¡ |
BML |
BML-SA483-0025 |
14-3-3(human)(recombinant), rabbit pAb(neat serum) |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian¡¢ chicken¡¢ plants¡¢ yeast¡¢ invertebrate | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA483-0100 |
14-3-3(human)(recombinant), rabbit pAb(neat serum) |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian¡¢ chicken¡¢ plants¡¢ yeast¡¢ invertebrate | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA484-0100 |
Voltage Gated Potassium Channel(Kv2.2 Subunit)(Xenopus and Rodent, peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Xenopus and rodent | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA485-0100 |
Sodium Calcium Exchanger 1 ¡ÚNa+/Ca2+ exchanger 1¡Û¡ÚNCX1¡Û(rabbit renal)(NT)[6H2], mouse mAb, purified |
100ug |
¡ï45,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG2b | 6H2 | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SA487-0100 |
DOPA Decarboxylase ¡ÚDDC¡Û¡ÚAromatic L-Amino Acid Decarboxylase¡Û¡ÚAADC¡Û(bovine)(denatured recombinant), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-SA488-0010 |
NMDA Receptor(NR2C Subunit)(rat)(recombinant)(NT), rabbit pAb |
10ug |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA491-0025 |
NMDA Receptor(NR1 Subunit, splice variant C2)(rat, peptide), rabbit pAb |
25ug |
¡ï44,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA492-0025 |
NMDA Receptor(NR1 Subunit, splice variant C2')(rat, peptide), rabbit pAb |
25ug |
¡ï44,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA493-0015 |
NMDA Receptor(NR1 Subunit)(rat, aa 1-564)(recombinant)[R1JHL], mouse mAb, purified |
15ug |
¡ï47,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse | R1JHL | mouse¡¢ rat | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA495-0050 |
Synapsin 1(bovine brain), rabbit pAb(neat serum) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA497-0100 |
Tyrosine Hydroxylase ¡ÚTH¡Û(rat), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA498-0100 |
Tyrosine Hydroxylase ¡ÚTH¡Û(rat), sheep pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | mammalian | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA500-0100 |
mGluR 2/3 ¡ÚMetabotropic Glutamate Receptor 2/3¡Û(rat, peptide)(CT), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ dog¡¢ zebrafish | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA501-0100 |
mGluR 1a ¡ÚMetabotropic Glutamate Receptor 1a¡Û(rat, peptide)(CT), rabbit pAb(specificity: rat) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA509-0100 |
Dopamine Transporter(Extracellular Loop)(human, peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ monkey | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA510-0200 |
Glycine Receptor(rat, peptide, a1-subunit)(NT), rabbit pAb |
200ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA512-0100 |
GABA A Receptor(a1-Subunit)¡Ú¦Ã-Aminobutyric Acid A Receptor¡Û(cytoplasmic loop)(recombinant)(CT), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA513-0100 |
GABA A Receptor(a1-Subunit)¡Ú¦Ã-Aminobutyric acid A Receptor¡Û(synthetic peptide)(NT), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA516-0100 |
GABA A Receptor(a5-Subunit)¡Ú¦Ã-Aminobutyric Acid A Receptor¡Û(rat)(recombinant)(CT), rabbit pAb, purified |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ zebrafish | WB |
|
|
¡¡ |
BML |
BML-SA518-0050 |
GABA A Receptor(a6-Subunit)¡Ú¦Ã-Aminobutyric Acid A Receptor¡Û(rat, peptide)(CT), rabbit pAb(neat serum) |
50ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB(57kDa) |
|
|
¡¡ |
BML |
BML-SA519-0100 |
GABA A Receptor(B1-Subunit)¡Ú¦Ã-Aminobutyric Acid A Receptor¡Û(rat)(recombinant)(CT), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ chicken¡¢ zebrafish | WB |
|
|
¡¡ |
BML |
BML-SA524-0100 |
[pThr305]Calmodulin Kinase II ¡ÚCalmodulin Kinase II, [pThr305]-¡Û¡ÚCaM Kinase II ¡Û (rat)(phosphorylated peptide), rabbit pAb(specificity: rat) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA525-0100 |
[pThr34]DARPP-32 ¡ÚDARPP-32, [pThr34]-¡Û¡ÚDopamine and cAMP-regulated Phosphoproteins with molecular weight 32kDa¡Û(rat)(phosphorylated peptide), rabbit pAb(specificity: rat) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA526-0100 |
[pThr75]DARPP-32 ¡ÚDARPP-32, [pThr75]-¡Û¡ÚDopamine and cAMP-regulated Phosphoproteins with molecular weight 32kDa¡Û(rat)(phosphorylated peptide), rabbit pAb(specificity: rat) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA529-0100 |
[pTyr331]EphrinB ¡ÚEphrinB, [pTyr331]-¡Û(chicken)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ chicken¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA532-0100 |
[pSer490/498]ATF2 ¡ÚATF2, [pSer490/498]-¡Û¡ÚCRE-BP1¡Û(human)(phosphorylated peptide), rabbit pAb(specificity: human) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB(¡Á74kDa) |
|
|
¡¡ |
BML |
BML-SA536-0100 |
[pSer33/37]B-Catenin ¡ÚB-Catenin, [pSer33/37]-¡Û(phosphorylated peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA543-0100 |
[pSer58]Tryptophan Hydroxylase ¡ÚTryptophan Hydroxylase, [pSer58]-¡Û¡ÚTPH¡Û(rat)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian¡¢ chicken¡¢ Xenopus | WB |
|
|
¡¡ |
BML |
BML-SA546-0100 |
[pSer40]Tyrosine Hydroxylase ¡ÚTyrosine Hydroxylase, [pSer40]¡Û¡ÚTH¡Û(rat)(phosphorylated peptide), rabbit pAb |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat¡¢ non-human primate | WB |
|
|
¡¡ |
BML |
BML-SA550-0025 |
AhR ¡ÚAryl Hydrocarbon Receptor¡Û(recombinant, aa 1-402)(NT), rabbit pAb(neat serum) |
25ul |
¡ï14,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA550-0100 |
AhR ¡ÚAryl Hydrocarbon Receptor¡Û(recombinant, aa 1-402)(NT), rabbit pAb(neat serum) |
100ul |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ mouse | WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA551-0100 |
Cannabinoid Receptor 1 ¡ÚCB1¡Û (human, aa 1-99)(recombinant), rabbit pAb |
100ul |
¡ï56,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA552-0100 |
Cannabinoid Receptor 2 ¡ÚCB2¡Û(human, aa 1-33)(recombinant), rabbit pAb(specificity: human) |
100ul |
¡ï48,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ FC¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA553-0100 |
Cannabinoid Receptor 1 ¡ÚCB1¡Û (rat, aa 1-77)(recombinant), rabbit pAb |
100ul |
¡ï53,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mammalian¡¢ fish¡¢ chicken¡¢ amphibian | IHC¡¢ WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA554-0100 |
Cannabinoid Receptor 2 ¡ÚCB2¡Û(rat, aa 1-32)(recombinant), rabbit pAb |
100ul |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA556-0100 |
TRPV1 ¡ÚVanilloid Receptor 1¡Û¡ÚVR-1¡Û¡ÚTransient Receptor Potential V1¡Û(human, aa 7-21), rabbit pAb, purified(specificity: human) |
100ug |
¡ï59,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA557-0100 |
S1P1 ¡ÚSphingosine 1-Phosphate Receptor 1¡Û¡ÚEDG-1 Receptor¡Û(mouse, aa 359-372), rabbit pAb(specificity: human) |
100ug |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA559-0050 |
TRPC1 ¡ÚShort Transient Receptor Potential Channel 1¡Û¡ÚTransient Receptor Potential C1¡Û(human, aa 557-571), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA559-0200 |
TRPC1 ¡ÚShort Transient Receptor Potential Channel 1¡Û¡ÚTransient Receptor Potential C1¡Û(human, aa 557-571), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA560-0050 |
TRPC3 ¡ÚShort Transient Receptor Potential Channel 3¡Û¡ÚTransient Receptor Potential C3¡Û(mouse, aa 822-835), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA561-0050 |
TRPC4 ¡ÚShort Transient Receptor Potential Channel 4¡Û¡ÚTransient Receptor Potential C4¡Û(mouse, aa 943-958), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA561-0200 |
TRPC4 ¡ÚShort Transient Receptor Potential Channel 4¡Û¡ÚTransient Receptor Potential C4¡Û(mouse, aa 943-958), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA562-0050 |
TRPC5 ¡ÚShort Transient Receptor Potential Channel 5¡Û¡ÚTransient Receptor Potential C5¡Û(mouse, aa 959-973), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA562-0200 |
TRPC5 ¡ÚShort Transient Receptor Potential Channel 5¡Û¡ÚTransient Receptor Potential C5¡Û(mouse, aa 959-973), rabbit pAb(specificity: rat) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA563-0050 |
TRPC6 ¡ÚShort Transient Receptor Potential Channel 6¡Û¡ÚTransient Receptor Potential C6¡Û(mouse, aa 24-38), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA563-0200 |
TRPC6 ¡ÚShort Transient Receptor Potential Channel 6¡Û¡ÚTransient Receptor Potential C6¡Û(mouse, aa 24-38), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA564-0050 |
TRPV1 ¡ÚTransient Receptor Potential Cation Channel Subfamily V Member 1¡Û¡ÚVanilloid Receptor 1¡Û¡ÚVR-1¡Û(rat, aa 824-838)(CT), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA564-0200 |
TRPV1 ¡ÚTransient Receptor Potential Cation Channel Subfamily V Member 1¡Û¡ÚVanilloid Receptor 1¡Û¡ÚVR-1¡Û(rat, aa 824-838)(CT), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA565-0050 |
TRPV4 ¡ÚTransient Receptor Potential V4¡Û(rat, aa 853-871)(CT), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA565-0200 |
TRPV4 ¡ÚTransient Receptor Potential V4¡Û(rat, aa 853-871)(CT), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA566-0050 |
TRPV5 ¡ÚTransient Receptor Potential V5¡Û(human, aa 715-729)(CT), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA566-0200 |
TRPV5 ¡ÚTransient Receptor Potential V5¡Û(human, aa 715-729)(CT), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA567-0050 |
TRPV6 ¡ÚTransient Receptor Potential V6¡Û(human, aa 712-725)(CT), rabbit pAb(specificity: human) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA568-0050 |
Potassium Channel K2p1.1 ¡ÚTWIK1¡Û¡ÚKCNK1¡Û(human, aa 53-69), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA570-0050 |
Potassium Channel K2p3.1 ¡ÚTASK1¡Û¡ÚKCNK3¡Û(human, aa 252-269), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢WB |
|
|
¡¡ |
BML |
BML-SA572-0050 |
Potassium Channel K2p5.1 ¡ÚTASK2¡Û¡ÚKCNK5¡Û(human, aa 483-499), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA575-0200 |
Potassium Channel K2p10.1 ¡ÚTREK2¡Û¡ÚKCNK10¡Û(rat, aa 475-494), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA576-0050 |
Endothelin Receptor A ¡ÚET-A¡Û¡ÚET1-Specific Type Endothelin Receptor¡Û¡ÚEdnra¡Û¡ÚETRA¡Û(rat, aa 413-426), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA577-0050 |
Endothelin Receptor B ¡ÚET-B¡Û¡ÚNonspecific Type Endothelin Receptor¡Û¡ÚEdnrb¡Û¡ÚETRB¡Û(rat, aa 298-314), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA580-0050 |
Muscarinic Receptor M1 ¡ÚCholinergic Muscarinic Receptor 1¡Û¡ÚChrm1¡Û¡ÚAcetylcholine Muscarinic Receptor 1¡Û(human, aa 227-353)(recombinant), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA581-0050 |
Muscarinic Receptor M2 ¡ÚCholinergic Muscarinic Receptor 2¡Û¡ÚChrm2¡Û¡ÚAcetylcholine Muscarinic Receptor 2¡Û(human, aa 225-356)(recombinant), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA582-0050 |
Muscarinic Receptor M3 ¡ÚCholinergic Muscarinic Receptor 3¡Û¡ÚChrm3¡Û¡ÚAcetylcholine Muscarinic Receptor 3¡Û(rat, aa 461-479), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA585-0050 |
P2Y4 Receptor ¡ÚP2RY4¡Û(rat, aa 337-350), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA586-0050 |
P2Y6 Receptor ¡ÚP2RY6¡Û(rat, aa 311-328), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA586-0200 |
P2Y6 Receptor ¡ÚP2RY6¡Û(rat, aa 311-328), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA588-0050 |
P2Y12 Receptor ¡ÚP2RY12¡Û(human, aa 125-142), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA588-0200 |
P2Y12 Receptor ¡ÚP2RY12¡Û(human, aa 125-142), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA590-0050 |
P2Y14 Receptor(extracellular)¡ÚP2RY14¡Û¡ÚGPR105¡Û(human, aa 172-188), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ FC |
|
|
¡¡ |
BML |
BML-SA590-0200 |
P2Y14 Receptor(extracellular)¡ÚP2RY14¡Û¡ÚGPR105¡Û(human, aa 172-188), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ FC |
|
|
¡¡ |
BML |
BML-SA591-0050 |
Somatostatin Receptor Type 1 ¡ÚSSTR1¡Û(rat, aa 26-40), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA592-0200 |
Somatostatin Receptor Type 2 ¡ÚSSTR2¡Û(rat, aa 30-43), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA593-0050 |
Somatostatin Receptor Type 3 ¡ÚSSTR3¡Û(rat, aa 233-246), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA593-0200 |
Somatostatin Receptor Type 3 ¡ÚSSTR3¡Û(rat, aa 233-246), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA594-0200 |
Somatostatin Receptor Type 4 ¡ÚSSTR4¡Û(rat, aa 182-194), rabbit pAb(specificity: rat) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA595-0050 |
Urotensin II Receptor ¡ÚUR2R¡Û¡ÚUTIIR¡Û(rat, aa 154-167), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA597-0200 |
HCN1 ¡ÚHyperpolarization-Activated Cyclic Nucleotide-gated Potassium Channel 1¡Û¡ÚHAC2¡Û¡ÚBCNG1¡Û(rat, aa 6-24), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA599-0050 |
HCN3 ¡ÚHyperpolarization-Activated Cyclic Nucleotide-gated Potassium Channel 3¡Û(rat, aa 727-744), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA600-0050 |
HCN4 ¡ÚHyperpolarization-Activated Cyclic Nucleotide-gated Potassium Channel 4¡Û(human, aa 119-155), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA601-0500 |
Myelin Basic Protein ¡ÚMBP¡Û(human), rabbit pAb |
0.5mL |
¡ï24,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA605-0050 |
TRPM1 ¡ÚTransient Receptor Potential Cation Channel Subfamily M Member 1¡Û(human, aa 1518-1533), rrabbit pAb(specificity: human) |
50ul |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-SA607-0050 |
TRPV2(extracellular)¡ÚTransient Receptor Potential Cation Channel Subfamily V Member 2¡Û(rat, aa 413-428), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB¡¢ IP¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA608-0050 |
AT1 Receptor(extracellular)¡ÚAngiotensin II Receptor type 1¡Û(human, aa 4-18), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ FC¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA609-0050 |
AT2 Receptor(extracellular)¡ÚAngiotensin II Receptor type 2¡Û(rat, aa 21-35), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA609-0200 |
AT2 Receptor(extracellular)¡ÚAngiotensin II Receptor type 2¡Û(rat, aa 21-35), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA610-0050 |
mGluR1(extracellular)¡ÚMetabotropic Glutamate Receptor 1¡Û¡ÚGRM1¡Û(rat, aa 501-516), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA610-0200 |
mGluR1(extracellular)¡ÚMetabotropic Glutamate Receptor 1¡Û¡ÚGRM1¡Û(rat, aa 501-516), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA611-0050 |
mGluR5(extracellular)¡ÚMetabotropic Glutamate Receptor 5¡Û¡ÚGRM5¡Û(rat, aa 367-380), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA612-0050 |
GluR1(extracellular)¡ÚGlutamate Receptor 1¡Û¡ÚAMPA-selective Glutamate Receptor 1¡Û¡ÚGlutamate Receptor Ionontropic AMPA 1¡Û(rat, aa 271-285), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA612-0200 |
GluR1(extracellular)¡ÚGlutamate Receptor 1¡Û¡ÚAMPA-Selective Glutamate Receptor 1¡Û¡ÚGlutamate Receptor Ionontropic AMPA 1¡Û(rat, aa 271-285), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA613-0050 |
GluR2(extracellular)¡ÚGlutamate Receptor 2¡Û¡ÚAMPA-Selective Glutamate Receptor 2¡Û¡ÚGlutamate Receptor Ionontropic AMPA 2¡Û(rat, aa179-193 ), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA614-0050 |
ZMPSTE24 ¡ÚZinc Metalloproteinase Ste24¡Û¡ÚFACE-1¡Û¡ÚFarnesylated/Prenylated Protein Converting Enzyme 1¡Û(human, aa 251-265), rabbit pAb |
50ul |
¡ï22,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ dog¡¢ bovine¡¢ chicken¡¢ frog¡¢ orangutan¡¢ zebrafish¡¢ sea urchin | WB |
|
|
¡¡ |
BML |
BML-SA615-0100 |
Acetyl-Lysine(acetylated KLH), rabbit pAb(neat serum) |
100ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SA616-0050 |
MMP-2 ¡ÚMatrix Metalloproteinase-2¡Û¡ÚGelatinase A¡Û¡Ú72kDa Type IV Collagenase¡Û(human, peptide)(CT), rabbit pAb |
50ug |
¡ï34,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ bovine¡¢ dog | IHC¡¢ WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA617-0050 |
TRPA1(extracellular)¡ÚTransient Receptor Potential Cation Channel Subfamily A Member 1¡Û¡ÚAnkyrin-Like Protein with Transmembrane Domains 1¡Û(human, aa 747-760), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA617-0200 |
TRPA1(extracellular)¡ÚTransient Receptor Potential Cation Channel Subfamily A Member 1¡Û¡ÚAnkyrin-Like Protein with Transmembrane Domains 1¡Û(human, aa 747-760), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA618-0050 |
TRPV2 ¡ÚTransient Receptor Potential Cation Channel Subfamily V Member 2¡Û(rat, aa 735-750), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA618-0200 |
TRPV2 ¡ÚTransient Receptor Potential Cation Channel Subfamily V Member 2¡Û(rat, aa 735-750), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA619-0050 |
Somatostatin Receptor Type 5 ¡ÚSSTR5¡Û(rat, aa 2-15), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA619-0200 |
Somatostatin Receptor Type 5 ¡ÚSSTR5¡Û(rat, aa 2-15), rabbit pAb(specificity: rat) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA620-0500 |
MMP-9 ¡ÚMatrix Metalloproteinase-9¡Û¡ÚGelatinase B¡Û¡Ú92 kDa Type IV Collagenase¡Û(human, peptide)(CT), rabbit pAb |
500ul |
¡ï32,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ guinea pig | IHC¡¢ WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA624-0100 |
ADAM12(cytoplasmic Domain)¡ÚA Disintegrin and Metalloproteinase 12¡Û¡ÚMeltrin a¡Û(human, peptide), rabbit pAb(specificity: human) |
100ug |
¡ï35,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA625-0050 |
MMP-7 ¡ÚMatrix Metalloproteinase 7¡Û¡ÚMatrilysin¡Û(human, peptide)(CT), rabbit pAb |
50ug |
¡ï30,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA626-0050 |
MMP-13(Hinge Region)¡ÚMatrix Metalloproteinase-13¡Û¡ÚCollagenase 3¡Û(human, peptide), rabbit pAb |
50ug |
¡ï30,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | WB¡¢ IP¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA627-0100 |
Acetyl-Lysine(acetylated KLH), rabbit pAb, Affinity-purified |
100ul |
¡ï39,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SA628-0050 |
15-Lipoxygenase ¡Ú18-LO¡Û(rabbit reticulocyte), sheep pAb(neat serum) |
50ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
sheep | - | human¡¢ rabbit | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA634-0050 |
Cannabinoid Receptor 1(extracellular)¡ÚCB1¡Û(rat, aa 84-99), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA636-0050 |
Cannabinoid Receptor 2(extracellular)¡ÚCB2¡Û(human, aa 11-24), rabbit pAb(specificity: human) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ICC. FC |
|
|
¡¡ |
BML |
BML-SA636-0200 |
Cannabinoid Receptor 2(extracellular)¡ÚCB2¡Û(human, aa 11-24), rabbit pAb(specificity: human) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB¡¢ ICC. FC |
|
|
¡¡ |
BML |
BML-SA637-0050 |
Calcium Sensing Receptor(extracellular)¡ÚCaSR¡Û(human, aa 216-229), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA637-0200 |
Calcium Sensing Receptor(extracellular)¡ÚCaSR¡Û(human, aa 216-229), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA638-0050 |
Melanocortin Receptor 1 ¡ÚMC1R¡Û(human, aa 217-232 ), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA638-0200 |
Melanocortin Receptor 1 ¡ÚMC1R¡Û(human, aa 217-232 ), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA639-0050 |
Melanocortin Receptor 2(extracellular)¡ÚMC2R¡Û(human, aa 87-99), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA639-0200 |
Melanocortin Receptor 2(extracellular)¡ÚMC2R¡Û(human, aa 87-99), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA640-0050 |
Melanocortin Receptor 3(extracellular)¡ÚMC3R¡Û(rat, aa 102-117), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ FC |
|
|
¡¡ |
BML |
BML-SA640-0200 |
Melanocortin Receptor 3(extracellular)¡ÚMC3R¡Û(rat, aa 102-117), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ FC |
|
|
¡¡ |
BML |
BML-SA641-0200 |
Melanocortin Receptor 4 ¡ÚMC4R¡Û(human, aa 6-20), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | mouse¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA642-0050 |
Neuropeptide Y1 Receptor ¡ÚNPY1R¡Û(human, aa 237-252), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA642-0200 |
Neuropeptide Y1 Receptor ¡ÚNPY1R¡Û(human, aa 237-252), rabbit pAb |
200ul |
¡ï65,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA643-0200 |
Neuropeptide Y2 Receptor ¡ÚNPY2R¡Û(mouse, aa 346-364), rabbit pAb(specificity: rat) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA644-0200 |
Neuropeptide Y4 Receptor ¡ÚNPY4R¡Û(rat, aa 326-340)(CT), rabbit pAb(specificity: rat) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA646-0050 |
Orexin Receptor 1 ¡ÚOX1R¡Û(rat, aa 256-269), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA647-0050 |
Orexin Receptor 2 ¡ÚOX2R¡Û(rat, aa 391-405), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA647-0200 |
Orexin Receptor 2 ¡ÚOX2R¡Û(rat, aa 391-405), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA650-0050 |
Proteinase-Activated Receptor-1(extracellular)¡ÚPAR-1¡Û(human, aa 61-76), rabbit pAb(specificity: human) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA650-0200 |
Proteinase-Activated Receptor-1(extracellular)¡ÚPAR-1¡Û(human, aa 61-76), rabbit pAb(specificity: human) |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA651-0050 |
Proteinase-Activated Receptor-2 ¡ÚPAR-2¡Û(rat, aa 368-382), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA651-0200 |
Proteinase-Activated Receptor-2 ¡ÚPAR-2¡Û(rat, aa 368-382), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA652-0050 |
Proteinase-Activated Receptor-4(extracellular)¡ÚPAR-4¡Û(human, aa 136-150), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA652-0200 |
Proteinase-Activated Receptor-4(extracellular)¡ÚPAR-4¡Û(human, aa 136-150), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC¡¢ FC |
|
|
¡¡ |
BML |
BML-SA653-0050 |
A1 Adenosine Receptor ¡ÚADORA-1¡Û(human, aa 213-229), rabbit pAb(specificity: rat) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA654-0050 |
A2A Adenosine Receptor ¡ÚADORA-2a¡Û(mouse, aa 201-215), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA654-0200 |
A2A Adenosine Receptor ¡ÚADORA-2a¡Û(mouse, aa 201-215), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA655-0050 |
A2B Adenosine Receptor ¡ÚADORA-2b¡Û(human, aa 147-166), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA655-0200 |
A2B Adenosine Receptor ¡ÚADORA-2b¡Û(human, aa 147-166), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB |
|
|
¡¡ |
BML |
BML-SA656-0050 |
A3 Adenosine Receptor ¡ÚADORA-3¡Û(human, aa 216-230), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA664-0050 |
TRPM8(extracellular)¡ÚTransient Receptor Potential Channel Subfamily M Member 8¡Û(human, aa 917-929), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | ICC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA664-0200 |
TRPM8(extracellular)¡ÚTransient Receptor Potential Channel Subfamily M Member 8¡Û(human, aa 917-929), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | ICC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SA665-0050 |
Brain-Derived Neurotrophic Factor ¡ÚBDNF¡Û(human brain, aa 166-178), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA665-0200 |
Brain-Derived Neurotrophic Factor ¡ÚBDNF¡Û(human brain, aa 166-178), rabbit pAb |
200ul |
¡ï63,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA666-0050 |
Brain-Derived Neurotrophic Factor Precursor ¡ÚproBDNF¡Û(human, aa 72-88), rabbit pAb |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SA667-0100 |
Dimethyl Lysine(Dimethylated bovine serum albumin), rabbit pAb(neat serum) |
100ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SA668-0050 |
Dimethyl Lysine(dimethylated KLH), rabbit pAb, Affinity-purified |
50ug |
¡ï45,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SA669-0100 |
MMP-12(hinge region)¡ÚMatrix Metalloproteinase-12¡Û(human, peptide), rabbit pAb |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB¡¢ IP¡¢ ELISA¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA674-0050 |
Orai1(extracellular) ¡ÚCalcium Release-Activated Calcium Channel Protein 1¡Û¡ÚTransmembrane Protein 142A¡Û(human, aa 203-214 ), rabbit pAb, Affinity-purified(specificity: human) |
50ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not mouse, rat) | WB¡¢ FC |
|
|
¡¡ |
BML |
BML-SA674-0200 |
Orai1(extracellular) ¡ÚCalcium Release-Activated Calcium Channel Protein 1¡Û¡ÚTransmembrane Protein 142A¡Û(human, aa 203-214 ), rabbit pAb, Affinity-purified(specificity: human) |
200ul |
¡ï61,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human (not mouse, rat) | WB, FC |
|
|
¡¡ |
BML |
BML-SA676-0200 |
STIM1(extracellular)¡ÚStromal Interaction Molecule 1¡Û(synthetic peptide, aa 56-69), rabbit pAb, Affinity-purified |
200ul |
¡ï61,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat | IHC¡¢ WB¡¢ FC¡¢ ICC |
|
|
¡¡ |
BML |
BML-SA677-0050 |
STIM2 ¡ÚStromal Interaction Molecule 2¡Û(human, aa 583-597), rabbit pAb, Affinity-purified(specificity: rat) |
50ul |
¡ï38,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat | WB |
|
|
¡¡ |
BML |
BML-SA679-0100 |
MMP-2(Hinge Region)¡ÚMatrix Metalloproteinase 2¡Û¡ÚGelatinase A¡Û¡Ú72kDa Type IV collagenase¡Û(human, peptide), rabbit pAb, Affinity-purified |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ monkey¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA680-0100 |
MMP-9(Hinge Region)¡ÚMatrix Metalloproteinase 9¡Û¡ÚGelatinase B¡Û¡Ú92kDa Type IV collagenase¡Û(human, peptide), rabbit pAb, Affinity-purified |
100ug |
¡ï31,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat¡¢ monkey¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SA682-0100 |
Butyryl-Lysine(butyrylated KLH), rabbit pAb, Affinity-purified |
100ul |
¡ï36,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | WB |
|
|
¡¡ |
BML |
BML-SC100-0001 |
IDE-1 ¡Ú7-(2-(2-Carboxybenzylidene)hydrazinyl)-7-oxoheptanoic Acid¡Û¡Ú2-[(6-Carboxyhexanoyl)hydrazonomethyl]benzoic Acid¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SC100-0005 |
IDE-1 ¡Ú7-(2-(2-Carboxybenzylidene)hydrazinyl)-7-oxoheptanoic Acid¡Û¡Ú2-[(6-Carboxyhexanoyl)hydrazonomethyl]benzoic Acid¡Û |
5mg |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SC101-0001 |
IDE-2 ¡Ú7-(2-Cyclopentylidenehydrazinyl)-7-oxoheptanoic Acid¡Û |
1mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SC101-0005 |
IDE-2 ¡Ú7-(2-Cyclopentylidenehydrazinyl)-7-oxoheptanoic Acid¡Û |
5mg |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SC103-0005 |
MoTP ¡Ú4-(4-Morpholinobutylthio)phenol¡Û |
5mg |
¡ï10,000 |
|
57055-82-0 |
|
|
|
¡¡ |
BML |
BML-SC103-0025 |
MoTP ¡Ú4-(4-Morpholinobutylthio)phenol¡Û |
25mg |
¡ï32,000 |
|
57055-82-0 |
|
|
|
¡¡ |
BML |
BML-SC104-0001 |
Reversine ¡Ú2-(4-Morpholinoanilino)-6-cyclohexylaminopurine¡Û |
1mg |
¡ï4,000 |
|
656820-32-5 |
|
|
|
¡¡ |
BML |
BML-SC104-0005 |
Reversine ¡Ú2-(4-Morpholinoanilino)-6-cyclohexylaminopurine¡Û |
5mg |
¡ï16,000 |
|
656820-32-5 |
|
|
|
¡¡ |
BML |
BML-SC105-0005 |
ID-8 ¡Ú1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol¡Û |
5mg |
¡ï8,000 |
|
147591-46-6 |
|
|
|
¡¡ |
BML |
BML-SC105-0025 |
ID-8 ¡Ú1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol¡Û |
25mg |
¡ï36,000 |
|
147591-46-6 |
|
|
|
¡¡ |
BML |
BML-SC106-0001 |
Stauprimide ¡ÚN-Benzoyl-7-oxostaurosporine¡Û |
1mg |
¡ï13,000 |
|
154589-96-5 |
|
|
|
¡¡ |
BML |
BML-SE100-0001 |
Diacylglycerol Kinase ¡Úsn-1,2-Diacylglycerol Kinase¡Û¡ÚDAGK¡Û |
1mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE104-0001 |
Phospholipase A2(Apis mellifera)¡ÚPhosphatidylcholine 2-Acylhydrolase¡Û¡ÚPLA2¡Û |
1mg |
¡ï12,000 |
|
9001-84-7 |
|
|
|
¡¡ |
BML |
BML-SE104-0005 |
Phospholipase A2(Apis mellifera)¡ÚPhosphatidylcholine 2-Acylhydrolase¡Û ¡ÚPLA2¡Û |
5mg |
¡ï47,000 |
|
9001-84-7 |
|
|
|
¡¡ |
BML |
BML-SE105-0100 |
Cyclophilin A ¡ÚPeptidylproline cis-trans-Isomerase¡Û(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE108-0010 |
Sphingomyelinase(Staphylococcus aureus)¡ÚSphingomyelin Cholinephosphohydrolase¡Û |
10U |
¡ï11,000 |
|
9031-54-3 |
|
|
|
¡¡ |
BML |
BML-SE108-0050 |
Sphingomyelinase(Staphylococcus aureus)¡ÚSphingomyelin Cholinephosphohydrolase¡Û |
50U |
¡ï45,000 |
|
9031-54-3 |
|
|
|
¡¡ |
BML |
BML-SE109-0010 |
MMP-3(catalytic domain)¡ÚMatrix Metalloproteinase 3¡Û¡ÚStromelysin-1¡Û¡ÚTransin¡Û(human)(recombinant), with a C-terminal purification Tag |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE113-0200 |
LAR ¡ÚLeukocyte Common Antigen-Related Protein Tyrosine Phosphatase¡Û(human)(recombinant) |
200U |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE114-0200 |
T cell Protein Tyrosine Phosphatase ¡ÚTCPTP¡Û(human)(recombinant) |
200U |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE116-0010 |
EGF Receptor(human)¡ÚEpidermal Growth Factor Receptor¡Û¡ÚEGFR¡Û(Isolated from human A431 cells) |
10U |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE117-0005 |
Procaspase-7(human)(recombinant) |
5ug |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE124-0010 |
Casein Kinase II ¡ÚCK II¡Û(human)(recombinant) |
10kU |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE127-0050 |
Retinoid X Receptor B ¡ÚRXRB¡Û(human)(recombinant) |
50ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE128-0100 |
CDK1/Cyclin B ¡ÚCyclin-dependent Kinase 1/Cyclin B¡Û¡Úp34cdc2/Cyclin B¡Û(human)(recombinant) |
100U |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE130-0010 |
Protein Phosphatase Inhibitor 2(rabbit)(recombinant) |
10ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE131-0100 |
H-Ras(wild-type)(human)(recombinant) |
100ug |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE132-0100 |
H-Ras(CVLL Type)(human)(recombinant) |
100ug |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE135-0020 |
CD45(Cytoplasmic Domain)(human)(recombinant) |
20ug |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE136-0100 |
Rab3a(human)(recombinant) |
100ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE138-0010 |
MMP-12 ¡ÚMatrix Metalloproteinase-12¡Û¡ÚMetalloelastase¡Û¡ÚMacrophage Elastase¡Û(Catalytic Domain)(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE144-0005 |
PKCBI ¡ÚProtein Kinase C BI¡Û(human)(recombinant) |
5ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE145-0100 |
Histone Deacetylase 8 ¡ÚHDAC8¡Û(human)(recombinant) |
100U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE151-0100 |
c-Jun(rat)(recombinant)with GST-Tag |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE155-5000 |
Caspase-11(mouse)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE160-0001 |
Leptin(mouse)(recombinant) |
1mg |
¡ï24,000 |
|
181030-10-4 |
|
|
|
¡¡ |
BML |
BML-SE160-0005 |
Leptin(mouse)(recombinant) |
5mg |
¡ï91,000 |
|
181030-10-4 |
|
|
|
¡¡ |
BML |
BML-SE161-0001 |
Leptin(human)(recombinant) |
1mg |
¡ï23,000 |
|
177404-21-6 |
|
|
|
¡¡ |
BML |
BML-SE161-0005 |
Leptin(human)(recombinant) |
5mg |
¡ï95,000 |
|
177404-21-6 |
|
|
|
¡¡ |
BML |
BML-SE163-5000 |
Calcineurin(human)(recombinant) |
5000U |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE168-5000 |
Caspase-1 ¡ÚICE¡Û¡ÚInterleukin-1B Converting enzyme¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE169-5000 |
Caspase-3 ¡ÚCPP32¡Û¡ÚYama¡Û¡ÚApopain¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE170-5000 |
Caspase-6 ¡ÚMch2¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE171-5000 |
Caspase-5 ¡ÚICErel¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE172-5000 |
Caspase-8 ¡ÚFLICE¡Û¡ÚMch5¡Û¡ÚMACH¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE173-5000 |
Caspase-9 ¡ÚMch6¡Û¡ÚICE-LAP-6¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE174-5000 |
Caspase-10 ¡ÚFLICE2¡Û¡ÚMch4¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE175-5000 |
Caspase-2(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE176-5000 |
Caspase-4 ¡ÚIch-2¡Û¡ÚTX¡Û¡ÚICErel¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE177-5000 |
Caspase-7 ¡ÚMch3¡Û¡ÚCMH-1¡Û(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE180-0010 |
MMP-1 ¡ÚMatrix Metalloproteinase-1¡Û¡ÚInterstitial Collagenase¡Û¡ÚFibroblast Collagenase¡Û(Catalytic Domain)(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE181-0010 |
MMP-7 ¡ÚMatrix Metalloproteinase-7¡Û¡ÚMatrilysin¡Û¡ÚPump¡Û(Catalytic Domain)(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE192-5000 |
PKAa(mouse)(Catalytic Domain)¡ÚcAMP-dependent Protein Kinase a¡Û¡ÚProtein Kinase Aa¡Û(recombinant) |
5000U |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE195-0020 |
Insulin Receptor(B Subunit)¡ÚBIRK¡Û(human)(recombinant), with GST-Tag |
20ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE198-0025 |
Cathepsin B(human liver), purified |
25ug |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE200-0025 |
Cathepsin H(human liver), purified |
25ug |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE201-0025 |
Cathepsin L(human liver), purified |
25ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE211-0025 |
Ubiquitin-AMC ¡ÚUb-AMC¡Û |
25ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE225-0003 |
NupherinTM Transfection Reagent |
3mg |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE225-0075 |
NupherinTM Transfection Reagent |
0.75mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE226-0100 |
Tetanolysin(Isolated from Clostridium tetani) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE232-0020 |
Insulin-like Growth Factor-1 Receptor ¡ÚIGF-1R¡Û(human)(recombinant), with GST-Tag |
20ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE237-0010 |
MMP-2(catalytic domain)¡ÚMatrix Metalloproteinase 2¡Û¡ÚGelatinase A¡Û¡Ú72 kDa Type IV Collagenase¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE238-5000 |
Granzyme B(human)(recombinant) |
5000U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE239-0100 |
SIRT1 ¡ÚSirtuin 1¡Û¡ÚSir2SIRT1¡Û(human)(recombinant), with His-Tag |
100U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE240-0050 |
Caspase-9(full-length)(human)(recombinant) |
50KU |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE242-0005 |
Phospholipase C(Bacillus cereus)¡ÚPLC¡Û¡Ú1-Phosphatidyl-D-myo-inosito Inositol Phosphohydrolase¡Û |
5U |
¡ï25,000 |
|
9001-86-9 |
|
|
|
¡¡ |
BML |
BML-SE244-0010 |
MMP-9(catalytic domain)¡ÚMatrix Metalloproteinase-9¡Û¡ÚGelatinase B¡Û¡Ú92 kDa Type IV Collagenase¡Û(human)(recombinant)(active) |
10ug |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE246-0010 |
MMP-13(catalytic domain)¡ÚMatrix Metalloproteinase 13¡Û¡ÚCollagenase-3¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE247-0020 |
Akt 2 ¡ÚProtein kinase B B¡Û¡ÚPKBB¡Û(human)(recombinant), with GST-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE248-0020 |
Akt 2(activated)¡Ú[T308E, S473D]Akt2¡Û¡ÚAkt 2, [T308E, S473D]¡Û¡ÚProtein Kinase B B¡Û¡ÚPKBB¡Û(human)(recombinant), with GST-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE251-0500 |
SIRT2 ¡ÚSirtuin 2¡Û(human)(recombinant), with His-Tag |
500U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE252-0001 |
AK/PAK-2(bovine kidney)(catalytic domain) ¡ÚPAK-2¡Û¡Úp21-Activated Protein Kinase 2¡Û, purified |
1U |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE255-0010 |
MMP-8(catalytic domain)¡ÚMatrix Metalloproteinase-8¡Û¡ÚNeutrophil Collagenase¡Û¡ÚCollagenase-2¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE258-0200 |
B-Synuclein(human)(recombinant) |
200ug |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE258-0500 |
B-Synuclein(human)(recombinant) |
500ug |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE259-0010 |
MMP-14(catalytic domain)¡ÚMatrix Metalloproteinase 14¡Û¡ÚMembrane type Matrix Metalloproteinase 1¡Û¡ÚMT-1 MMP¡Û(human),(recombinant)with C-terminal purification Tag |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE263-0025 |
I¦ÊBa(human)(recombinant) |
25ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE268-0010 |
ADAM17(catalytic domain)¡ÚTACE¡Û¡ÚA Disintegrin and Metalloproteinase 17¡Û¡ÚTumor Necrosis Factor-a-Converting Enzyme¡Û(human),(recombinant)with C-terminal His-Tag |
10ug |
¡ï48,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE269-0010 |
CDK2/Cyclin E ¡ÚCyclin E¡Û¡ÚCyclin-Dependent Kinase 2/ Cyclin E¡Û(human)(recombinant)with GST-Tag |
10ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE270-0500 |
SIRT3 ¡ÚSirtuin 3¡Û(human)(recombinant), with His-Tag |
500U |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE271-0050 |
pCAF ¡Úp300/CREB-Binding Protein Associated Factor¡Û¡ÚHistone Acetyltransferase pCAF¡Û(human)(recombinant) |
50ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE272-0050 |
hGCN5 ¡ÚGCN5¡Û¡ÚGCN5L2¡Û¡ÚHistone Acetyltransferase GCN5¡Û(human)(recombinant) |
50ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE273-0020 |
Shp-2 ¡ÚSrc Homology-2(SH2)containing Phosphatases 2¡Û(human)(recombinant) |
20ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE274-0010 |
PRL-1(catalytic domain)¡ÚPhosphatase of Regenerating Liver 1¡Û(human)(recombinant)with GST-Tag |
10ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE275-0010 |
PRL-2(catalytic domain)¡ÚPhosphatase of Regenerating Liver 2¡Û(human)(recombinant)with GST-Tag |
10ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE276-0010 |
PRL-3(catalytic domain)¡ÚPhosphatase of Regenerating Liver 3¡Û(human)(recombinant)with GST-Tag |
10ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE277-0020 |
MEG2(catalytic domain)¡ÚMEG2 Protein Tyrosine Phosphatase¡Û¡ÚPTP-MEG2¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE278-0020 |
PTP-IA2(catalytic domain)¡ÚICA512¡Û¡ÚProtein Tyrosine Phosphatase IA2¡Û¡ÚIA2 Protein Tyrosine Phosphatase¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE281-0010 |
Chymase(human skin), purified |
10U |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE282-0010 |
MMP-11(catalytic domain)¡ÚMatrix Metalloproteinase-11¡Û¡ÚStromelysin-3¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE283-0100 |
Cathepsin G(human neutrophils), purified |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE284-0100 |
Elastase, neutrophils- ¡ÚNeutrophil elastase¡Û¡ÚLeukocyte elastase¡Û¡ÚLE¡Û(human), purified |
100ug |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE285-0020 |
DEP-1(catalytic domain)¡ÚDensity-Enhanced Phosphatase-1¡Û¡ÚPTP¦Ç¡Û¡ÚProtein Tyrosine Phosphatase ¦Ç¡Û¡ÚCD148¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE286-0020 |
PTP¦Ì(catalytic domain) ¡ÚProtein Tyrosine Phosphatase ¦Ì¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE287-0005 |
FynT(human)(recombinant)with His-Tag |
5ug |
¡ï41,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE291-0010 |
FGFR1(cytoplasmic domain)¡ÚFibroblast Growth Factor Receptor 1¡Û¡ÚFMS-Like Tyrosine Kinase 2¡Û¡ÚFLT2¡Û¡ÚFLG¡Û(human)(recombinant) |
10ug |
¡ï78,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE295-0010 |
CDK1/Cyclin B ¡ÚCyclin B¡Û¡ÚCyclin-dependent kinase 1/Cyclin B¡Û¡Úp34cdc2/Cyclin B¡Û(human)(recombinant) |
10ug |
¡ï59,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE299-0250 |
Angiostatin(human)(recombinant) |
250ug |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE300-0250 |
Endostatin(human)(recombinant) |
250ug |
¡ï52,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE301-0025 |
Phospholipase D(Streptomyces chromofuscus)¡ÚPLD¡Û¡ÚPhophatidylcholine Phosphatidohydrolase¡Û |
25kU |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE302-0010 |
Phospholipase (Streptomyces sp.)¡ÚPLD¡Û¡ÚPhophatidylcholine Phosphatidohydrolase¡Û |
10kU |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE303-0100 |
TNF-a ¡ÚTumor Necrosis Factor a¡Û(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE304-0020 |
TNF-B ¡ÚTumor Necrosis Factor B¡Û(human)(recombinant) |
20ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE305-0100 |
Cu/Zn Superoxide Dismutase ¡ÚCu/Zn SOD¡Û¡ÚSOD¡Û(human)(recombinant) |
100ug |
¡ï61,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE308-0025 |
PRAS40 ¡ÚProline-Rich Akt Substrate¡Û(human)(recombinant) |
25ug |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE312-0100 |
14-3-3B(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE313-0100 |
14-3-3¦Ã(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE314-0100 |
14-3-3¦Å(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE315-0100 |
14-3-3¦Ç(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE316-0100 |
14-3-3¦Ò(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE317-0100 |
14-3-3¦È/¦Ó(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE318-0100 |
14-3-3¦Æ(human)(recombinant)with GST-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE320-0005 |
JNK 3 ¡ÚMAPK10¡Û¡ÚMAP Kinase 10¡Û(human)(recombinant)with His-Tag |
5ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE320-0025 |
JNK 3 ¡ÚMAPK10¡Û¡ÚMAP Kinase 10¡Û(human)(recombinant)with His-Tag |
25ug |
¡ï78,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE321-0100 |
¦Ó-441(2N4R variant)¡ÚTau-441¡Û(human)(recombinant) |
100ug |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE322-0100 |
¦Ó-352(0N3R variant)¡ÚTau-352¡Û(human)(recombinant) |
100ug |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE323-0100 |
¦Ó-381(1N3R variant)¡ÚTau-381¡Û(human)(recombinant) |
100ug |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE324-0100 |
¦Ó-383(0N4R variant)¡ÚTau-383¡Û(human)(recombinant) |
100ug |
¡ï71,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE325-0001 |
Calmodulin ¡ÚCaM¡Û¡ÚPhosphodiesterase 3':5'-Cyclic Nucleotide Activator¡Û(human)(recombinant) |
1mg |
¡ï26,000 |
|
73298-54-1 |
|
|
|
¡¡ |
BML |
BML-SE327-0050 |
S1P Receptor 1(rat),(membrane preparation)¡ÚEDG-1¡Û¡ÚSphingosine-1-Phosphate Receptor¡Û |
50assays |
¡ï87,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE328-0020 |
PTPRB(catalytic domain)¡ÚReceptor-type Protein Tyrosine Phosphatase B¡Û¡ÚHPTPB¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE329-0010 |
MMP-10(catalytic domain)¡ÚMatrix Metalloproteinase-10¡Û¡ÚStromelysin-2¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE330-0050 |
YOP51*/D162 PTPase(Yersinia enterocolitica)¡ÚPTPase, YOP51*/D162-¡Û¡ÚD162 PTPase¡Û(recombinant) |
50ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE331-0050 |
STP1(Schizosaccharomyces pombe)¡ÚSmall Tyrosine Phosphatase¡Û¡ÚLow molecular weight PTPase¡Û(recombinant) |
50ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE332-0050 |
PTP1B ¡ÚProtein Tyrosine Phosphatase 1B¡Û(human, aa 1-322)(recombinant) |
50ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE333-0050 |
VHR Dual-specificity Phosphatase ¡ÚDual Specificity Protein Phosphatase 3¡Û¡ÚDUSP3¡Û(human)(recombinant) |
50ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE334-0020 |
Shp-1 ¡ÚSrc Homology-2 containing Protein Tyrosine Phosphatase-1¡Û(human, aa 1-595)(recombinant) |
20ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE342-0005 |
Chk2 ¡ÚCheckpoint Kinase 2¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE343-0005 |
Erk1 ¡ÚMAPK3¡Û¡ÚMAP Kinase 3¡Û(human)(recombinant) |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE343-0020 |
Erk1 ¡ÚMAPK3¡Û¡ÚMAP Kinase 3¡Û(human)(recombinant) |
20ug |
¡ï74,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE345-0005 |
p70 S6 Kinase ¡Úp70 S6K¡Û(human)(recombinant) |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE345-0020 |
p70 S6 Kinase ¡Úp70 S6K¡Û(human)(recombinant) |
20ug |
¡ï76,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE346-0005 |
PKC¦Ä ¡ÚProtein Kinase C¦Ä¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE347-0005 |
PKC¦É ¡ÚProtein Kinase C ¦É¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE348-0005 |
PKC¦Ì ¡ÚProtein Kinase C¦Ì¡Û¡ÚProtein Kinase D¡Û¡ÚPKD¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE349-0005 |
PKC¦Í ¡ÚProtein Kinasee C¦Í¡Û¡ÚProtein Kinase D3¡Û¡ÚPKD3¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE351-0005 |
PDK1 ¡Ú3-Phosphoinositide-Dependent Protein Kinase 1¡Û¡ÚPDPK1¡Û(human)(recombinant)with His-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE355-0005 |
GSK3B ¡ÚGlycogen Synthase Kinase 3B¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE356-0005 |
Lck ¡Úp56lck¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE357-0005 |
src ¡Úpp60src¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE360-0010 |
MMP-9(catalytic domain)¡ÚMatrix Metalloproteinase-9¡Û¡ÚGelatinase B¡Û¡Ú92 kDa Type IV Collagenase¡Û(human)(recombinant)(refolded) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE361-0005 |
MMP-1(human fibroblasts)¡ÚMatrix Metalloproteinase-1¡Û¡ÚInterstitial Collagenase¡Û¡ÚFibroblast Collagenase¡Û, -purified |
5ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE362-0100 |
Factor Xa(human plasma), purified |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE363-1000 |
Thrombin(human plasma), purified |
1000U |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE364-0050 |
CDC25A ¡ÚCell Division Cycle 25A¡Û(human)(recombinant) |
50ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE365-0050 |
CDC25B ¡ÚCell Division Cycle 25B¡Û(human)(recombinant) |
50ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE366-0050 |
CDC25C ¡ÚCell Division Cycle 25C¡Û(human)(recombinant) |
50ug |
¡ï46,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE367-0010 |
Cathepsin K Proenzyme ¡ÚProcathepsin K¡Û¡ÚCathepsin O¡Û(human)(recombinant) |
10ug |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE368-0010 |
ADAM12(catalytic domain)¡ÚA Disintegrin And Metalloproteinase 12¡Û¡ÚMeltrin a¡Û(human, aa 179-388)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE369-0005 |
Akt 3 ¡ÚPKB¦Ã¡Û¡ÚProtein Kinase B¦Ã¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE370-0020 |
ASK1 ¡ÚMAP3K5¡Û(human, aa 649-946)(recombinant)with GST-Tag |
20ug |
¡ï77,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE372-0005 |
BMX(human)(recombinant)with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE377-0005 |
CaM Kinase4 ¡ÚCa2+/Calmodulin-dependent Protein Kinase 4¡Û¡ÚCaMK4¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE378-0005 |
Chk1 ¡ÚCheckpoint Kinase 1¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE379-0005 |
Casein Kinase 2a1 ¡ÚCK2a1¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE380-0005 |
Csk(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE382-0005 |
FGR(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE382-0020 |
FGR(human)(recombinant)with GST-Tag |
20ug |
¡ï77,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE384-0005 |
Hck(human, aa 230-497)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE385-0005 |
Lyn B(human)(recombinant), with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE385-0020 |
Lyn B(human)(recombinant), with GST-Tag |
20ug |
¡ï74,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE386-0005 |
MAPKAPK2 ¡ÚMAP Kinase-Activated Protein Kinase 2¡Û¡ÚMAPKAP Kinase 2¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE393-0005 |
PKA C-¦Ã ¡ÚcAMP-dependent Protein Kinase Catalytic Subunit ¦Ã¡Û¡ÚProtein Kinase A C-¦Ã¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï29,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE400-0005 |
ZAP70 ¡ÚZeta Chain(TCR)Associated Protein Kinase 70 kDa¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE402-0010 |
PTEN ¡ÚPhosphatase and Tensin Homolog Deleted on Chromosome 10¡Û(human)(recombinant)with His-Tag |
10ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE404-0010 |
VEGFR2 ¡ÚKDR¡Û¡ÚFLK-1¡Û¡ÚVascular Endothelial Growth Factor Receptor 2¡Û(human, aa 805-1356)(recombinant)with GST-Tag |
10ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE405-0010 |
EphB4(human, aa 563-975)(recombinant)with His-Tag |
10ug |
¡ï42,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE406-0010 |
Aurora A(human)(recombinant), with His-tag |
10ug |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE408-0020 |
Glucokinase ¡ÚHexakinase D¡Û(human)(recombinant) |
20ug |
¡ï27,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE409-0010 |
FAP ¡ÚFibroblast Activation Protein a¡Û¡ÚSeprase¡Û¡ÚSurface Expressed Protease¡Û¡ÚAPCE¡Û¡ÚAntiplasmin Cleaving Enzyme¡Û(human, aa 29-726)(recombinant) |
10ug |
¡ï60,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE410-0005 |
PKA C-a ¡ÚcAMP-dependent Protein Kinase Catalytic Subunit a¡Û¡ÚProtein Kinase A C-a¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE411-0005 |
PKCB II ¡ÚProtein Kinase CBII¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï21,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE413-0005 |
PKC¦Æ ¡ÚProtein Kinase C ¦Æ¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE416-0005 |
Akt 1 ¡ÚProtein Kinase Ba¡Û¡ÚPKBa¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE416-0020 |
Akt 1 ¡ÚProtein Kinase Ba¡Û¡ÚPKBa¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï79,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE417-5000 |
Caspase-14(activated)(human)(recombinant) |
5000U |
¡ï63,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE418-0020 |
Tryptase B11(human)(recombinant) |
20ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE424-0010 |
Sphingosine Kinase 1 ¡ÚSPHK1¡Û(human)(recombinant), with His-Tag |
10ug |
¡ï58,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE425-0010 |
Sphingosine Kinase 2 ¡ÚSPHK2¡Û(human)(recombinant), with His-Tag |
10ug |
¡ï58,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE426-0005 |
p38¦Ã ¡ÚMAPK12¡Û¡ÚMAP Kinase 12¡Û¡ÚERK6¡Û¡ÚSAPK3¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE427-0020 |
p38¦Ä ¡ÚMAPK13¡Û¡ÚMAP Kinase 13¡Û¡ÚSAPK4¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï77,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE430-0005 |
DDR2 ¡ÚDiscoidin Domain-containing Receptor 2¡Û¡ÚReceptor Protein Tyrosine Kinase TKT¡Û¡ÚCD167b¡Û¡ÚTYRO10¡Û(human, aa 467-end)(recombinant)with GST-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE430-0020 |
DDR2 ¡ÚDiscoidin Domain-containing Receptor 2¡Û¡ÚReceptor Protein Tyrosine Kinase TKT¡Û¡ÚCD167b¡Û¡ÚTYRO10¡Û(human, aa 467-end)(recombinant)with GST-Tag |
20ug |
¡ï77,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE432-0010 |
EphA2 ¡ÚEphrin Receptor EphA2¡Û¡ÚECK¡Û(human, aa 596-end)(recombinant)with His-Tag |
10ug |
¡ï55,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE433-0010 |
EphB2 ¡ÚEphrin Receptor EphB2¡Û¡ÚHEK5¡Û¡ÚTYRO5¡Û(human, aa 596-end)(recombinant)with His-Tag |
10ug |
¡ï42,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE434-0025 |
DPPIV ¡ÚDipeptidyl Peptidase IV¡Û¡ÚDPP4¡Û¡ÚCD26¡Û(human, aa 29-766)(recombinant) |
25mU |
¡ï42,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE435-0010 |
JAK2 ¡ÚJanus Kinase 2¡Û(human, aa 808-end)(recombinant)with His-Tag |
10ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE436-0020 |
PI3 kinase p110a/p85a ¡Úp110a/p85a, PI3 Kinase-¡Û¡ÚPhosphoinositide 3-Kinase¡Û¡ÚPI(3)K¡Û(human)(recombinant) |
20ug |
¡ï64,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE437-0010 |
TIE2 ¡ÚTEK¡Û(human, aa 771-end)(recombinant)with His-Tag |
10ug |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE438-0010 |
Factor Vlla(human plasma), purified |
10ug |
¡ï39,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE439-0100 |
MKP-1 ¡ÚMAP Kinase Phosphatse-1¡Û¡ÚDUSP1¡Û¡ÚCL100¡Û(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE440-0100 |
MKP-1/p38a ¡Úp38a/MKP-1¡Û Complex(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE443-0005 |
PKC¦Å ¡ÚProtein Kinase C ¦Å¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï21,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE443-0020 |
PKC¦Å ¡ÚProtein Kinase C ¦Å¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï62,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE444-0010 |
BTK ¡ÚBurton's Tyrosine Kinase¡Û(human)(recombinant)with GST-Tag |
10ug |
¡ï42,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE445-0010 |
Flt1 ¡ÚFMS-related Tyrosine Kinase 1¡Û¡ÚVEGRF-1¡Û¡ÚVascular Endothelial Growth Factor Receptor 1¡Û(human, aa 783-end)(recombinant)with His-Tag |
10ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE447-0010 |
Kit ¡ÚSCFR¡Û¡ÚMast/Stem Cell Growth Factor Receptor¡Û¡Úc-kit¡Û¡ÚCD117¡Û(human, aa 544-end)(recombinant)with His-Tag |
10ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE448-0010 |
FAK ¡ÚFocal Adhesion Kinase¡Û(human, aa 411-686)(recombinant)with His-Tag |
10ug |
¡ï43,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE449-0010 |
Axl ¡ÚTyrosine Protein Kinase Receptor UFO¡Û(human, aa 473-894)(recombinant)with GST-Tag |
10ug |
¡ï35,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE450-0010 |
Pyk2 ¡ÚProline-rich Tyrosine Kinase 2¡Û¡ÚCAKB¡Û¡ÚCell Adhesion Kinase B¡Û¡ÚFocal Adhesion Kinase 2¡Û¡ÚFAK2¡Û(human)(recombinant)with His-Tag |
10ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE451-0100 |
p300(catalytic domain)¡ÚE1A Binding Protein p300¡Û¡ÚHistone Acetyltransferase p300¡Û(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE452-0100 |
CBP ¡ÚCREB Binding Protein¡Û(catalytic domain)(human)(recombinant) |
100ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE453-0010 |
Cathepsin S(human)(recombinant) |
10ug |
¡ï43,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE454-0100 |
MKP-3 ¡ÚMAP Kinase Phosphatase 3¡Û¡ÚDUSP6¡Û¡ÚDual Specificity Protein Phosphatase 6¡Û¡ÚPYST1¡Û(human)(recombinant) |
100ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE455-0100 |
MKP-3/p38a ¡Úp38a/MKP-3¡Û(human)(recombinant) |
100ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE456-0050 |
Histone Deacetylase 1 ¡ÚHDAC1¡Û(human)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE460-0010 |
c-erbB-2 ¡ÚErbB2¡Û¡ÚHer2¡Û¡ÚNeu¡Û¡ÚCD340¡Û(human, aa 679-1255)(recombinant) |
10ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE462-0100 |
MKP-2 ¡ÚMAP Kinase Phosphatase 2¡Û¡ÚDUSP4¡Û¡ÚDual Specificity Protein Phosphatase 4¡Û¡ÚHVH2¡Û(human)(recombinant), with His-Tag |
100ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE463-0100 |
MKP-2/Erk1 ¡ÚErk1¡Û(human)(recombinant) |
100ug |
¡ï44,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE466-0005 |
PLK1 ¡ÚPolo-Like Kinase 1¡Û¡ÚSTPK13¡Û¡ÚSerine/Threonine Protein Kinase 13¡Û(human)(recombinant), with His-Tag |
5ug |
¡ï30,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE467-0100 |
MKP-5 ¡ÚMAP Kinase Phosphatase 5¡Û¡ÚDUSP10¡Û¡ÚDual Specificity Protein Phosphatase 10¡Û(human)(recombinant), with His-Tag |
100ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE468-0100 |
MKP-5/p38a ¡Úp38a/MKP-5¡Û¡ÚDUSP10 / MAPK14¡Û¡ÚDual Specificity Protein Phosphatase 10¡Û(human)(recombinant) |
100ug |
¡ï45,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE469-0005 |
TIMP-2(human fibroblasts)¡ÚTissue Inhibitor of Metalloproteinases 2¡Û, purified |
5ug |
¡ï32,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE470-0005 |
CaM kinase IIa ¡ÚCAMKIIa¡Û¡ÚCa2+/Calmodulin-dependent Protein Kinase IIa¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï29,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE470-0020 |
CaM kinase IIa ¡ÚCAMKIIa¡Û¡ÚCa2+/Calmodulin-dependent Protein Kinase IIa¡Û(human)(recombinant)with GST-Tag |
20ug |
¡ï74,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE471-0005 |
CDK5/p25 ¡Úp25/CDK5¡Û(human)(recombinant)with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE479-0100 |
Cystatin C ¡ÚCystatin-3¡Û¡ÚNeuroendocrine Basic Polypeptide¡Û¡ÚCST3¡Û(human), purified |
100ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE480-0005 |
FGFR1 ¡ÚFibroblast Grwoth Factor Receptor 1¡Û¡ÚFlt2¡Û¡ÚFMS-like Tyrosine Kinase 2¡Û¡ÚCD331¡Û(human, aa 399-822)(recombinant)with GST-Tag |
5ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE480-0020 |
FGFR1 ¡ÚFibroblast Grwoth Factor Receptor 1¡Û¡ÚFlt2¡Û¡ÚFMS-like Tyrosine Knase 2¡Û¡ÚCD331¡Û(human, aa 399-822)(recombinant)with GST-Tag |
20ug |
¡ï74,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE482-0100 |
14-3-3¦Ã(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE483-0100 |
14-3-3B(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE484-0100 |
14-3-3¦Å(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE485-0100 |
14-3-3¦Æ(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE486-0100 |
14-3-3¦Ç(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE487-0100 |
14-3-3¦È/¦Ó(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE488-0100 |
14-3-3¦Ò(human)(recombinant)with His-Tag |
100ug |
¡ï33,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE490-0100 |
MKP-6/Erk1 ¡ÚErk1¡Û(human)(recombinant) |
100ug |
¡ï46,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE491-0005 |
AMPK ¡ÚAMP-Activated Kinase¡Û(human)(recombinant)with His-Tag |
5ug |
¡ï76,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE492-0005 |
MMP-8 ¡ÚMatrix Metalloproteinase-8¡Û¡ÚNeutrophil Collagenase¡Û¡ÚCollagenase-2¡Û(human neutrophils), purified |
5ug |
¡ï32,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE493-0010 |
MMP-13 ¡ÚMatrix Metalloproteinase-13¡Û¡ÚCollagenase-3¡Û(human), purified |
10ug |
¡ï43,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE494-0005 |
PKCa ¡ÚProtein Kinase Ca¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï19,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE495-0100 |
MKP-7 ¡ÚMAP Kinase Phosphatase 7¡Û¡ÚDUSP16¡Û¡ÚDual Specificity Phosphatase 16¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE496-0100 |
MKP-7/p38a ¡Úp38a¡Û(human)(recombinant) |
100ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE498-0025 |
Proteinase 3(human neutrophils)¡ÚPR3¡Û¡ÚMyeloblastin¡Û¡ÚWegener's Autoantigen¡Û |
25ug |
¡ï29,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE499-0020 |
p38a ¡ÚMAPK14¡Û¡ÚMAP Kinase 14¡Û(human)(recombinant), with His-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE500-0050 |
Histone Deacetylase 2 ¡ÚHDAC2¡Û(human, aa 1-488)(recombinant)with His-Tag |
50ug |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE502-0001 |
a2-Macroglobulin(human plasma), purified |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE503-0005 |
MMP-2(human fibroblasts)¡ÚMatrix Metalloproteinase-2¡Û¡ÚGelatinase A¡Û¡Ú72 kDa Type IV Collagenase¡Û, purified |
5ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE504-0005 |
MMP-9(human neutrophils)¡ÚMatrix Metalloproteinase-9¡Û¡ÚGelatinase B¡Û¡Ú92kDa Type IV Collagenase¡Û, purified |
5ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE505-0005 |
MMP-2(human fibroblasts)¡ÚMatrix Metalloproteinase-2¡Û¡ÚGelatinase A¡Û¡Ú72kDa Type IV collagenase¡Û, purified |
5ug |
¡ï42,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE507-0050 |
Histone Deacetylase 3 ¡ÚHDAC3¡Û(human)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE508-0050 |
Histone Deacetylase 6 ¡ÚHDAC6¡Û(human)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE509-0020 |
MEK1 ¡ÚMAPKK1¡Û¡ÚMAP Kinase Kinase 1¡Û¡ÚMAPK/ERK Kinase 1¡Û(human)(recombinant)with His-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE511-0020 |
Erk1¡ÚMAPK3¡Û¡ÚMAP Kinase 3¡Û(human)(recombinant), with His-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE514-0050 |
Defensins(human neutrophils)¡ÚHNPs¡Û¡ÚHuman Neutrophil Peptides¡Û |
50ug |
¡ï24,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE515-0050 |
HDAC3/NCOR1 Complex ¡ÚHistone Deacetylase 3/Nuclear Receptor Corepressor 1 Complex¡Û(human)(recombinant) |
50ug |
¡ï50,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE516-0020 |
Insulin Receptor Kinase B ¡ÚIRKB¡Û(human)(recombinant), with His-Tag |
20ug |
¡ï46,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE517-0005 |
PKC¦È ¡ÚProtein Kinase C ¦È¡Û(human)(recombinant), with GST-Tag |
5ug |
¡ï31,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE517-0020 |
PKC¦È ¡ÚProtein Kinase C ¦È¡Û(human)(recombinant), with GST-Tag |
20ug |
¡ï77,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE518-0005 |
TRKA ¡ÚHigh Affinity Nerve Growth Factor Receptor¡Û¡ÚTyrosine Kinase Receptor A¡Û¡ÚTropomyosin-related Receptor¡Û¡ÚNeurotrophic Tyrosine Kinase Receptor type 1¡Û(human, aa 440-end)(recombinant), with |
5ug |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE521-0020 |
PDE4A(catalytic domain) ¡ÚPhosphodiesterase 4A¡Û(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE522-0020 |
PDE4B2(catalytic domain) ¡ÚPhosphodiesterase 4B2¡Û(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE523-0020 |
PDE4D(catalytic domain)¡Úphosphodiesterase 4D¡Û(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE524-0020 |
PDE7A(catalytic domain)¡ÚPhosphodiesterase 7A¡Û(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE525-0020 |
PDE10A(catalytic domain)¡ÚPhosphodiesterase 10A¡Û(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE526-0020 |
PDE10A(catalytic domain)¡ÚPhosphodiesterase 10A¡Û(rat)(recombinant) |
20ug |
¡ï52,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE527-0010 |
DPP8 ¡ÚDipeptidyl Peptidase 8¡Û(human)(recombinant), with purification-Tag |
10ug |
¡ï63,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE528-0010 |
DPP9 ¡ÚDipeptidyl Peptidase 9¡Û(human)(recombinant), with purification-Tag |
10ug |
¡ï63,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE529-0010 |
DPPIII ¡ÚDipeptidyl Peptidase III¡Û¡ÚDPP3¡Û(human)(recombinant), with purification-Tag |
10ug |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE530-0005 |
TIMP-1(human neutrophils)¡ÚTissue Inhibitor of Metalloproteinases 1¡Û(human),-purified |
5ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE531-0050 |
BACE-1 ¡ÚB Secretase¡Û¡ÚMemapsin-2¡Û¡ÚAsp-1¡Û¡ÚBeta-site APP-Cleaving Enzyme-1¡Û(human)(recombinant) |
50ug |
¡ï38,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE532-0010 |
Neprilysin ¡ÚNEP¡Û¡ÚNeutral Endopeptidase 24.11¡Û¡ÚEnkephalinase¡Û¡ÚCALLA¡Û¡ÚCommon Acute Lymphoblastic Leukemia Antigen¡Û¡ÚCD10¡Û(human, aa 53-750)(recombinant), with His-Tag |
10ug |
¡ï44,000 |
|
¡¡ |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE533-0050 |
Histone Deacetylase 2 ¡ÚHDAC2¡Û(full-length)(human)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE534-0020 |
PDE10A ¡ÚPhosphodiesterase 10A¡Û(full-length)(human)(recombinant) |
20ug |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE535-0100 |
Tyrosinase ¡ÚMonophenol Monooxygenase¡Û¡ÚTYR¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï37,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE536-0050 |
Furin ¡ÚPACE¡Û¡ÚPaired Basic Amino Acid Residue Cleaving Enzyme¡Û(human, truncated at 595)(recombinant) |
50U |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE540-0010 |
MMP-20(catalytic domain) ¡ÚMatrix Metalloproteinase-20¡Û¡ÚEnamelysin¡Û(human)(recombinant) |
10ug |
¡ï45,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE541-0005 |
Cathepsin F Proenzyme ¡ÚProcathepsin F¡Û(human)(recombinant) |
5ug |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE542-0010 |
Aminopeptidase N ¡ÚAPN¡Û¡ÚAminopeptidase M¡Û¡ÚAlanyl Aminopeptidase¡Û¡ÚAAP¡Û¡ÚCD13¡Û(human serum), purified |
10ug |
¡ï38,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE543-0010 |
PCSK9 ¡ÚProprotein Convertase Subtilisin/Kexin 9¡Û¡ÚNarc-1¡Û¡ÚNeural Apoptosis Related Convertase 1¡Û(human)(recombinant)with His-Tag |
10ug |
¡ï50,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE544-0050 |
LSD1 ¡ÚKDM1¡Û¡ÚLysine-Specific Histone Demethylase 1¡Û¡ÚBHC110¡Û¡ÚAOF2¡Û¡ÚKIAA0601¡Û(human)(recombinant) |
50ug |
¡ï50,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE545-0010 |
POP/PREP ¡ÚPREP¡Û¡ÚProlyl Oligopeptidase¡Û¡ÚProlyl Endopeptidase¡Û¡ÚPost-Proline Cleaving Enzyme¡Û(human)(recombinant), with purification-Tag |
10ug |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE546-0001 |
Brain-Derived Neurotrophic Factor ¡ÚBDNF¡Û(human)(recombinant) |
1ug |
¡ï12,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE546-0005 |
Brain-Derived Neurotrophic Factor ¡ÚBDNF¡Û(human)(recombinant) |
5ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE547-0001 |
Brain Derived Neurotrophic Factor Precursor ¡ÚproBDNF¡Û(mouse)(recombinant) |
1ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE547-0005 |
Brain Derived Neurotrophic Factor Precursor ¡ÚproBDNF¡Û(mouse)(recombinant) |
5ug |
¡ï68,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE548-0001 |
Brain Derived Neurotrophic Factor Precursor, [R112A, R113G]- ¡Ú[R112A, R113G]Brain Derived Neurotrophic Factor Precursor¡Û¡ÚproBDNF¡Û(mouse)(recombinant) |
1ug |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE548-0005 |
Brain Derived Reurotrophic Factor Precursor, [R112A, R113G]- ¡Ú[R112A, R113G]Brain Derived Neurotrophic Factor Precursor¡Û¡ÚproBDNF¡Û(mouse)(recombinant) |
5ug |
¡ï105,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE550-0010 |
BACE2 ¡ÚB-Secretase 2¡Û¡ÚB-Site APP-Cleaving Enzyme 2¡Û¡ÚMemapsin-1¡Û¡ÚASP-1¡Û(soluble)(human)(recombinant)with C-terminal His-Tag |
10ug |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE551-0050 |
Lipocalin 2/NGAL ¡ÚNGAL¡Û¡ÚNeutrophil Gelatinase-Associated Lipocalin¡Û(human)(recombinant) |
50ug |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE552-0100 |
RAP ¡ÚLDL Receptor Associated Protein¡Û¡ÚLRPAP1¡Û¡ÚLDL Receptor-related Protein-Associated Protein 1¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï37,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE553-0010 |
Cathepsin K ¡ÚCathepsin O2¡Û¡ÚCathepsin O¡Û(human)(recombinant) |
10ug |
¡ï47,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE554-0010 |
Cathepsin V Proenzyme ¡ÚProcathepsin V¡Û¡ÚCathepsin L2¡Û(human)(recombinant), with His-Tag |
10ug |
¡ï53,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE555-0050 |
SIRT5 ¡ÚSirtuin 5¡Û¡ÚSir2-Like protein 5¡Û¡ÚSIR2L5¡Û¡ÚNAD-dependent Deacetylase Sirtuin-5¡Û(human),(recombinant)with His-tag |
50KU |
¡ï41,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE556-0050 |
PRL-1 ¡ÚPhosphatase of Regenerating Liver 1¡Û¡ÚProtein Tyrosine Phosphatase Type IVA 1¡Û(human, aa 2-173)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
¡¡ |
|
|
|
¡¡ |
BML |
BML-SE557-0050 |
PRL-2 ¡ÚPhosphatase of Regenerating Liver 2¡Û¡ÚProtein Tyrosine Phosphatase Type IVA 2¡Û(human, aa 2-167)(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
¡¡ |
|
|
|
¡¡ |
BML |
BML-SE558-0050 |
PRL-3 ¡ÚPhosphatase of Regenerating Liver 3¡Û¡ÚProtein Tyrosine Phosphatase Type IVA 3¡Û(human, aa 2-173)(recombinant), with His-Tag |
50ug |
¡ï42,000 |
|
¡¡ |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE559-0050 |
Histone Deacetylase 10 ¡ÚHDAC 10¡Û(human),(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
¡¡ |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE560-0050 |
Histone Deacetylase 11 ¡ÚHDAC 11¡Û(human),(recombinant), with His-Tag |
50ug |
¡ï50,000 |
|
¡¡ |
|
|
|
¡¡ |
BML |
BML-SE561-0010 |
MMP-19(catalytic domain)¡ÚMatrix Metalloproteinase 19¡Û¡ÚRASI¡Û(human)(recombinant)with a C-terminal purification Tag. |
10ug |
¡ï37,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE562-0005 |
Abl1 ¡ÚAbelson Murine Leukemia Viral Oncogene Homolog 1¡Û(human)(recombinant, aa 27-1130)with N-terminal His-Tag |
5ug |
¡ï29,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE563-0005 |
Abl1 ¡ÚAbelson Murine Leukemia Viral Oncogene Homolog 1¡Û(mouse)(recombinant, aa 27-1123)with N-terminal His-Tag |
5ug |
¡ï22,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE568-0005 |
Cathepsin F(human),(recombinant) |
5ug |
¡ï43,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-SE569-0010 |
MetAP2 ¡ÚMethionine Aminopeptidase 2¡Û¡Úp67eIF2¡Û¡ÚEukaryotic Initiation Factor 2-Associated Protein¡Û(human),(recombinant)with HA-tag |
10ug |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE700-0100 |
Procaspase-7(truncated)¡ÚTruncated Procaspase-7¡Û(human)(recombinant) |
100ug |
¡ï56,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE721-0100 |
TRAIL ¡ÚApo-2L¡Û¡ÚTNFSF 10¡Û¡ÚCD253¡Û¡ÚTNF-Related Apoptosis-Inducing Ligand¡Û(soluble)(human)(recombinant)(untagged) |
100ug |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE722-0100 |
TRAIL ¡ÚApo-2L¡Û¡ÚTNFSF 10¡Û¡ÚCD253¡Û¡ÚTNF-Related Apoptosis-Inducing Ligand¡Û(soluble)(mouse)(recombinant) |
100ug |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE730-0005 |
Procaspase-3(human)(recombinant) |
5ug |
¡ï58,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE760-0025 |
Casputin Reagent(human)(recombinant) |
25U |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SE761-0025 |
Ubiquitin-Rhodamine(length: 76 amino acid residues.) |
25ug |
¡ï22,000 |
-80¡î |
none |
|
Purity: ¡ä95%, MW: ~89kDa Source: produced in E. coli and covalently attached to modified rhodamine-110. Application: Substrate for deubiquitinylating enzyme activity assays. Identification/confirmation of enzyme deubiquitinylation activity. Investigation of deconjugating enzyme substrate specificity in comparison with alternative UBL substrates.
|
|
¡¡ |
BML |
BML-SG1931-0100 |
a/B SNAP ¡ÚSoluble NSF Attachment Protein¡Û(human, full length)(recombinant)[16D1], mouse mAb, Affinity-purified |
100ug |
¡ï32,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 16D1 | human¡¢ rat¡¢ chicken | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-SG1936-0100 |
a SNAP ¡ÚSoluble NSF Attachment Protein¡Û(human, full length)(recombinant)[15D4], mouse mAb, Affinity-purified |
100ug |
¡ï32,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 15D4 | human¡¢ rat | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-SK002-0001 |
Anti-nNOS(NOS1)Kit(96 assays) |
Kit |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL100-0005 |
C2 Ceramide ¡ÚCeramide C2¡Û¡ÚN-Acetyl-D-erythro-sphingosine¡Û |
5mg |
¡ï7,000 |
|
3102-57-6 |
|
|
|
¡¡ |
BML |
BML-SL100-0025 |
C2 Ceramide ¡ÚCeramide C2¡Û¡ÚN-Acetyl-D-erythro-sphingosine¡Û |
25mg |
¡ï28,000 |
|
3102-57-6 |
|
|
|
¡¡ |
BML |
BML-SL101-0005 |
C2 Dihydroceramide ¡ÚDihydroceramide C2¡Û¡ÚD-erythro-N-Acetylsphinganine¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL101-0025 |
C2 Dihydroceramide ¡ÚDihydroceramide C2¡Û¡ÚD-erythro-N-Acetylsphinganine¡Û |
25mg |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL105-0005 |
N,N-Dimethylsphingosine, D-erythro- ¡ÚN,N-Dimethyl-D-erythro-sphingosine¡Û¡ÚD-erythro-N,N-Dimethylsphingosine¡Û |
5mg |
¡ï8,000 |
|
119567-63-4 |
|
|
|
¡¡ |
BML |
BML-SL105-0025 |
N,N-Dimethylsphingosine, D-erythro- ¡ÚN,N-Dimethyl-D-erythro-sphingosine¡Û¡ÚD-erythro-N,N-Dimethylsphingosine¡Û |
25mg |
¡ï34,000 |
|
119567-63-4 |
|
|
|
¡¡ |
BML |
BML-SL110-0005 |
C6 Ceramide ¡ÚCeramide C6¡Û¡ÚN-Hexanoyl-D-erythro-sphingosine¡Û¡ÚD-erythro-N-Hexanoylsphingosine¡Û |
5mg |
¡ï7,000 |
|
124753-97-5 |
|
|
|
¡¡ |
BML |
BML-SL110-0025 |
C6 Ceramide ¡ÚCeramide C6¡Û¡ÚN-Hexanoyl-D-erythro-sphingosine¡Û¡ÚD-erythro-N-Hexanoylsphingosine¡Û |
25mg |
¡ï29,000 |
|
124753-97-5 |
|
|
|
¡¡ |
BML |
BML-SL111-0005 |
C6 Dihydroceramide ¡ÚDihydroceramide C6¡Û¡ÚD-erythro-N-Hexanoylsphinganine¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL111-0025 |
C6 Dihydroceramide ¡ÚDihydroceramide C6¡Û¡ÚD-erythro-N-Hexanoylsphinganine¡Û |
25mg |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL112-0005 |
C8 Ceramide ¡ÚCeramide C8¡Û¡ÚD-erythro-N-Octanoylsphingosine¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL112-0025 |
C8 Ceramide ¡ÚCeramide C8¡Û¡ÚD-erythro-N-Octanoylsphingosine¡Û |
25mg |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL113-0005 |
C8-Dihydroceramide ¡ÚDihydroceramide C8¡Û¡ÚD-erythro-N-Octanoylsphinganine¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL113-0025 |
C8-Dihydroceramide ¡ÚDihydroceramide C8¡Û¡ÚD-erythro-N-Octanoylsphinganine¡Û |
25mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL115-0005 |
C16 Ceramide ¡ÚCeramide C16¡Û¡ÚN-Palmitoylsphingosine, D-erythro¡Û¡ÚN-Hexadecanoyl-D-erythro-sphingosine¡Û¡ÚN-Palmitoyl ceramide¡Û |
5mg |
¡ï8,000 |
|
24696-26-2 |
|
|
|
¡¡ |
BML |
BML-SL115-0025 |
C16 Ceramide ¡ÚCeramide C16¡Û¡ÚN-Palmitoylsphingosine, D-erythro¡Û¡ÚN-Hexadecanoyl-D-erythro-sphingosine¡Û¡ÚN-Palmitoyl ceramide¡Û |
25mg |
¡ï32,000 |
|
24696-26-2 |
|
|
|
¡¡ |
BML |
BML-SL125-0010 |
Dihydrosphingosine, D-erythro ¡ÚD-erythro-Sphingosine, Dihydro-¡Û¡ÚSphinganine¡Û |
10mg |
¡ï7,000 |
|
3102-56-5 |
|
|
|
¡¡ |
BML |
BML-SL125-0050 |
Dihydrosphingosine, D-erythro ¡ÚD-erythro-Sphingosine, Dihydro-¡Û¡ÚSphinganine¡Û |
50mg |
¡ï31,000 |
|
3102-56-5 |
|
|
|
¡¡ |
BML |
BML-SL130-0001 |
3-Ketosphingosine |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL140-0001 |
Sphingosine-1-phosphate, D-erythro ¡ÚD-erythro-Sphingosine-1-phosphate¡Û |
1mg |
¡ï19,000 |
|
26993-30-6 |
|
|
|
¡¡ |
BML |
BML-SL141-0010 |
Sphingosylphosphorylcholine, D-erythro ¡ÚD-erythro-Sphingosine-1-phosphate¡Û |
10mg |
¡ï35,000 |
|
1670-26-4 |
|
|
|
¡¡ |
BML |
BML-SL142-0001 |
C8 Ceramide-1-phosphate, D-erythro ¡ÚCeramide-1-phosphate C8, D-erythro¡Û |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL143-0001 |
Dihydrosphingosine-1-phosphate, D-erythro ¡ÚD-erythro-Dihydrosphingosine¡Û |
1mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL145-0001 |
C8 ceramine, D-erythro ¡ÚCeramine C8, D-erythro¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL145-0005 |
C8 ceramine, D-erythro ¡ÚCeramine C8, D-erythro¡Û |
5mg |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL150-0005 |
Phytosphingosine |
5mg |
¡ï8,000 |
|
554-62-1 |
|
|
|
¡¡ |
BML |
BML-SL150-0025 |
Phytosphingosine |
25mg |
¡ï37,000 |
|
554-62-1 |
|
|
|
¡¡ |
BML |
BML-SL151-0001 |
C2 Phytoceramide |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL151-0005 |
C2 Phytoceramide |
5mg |
¡ï31,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL205-0010 |
DL-threo-Dihydrosphingosine ¡ÚDihydrosphingosine, DL-threo¡Û |
10mg |
¡ï8,000 |
|
73938-69-9 |
|
|
|
¡¡ |
BML |
BML-SL205-0050 |
DL-threo-Dihydrosphingosine ¡ÚDihydrosphingosine, DL-threo¡Û |
50mg |
¡ï33,000 |
|
73938-69-9 |
|
|
|
¡¡ |
BML |
BML-SL210-0010 |
DL-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol ¡ÚD,L-threo-PDMP, HCl¡Û¡ÚDL-PDMP¡Û |
10mg |
¡ï6,000 |
|
73257-80-4 |
|
|
|
¡¡ |
BML |
BML-SL210-0050 |
DL-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol ¡ÚD,L-threo-PDMP, HCl¡Û¡ÚDL-PDMP¡Û |
50mg |
¡ï28,000 |
|
73257-80-4 |
|
|
|
¡¡ |
BML |
BML-SL215-0005 |
DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol ¡ÚDL-PPMP¡Û |
5mg |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL215-0025 |
DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol ¡ÚDL-PPMP¡Û |
25mg |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL219-0001 |
Fumonisin B2 |
1mg |
¡ï27,000 |
|
116355-84-1 |
|
|
|
¡¡ |
BML |
BML-SL219-0005 |
Fumonisin B2 |
5mg |
¡ï107,000 |
|
116355-84-1 |
|
|
|
¡¡ |
BML |
BML-SL220-0001 |
Fumonisin B1 |
1mg |
¡ï9,000 |
|
116355-83-0 |
|
|
|
¡¡ |
BML |
BML-SL220-0005 |
Fumonisin B1 |
5mg |
¡ï39,000 |
|
116355-83-0 |
|
|
|
¡¡ |
BML |
BML-SL221-0005 |
D-erythro MAPP ¡ÚMAPP, D-erythro¡Û¡Ú(1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol¡Û |
5mg |
¡ï7,000 |
|
66085-59-4 |
|
|
|
¡¡ |
BML |
BML-SL221-0025 |
D-erythro MAPP ¡ÚMAPP, D-erythro¡Û¡Ú(1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol¡Û |
25mg |
¡ï23,000 |
|
66085-59-4 |
|
|
|
¡¡ |
BML |
BML-SL222-0005 |
L-erythro MAPP ¡ÚMAPP, L-erythro¡Û¡Ú(1R,2S)-L-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol¡Û |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL222-0025 |
L-erythro MAPP ¡ÚMAPP, L-erythro¡Û¡Ú(1R,2S)-L-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol¡Û |
25mg |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL225-0001 |
3-O-Methyl-Sphingomyelin |
1mg |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL225-0005 |
3-O-Methyl-Sphingomyelin |
5mg |
¡ï65,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL226-0005 |
Myriocin ¡ÚISP-1¡Û¡ÚThermozymocidin¡Û¡Ú2S,3R,4R,6E-2-Amino-3,4-dihydroxy-2-hydroxymethyl-14-oxo-6-eicosenoic Acid¡Û |
5mg |
¡ï9,000 |
|
35891-70-4 |
|
|
|
¡¡ |
BML |
BML-SL227-0005 |
BML-241 ¡ÚS1P Receptor Antagonist¡Û¡Ú2(R,S)-Undecylthiazolidine-4(R)-carboxylic Acid¡Û |
5mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL227-0025 |
BML-241 ¡ÚS1P Receptor Antagonist¡Û¡Ú2(R,S)-Undecylthiazolidine-4(R)-carboxylic Acid¡Û |
25mg |
¡ï37,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL230-0005 |
N-Butyldeoxynojirimycin, HCl |
5mg |
¡ï14,000 |
|
72599-27-0 |
|
|
|
¡¡ |
BML |
BML-SL230-0025 |
N-Butyldeoxynojirimycin, HCl |
25mg |
¡ï61,000 |
|
72599-27-0 |
|
|
|
¡¡ |
BML |
BML-SL231-0010 |
N-Oleylethanolamide |
10mg |
¡ï7,000 |
|
111-58-0 |
|
|
|
¡¡ |
BML |
BML-SL231-0050 |
N-Oleylethanolamide |
50mg |
¡ï28,000 |
|
111-58-0 |
|
|
|
¡¡ |
BML |
BML-SL232-0100 |
KNR7000 ¡Úa-Galactosylceramide¡Û¡Ú(2S,3S,4R)-1-O-(a-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol¡Û |
100ug |
¡ï35,000 |
|
158021-47-7 |
|
|
|
¡¡ |
BML |
BML-SL232-1000 |
KNR7000 ¡Úa-Galactosylceramide¡Û¡Ú(2S,3S,4R)-1-O-(a-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol¡Û |
1mg |
¡ï123,000 |
|
158021-47-7 |
|
|
|
¡¡ |
BML |
BML-SL233-0005 |
FTY-720, HCl ¡Ú2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, HCl¡Û¡ÚFingolimod, HCl¡Û |
5mg |
¡ï8,000 |
|
162359-56-0 |
|
|
|
¡¡ |
BML |
BML-SL233-0025 |
FTY-720, HCl ¡Ú2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, HCl¡Û¡ÚFingolimod, HCl¡Û |
25mg |
¡ï35,000 |
|
162359-56-0 |
|
|
|
¡¡ |
BML |
BML-SL300-0005 |
C17-Sphingosine ¡ÚSphingosine C17¡Û |
5mg |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL300-0025 |
C17-Sphingosine ¡ÚSphingosine C17¡Û |
25mg |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SL3730-0025 |
SNAP 25 ¡ÚSynaptosome-Associated Protein of 25kDa¡Û(mouse, synthetic heptadecapeptide)(CT), rabbit pAb,-neat serum |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ bovine | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SL3730-0100 |
SNAP 25 ¡ÚSynaptosome-Associated Protein of 25kDa¡Û(mouse, synthetic heptadecapeptide)(CT), rabbit pAb,-neat serum |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | rat¡¢ bovine | IHC¡¢ WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-SM100-0001 |
HETE Mixture |
Ampoule |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SM105-0001 |
Cysteinyl Leukotriene Mixture |
Ampoule |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SM110-0001 |
Dihydroxyeicosatetraenoic Acids Mixture ¡ÚLeukotriene A4 Hydrolysis Products(DiHETEs)Mixture¡Û |
Ampoule |
¡ï25,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SM115-0001 |
Leukotriene B4 & ¦Ø Oxidation Metabolites Mixture |
Ampoule |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP1373-0100 |
SNAP 25 C-terminal Peptide ¡ÚSynaptosome-Associated Protein of 25 kDa C-terminal Peptide¡Û, Blocking peptide for SNAP 25 pAb(Prod. No. BML-SL3730) |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP146-0100 |
Control Peptide for SA146(Blocking peptide for PKCBII pAb(Prod. No. BML-SA146)) |
100ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP148-0100 |
Control Peptide for SA148(Blocking peptide for PKC¦Ä pAb(Prod. No. BML-SA148)) |
100ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP149-0100 |
Control Peptide for SA149(Blocking peptide for PKC¦Å pAb(Prod. No. BML-SA149)) |
100ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP150-0100 |
Control Peptide for SA150(Blocking peptide for PKC¦Æ pAb(Prod. No. BML-SA150)) |
100ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP183-0001 |
Control Peptide for SA183(Blocking peptides for Protein kinase C set(Prod. No. BML-SA183)) |
1Each |
¡ï84,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP200-0100 |
Inducible Nitric Oxide Synthase Antibody(SA200)Control Peptide(Blocking peptide for Nitric oxide synthase(inducible)pAb(Prod. No. BML-SA200)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP227-0100 |
Control Peptide for SA-227(Blocking peptide for nNOS pAb(Prod. No. BML-SA227)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP253-0100 |
Control Peptide for SA-253(Blocking peptide for Poly(ADP-ribose)polymerase pAb(Prod. No. BML-SA253)) |
100ug |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP270-0100 |
Control Peptide for SA-270(Blocking peptide for PKA RIIB subunit pAb(Prod. No. BML-SA270)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP390-0001 |
Insulin Receptor/IGF-1R(pTyr1158)Control Peptide Pair for [pTyr1158]Insulin Receptor and [pTyr1131]IGF-1 Receptor(human)pAb(Prod. No. BML-SA390) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP392-0001 |
Insulin Receptor/IGF-1R(pTyr1158, pTyr1162, pTyr1163)Control Peptide Pairfor [pTyr1158/1162/1163]Insulin Receptor and [pTyr1131/1135/1136]IGF-1 receptor pAb(Prod. No. BML-SA392) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP393-0001 |
Receptor substrate 1(human)pAb(Prod. No. BML-SA393) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP394-0001 |
Insulin Receptor Substrate-1(pTyr941)Control Peptide Pair for [pTyr941]Insulin Receptor Substrate 1(human)pAb(Prod. No. BML-SA394) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP396-0001 |
Insulin Receptor Substrate-1(pTyr896)Control Peptide Pair for [pTyr896]Insulin Receptor Substrate 1(human)pAb(Prod. No. BML-SA396) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP399-0001 |
Activating Transcription Factor 2(pTyr71)Control Peptide Pair for [pThr71]Activating Transcription fFactor 2(human)pAb(Prod. No. BML-SA399) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP474-0100 |
14-3-3B Control Peptide(Blocking peptide for 14-3-3B pAb(Prod. No. BML-SA474)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP475-0100 |
14-3-3¦Å(CT)Control Peptide(Blocking peptide for 14-3-3¦Å(CT)pAb(Prod. No. BML-SA475) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP476-0100 |
14-3-3¦Ç Control Peptide(Blocking peptide for 14-3-3¦Ç pAb(Prod. No. BML-SA476)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP477-0100 |
14-3-3¦Ã Control Peptide(Blocking peptide for 14-3-3¦Ã pAb(Prod. No. BML-SA477)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP478-0100 |
14-3-3¦Å(NT)Control Peptide(Blocking peptide for 14-3-3¦Å(NT)pAb(Prod. No. BML-SA478) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP480-0100 |
14-3-3¦Ò Control Peptide(Blocking peptide for 14-3-3¦Ò pAb(Prod. No. BML-SA480)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP481-0100 |
14-3-3¦Ó/¦È Control Peptide(Blocking peptide for 14-3-3¦Ó/¦È pAb(Prod. No. BML-SA481)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP482-0100 |
14-3-3¦Æ Control Peptide(Blocking peptide for 14-3-3¦Æ pAb(Prod. No. BML-SA482)) |
100ug |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP9340-0050 |
a-Synuclein Peptide(117-131)(complementary to rabbit pAb to a-Synuclein SA3400) |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SP9345-0050 |
B-Synuclein Peptide(97-111)(complementary to rabbit pAb to B-Synuclein SA3405)(Blocking peptide for B-Synuclein pAb(Prod. No. BML-SA3405)) |
50ug |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST101-0005 |
Adenosine-5'-O-(3-thiotriphosphate)¡ÚATP¦Ã-S¡Û, 4Li salt |
5mg |
¡ï11,000 |
|
93839-89-5 |
|
|
|
¡¡ |
BML |
BML-ST101-0025 |
Adenosine-5'-O-(3-thiotriphosphate)¡ÚATP¦Ã-S¡Û, 4Li salt |
25mg |
¡ï43,000 |
|
93839-89-5 |
|
|
|
¡¡ |
BML |
BML-ST102-0010 |
Anisomycin ¡Ú2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate¡Û |
10mg |
¡ï5,000 |
|
22862-76-6 |
|
|
|
¡¡ |
BML |
BML-ST102-0050 |
Anisomycin ¡Ú2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate¡Û |
50mg |
¡ï21,000 |
|
22862-76-6 |
|
|
|
¡¡ |
BML |
BML-ST103-0010 |
Bryostatin 1 |
10ug |
¡ï17,000 |
|
83314-01-6 |
|
|
|
¡¡ |
BML |
BML-ST200-0005 |
Z36 ¡Ú(Z)-5-Fluoro-1-(3'-dimethylamino)propyl-3-[(5'-methoxyindol-3-ylidene)methyl]indolin-2-one¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST200-0025 |
Z36 ¡Ú(Z)-5-Fluoro-1-(3'-dimethylamino)propyl-3-[(5'-methoxyindol-3-ylidene)methyl]indolin-2-one¡Û |
25mg |
¡ï49,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST300-0010 |
RHC-80267 ¡ÚU-57908¡Û¡Ú1,6-bis-(Cyclohexyloximinocarbonylamino)hexane¡Û |
10mg |
¡ï8,000 |
|
83654-05-1 |
|
|
|
¡¡ |
BML |
BML-ST300-0050 |
RHC-80267 ¡ÚU-57908¡Û¡Ú1,6-bis-(Cyclohexyloximinocarbonylamino)hexane¡Û |
50mg |
¡ï32,000 |
|
83654-05-1 |
|
|
|
¡¡ |
BML |
BML-ST310-0001 |
Luffariellolide(PLA2 Inhibitor)(Isolated from sponge Luffariella sp.) |
1mg |
¡ï16,000 |
|
111149-87-2 |
|
|
|
¡¡ |
BML |
BML-ST320-0020 |
ONO-RS-082 ¡Ú2-(p-Amylcinnamoyl)amino-4-chlorobenzoic Acid¡Û |
20mg |
¡ï9,000 |
|
99754-06-0 |
|
|
|
¡¡ |
BML |
BML-ST320-0100 |
ONO-RS-082 ¡Ú2-(p-Amylcinnamoyl)amino-4-chlorobenzoic Acid¡Û |
100mg |
¡ï37,000 |
|
99754-06-0 |
|
|
|
¡¡ |
BML |
BML-ST325-0005 |
Thioetheramidephosphorylcholine ¡Ú1-Palmitylthio-2-palmitoylamino-1,2-dideoxy-sn-glycero-3-phosphorylcholine¡Û |
5mg |
¡ï10,000 |
|
116457-99-9 |
|
|
|
¡¡ |
BML |
BML-ST325-0025 |
Thioetheramidephosphorylcholine ¡Ú1-Palmitylthio-2-palmitoylamino-1,2-dideoxy-sn-glycero-3-phosphorylcholine¡Û |
25mg |
¡ï43,000 |
|
116457-99-9 |
|
|
|
¡¡ |
BML |
BML-ST330-0005 |
D609 ¡ÚTricyclodecan-9-yl xanthogenate, K¡Û |
5mg |
¡ï9,000 |
|
83373-60-8 |
|
|
|
¡¡ |
BML |
BML-ST330-0025 |
D609 ¡ÚTricyclodecan-9-yl xanthogenate, K¡Û |
25mg |
¡ï38,000 |
|
83373-60-8 |
|
|
|
¡¡ |
BML |
BML-ST335-0010 |
AACOCF3 ¡ÚArachidonyltrifluoromethyl Ketone¡Û |
10mg |
¡ï12,000 |
|
149301-79-1 |
|
|
|
¡¡ |
BML |
BML-ST335-0050 |
AACOCF3 ¡ÚArachidonyltrifluoromethyl Ketone¡Û |
50mg |
¡ï38,000 |
|
149301-79-1 |
|
|
|
¡¡ |
BML |
BML-ST336-0010 |
PACOCF3 ¡ÚPalmityl Trifluoromethylketone¡Û¡ÚPTK¡Û |
10mg |
¡ï7,000 |
|
141022-99-3 |
|
|
|
¡¡ |
BML |
BML-ST336-0050 |
PACOCF3 ¡ÚPalmityl Trifluoromethylketone¡Û¡ÚPTK¡Û |
50mg |
¡ï30,000 |
|
141022-99-3 |
|
|
|
¡¡ |
BML |
BML-ST337-0010 |
AACOCH3 ¡ÚArachidonylmethyl Ketone¡Û |
10mg |
¡ï9,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST337-0050 |
AACOCH3 ¡ÚArachidonylmethyl Ketone¡Û |
50mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST338-0010 |
PACOCH3 ¡ÚHeptadeca-2-one¡Û |
10mg |
¡ï6,000 |
|
2922-51-2 |
|
|
|
¡¡ |
BML |
BML-ST338-0050 |
PACOCH3 ¡ÚHeptadeca-2-one¡Û |
50mg |
¡ï26,000 |
|
2922-51-2 |
|
|
|
¡¡ |
BML |
BML-ST340-0005 |
HELSS ¡ÚE-6-(Bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one¡Û |
5mg |
¡ï15,000 |
|
88070-98-8 |
|
|
|
¡¡ |
BML |
BML-ST340-0025 |
HELSS ¡ÚE-6-(Bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one¡Û |
25mg |
¡ï64,000 |
|
88070-98-8 |
|
|
|
¡¡ |
BML |
BML-ST360-0005 |
Methyl Arachidonyl Fluorophosphonate ¡ÚMAFP¡Û¡ÚMethylphosphonofluoridic acid 5,8,11,14-eicosatetraenyl Ester¡Û |
5mg |
¡ï14,000 |
|
149301-79-1 |
|
|
|
¡¡ |
BML |
BML-ST360-0025 |
Methyl Arachidonyl Fluorophosphonate ¡ÚMAFP¡Û¡ÚMethylphosphonofluoridic acid 5,8,11,14-eicosatetraenyl Ester¡Û |
25mg |
¡ï57,000 |
|
149301-79-1 |
|
|
|
¡¡ |
BML |
BML-ST370-0005 |
VU0155069 ¡ÚN-[(2S)-1-[4-(5-Chloro-2-oxo-3H-benzimidazol-1-yl)-piperidin-1-yl]-propan-2-yl]naphthalene-2-carboxamide¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST370-0025 |
VU0155069 ¡ÚN-[(2S)-1-[4-(5-Chloro-2-oxo-3H-benzimidazol-1-yl)-piperidin-1-yl]-propan-2-yl]naphthalene-2-carboxamide¡Û |
25mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST371-0005 |
BML-280 ¡ÚN-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)quinoline-3-carboxamide¡Û¡ÚVU0285655-1¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST371-0025 |
BML-280 ¡ÚN-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)quinoline-3-carboxamide¡Û¡ÚVU0285655-1¡Û |
25mg |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST372-0005 |
BML-279 ¡ÚN-{1-[4-(2-Oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl}quinoline-3-carboxamide¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST372-0025 |
BML-279 ¡ÚN-{1-[4-(2-Oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl}quinoline-3-carboxamide¡Û |
25mg |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST391-0005 |
U-73122 ¡Ú1-{6-[(17B-3-methoxyestra-1,3,5(10)-trien-17-yl)amino]hexyl}-1H-pyrrole-2,5-dione¡Û |
5mg |
¡ï11,000 |
|
112648-68-7 |
|
|
|
¡¡ |
BML |
BML-ST391-0025 |
U-73122 ¡Ú1-{6-[(17B-3-methoxyestra-1,3,5(10)-trien-17-yl)amino]hexyl}-1H-pyrrole-2,5-dione¡Û |
25mg |
¡ï43,000 |
|
112648-68-7 |
|
|
|
¡¡ |
BML |
BML-ST392-0005 |
U-73343 ¡Ú1-[6-[[(17B)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]pyrrolidine-2,5-dione¡Û |
5mg |
¡ï11,000 |
|
142878-12-4 |
|
|
|
¡¡ |
BML |
BML-ST392-0025 |
U-73343 ¡Ú1-[6-[[(17B)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]pyrrolidine-2,5-dione¡Û |
25mg |
¡ï43,000 |
|
142878-12-4 |
|
|
|
¡¡ |
BML |
BML-ST400-0010 |
Phosphatidylethanol ¡Ú1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST400-0050 |
Phosphatidylethanol ¡Ú1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol¡Û |
50mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST401-0010 |
Phosphatidylbutanol ¡Ú1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphobutanol¡Û |
10mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST401-0050 |
Phosphatidylbutanol ¡Ú1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphobutanol¡Û |
50mg |
¡ï44,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST405-0001 |
Propranolol ¡Ú(¡Þ)1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol, HCl¡Û |
1g |
¡ï2,000 |
|
3506-09-0 |
|
|
|
¡¡ |
BML |
BML-ST405-0005 |
Propranolol ¡Ú(¡Þ)1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol, HCl¡Û |
5g |
¡ï6,000 |
|
3506-09-0 |
|
|
|
¡¡ |
BML |
BML-ST415-0001 |
Wortmannin ¡ÚKY 12420¡Û |
1mg |
¡ï7,000 |
|
19545-26-7 |
|
|
|
¡¡ |
BML |
BML-ST415-0005 |
Wortmannin ¡ÚKY 12420¡Û |
5mg |
¡ï27,000 |
|
19545-26-7 |
|
|
|
¡¡ |
BML |
BML-ST415-0020 |
Wortmannin ¡ÚKY 12420¡Û |
20mg |
¡ï53,000 |
|
19545-26-7 |
|
|
|
¡¡ |
BML |
BML-ST420-0005 |
LY 294002 ¡Ú2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one¡Û |
5mg |
¡ï12,000 |
|
154447-36-6 |
|
|
|
¡¡ |
BML |
BML-ST420-0025 |
LY 294002 ¡Ú2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one¡Û |
25mg |
¡ï50,000 |
|
154447-36-6 |
|
|
|
¡¡ |
BML |
BML-ST425-0500 |
PI 3K-SH2-OMT ¡ÚAcetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 Trimethyl Ester¡Û |
0.5mg |
¡ï18,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST500-0005 |
1,2-bis(Heptanoylthio)-1,2-dideoxy-sn-glycero-3-phosphorylcholine |
5mg |
¡ï27,000 |
|
89019-63-6 |
|
|
|
¡¡ |
BML |
BML-ST501-0010 |
7-HC-6-Heptenoate ¡Ú7-Hydroxycoumarinyl 6-Heptenoate¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST501-0050 |
7-HC-6-Heptenoate ¡Ú7-Hydroxycoumarinyl 6-Heptenoate¡Û |
50mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST502-0010 |
7-HC-Arachidonate ¡Ú7-Hydroxycoumarinyl-Arachidonate¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST502-0050 |
7-HC-Arachidonate ¡Ú7-Hydroxycoumarinyl-Arachidonate¡Û |
50mg |
¡ï40,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST503-0010 |
7-HC-¦Ã-Linolenate ¡Ú7-Hydroxycoumarinyl-¦Ã-Linolenate¡Û |
10mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST503-0050 |
7-HC-¦Ã-Linolenate ¡Ú7-Hydroxycoumarinyl-¦Ã-Linolenate¡Û |
50mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST504-0005 |
Arachidonoyl-AMC ¡ÚAAMCA¡Û |
5mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST504-0025 |
Arachidonoyl-AMC ¡ÚAAMCA¡Û |
25mg |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ST505-0020 |
Decanoyl-p-nitroanilide |
20mg |
¡ï8,000 |
|
72298-63-6 |
|
|
|
¡¡ |
BML |
BML-ST505-0100 |
Decanoyl-p-nitroanilide |
100mg |
¡ï34,000 |
|
72298-63-6 |
|
|
|
¡¡ |
BML |
BML-ST506-0050 |
NOB ¡Ú4-Nitro-3-(octanoyloxy)benzoic Acid¡Û |
50mg |
¡ï10,000 |
|
55894-52-5 |
|
|
|
¡¡ |
BML |
BML-ST506-0250 |
NOB ¡Ú4-Nitro-3-(octanoyloxy)benzoic Acid¡Û |
250mg |
¡ï43,000 |
|
55894-52-5 |
|
|
|
¡¡ |
BML |
BML-SW100-0025 |
Poly(ADP-ribose)Immunoblotting Standard |
25ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW101-0200 |
HL60 Cell Extract(non-induced) |
200ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW102-0200 |
HL60 Cell Extract(Etoposide-induced) |
200ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW103-0200 |
Rat Brain Lysate as Immunoblotting Standard |
200ul |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW106-0200 |
Mouse Liver Extract |
200ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW109-0100 |
bNOS Standard(rat)¡ÚNitric oxide synthase(neuronal)¡Û¡ÚnNOS¡Û¡ÚNOS I¡Û¡ÚNitric Oxide Synthase(brain)¡Û(recombinant) |
100ul |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW110-0200 |
Mouse Thymus Extract Standard |
200ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW112-0200 |
Rat Thymus Extract Standard |
200ul |
¡ï3,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW115-0100 |
Jurkat Cell Extract(non-induced) |
100ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW116-0100 |
Jurkat Cell Extract(induced) |
100ul |
¡ï5,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW119 |
MMP-7(human)¡ÚMatrix Metalloproteinase-7¡Û¡ÚMatrilysin¡Û Immunoblotting Standard |
300ul |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW121-0100 |
TIMP-1, -2, -3, -4 immunoblotting standard(human)¡ÚTissue Inhibitor of Matrix Metalloproteinase-1, -2, -3, -4¡Û |
100ul |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW124-0100 |
MMP(human), immunoblotting standard ¡ÚMatrix Metalloproteinase Immunoblotting Standard¡Û |
100ul |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW126-0100 |
Dimethylated Protein Standard(bovine)¡ÚBSA(dimethylated)¡Û¡ÚBovine Serum Albumin¡Û |
100ug |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW8525-0005 |
Suc-Arg-Pro-Phe-His-Leu-Leu-Val-Tyr-AMC(Fluorogenic) |
5mg |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SW8750-0001 |
HeLa S100 Fraction |
1mg |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SX5800-0001 |
Substance P(5'-TAMRA conjugate)¡ÚTMR-SP¡Û¡ÚDetection Probe for Neurokinin-1 Receptor¡Û |
1mg |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-SZ1011-0025 |
Serotonin ¡Ú5-HT¡Û¡Ú5-hydroxytryptamine¡Û(Serotonin Glutaraldehyde-Haemocyanin Complex), rat pAb(antiserum) |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SZ1021-0100 |
Serotonin ¡Ú5-HT¡Û¡Ú5-hydroxytryptamine¡Û(Serotonin Glutaraldehyde-Haemocyanin Complex), rabbit pAb(antiserum) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SZ1062-0100 |
Substance P(synthetic peptide(H-RPKPQQFFGLM-NH2)), rabbit pAb |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SZ1114-0100 |
Somatostatin(Somatostatin-28), rabbit pAb |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-SZ1116-0025 |
Somatostatin(Somatostatin-28), rat pAb |
25ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rat | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC |
|
|
¡¡ |
BML |
BML-T101-0010 |
Nocodazole ¡ÚMethyl-[5-(2-thienylcarbonyl)-1H-benzimidazole-2-yl]carbamate¡Û¡ÚR 17934¡Û |
10mg |
¡ï11,000 |
|
31430-18-9 |
|
|
|
¡¡ |
BML |
BML-T101-0050 |
Nocodazole ¡ÚMethyl-[5-(2-thienylcarbonyl)-1H-benzimidazole-2-yl]carbamate¡Û¡ÚR 17934¡Û |
50mg |
¡ï43,000 |
|
31430-18-9 |
|
|
|
¡¡ |
BML |
BML-T104-0005 |
Taxol ¡ÚPaclitaxel¡Û(Isolated from the bark of the Pacific Yew tree(Taxus brevifolia)) |
5mg |
¡ï8,000 |
|
33069-62-4 |
|
|
|
¡¡ |
BML |
BML-T104-0025 |
Taxol ¡ÚPaclitaxel¡Û(Isolated from the bark of the Pacific Yew tree(Taxus brevifolia)) |
25mg |
¡ï26,000 |
|
33069-62-4 |
|
|
|
¡¡ |
BML |
BML-T104-0250 |
Taxol ¡ÚPaclitaxel¡Û(Isolated from the bark of the Pacific Yew tree(Taxus brevifolia)) |
250mg |
¡ï119,000 |
|
33069-62-4 |
|
|
|
¡¡ |
BML |
BML-T105-0010 |
N1, N12-Diethylspermine, 4HCl |
10mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T108-0005 |
Cytochalasin B(Isolated from Drechslera dematoidea ) |
5mg |
¡ï13,000 |
|
14930-96-2 |
|
|
|
¡¡ |
BML |
BML-T109-0001 |
Cytochalasin D(Isolated from Zygosporium mansonii) |
1mg |
¡ï10,000 |
|
22144-77-0 |
|
|
|
¡¡ |
BML |
BML-T110-0001 |
Latrunculin B(Isolated from Latrunculia magnifica.) |
1mg |
¡ï19,000 |
|
76343-94-7 |
|
|
|
¡¡ |
BML |
BML-T112-0010 |
Alrestatin ¡Ú1,3-Dioxo-1H-benz[de]isoquinoline-2(3H)acetic Acid¡Û |
10mg |
¡ï19,000 |
|
51411-04-2 |
|
|
|
¡¡ |
BML |
BML-T113-0050 |
Parthenolide(Isolated from feverfew(Chrysanthemum parthenium)leaves)¡Ú(1aR-[1aR*,4E,7aS*,-10aS*,-10bR*])-2,3-6,7,7a,8,10a,10b-Octahydro-1a,5-dimethyl-8-methyleneoxireno[9,10]cyclo deca[1,2-b]furan-9(1 |
50mg |
¡ï9,000 |
|
20554-84-1 |
|
|
|
¡¡ |
BML |
BML-T113-0250 |
Parthenolide(Isolated from feverfew(Chrysanthemum parthenium)leaves)¡Ú(1aR-[1aR*,4E,7aS*,-10aS*,-10bR*])-2,3-6,7,7a,8,10a,10b-Octahydro-1a,5-dimethyl-8-methyleneoxireno[9,10]cyclo deca[1,2-b]furan-9(1 |
250mg |
¡ï37,000 |
|
20554-84-1 |
|
|
|
¡¡ |
BML |
BML-T114-0050 |
S-(N-(3-Phenylpropyl)thiocarbamoyl)-L-cysteine |
50mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T114-0250 |
S-(N-(3-Phenylpropyl)thiocarbamoyl)-L-cysteine |
250mg |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T115-0100 |
Thalidomide ¡Ú(¡Þ)-N-(2,6-Dioxo-3-piperidinyl)phthalimide¡Û |
100mg |
¡ï11,000 |
|
50-35-1 |
|
|
|
¡¡ |
BML |
BML-T115-0500 |
Thalidomide ¡Ú(¡Þ)-N-(2,6-Dioxo-3-piperidinyl)phthalimide¡Û |
500mg |
¡ï42,000 |
|
50-35-1 |
|
|
|
¡¡ |
BML |
BML-T117-0005 |
Vincristine Sulfate ¡ÚVCR Sulfate¡Û¡ÚLeukocristine Sulfate¡Û |
5mg |
¡ï14,000 |
|
2068-78-2 |
|
|
|
¡¡ |
BML |
BML-T117-0025 |
Vincristine Sulfate ¡ÚVCR Sulfate¡Û¡ÚLeukocristine Sulfate¡Û |
25mg |
¡ï55,000 |
|
2068-78-2 |
|
|
|
¡¡ |
BML |
BML-T119-0100 |
Latrunculin A |
100ug |
¡ï17,000 |
|
76343-93-6 |
|
|
|
¡¡ |
BML |
BML-T119-0500 |
Latrunculin A |
500ug |
¡ï72,000 |
|
76343-93-6 |
|
|
|
¡¡ |
BML |
BML-T120-0050 |
TN-16 ¡Ú3-(Anilinoethylidene)-5-benzylpyrrolidine-2,4-dione¡Û |
50mg |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T121-0001 |
Ansamitocin P-3 |
1mg |
¡ï42,000 |
|
66547-09-9 |
|
|
|
¡¡ |
BML |
BML-T123-0020 |
Mycalolide B(Isolated from the marine sponge Mycale sp) |
20ug |
¡ï36,000 |
|
122752-21-0 |
|
|
|
¡¡ |
BML |
BML-T124-0001 |
Dolastatin 15 |
1mg |
¡ï24,000 |
|
123884-00-4 |
|
|
|
¡¡ |
BML |
BML-T125-0020 |
Swinholide A(Isolated from marine sponge Theonella swinhoei.) |
20ug |
¡ï17,000 |
|
95927-67-6 |
|
|
|
¡¡ |
BML |
BML-T126-0001 |
Wiskostatin ¡Ú1-(3,6-Dibromocarbazol-9-yl)-3-dimethylaminopropan-2-ol¡Û |
1mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T126-0005 |
Wiskostatin ¡Ú1-(3,6-Dibromocarbazol-9-yl)-3-dimethylaminopropan-2-ol¡Û |
5mg |
¡ï32,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-T127-0001 |
Pironetin |
1mg |
¡ï17,000 |
|
151519-02-7 |
|
|
|
¡¡ |
BML |
BML-T129-0005 |
Docetaxel ¡ÚTaxotere¡Û¡ÚNSC-628503¡Û¡ÚRP-56976¡Û |
5mg |
¡ï9,000 |
|
114977-28-5 |
|
|
|
¡¡ |
BML |
BML-T129-0025 |
Docetaxel ¡ÚTaxotere¡Û¡ÚNSC-628503¡Û¡ÚRP-56976¡Û |
25mg |
¡ï40,000 |
|
114977-28-5 |
|
|
|
¡¡ |
BML |
BML-T129-0250 |
Docetaxel ¡ÚTaxotere¡Û¡ÚNSC-628503¡Û¡ÚRP-56976¡Û |
250mg |
¡ï136,000 |
|
114977-28-5 |
|
|
|
¡¡ |
BML |
BML-TA1721-0100 |
Talin(human fibroblasts)[TA205], mouse mAb, Affinity-purified(specificity: human) |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | TA205 | human | WB¡¢ IHC |
|
|
¡¡ |
BML |
BML-TA3119-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 12-27)(TAUY9), rabbit pAb(specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3119-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 12-27)(TAUY9), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3121-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 21-36)(TAUY21), rabbit pAb(specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3121-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 21-36)(TAUY21), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3135-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 186-201)(TAUY5), rabbit pAb (specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TA3135-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 186-201)(TAUY5), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TA3136-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 186-201)(TAUY6), rabbit pAb(specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3136-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 186-201)(TAUY6), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-TA3247-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 384-397)(TAUY7), rabbit pAb(specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TA3247-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 384-397)(TAUY7), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TA3248-0025 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 384-397)(TAUY8), rabbit pAb(specificity: human) |
25ul |
¡ï11,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TA3248-0100 |
Tau ¡ÚMicrotubule-Associated Protein ¦Ó¡Û(human, aa 384-397)(TAUY8), rabbit pAb(specificity: human) |
100ul |
¡ï40,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human | WB |
|
|
¡¡ |
BML |
BML-TB004-0100 |
11-Dehydro-Thromboxane B2 ¡Ú11-Dehydro-TXB2¡Û |
100ug |
¡ï23,000 |
|
67910-12-7 |
|
|
|
¡¡ |
BML |
BML-TG1914-0100 |
14-3-3¦Ó/¦È(mouse, full length)(recombinant)[3B9], mouse mAb, purified |
100ug |
¡ï39,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG | 3B9 | human¡¢ mouse¡¢ rat¡¢ bovine | WB¡¢ ELISA |
|
|
¡¡ |
BML |
BML-TG6040-0100 |
Tenascin C ¡ÚTN-C¡Û(human)[EB2], mouse mAb, purified(specificity: human) |
100ul |
¡ï27,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | EB2 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-TG6044-0100 |
Tenascin C ¡ÚTN-C¡Û(human)[DB7], mouse mAb, purified(specificity: human) |
100ul |
¡ï27,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | DB7 | human | IHC¡¢ WB¡¢ IP |
|
|
¡¡ |
BML |
BML-TK4000-0001 |
Microtubule-Associated Protein ¦Ó Detection Pack |
Pack |
¡ï73,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TP9119-0001 |
hTau ¡ÚTau¡Û¡Ú¦Ó¡Û(human, aa 12-27, Y18 & pY18)Peptide Control Pair for Tau(human)pAb(Prod. No. BML-TA3119) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TP9121-0001 |
hTau ¡ÚTau¡Û¡Ú¦Ó¡Û(human, aa 21-26, Y29 & pY29)Peptide Control Pair for Tau(human)pAb(Prod. No. BML-TA3121) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TP9136-0001 |
hTau ¡ÚTau¡Û¡Ú¦Ó¡Û(human, aa 186-201, Y197 & pY197)Peptide Control Pair for Tau(human)pAbs(Prod. No. BML-TA3135 & Prod. No. BML-TA3136) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TP9247-0001 |
hTau ¡ÚTau¡Û¡Ú¦Ó¡Û(human, aa 384-397, Y394 & pY394)Peptide Control Pairfor Tau(human)pAbs(Prod. No. BML-TA3247 & Prod. No. BML-TA3248) |
2x100ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TZ0001-0050 |
Tyrosine Hydroxylase ¡ÚTH¡Û(recombinant) |
50ug |
¡ï69,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-TZ1010-0050 |
Tyrosine Hydroxylase ¡ÚTH¡Û(bovine), rabbit pAb |
50ul |
¡ï49,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ mouse¡¢ rat | WB¡¢ IHC(PS) |
|
|
¡¡ |
BML |
BML-TZ1050-0050 |
Tryptophan Hydroxylase ¡ÚTPH¡Û(rabbit)(recombinant)[WH-S], mouse mAb, purified |
50ul |
¡ï48,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG3 | WH-S | rat¡¢ rabbit¡¢ cat¡¢ primate | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-UG9510-0025 |
Ubiquitin-Protein Conjugates(ubiquitin conjugated to KLH), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC(PS) |
|
|
¡¡ |
BML |
BML-UG9510-0100 |
Ubiquitin-Protein Conjugates(ubiquitin conjugated to KLH), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢mouse¡¢rat¡¢ goat¡¢sheep¡¢dog¡¢pig¡¢monkey | IHC(PS) |
|
|
¡¡ |
BML |
BML-UG9520-0025 |
Ubiquitin Conjugating Enzyme UbcH1 ¡ÚUbcH1¡Û(bovine E2(25kDa), aa 1-10), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ bovine | WB |
|
|
¡¡ |
BML |
BML-UG9520-0100 |
Ubiquitin Conjugating Enzyme UbcH1 ¡ÚUbcH1¡Û(bovine E2(25kDa), aa 1-10), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | Human¡¢ bovine | WB(25kDa) |
|
|
¡¡ |
BML |
BML-UW0040-0025 |
SUMO-1-AMC ¡ÚSentrin-1-AMC¡Û¡ÚSMT3C-AMC¡Û¡ÚSMT3H3-AMC¡Û¡ÚSmall Ubiquitin-related Modifier-1-AMC¡Û |
25ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0045-0025 |
SUMO-2-AMC ¡ÚSentrin-2-AMC¡Û¡ÚSMT3B-AMC¡Û¡ÚSMT3H2-AMC¡Û¡ÚSmall Ubiquitin-related Modifier-2-AMC¡Û |
25ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0050-0025 |
NEDD8-AMC |
25ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0060-0025 |
SUMO-1 Aldehyde |
25ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0065-0025 |
SUMO-2 Aldehyde |
25ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0070-0050 |
NEDD8 Aldehyde |
50ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0095-0500 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier-1¡Û(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0100-0500 |
SUMO-2 ¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0105-0500 |
SUMO-3 ¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0110-0500 |
NEDD8(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0115-0500 |
ISG15 ¡ÚInterferon-Stimulated Gene 15¡Û(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0120-0001 |
Ubiquitin Binding Entities Sampler Pack |
Pack |
¡ï75,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0125-0500 |
UbiQapture-Q Matrix |
0.5mL |
¡ï34,000 |
|
|
|
|
|
¡¡ |
BML |
BML-UW0140-0500 |
FAT10 ¡ÚUbiquitin-like Protein FAT10¡Û(human)(recombinant)(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0155-0025 |
Ubiquitin Vinyl Sulfone ¡ÚHA-Ub-VS¡Û(human)(recombinant), -HA-Tag |
25ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0160-0500 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier-1¡Û(human)(recombinant)with GST-Tag |
500ug |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0165-0500 |
SUMO-2 ¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant)with GST-Tag |
500ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0170-0500 |
SUMO-3 ¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant)with GST-Tag |
500ug |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0175-0100 |
[E93R]SUMO-1 ¡ÚSUMO-1, [E93R]-¡Û¡ÚSmall Ubiquitin-related Modifier-1¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0200-0025 |
Hdm2(catalytic RING domain)¡ÚHuman Double Minute 2 Protein¡Û(human)(recombinant)with GST-Tag |
25ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0205-1000 |
[KallR]Ubiquitin ¡ÚUbiquitin, [KallR]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0210-0001 |
K6-only Ubiquitin ¡ÚUbiquitin, K6-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0215-0001 |
K11-only Ubiquitin ¡ÚUbiquitin, K11-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0220-0001 |
K27-only Ubiquitin ¡ÚUbiquitin, K27-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0225-0001 |
K29-only Ubiquitin ¡ÚUbiquitin, K29-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0230-0001 |
K33-only Ubiquitin ¡ÚUbiquitin, K33-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0235-0001 |
K48-only Ubiquitin ¡ÚUbiquitin, K48-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0240-0001 |
K63-only Ubiquitin ¡ÚUbiquitin, K63-only-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0245-0001 |
[K6R]Ubiquitin ¡ÚUbiquitin, [K6R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0250-0001 |
[K11R]Ubiquitin ¡ÚUbiquitin, [K11R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0255-0001 |
[K27R]Ubiquitin ¡ÚUbiquitin, [K27R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0260-0001 |
[K29R]Ubiquitin ¡ÚUbiquitin, [K29R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0275-0001 |
[K63R]Ubiquitin ¡ÚUbiquitin, [K63R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0280-0001 |
Ubiquitin(human)(recombinant)(E. coli.) |
1mg |
¡ï4,000 |
-20¡î |
none |
|
Purity: ¡ä95%, MW: ~8.6kDa Application: for use in ubiquitinylation studies.
|
|
¡¡ |
BML |
BML-UW0335-0100 |
IRF2 ¡ÚInterferon Regulatory Factor 2¡Û(human)(recombinant), with His-Tag |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0345-0001 |
[D77]Ubiquitin ¡ÚUbiquitin, [D77]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï13,000 |
|
none |
|
|
|
¥« ¥ë ¥¿ ¥Ø ¥Ê |
BML |
BML-UW0350-0050 |
Uba6(human),(recombinant) |
50ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0380-0100 |
SUMO-2(K11R mutant)¡Ú[K11R]SUMO-2¡Û¡ÚSUMO-2, [K11R]¡Û¡ÚSentrin-2¡Û¡ÚSMT3B¡Û¡ÚMT3H2¡Û¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant), with GST-Tag |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0385-0100 |
SUMO-3(K11R mutant)¡Ú[K11R]SUMO-3¡Û¡ÚSUMO-3, [K11R]¡Û¡ÚSMT3A¡Û¡ÚSMT3H1¡Û¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant), with GST-Tag |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0395-0025 |
Rbx1 ¡ÚRING box protein-1¡Û¡ÚROC1¡Û¡ÚRegulator of cullins 1¡Û¡ÚRing finger protein 75¡Û(human)(recombinant), with His-Tag |
25ug |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0400-0001 |
Ubiquitin Activating Kit(96 assays ) |
Kit |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0405-0025 |
MuRF1 ¡ÚTRIM63¡Û¡ÚTripartite Motif-containing Protein 63¡Û¡ÚE3 Ubiquitin-Protein Ligase TRIM63¡Û(rat)(recombinant), with GST-Tag |
25ug |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0475-0050 |
USP25(isoform 2)¡ÚUbiquitin Thioesterase 25¡Û¡ÚUbiquitin-specific Protease 25¡Û¡ÚDeubiquitinating Enzyme 25¡Û¡ÚUSP on Chromosome 21¡Û(human)(recombinant), with His-Tag |
50ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0500-1000 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier-1¡Û(93-97)-AMCA Peptide |
1mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0515-0100 |
SUMO-2(K11R mutant)¡Ú[K11R]SUMO-2¡Û¡ÚSUMO-2, [K11R]-¡Û¡ÚSentrin-2¡Û¡ÚSMT3B¡Û¡ÚSMT3H2¡Û¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant)(untagged) |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0520-0100 |
SUMO-3(K11R mutant)¡Ú[K11R]SUMO-3¡Û¡ÚSUMO-3, [K11R]-¡Û¡ÚSMT3A¡Û¡ÚSMT3H1¡Û¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant)(untagged) |
100ug |
¡ï11,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0545-0100 |
SUMO-1 ¡ÚSentrin-1¡Û¡ÚSMT3C¡Û¡ÚSMT3H3¡Û¡ÚSmall Ubiquitin-related Modifier-1¡Û(human)(recombinant), -Biotin conj. |
100ug |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0550-0100 |
SUMO-2 ¡ÚSentrin-2¡Û¡ÚSMT3B¡Û¡ÚSMT3H2¡Û¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant), -Biotin conj. |
100ug |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0555-0100 |
SUMO-3 ¡ÚSMT3A¡Û¡ÚSMT3H1¡Û¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant), -Biotin conj. |
100ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0560-0100 |
NEDD8(human)(recombinant), -Biotin conj. |
100ug |
¡ï24,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0565-0100 |
UbcH5b ¡ÚUbc4¡Û¡ÚE2(17)KB2¡Û¡ÚUbiquitin-conjugating Enzyme E2 D2¡Û(human)(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0590-0001 |
NEDDylation Kit(20 assays ) |
Kit |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0610-0025 |
Ubn-ubiquitinylated Substrate |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0615-0025 |
(K6-only)Ubn-Ubiquitinylated Substrate ¡Ú([K6-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0620-0025 |
(K11-only)Ubn-Ubiquitinylated Substrate ¡Ú([K11-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0625-0025 |
(K27-only)Ubn-Ubiquitinylated Substrate ¡Ú([K27-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0630-0025 |
(K29-only)Ubn-Ubiquitinylated Substrate ¡Ú([K29-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0635-0025 |
(K33-only)Ubn-Ubiquitinylated Substrate ¡Ú([K33-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0640-0025 |
(K48-only)Ubn-Ubiquitinylated Substrate ¡Ú([K48-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0645-0025 |
(K63-only)Ubn-Ubiquitinylated Substrate ¡Ú([K63-only]Ub)n-Ubiquitinylated Substrate¡Û |
25ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0670-0100 |
Poly-Ubiquitin Chains(Ub2-16)(K48-linked) |
100ug |
¡ï36,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0680-0100 |
Otubain-1 ¡ÚOTUB1¡Û¡ÚUbiquitin Thioesterase OTUB1¡Û¡ÚUbiquitin-specific-Processing Protease OTUB1¡Û¡ÚDeubiquitinating Enzyme OTUB1¡Û(human)(recombinant), with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0715-0025 |
Tetra-ubiquitin(K63-linked)¡ÚUb4¡Û |
25ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0730-0050 |
Di-ubiquitin(K63-linked)¡ÚUb2¡Û |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0745-0050 |
Tri-ubiquitin(K63-linked)¡ÚUb3¡Û |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0775-0100 |
Di-Ubiquitin(linear)¡ÚUb2¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0780-0100 |
Tri-Ubiquitin(linear)¡ÚUb3¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0785-0100 |
Tetra-Ubiquitin(linear)¡ÚUb4¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0790-0100 |
Penta-Ubiquitin(linear)¡ÚUb5¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0795-0100 |
Hexa-Ubiquitin(linear)¡ÚUb6¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0800-0100 |
Hepta-Ubiquitin(linear)¡ÚUb7¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0805-0100 |
Octa-Ubiquitin(linear)¡ÚUb8¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0810-0100 |
Nona-Ubiquitin(linear)¡ÚUb9¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0815-0100 |
Deca-Ubiquitin(linear)¡ÚUb10¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0820-0100 |
Undeca-Ubiquitin(linear)¡ÚUb11¡Û |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0825-0001 |
Linear Polyubiquitin Chains, Sampler Pack |
1Pack |
¡ï43,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0830-0001 |
([Kxonly]Ub)n-Ubiquitinylated Substrates ¡ÚUbiquitinylated Substrates,([Kxonly]Ub)n-¡Û, Sampler Pack |
1Pack |
¡ï62,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0880-0025 |
Ubiquitin Vinyl Methyl Ester ¡ÚHA-Ub-VME¡Û, with HA-Tag |
25ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0885-0025 |
Chloroethyl Ubiquitin ¡ÚHA-Ub-Cl¡Û, with HA-Tag |
25ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0895-0001 |
Deubiquitinylating Enzyme Probes, Sampler Pack |
1Pack |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0905-0100 |
SUMO-4(human),(recombinant), with His-tag |
100ug |
¡ï15,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0940-0050 |
Ube2F ¡ÚNEDD8-conjugating Enzyme UBE2F¡Û(human)(recombinant)with His-tag |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0955-0001 |
PolySUMO-Qapture Kit(10 binding assays) |
Kit |
¡ï46,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0960-0100 |
UbcH10 ¡ÚUBE2C¡Û¡ÚUbiquitin-Protein Ligase C¡Û(human),(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW0970-0001 |
Auto-ubiquitinylation Kit(10 auto-ubiquitinylation assays) |
Kit |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1000A-0001 |
SUMO-Qapture-T kit(for isolation and enrichment of SUMOylated proteins)(10 binding assays) |
Kit |
¡ï41,000 |
-80¡î |
none |
|
Replaces Prod. #: BML-UW1000
|
|
¡¡ |
BML |
BML-UW1010-0100 |
Polyubiquitin Chains(Ub2-7),(linear)(recombinant) |
100ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1015-0100 |
A20(catalytic domain)¡ÚTumor Necrosis Factor alpha-Induced Protein 3¡Û¡ÚTNAP3¡Û¡ÚTNFAIP3¡Û¡ÚOTU Domain-containing Protein 7C¡Û¡ÚPutative DNA-binding Protein A20¡Û¡ÚZinc Finger Protein A20¡Û(human),(re |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1035-0050 |
p62(human),(recombinant), with GST-tag |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1065-0050 |
Rpn10(S5a)¡ÚMCB1¡Û¡ÚPSMD4¡Û¡Ú 26S Proteasome Regulatory Subunit S5A¡Û(human),(recombinant), with His-tag |
50ug |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1145-0500 |
LC3A ¡ÚMicrotubule-Associated Proteins 1A/1B Light Chain 3A¡Û(human),(recombinant), with GST-tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1155-0500 |
LC3B ¡ÚMicrotubule-Associated Proteins 1A/1B Light Chain 3B¡Û(human),(recombinant), with GST-tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1175-0500 |
GABARAP ¡Úgamma-Aminobutyric Acid Receptor-Associated Protein¡Û(human),(recombinant), with GST-tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1185-0500 |
GABARAP-L1 ¡Úgamma-Aminobutyric Acid Receptor-Associated Protein-Like 1¡Û¡ÚGlandular Epithelial Cell Protein 1¡Û¡ÚEarly Estrogen-regulated Protein¡Û(human),(recombinant), with GST-tag |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1195-0500 |
GABARAP-L2 ¡Úgamma-Aminobutyric Acid Receptor-Associated Protein-like 2¡Û¡ÚGolgi-Associated ATPase Enhancer of 16 kDa¡Û¡ÚGeneral Protein Transport Factor p16¡Û¡ÚMAP1 Light Chain 3-related Protein¡Û¡ÚG |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW1240-0100 |
Ubiquitin(human),(fluorescein labeled) |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8450-0050 |
Ubiquitin Aldehyde ¡ÚUb-H¡Û(recombinant) |
50ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8465-0100 |
Proteasome 19S(Rpn10/S5a Subunit),(human)(recombinant)with GST-Tag |
100ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8470-0100 |
Ubiquitin(N¦Å-Biotinyl Lys6)¡Ú[(N¦Å-Biotinyl)Lys6]Ubiquitin¡Û¡ÚUbiquitin, [(N¦Å-biotinyl)Lys6]-¡Û |
100ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8475-0100 |
Ubiquitin(N¦Å-Biotinyl Lys6,(N¦Å-biotinyl)Lys48)¡Ú[(N¦Å-Biotinyl)Lys6,(N¦Å-biotinyl)Lys48]Ubiquitin¡Û¡ÚUbiquitin, [(N¦Å-Biotinyl)Lys6,(N¦Å-Biotinyl)Lys48]-¡Û |
100ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8480-0100 |
Ubiquitin(N¦Å-Biotinyl Lys6,(N¦Å-biotinyl)Lys63)¡Ú[(N¦Å-Biotinyl)Lys6,(N¦Å-Biotinyl)Lys63]Ubiquitin¡Û¡ÚUbiquitin, [(N¦Å-Biotinyl)Lys6,(N¦Å-Biotinyl)Lys63]-¡Û |
100ug |
¡ï27,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8555-0001 |
Ubiquitin, Methylated ¡ÚMethylated Ubiquitin¡Û |
1mg |
¡ï4,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8610-0001 |
Ubiquitin(human)(recombinant)with His-Tag |
1mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8615-0001 |
Ubiquitin(K48R)¡Ú[K48R]Ubiquitin¡Û¡ÚUbiquitin, [K48R]-¡Û(human)(recombinant)(untagged) |
1mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8620-0001 |
Ubiquitin(human)(recombinant)with GST-Tag |
1mg |
¡ï14,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8630-0500 |
Ubiquitin(Agarose Immobilized) |
0.5mL |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8635-0500 |
Proteasome 19S(Rpn10/S5a Subunit),(human)(recombinant)with GST-Tag(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8645-0025 |
Tetra-Ubiquitin(K48-linked)¡ÚUb4¡Û |
25ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8705-0100 |
Ubiquitin, Biotinylated ¡ÚBiotinylated Ubiquitin¡Û |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8710-0100 |
UbcH6(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8730-0100 |
UbcH3(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8740-0100 |
pro-NEDD8(human)(recombinant)with GST-Tag |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8790-0100 |
Ubiquitin+1 ¡ÚUb+1¡Û(recombinant)with His-Tag |
100ug |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8795-0005 |
Ubiquitin |
5mg |
¡ï8,000 |
|
79586-22-4 |
|
|
|
¡¡ |
BML |
BML-UW8855-0025 |
Ubiquitin5+1 ¡ÚUb5+1¡Û(recombinant)with His-Tag |
25ug |
¡ï35,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8860-0100 |
Poly-ubiquitin Chains(Ub2-7)(K48-linked) |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8955-0001 |
SUMOylation Kit(20 assays) |
Kit |
¡ï49,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8975-0001 |
Ubiquitin-Conjugating Enzyme Sampler Pack |
Pack |
¡ï42,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW8995-0001 |
UbiQapture-Q kit(20 x 20¦Ìl reactions) |
Kit |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9010-0500 |
p62-Derived UBA Domain ¡Úp62-Derived Ubiquitin-Associated¡Û(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9020-0100 |
UbcH1(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9025-0100 |
UbcH2(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9050-0100 |
UbcH5a(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9055-0100 |
UbcH5a(C85A)¡Ú[C85A]UbcH5a¡Û¡ÚUbcH5a, [C85A]-¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9060-0100 |
UbcH5b(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9060-1000 |
UbcH5b(human)(recombinant)with His-Tag |
1mg |
¡ï256,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9065-0100 |
UbcH5b(C85A)¡Ú[C85A]UbcH5b¡Û¡ÚUbcH5b, [C85A]-¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9070-0100 |
UbcH5c(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9075-0100 |
UbcH5c(C85A)¡Ú[C85A]UbcH5c¡Û¡ÚUbcH5c, [C85A]-¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï29,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9075-1000 |
UbcH5c(C85A)¡Ú[C85A]UbcH5c¡Û¡ÚUbcH5c, [C85A]-¡Û(human)(recombinant)with His-Tag |
1mg |
¡ï252,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9080-0100 |
UbcH7(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9135-0100 |
UbcH8(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9145-0100 |
UbcH12(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9190-0500 |
pro-SUMO-1 ¡Úpro-Small Ubiquitin-related Modifier-1¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9195-0500 |
SUMO-1 ¡ÚSmall Ubiquitin-related Modifier-1¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9200-0500 |
pro-SUMO-2 ¡Úpro-Small Ubiquitin-related Modifier-2¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9205-0500 |
SUMO-2 ¡ÚSmall Ubiquitin-related Modifier-2¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9210-0500 |
pro-SUMO-3 ¡Úpro-Small Ubiquitin-related Modifier-3¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9215-0500 |
SUMO-3 ¡ÚSmall Ubiquitin-related Modifier-3¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9220-0500 |
pro-NEDD8(human)(recombinant)with His-Tag |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9225-0500 |
NEDD8(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9230-0500 |
pro-ISG15 ¡Úpro-Interferon-Stimulated Gene 15¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9235-0500 |
ISG15 ¡ÚInterferon-Stimulated Gene 15¡Û(human)(recombinant)with His-Tag |
500ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9240-0250 |
FAT10 ¡ÚUbiquitin-like Protein FAT10¡Û(human)(recombinant)with His-Tag |
250ug |
¡ï22,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9320-0100 |
Ubc9 ¡ÚSUMO E2¡Û(human)(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9330-0025 |
SUMO Activating Enzyme E1(human)(recombinant) with His-Tag |
25ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9410-0050 |
Ubiquitin Activating Enzyme E1(human)(recombinant)with His-Tag |
50ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9440-0500 |
hHR23B-derived UBA2 domain ¡ÚHR23B-derived UBA2 domain¡Û(human)(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9445-0500 |
NBR1-derived UBA Domain(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9450-0500 |
VPS9-derived CUE Domain(Agarose Immobilized) |
0.5mL |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9455-0100 |
RanBP2 ¦Ä(FG Fragment) ¡ÚRanBP2¦¤FG¡Û¡ÚSUMO E3 Ligase¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9495-0100 |
pro-Ubl5 ¡Úpro-Ubiquitin-like Protein 5¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9525-0100 |
Ubl5 ¡ÚUbiquitin-like Protein 5¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9530-0100 |
Urm1(human)(recombinant)with His-Tag |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9535-0100 |
Fub1(human)(recombinant)with His-Tag |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9565-0100 |
UbcH13/Mms2 Complex ¡ÚMms2/UbcH13 Complex¡Û(human)(recombinant) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9570-0100 |
Poly-ubiquitin chains(Ub2-7)(K63-linked) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9635-0100 |
hHR6A ¡ÚHR6A¡Û¡ÚUbcH2A¡Û¡ÚUbiquitin Conjugating Enzyme UbcH2A¡Û¡ÚHomolog of RAD6A¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9640-0100 |
hHR6B ¡ÚHR6B¡Û¡ÚUbcH2B¡Û¡ÚUbiquitin Conjugating Enzyme UbcH2B¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9670-0025 |
Poly-SUMO-2 chains([SUMO-2]2-7) |
25ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9675-0025 |
Poly-SUMO-3 chains([SUMO-3]2-7)¡ÚSentrin-2¡Û |
25ug |
¡ï21,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9690-0025 |
USP5(long form)¡ÚIsopeptidase T¡Û¡ÚUBP5¡Û(human)(recombinant) |
25ug |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9695-0025 |
USP5(short form)¡ÚIsopeptidase T¡Û¡ÚUBP5¡Û¡ÚUbiquitin-specific protease 5¡Û(human)(recombinant) |
25ug |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9700-0500 |
NUB1/NUB1L UBA Domain ¡ÚNUB1/NUB1L UBA Domain¡Û¡ÚNEDD8 Ultimate Buster-1¡Û(Agarose Immobilized) |
0.5mL |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9730-0100 |
UbcH1 ¡ÚE2-25K¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9735-0100 |
UbcH1 ¡ÚE2-25K¡Û(human)(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9740-0050 |
UCH-L1 ¡ÚUbiquitin C-terminal Hydrolase-L1¡Û¡ÚPGP9.5¡Û(human)(recombinant)with His-Tag |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9745-0050 |
UCH-L3 ¡ÚUbiquitin C-terminal Hydrolase-L3¡Û(human)(recombinant)with His-Tag |
50ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9755-0100 |
RanGAP1 Fragment(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9760-0100 |
SENP1(Catalytic Domain)¡ÚSentrin-specific protease 1¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9765-0100 |
SENP2(Catalytic Domain)¡ÚSentrin-specific protease 2¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9770-0100 |
NEDP1 ¡ÚNEDD8-specific protease 1¡Û¡ÚSENP8¡Û¡ÚSentrin-specific protease 8¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9800-0100 |
Di-Ubiquitin(K48-linked)¡ÚUb2¡Û |
100ug |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9815-0100 |
Gankyrin(human)(recombinant), with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9820-0500 |
S5a UIM ¡ÚS5a Ubiquitin-Interacting Motif¡Û(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9825-0100 |
SP100 Fragment(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9830-0500 |
UQ1 UBA Domain(Agarose Immobilized) |
0.5mL |
¡ï38,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9835-0500 |
Dsk2 UBA Domain(Agarose Immobilized) |
0.5mL |
¡ï39,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9840-0100 |
USP14 ¡ÚUbiquitin-Specific Protease 14¡Û(human)(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9845-0100 |
USP15 ¡ÚUbiquitin-Specific Protease 15¡Û(human)(recombinant)with His-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9850-0100 |
USP2 ¡ÚUbiquitin-Specific Protease 2¡Û(Catalytic Domain)(rat)(recombinant)(untagged) |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9855-0050 |
BAP1 ¡ÚBRCA1 Associated Protein 1¡Û¡ÚUbiquitin C-terminal Hydrolase BAP1¡Û(human)(recombinant)with His-Tag |
50ug |
¡ï16,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9915-0001 |
Ubiquitin Conjugating Kit(HeLa Lysate-based)(20 x 50¦Ìl reactions) |
Kit |
¡ï67,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9920-0001 |
Ubiquitinylation Kit(50 x 50¦Ìl reactions) |
Kit |
¡ï59,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9950-0025 |
NEDD8 Activating Enzyme E1(human)(recombinant)(untagged) |
25ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9955-0025 |
ISG15 Activating Enzyme(E1)(human)(recombinant)with His-Tag |
25ug |
¡ï28,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9960-0025 |
PIAS1 ¡ÚProtein Inhibitor of Activated STAT Protein 1¡Û¡ÚSUMO E3 Ligase PIAS1¡Û(human)(recombinant)with GST-Tag |
25ug |
¡ï20,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9965-0100 |
PML SUMOylation site Peptide ¡ÚPromyelocytic Leukemia Protein¡Û(human)(recombinant)with GST-Tag |
100ug |
¡ï30,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9970-0050 |
I¦ÊBa(human)(recombinant)with GST-Tag |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9975-0050 |
I¦ÊBa(human)(recombinant)(untagged)
|
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9980-0050 |
NF-¦ÊBa p50 Subunit(human, aa 35-381)(recombinant)with GST-Tag |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9985-0050 |
NF-¦ÊBa p50 Subunit(human, aa 35-381)(recombinant)(untagged) |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9990-0050 |
NF-¦ÊB p65 Subunits(human)(12-317)(recombinant)with GST-Tag |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-UW9995-0050 |
NF-¦ÊB p65 Subunits(human)(12-317)(recombinant)(untagged) |
50ug |
¡ï23,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-VA1285-0025 |
Vasoactive Intestinal(Poly)peptide ¡ÚVIP¡Û(pig, natural ), rabbit pAb |
25ul |
¡ï13,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-VA1285-0100 |
Vasoactive Intestinal(Poly)peptide ¡ÚVIP¡Û(pig, natural ), rabbit pAb |
100ul |
¡ï42,000 |
|
none |
|
ÌȱÖưʪ |
·Á¾õ |
ÆðÛÀ |
ŬÍÑ |
rabbit | - | human¡¢ rat¡¢ pig | IHC |
|
|
¡¡ |
BML |
BML-VG6050-0100 |
Vitronectin(human plasma)[BE10], mouse mAb, purified |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | BE10 | human | ICC¡¢ WB |
|
|
¡¡ |
BML |
BML-VG6100-0100 |
Vimentin(human cultured fibroblasts)[65E], mouse mAb, purified |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | 65E | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-VG6110-0100 |
Vinculin(human smooth muscle cells)[FB11], mouse mAb, purified |
100ul |
¡ï23,000 |
|
none |
|
¥µ¥Ö¥¯¥é¥¹ |
¥¯¥í¡¼¥ó̾ |
ÆðÛÀ |
ŬÍÑ |
mouse IgG1 | FB11 | human | IHC¡¢ WB |
|
|
¡¡ |
BML |
BML-VR100-0005 |
Olvanil ¡ÚNE-19550¡Û¡ÚN-Vanillyloleamide¡Û |
5mg |
¡ï6,000 |
|
58493-49-5 |
|
|
|
¡¡ |
BML |
BML-VR100-0025 |
Olvanil ¡ÚNE-19550¡Û¡ÚN-Vanillyloleamide¡Û |
25mg |
¡ï26,000 |
|
58493-49-5 |
|
|
|
¡¡ |
BML |
BML-VR101-0005 |
Arvanil ¡ÚN-Vanillylarachidonamide¡Û¡ÚN-[(4-Hydroxy-3-methoxyphenyl)methyl]-5Z,8Z,11Z,14Z-eicosatetraenamide¡Û |
5mg |
¡ï8,000 |
|
128007-31-8 |
|
|
|
¡¡ |
BML |
BML-VR102-0005 |
N-Oleoyldopamine ¡ÚOLDA¡Û¡ÚN-[2-(3,4-Dihydroxyphenyl)ethyl]-9Z-octadecenamide¡Û |
5mg |
¡ï6,000 |
|
105955-11-1 |
|
|
|
¡¡ |
BML |
BML-VR102-0025 |
N-Oleoyldopamine ¡ÚOLDA¡Û¡ÚN-[2-(3,4-Dihydroxyphenyl)ethyl]-9Z-octadecenamide¡Û |
25mg |
¡ï26,000 |
|
105955-11-1 |
|
|
|
¡¡ |
BML |
BML-VR103-0005 |
N-Palmitoyldopamine ¡ÚPALDA¡Û |
5mg |
¡ï6,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-VR103-0025 |
N-Palmitoyldopamine ¡ÚPALDA¡Û |
25mg |
¡ï26,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-VR104-0005 |
N-Arachidonoyldopamine ¡ÚNADA¡Û¡ÚAA-DA¡Û¡ÚN-Arachidonoyl-3-hydroxytyramine¡Û |
5mg |
¡ï6,000 |
|
199875-69-9 |
|
|
|
¡¡ |
BML |
BML-VR104-0025 |
N-Arachidonoyldopamine ¡ÚNADA¡Û¡ÚAA-DA¡Û¡ÚN-Arachidonoyl-3-hydroxytyramine¡Û |
25mg |
¡ï27,000 |
|
199875-69-9 |
|
|
|
¡¡ |
BML |
BML-VR105-0005 |
SB-366791 ¡ÚN-(3-Methoxyphenyl)-4-chlorocinnamide¡Û |
5mg |
¡ï8,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-VR105-0025 |
SB-366791 ¡ÚN-(3-Methoxyphenyl)-4-chlorocinnamide¡Û |
25mg |
¡ï33,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-VR106-0010 |
N-Arachidonoyl-serotonin ¡ÚN-AA-5HT¡Û |
10mg |
¡ï10,000 |
|
187947-37-1 |
|
|
|
¡¡ |
BML |
BML-VR106-0050 |
N-Arachidonoyl-serotonin ¡ÚN-AA-5HT¡Û |
50mg |
¡ï34,000 |
|
187947-37-1 |
|
|
|
¡¡ |
BML |
BML-WN100-0005 |
XAV939 ¡Ú3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one¡Û |
5mg |
¡ï6,000 |
|
284028-89-3 |
|
|
|
¡¡ |
BML |
BML-WN100-0025 |
XAV939 ¡Ú3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one¡Û |
25mg |
¡ï26,000 |
|
284028-89-3 |
|
|
|
¡¡ |
BML |
BML-WN101-0005 |
PNU-74654 ¡Ú2-Phenoxybenzoic Acid [(5-methyl-2-furanyl)methylene]hydrazide¡Û |
5mg |
¡ï9,000 |
|
113906-27-7 |
|
|
|
¡¡ |
BML |
BML-WN101-0025 |
PNU-74654 ¡Ú2-Phenoxybenzoic Acid [(5-methyl-2-furanyl)methylene]hydrazide¡Û |
25mg |
¡ï41,000 |
|
113906-27-7 |
|
|
|
¡¡ |
BML |
BML-WN102-0005 |
IM-12 ¡Ú3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)¡Û |
5mg |
¡ï10,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN102-0025 |
IM-12 ¡Ú3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)¡Û |
25mg |
¡ï41,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN103-0005 |
IWR-1 ¡Ú4-(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)-N-8-quinolinylbenzamide¡Û |
5mg |
¡ï8,000 |
|
1127442-82-3 |
|
|
|
¡¡ |
BML |
BML-WN103-0025 |
IWR-1 ¡Ú4-(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)-N-8-quinolinylbenzamide¡Û |
25mg |
¡ï34,000 |
|
1127442-82-3 |
|
|
|
¡¡ |
BML |
BML-WN104-0005 |
IWP-2 ¡ÚN-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide¡Û |
5mg |
¡ï12,000 |
|
686770-61-6 |
|
|
|
¡¡ |
BML |
BML-WN104-0025 |
IWP-2 ¡ÚN-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide¡Û |
25mg |
¡ï48,000 |
|
686770-61-6 |
|
|
|
¡¡ |
BML |
BML-WN105-0005 |
BML-284 ¡Ú2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN105-0025 |
BML-284 ¡Ú2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine¡Û |
25mg |
¡ï54,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN108-0005 |
BML-287 ¡ÚN-[2,(3,4-dimethoxyphenyl)ethyl]-2-ethyl-5-(phenylsulfonul)benzenesulfonamide¡Û |
5mg |
¡ï17,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN110-0005 |
WAY-262611 ¡Ú(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine¡Û |
5mg |
¡ï13,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN110-0025 |
WAY-262611 ¡Ú(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine¡Û |
25mg |
¡ï57,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-WN112-0005 |
FH535 ¡ÚN-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide¡Û |
5mg |
¡ï6,000 |
|
108409-83-2 |
|
|
|
¡¡ |
BML |
BML-WN112-0025 |
FH535 ¡ÚN-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide¡Û |
25mg |
¡ï29,000 |
|
108409-83-2 |
|
|
|
¡¡ |
BML |
BML-WN113-0010 |
BML-286 ¡Ú3289-8625¡Û¡Ú2-[[3-[(Phenylacetyl)aMino]benzoyl]amino]benzoic Acid¡Û |
10mg |
¡ï10,000 |
|
294891-81-9 |
|
|
|
¡¡ |
BML |
BML-WN114-0005 |
CCT036477 ¡ÚN-((4-Chlorophenyl)(2-methyl-1H-indol-3-yl)methyl)pyridin-2-amine¡Û |
5mg |
¡ï10,000 |
|
305372-78-5 |
|
|
|
¡¡ |
BML |
BML-WN114-0025 |
CCT036477 ¡ÚN-((4-Chlorophenyl)(2-methyl-1H-indol-3-yl)methyl)pyridin-2-amine¡Û |
25mg |
¡ï44,000 |
|
305372-78-5 |
|
|
|
¡¡ |
BML |
BML-WN115-0005 |
IQ-1 ¡Ú2-(4-Acetylphenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)acetamide¡Û |
5mg |
¡ï12,000 |
|
331001-62-8 |
|
|
|
¡¡ |
BML |
BML-WN115-0025 |
IQ-1 ¡Ú2-(4-Acetylphenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)acetamide¡Û |
25mg |
¡ï51,000 |
|
331001-62-8 |
|
|
|
¡¡ |
BML |
BML-WN117-0005 |
QS11 ¡Ú(2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-ylmethyl)-9H-purin-6-ylamino]-3-phenylpropan-1-ol¡Û |
5mg |
¡ï15,000 |
|
944328-88-5 |
|
|
|
¡¡ |
BML |
BML-WN117-0025 |
QS11 ¡Ú(2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-ylmethyl)-9H-purin-6-ylamino]-3-phenylpropan-1-ol¡Û |
25mg |
¡ï65,000 |
|
944328-88-5 |
|
|
|
¡¡ |
BML |
BML-ZW8505-0005 |
Z-Gly-Gly-Leu-AMC ¡ÚZ-GGL-AMC¡Û(Fluorogenic) |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW8510-0005 |
Z-Gly-Gly-Leu-BNA(Chromogenic) |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW8520-0005 |
Z-Leu-Leu-Glu-BNA(Chromogenic) |
5mg |
¡ï7,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW8585-0005 |
Z-Arg-Leu-Arg-Gly-Gly-AMC(Fluorogenic) |
5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW8655-0005 |
Z-Leu-Leu-Tyr-ketoaldehyde |
5mg |
¡ï97,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW9170-0500 |
Z-Leu-Leu-Leu-vinyl Sulfone |
500ug |
¡ï34,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW9345-0005 |
Z-Leu-Leu-Glu-AMC ¡ÚZ-LLE-AMC¡Û¡ÚProteasome Substrate II¡Û(Fluorogenic) |
5mg |
¡ï19,000 |
|
none |
|
|
|
¡¡ |
BML |
BML-ZW9490-0100 |
Z-Pro-Nle-Asp-al ¡ÚZ-Pro-Nle-Asp-CHO¡Û |
100ug |
¡ï16,000 |
|
none |
|
|
|
|